
<html lang="en"     class="pb-page"  data-request-id="c9517c01-efb9-4f00-a0ed-cd8cf04df018"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-11;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.7b01826;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3-a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNaV1.7 Inhibitors for the Treatment of Pain" /></meta><meta name="dc.Creator" content="Thilo  Focken" /></meta><meta name="dc.Creator" content="Sultan  Chowdhury" /></meta><meta name="dc.Creator" content="Alla  Zenova" /></meta><meta name="dc.Creator" content="Michael E.  Grimwood" /></meta><meta name="dc.Creator" content="Christine  Chabot" /></meta><meta name="dc.Creator" content="Tao  Sheng" /></meta><meta name="dc.Creator" content="Ivan  Hemeon" /></meta><meta name="dc.Creator" content="Shannon M.  Decker" /></meta><meta name="dc.Creator" content="Michael  Wilson" /></meta><meta name="dc.Creator" content="Paul  Bichler" /></meta><meta name="dc.Creator" content="Qi  Jia" /></meta><meta name="dc.Creator" content="Shaoyi  Sun" /></meta><meta name="dc.Creator" content="Clint  Young" /></meta><meta name="dc.Creator" content="Sophia  Lin" /></meta><meta name="dc.Creator" content="Samuel J.  Goodchild" /></meta><meta name="dc.Creator" content="Noah G.  Shuart" /></meta><meta name="dc.Creator" content="Elaine  Chang" /></meta><meta name="dc.Creator" content="Zhiwei  Xie" /></meta><meta name="dc.Creator" content="Bowen  Li" /></meta><meta name="dc.Creator" content="Kuldip  Khakh" /></meta><meta name="dc.Creator" content="Girish  Bankar" /></meta><meta name="dc.Creator" content="Matthew  Waldbrook" /></meta><meta name="dc.Creator" content="Rainbow  Kwan" /></meta><meta name="dc.Creator" content="Karen  Nelkenbrecher" /></meta><meta name="dc.Creator" content="Parisa  Karimi Tari" /></meta><meta name="dc.Creator" content="Navjot  Chahal" /></meta><meta name="dc.Creator" content="Luis  Sojo" /></meta><meta name="dc.Creator" content="C. Lee  Robinette" /></meta><meta name="dc.Creator" content="Andrew D.  White" /></meta><meta name="dc.Creator" content="Chien-An  Chen" /></meta><meta name="dc.Creator" content="Yi  Zhang" /></meta><meta name="dc.Creator" content="Jodie  Pang" /></meta><meta name="dc.Creator" content="Jae H.  Chang" /></meta><meta name="dc.Creator" content="David H.  Hackos" /></meta><meta name="dc.Creator" content="J. P.  Johnson, Jr." /></meta><meta name="dc.Creator" content="Charles J.  Cohen" /></meta><meta name="dc.Creator" content="Daniel F.  Ortwine" /></meta><meta name="dc.Creator" content="Daniel P.  Sutherlin" /></meta><meta name="dc.Creator" content="Christoph M.  Dehnhardt" /></meta><meta name="dc.Creator" content="Brian S.  Safina" /></meta><meta name="dc.Description" content="The sodium channel NaV1.7 has emerged as a promising target for the treatment of pain based on strong genetic validation of its role in nociception. In recent years, a number of aryl and acyl sulfo..." /></meta><meta name="Description" content="The sodium channel NaV1.7 has emerged as a promising target for the treatment of pain based on strong genetic validation of its role in nociception. In recent years, a number of aryl and acyl sulfo..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 8, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01826" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01826" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01826" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01826" /></link>
        
    
    

<title>Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3-a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNaV1.7 Inhibitors for the Treatment of Pain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01826" /></meta><meta property="og:title" content="Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3-a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNaV1.7 Inhibitors for the Treatment of Pain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0018.jpeg" /></meta><meta property="og:description" content="The sodium channel NaV1.7 has emerged as a promising target for the treatment of pain based on strong genetic validation of its role in nociception. In recent years, a number of aryl and acyl sulfonamides have been reported as potent inhibitors of NaV1.7, with high selectivity over the cardiac isoform NaV1.5. Herein, we report on the discovery of a novel series of N-([1,2,4]triazolo[4,3-a]pyridin-3-yl)methanesulfonamides as selective NaV1.7 inhibitors. Starting with the crystal structure of an acyl sulfonamide, we rationalized that cyclization to form a fused heterocycle would improve physicochemical properties, in particular lipophilicity. Our design strategy focused on optimization of potency for block of NaV1.7 and human metabolic stability. Lead compounds 10, 13 (GNE-131), and 25 showed excellent potency, good in vitro metabolic stability, and low in vivo clearance in mouse, rat, and dog. Compound 13 also displayed excellent efficacy in a transgenic mouse model of induced pain." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01826"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01826">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01826&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01826&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01826&amp;href=/doi/10.1021/acs.jmedchem.7b01826" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4810-4831</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00004" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00071" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of <i>N</i>-([1,2,4]Triazolo[4,3-<i>a</i>]pyridin-3-yl)methane-sulfonamides as Potent and Selective <i>h</i>Na<sub>V</sub>1.7 Inhibitors for the Treatment of Pain</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Thilo Focken</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thilo Focken</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#99edfff6faf2fcf7d9e1fcf7f6f7b4e9f1f8ebf4f8b7faf6f4"><span class="__cf_email__" data-cfemail="f7839198949c9299b78f92999899da879f96859a96d994989a">[email protected]</span></a>. Phone: 604-484-3300.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thilo++Focken">Thilo Focken</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1993-2476" title="Orcid link">http://orcid.org/0000-0003-1993-2476</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sultan Chowdhury</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sultan Chowdhury</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sultan++Chowdhury">Sultan Chowdhury</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alla Zenova</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alla Zenova</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alla++Zenova">Alla Zenova</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael E. Grimwood</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael E. Grimwood</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+E.++Grimwood">Michael E. Grimwood</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christine Chabot</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christine Chabot</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Chabot">Christine Chabot</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tao Sheng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tao Sheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Sheng">Tao Sheng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ivan Hemeon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ivan Hemeon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ivan++Hemeon">Ivan Hemeon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shannon M. Decker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shannon M. Decker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shannon+M.++Decker">Shannon M. Decker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Wilson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Wilson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Wilson">Michael Wilson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul Bichler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul Bichler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Bichler">Paul Bichler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qi Jia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qi Jia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Jia">Qi Jia</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shaoyi Sun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shaoyi Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shaoyi++Sun">Shaoyi Sun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Clint Young</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Clint Young</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Clint++Young">Clint Young</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sophia Lin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sophia Lin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sophia++Lin">Sophia Lin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Samuel J. Goodchild</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Samuel J. Goodchild</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Samuel+J.++Goodchild">Samuel J. Goodchild</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Noah G. Shuart</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Noah G. Shuart</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Noah+G.++Shuart">Noah G. Shuart</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elaine Chang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elaine Chang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elaine++Chang">Elaine Chang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhiwei Xie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhiwei Xie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhiwei++Xie">Zhiwei Xie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bowen Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bowen Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bowen++Li">Bowen Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kuldip Khakh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kuldip Khakh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kuldip++Khakh">Kuldip Khakh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Girish Bankar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Girish Bankar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Girish++Bankar">Girish Bankar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthew Waldbrook</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew Waldbrook</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Waldbrook">Matthew Waldbrook</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rainbow Kwan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rainbow Kwan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rainbow++Kwan">Rainbow Kwan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karen Nelkenbrecher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karen Nelkenbrecher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Nelkenbrecher">Karen Nelkenbrecher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Parisa Karimi Tari</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Parisa Karimi Tari</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Parisa++Karimi+Tari">Parisa Karimi Tari</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Navjot Chahal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Navjot Chahal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Navjot++Chahal">Navjot Chahal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Luis Sojo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Luis Sojo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luis++Sojo">Luis Sojo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">C. Lee Robinette</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">C. Lee Robinette</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=C.+Lee++Robinette">C. Lee Robinette</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrew D. White</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew D. White</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chempartner, Building No. 5, 998 Halei Rd., Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+D.++White">Andrew D. White</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chien-An Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chien-An Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chempartner, Building No. 5, 998 Halei Rd., Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chien-An++Chen">Chien-An Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yi Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yi Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chempartner, Building No. 5, 998 Halei Rd., Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yi++Zhang">Yi Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jodie Pang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jodie Pang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jodie++Pang">Jodie Pang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jae H. Chang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jae H. Chang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jae+H.++Chang">Jae H. Chang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David H. Hackos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David H. Hackos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+H.++Hackos">David H. Hackos</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">J. P. Johnson Jr.</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">J. P. Johnson, Jr.</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J.+P.++Johnson%2C++Jr.">J. P. Johnson, Jr.</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Charles J. Cohen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Charles J. Cohen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Charles+J.++Cohen">Charles J. Cohen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel F. Ortwine</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel F. Ortwine</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+F.++Ortwine">Daniel F. Ortwine</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel P. Sutherlin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel P. Sutherlin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+P.++Sutherlin">Daniel P. Sutherlin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christoph M. Dehnhardt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christoph M. Dehnhardt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christoph+M.++Dehnhardt">Christoph M. Dehnhardt</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Brian S. Safina</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian S. Safina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#c7a5b4a6a1aea9a687a5a8abb3a5aea8e9a4a8aa"><span class="__cf_email__" data-cfemail="ec8e9f8d8a85828dac8e8380988e8583c28f8381">[email protected]</span></a>. Phone: 650-339-4618.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian+S.++Safina">Brian S. Safina</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8134-9949" title="Orcid link">http://orcid.org/0000-0001-8134-9949</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01826&amp;href=/doi/10.1021%2Facs.jmedchem.7b01826" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4810–4831</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 8, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 January 2018</li><li><span class="item_label"><b>Published</b> online</span>8 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 June 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01826" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01826</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4810%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DThilo%2BFocken%252C%2BSultan%2BChowdhury%252C%2BAlla%2BZenova%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D11%26contentID%3Dacs.jmedchem.7b01826%26title%3DDesign%2Bof%2BConformationally%2BConstrained%2BAcyl%2BSulfonamide%2BIsosteres%253A%2BIdentification%2Bof%2BN-%2528%255B1%252C2%252C4%255DTriazolo%255B4%252C3-a%255Dpyridin-3-yl%2529methane-sulfonamides%2Bas%2BPotent%2Band%2BSelective%2BhNaV1.7%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BPain%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4831%26publicationDate%3DJune%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01826"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3089</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01826" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3-a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNaV1.7 Inhibitors for the Treatment of Pain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Thilo&quot;,&quot;last_name&quot;:&quot;Focken&quot;},{&quot;first_name&quot;:&quot;Sultan&quot;,&quot;last_name&quot;:&quot;Chowdhury&quot;},{&quot;first_name&quot;:&quot;Alla&quot;,&quot;last_name&quot;:&quot;Zenova&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;E. Grimwood&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Chabot&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Sheng&quot;},{&quot;first_name&quot;:&quot;Ivan&quot;,&quot;last_name&quot;:&quot;Hemeon&quot;},{&quot;first_name&quot;:&quot;Shannon&quot;,&quot;last_name&quot;:&quot;M. Decker&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Wilson&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Bichler&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Jia&quot;},{&quot;first_name&quot;:&quot;Shaoyi&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Clint&quot;,&quot;last_name&quot;:&quot;Young&quot;},{&quot;first_name&quot;:&quot;Sophia&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Samuel&quot;,&quot;last_name&quot;:&quot;J. Goodchild&quot;},{&quot;first_name&quot;:&quot;Noah&quot;,&quot;last_name&quot;:&quot;G. Shuart&quot;},{&quot;first_name&quot;:&quot;Elaine&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Zhiwei&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Bowen&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Kuldip&quot;,&quot;last_name&quot;:&quot;Khakh&quot;},{&quot;first_name&quot;:&quot;Girish&quot;,&quot;last_name&quot;:&quot;Bankar&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Waldbrook&quot;},{&quot;first_name&quot;:&quot;Rainbow&quot;,&quot;last_name&quot;:&quot;Kwan&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Nelkenbrecher&quot;},{&quot;first_name&quot;:&quot;Parisa&quot;,&quot;last_name&quot;:&quot;Karimi Tari&quot;},{&quot;first_name&quot;:&quot;Navjot&quot;,&quot;last_name&quot;:&quot;Chahal&quot;},{&quot;first_name&quot;:&quot;Luis&quot;,&quot;last_name&quot;:&quot;Sojo&quot;},{&quot;first_name&quot;:&quot;C.&quot;,&quot;last_name&quot;:&quot;Lee Robinette&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;D. White&quot;},{&quot;first_name&quot;:&quot;Chien-An&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Yi&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Jodie&quot;,&quot;last_name&quot;:&quot;Pang&quot;},{&quot;first_name&quot;:&quot;Jae&quot;,&quot;last_name&quot;:&quot;H. Chang&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;H. Hackos&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;P. Johnson&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;J. Cohen&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;F. Ortwine&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;P. Sutherlin&quot;},{&quot;first_name&quot;:&quot;Christoph&quot;,&quot;last_name&quot;:&quot;M. Dehnhardt&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;S. Safina&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;4810-4831&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01826&quot;},&quot;abstract&quot;:&quot;The sodium channel NaV1.7 has emerged as a promising target for the treatment of pain based on strong genetic validation of its role in nociception. In recent years, a number of aryl and acyl sulfonamides have been reported as potent inhibitors of NaV1.7, with high selectivity over the cardiac isoform NaV1.5. Herein, we report on the discovery of a novel series of N-([1,2,4]triazolo[4,3-a]pyridin-3-yl)methanesulfonamides as selective NaV1.7 inhibitors. Starting with the crystal structure of an acyl sulfonamide, we rationalized that cyclization to form a fused heterocycle would improve physicochemical properties, in particular lipophilicity. Our design strategy focused on optimization of potency for block of NaV1.7 and human metabolic stability. Lead compounds 10, 13 (GNE-131), and 25 showed excellent potency, good in vitro metabolic stability, and low in vivo clearance in mouse, rat, and dog. Compound 13 also displayed excellent efficacy in a transgenic mouse model of induced pain.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01826&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01826" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01826&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01826" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01826&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01826" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01826&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01826&amp;href=/doi/10.1021/acs.jmedchem.7b01826" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01826" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01826" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01826%26sid%3Dliteratum%253Aachs%26pmid%3D29737846%26genre%3Darticle%26aulast%3DFocken%26date%3D2018%26atitle%3DDesign%2Bof%2BConformationally%2BConstrained%2BAcyl%2BSulfonamide%2BIsosteres%253A%2BIdentification%2Bof%2BN-%2528%255B1%252C2%252C4%255DTriazolo%255B4%252C3-a%255Dpyridin-3-yl%2529methane-sulfonamides%2Bas%2BPotent%2Band%2BSelective%2BhNaV1.7%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BPain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D11%26spage%3D4810%26epage%3D4831%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291783" title="Triazole">Triazole</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a>,</li><li><a href="/action/doSearch?ConceptID=291645" title="Acyls">Acyls</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/jmcmar.2018.61.issue-11/20180614/jmcmar.2018.61.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The sodium channel Na<sub>V</sub>1.7 has emerged as a promising target for the treatment of pain based on strong genetic validation of its role in nociception. In recent years, a number of aryl and acyl sulfonamides have been reported as potent inhibitors of Na<sub>V</sub>1.7, with high selectivity over the cardiac isoform Na<sub>V</sub>1.5. Herein, we report on the discovery of a novel series of <i>N</i>-([1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamides as selective Na<sub>V</sub>1.7 inhibitors. Starting with the crystal structure of an acyl sulfonamide, we rationalized that cyclization to form a fused heterocycle would improve physicochemical properties, in particular lipophilicity. Our design strategy focused on optimization of potency for block of Na<sub>V</sub>1.7 and human metabolic stability. Lead compounds <b>10</b>, <b>13</b> (GNE-131), and <b>25</b> showed excellent potency, good <i>in vitro</i> metabolic stability, and low <i>in vivo</i> clearance in mouse, rat, and dog. Compound <b>13</b> also displayed excellent efficacy in a transgenic mouse model of induced pain.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Voltage-gated sodium channels are transmembrane ion channels involved in many important physiological processes. Nine isoforms are known in mammals (Na<sub>V</sub>1.1 to Na<sub>V</sub>1.9), with different expression patterns in muscle, the central (CNS) and peripheral nervous systems (PNS), and neuroendocrine cells.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Three isoforms are expressed primarily in nociceptors and mediate pain signaling and amplification in humans (Na<sub>V</sub>1.7, 1.8, and 1.9). In particular, there is strong genetic evidence supporting the crucial role of Na<sub>V</sub>1.7 and its encoding <i>SCN9A</i> gene in pain sensation. Gain-of-function mutations in the <i>SCN9A</i> gene lead to painful human disorders, including inherited erythromelalgia (IEM), paroxysmal extreme pain disorder (PEPD), and idiopathic small fiber neuropathies.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In contrast, congenital insensitivity to pain (CIP), a rare disorder characterized by a complete loss of the ability to sense painful stimuli, was found to be caused by loss-of-function mutations in the <i>SCN9A</i> gene.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Notably, <i>SCN9A</i> loss-of-function mutations have little or no effect on motor, cognitive, or non-nociceptive sensory function. These findings suggest that selective Na<sub>V</sub>1.7 antagonism may be a highly effective strategy to develop novel analgesics with minimal side effects and have made Na<sub>V</sub>1.7 a promising target for the treatment of pain. Indeed, there is considerable interest in developing small molecule Na<sub>V</sub>1.7 inhibitors as analgesics, and progress has been covered in several excellent reviews.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> However, non-isoform-selective sodium channel block may lead to undesirable side effects. In particular, inhibition of the cardiac sodium channel, Na<sub>V</sub>1.5, is of concern due to the potential for arrhythmia, which would limit the therapeutic potential. Loss of function mutations in the <i>SCN5A</i> gene encoding Na<sub>V</sub>1.5 lead to Brugada Syndrome or Lenègre’s disease, a slowly developing myocardial conduction defect.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Isoform-selective Na<sub>V</sub>1.7 inhibitors have attracted considerable interest in recent years due to their potential to avoid nonselective block of sodium channels and thus to provide an improved therapeutic index. Two distinct series of isoform-selective Na<sub>V</sub>1.7 inhibitors have been reported. Initial reports described heteroaryl sulfonamides containing an acidic sulfonamide that showed high selectivity for Na<sub>V</sub>1.7 over Na<sub>V</sub>1.5.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This series was shown to bind to a unique site in the voltage sensor domain 4 (VSD4) of Na<sub>V</sub>1.7 by elegant mutagenesis studies.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> We were able to confirm the binding mode of aryl sulfonamides and recently disclosed the cocrystal structure of an analog in complex with a chimeric construct consisting of human Na<sub>V</sub>1.7 VSD4 and a bacterial sodium channel pore domain.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Subsequently, a second series of highly isoform-selective Na<sub>V</sub>1.7 inhibitors was disclosed, characterized by an acidic acyl sulfonamide headgroup (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> The latter series was shown to also occupy the VSD4 binding site based on Na<sub>V</sub>1.7 radioligand binding data using a tritiated aryl sulfonamide.<a onclick="showRef(event, 'cit9b'); return false;" href="javascript:void(0);" class="ref cit9b">(9b)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Acyl sulfonamide Na<sub>V</sub>1.7 inhibitors.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a><sup><i>a</i></sup>IC<sub>50</sub> values ± SD were generated on a PatchXpress automated voltage-clamp platform. <sup><i>b</i></sup>Published voltage-clamp data, which were derived on various voltage-clamp platforms. <sup><i>c</i></sup>cLogP was calculated using MoKa, version 2.6.5.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We have had a long-standing interest in developing small molecule inhibitors of Na<sub>V</sub>1.7 for the treatment of pain<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and initially explored the aryl sulfonamide scaffold in search of a lead series for further development. Although we identified potent and highly selective Na<sub>V</sub>1.7 blockers and discovered a tool compound that demonstrated significant <i>in vivo</i> efficacy in preclinical proof-of-concept studies, this series of compounds lacked adequate oral bioavailability.<a onclick="showRef(event, 'cit6a cit6b'); return false;" href="javascript:void(0);" class="ref cit6a cit6b">(6a,b)</a> We next pursued acyl sulfonamides, since this class of Na<sub>V</sub>1.7 inhibitors occupies a different physicochemical property space compared to aryl sulfonamides, in particular with respect to molecular weight and lipophilicity. We identified compound <b>1</b> as a lead, a highly potent and novel acyl sulfonamide with good selectivity over Na<sub>V</sub>1.5, albeit only poor stability in human liver microsomes (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Furthermore, acyl sulfonamide <b>1</b> required high plasma exposure (>30 μM) to show efficacy in an induced-pain model using transgenic FVB mice. Compound <b>1</b> displays a high fraction of sp<sup>3</sup> hybridized carbons (<i>F</i><sub>sp<sup>3</sup></sub>), a rather unique feature among other acyl sulfonamide scaffolds (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which is considered beneficial for successful clinical development.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">In parallel to the optimization of acyl sulfonamides exemplified by <b>1</b>, we were looking for alternative acidic head groups to mitigate any potential issues arising from the acyl sulfonamide moiety. In addition, we sought to improve potency and metabolic stability and optimize the physicochemical properties of the molecules. In particular, we were interested in compounds with a lower lipophilicity (cLogP < 3) and improved lipophilic efficiency (LipE), as they are generally thought to improve drug-like properties and safety.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">An opportunity to achieve these goals became apparent from a small molecule crystal structure of compound <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Analysis of the crystal structure revealed that the carbonyl oxygen and the aryl fluoride adopt a <i>syn</i>-orientation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). The carbonyl oxygen is rotated out of plane with a measured 38° dihedral angle relative to the C15–C16 bond. Energy calculations revealed that the molecule possessed a low energy barrier to rotation with respect to the C15–C16 bond (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S1). We reasoned that the small molecule crystal structure conformation might resemble the bioactive conformation of the molecule. It was hypothesized that reinforcing this conformation with an appropriate cyclic constraint would be tolerated and thus provide conformationally rigidified isosteres of acyl sulfonamides.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> We envisioned that replacing the aryl fluoride and carbonyl group of acyl sulfonamide <b>1</b> by a fused five membered heterocycle would be suitable to test our hypothesis. It was anticipated that this approach would allow retaining the acidic nature of the headgroup and maintaining key pharmacophore features, such as hydrogen bond acceptors (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S2), while also potentially reducing lipophilicity. To this end, we calculated p<i>K</i><sub>a</sub> and LogP of a range of fused, bicyclic aromatic systems that we considered as acyl sulfonamide replacements (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compared with the acyl sulfonamide group (core A), a benzo[<i>d</i>]isoxazole (core B) and [1,2,4]triazolo[4,3-<i>a</i>]pyridine (core F) appeared most attractive in terms of cp<i>K</i><sub>a</sub> or cLogP, and were therefore selected for synthesis. Despite acceptable calculated properties, indazole core D was initially not considered for synthesis as the additional hydrogen bond donor was thought to not match the pharmacophore requirements (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S2).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of triazole sulfonamides. (A) ORTEP plot of a small molecule crystal structure of <b>1</b> (CCDC 1590582) and restriction of conformational flexibility of acyl sulfonamides by cyclization. (B) Overlay of minimized version of the acyl sulfonamide and triazole cores (gray and orange, respectively). The conformations were minimized in the gas phase using the MMFF94x force field in MOE<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and manually superimposed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Calculated Parameters of Acyl Sulfonamide and Selected Heterocyclic Cores</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0012.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">cpKa and cLogP were calculated using MoKa, version 2.6.5.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div></div><div></div></div><div class="NLM_p last">As a consequence of rigidifying <b>1</b>, the heteroatoms of the five membered heterocycles are now coplanar with the central phenyl ring, whereas the carbonyl oxygen of <b>1</b> that they are replacing is rotated out of plane by 38° (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). We expected that despite this difference in the placement of a potential hydrogen bond acceptor, the cyclic constraint might be able to maintain key interactions with the protein.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Benzisoxazole <b>4</b>, triazole <b>5</b>, and acyl sulfonamide <b>1</b> were tested for activity in a human Na<sub>V</sub>1.7 radioligand-binding assay (LBA) measuring the displacement of tritiated aryl sulfonamide [<sup>3</sup>H]GX-545.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> A strong correlation was previously observed for functional channel inhibition and [<sup>3</sup>H]GX-545 radioligand binding,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> so we used the LBA as our primary screening assay. Functional activity of selected analogs was evaluated by automated voltage-clamp on a PatchXpress (PX) platform, measuring the inhibition of sodium currents mediated by human Na<sub>V</sub>1.7 channels expressed in HEK293 cells.</div><div class="NLM_p">Benzisoxazole <b>4</b> showed a 14-fold drop in potency compared to its acyl sulfonamide counterpart <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Gratifyingly, triazole <b>5</b> was only 3-fold less potent than <b>1</b>, supporting our initial hypothesis. Furthermore, while <b>5</b> displayed comparable lipophilicity to <b>1</b>, improved metabolic stability was seen. Measured p<i>K</i><sub>a</sub> values showed that, while <b>5</b> displayed an increased acidic p<i>K</i><sub>a</sub> relative to <b>1</b> (p<i>K</i><sub>a</sub> 5.6 vs 3.8), it would remain fully ionized at physiological pH 7.4. Based on these promising results, we decided to further explore the triazole sulfonamide scaffold represented by compound <b>5</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Potencies of Constrained Heterocyclic Acyl Sulfonamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0013.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Human Na<sub>V</sub>1.7 radioligand binding assay (LBA); IC<sub>50</sub> for displacement of [<sup>3</sup>H]GX-545, reported as mean value ± SD from at least two independent determinations.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">LogD measured at pH 7.4 (<i>n</i> = 1).</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">cLogP and cpKa were calculated using MoKa, version 2.6.5.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Measured using an UV-metric method.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Calculated from Na<sub>V</sub>1.7 LBA IC<sub>50</sub> and measured LogD.</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">Predicted hepatic clearance extrapolated from <i>in vitro</i> human liver microsome (HLM) experiments; SD not applicable.</p></div></div><div></div></div><div class="NLM_p">Optimization of the triazole series focused on improving LipE and probing SAR relative to the corresponding acyl sulfonamides. In particular, we were interested in further validating our hypothesis that triazoles, as constrained acyl sulfonamides, would present a similar binding mode and as a result display similar SAR. We therefore applied SAR knowledge from the optimization of the acyl sulfonamide series to generate matched molecular pairs. We included compounds that would not necessarily be considered beneficial in terms of lead optimization but were useful to compare SAR between the two series. Selected examples of triazole SAR are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Adamantyl Triazole SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0014.gif" alt="" id="GRAPHIC-d126e1050-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char=".">Na<sub>V</sub>1.7 LBA IC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">LogD<sub>7.4</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">LipE<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">HLM Cl<sub>hep</sub><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a> (mL/min/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.20 ± 0.05</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">3.88 ± 0.51</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.16 ± 0.06</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.17 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.14 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">cBu</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.02 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.12 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="char" char=".">0.01 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">cBu</td><td class="colsep0 rowsep0" align="char" char=".">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">NHMe</td><td class="colsep0 rowsep0" align="char" char=".">0.05 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Human Na<sub>V</sub>1.7 radioligand binding assay (LBA); IC<sub>50</sub> for displacement of [<sup>3</sup>H]GX-545, reported as mean value ± SD from at least two independent determinations.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">LogD measured at pH 7.4 (<i>n</i> = 1).</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Calculated from Na<sub>V</sub>1.7 LBA IC<sub>50</sub> and measured LogD.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Predicted hepatic clearance extrapolated from <i>in vitro</i> human liver microsome (HLM) experiments; SD not applicable.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of Cycloalkyl Ether Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0015.gif" alt="" id="GRAPHIC-d126e1421-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0016.gif" alt="" id="gr15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Human Na<sub>V</sub>1.7 radioligand binding assay (LBA); IC<sub>50</sub> for displacement of [<sup>3</sup>H]GX-545, reported as mean value ± SD from at least two independent determinations.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">LogD measured at pH 7.4 (<i>n</i> = 1).</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Calculated from Na<sub>V</sub>1.7 LBA IC<sub>50</sub> and measured LogD.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Predicted hepatic clearance extrapolated from <i>in vitro</i> human liver microsome (HLM) experiments; SD not applicable.</p></div></div><div></div></div><div class="NLM_p">Based on prior experience, we began by exploring modifications of the R<sup>1</sup> substituent on the triazole core (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The size and nature of this substituent proved to be crucial for improving potency.</div><div class="NLM_p">The replacement of chlorine at R<sup>1</sup> (<b>5</b>) with bromine (<b>7</b>) or aliphatic groups such as ethyl (<b>8</b>) and isopropyl (<b>9</b>) was tolerated, without affecting potency against Na<sub>V</sub>1.7. In contrast, removal of the R<sup>1</sup> substituent altogether (compound <b>6</b>) led to a 19-fold drop in potency, highlighting the importance of this substituent. Notably, the R<sup>1</sup> substituent also affected the metabolic stability. In particular, introduction of aliphatic substituents led to a decrease in HLM (human liver microsome) stability (compound <b>8</b> vs <b>5</b>).</div><div class="NLM_p">Consistent with data from our acyl sulfonamide series,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> employing a cyclopropyl group at R<sup>1</sup> provided a marked improvement in potency. In this case, changing an isopropyl (compound <b>9</b>) to a cyclopropyl group (compound <b>10</b>) led to a 14-fold boost in potency and slightly better HLM stability. Functional activity of <b>10</b> against human Na<sub>V</sub>1.7 was assessed by voltage-clamp to give an IC<sub>50</sub> of 0.003 ± 0.002 μM (mean ± SD).</div><div class="NLM_p">Increasing the ring size was tolerated, with cyclobutyl analog <b>11</b> maintaining potency relative to cyclopropyl triazole <b>10</b>, although LipE was decreased. The excellent potency of <b>10</b> and its superior LipE compared to cyclobutyl <b>11</b> prompted us to use the cyclopropyl group at R<sup>1</sup> for further SAR studies. Next, we probed analogs of methyl sulfonamide for their effect on Na<sub>V</sub>1.7 inhibition and HLM stability. Addition of fluorine atoms to the methyl sulfonamide moiety of <b>10</b> to give compound <b>12</b> was not tolerated, leading to a 12-fold drop in potency. Conversely, replacement of the methyl group at R<sup>2</sup> with bigger groups such as cyclopropyl (compound <b>13</b>) or cyclobutyl (compound <b>14</b>) was tolerated and potency was maintained relative to <b>10</b>. Lipophilicity increased, in particular for <b>14</b>, resulting in an erosion of LipE. Compound <b>13</b> showed moderate clearance in human liver microsomes and excellent functional activity against human Na<sub>V</sub>1.7 with an IC<sub>50</sub> of 0.003 ± 0.001 μM.</div><div class="NLM_p">In addition to <i>C</i>-linked groups at R<sup>2</sup>, we also probed a few <i>N</i>-linked analogs such methylamine <b>15</b>, which was 5-fold less potent than methyl sulfonamide <b>10</b>. Despite reduced lipophilicity, <b>15</b> did not show better metabolic stability over more lipophilic analogs such as <b>14</b>.</div><div class="NLM_p">We suspected that oxidation of the adamantane moiety was a major metabolic clearance pathway as previously observed.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Our strategy to reduce metabolism focused on commonly used approaches, such as reducing lipophilicity or increasing steric bulk to reduce recognition by CYP enzymes. In addition, we expected that either removing or blocking metabolically labile sites on the lipophilic appendage by fluorine substituents would improve HLM stability. Therefore, with the optimal groups identified for R<sup>1</sup> (cyclopropyl) and R<sup>2</sup> (methyl or cyclopropyl), we then explored SAR of the substituent at the ether linkage, R<sup>3</sup>. Representative examples summarizing our efforts are shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Eliminating a methylene between the triazole core and the adamantane reduced lipophilicity but also resulted in a steep drop in potency (compound <b>16</b>, 118-fold compared to <b>10</b>). In contrast, extending the linker by one methylene group (compound <b>17</b>) had no impact on the potency against Na<sub>V</sub>1.7. However, the extended linker led to a considerable drop in metabolic stability. We explored several different aliphatic appendages as adamantane replacements, exemplified by cyclohexane <b>18</b> and 6,6-dimethylbicyclo[3.1.1]heptane <b>19</b>. Compound <b>18</b> markedly improved LipE, despite an 11-fold drop in LBA potency. The potency loss of <b>18</b> relative to <b>10</b> was confirmed by voltage clamp, and a human Na<sub>V</sub>1.7 IC<sub>50</sub> of 0.014 μM ± 0.002 μM was measured for compound <b>18</b>. Most notably, the reduced lipophilicity of <b>18</b> also provided excellent HLM stability. Other aliphatic appendages such 6,6-dimethylbicyclo[3.1.1]heptane (compound <b>19</b>), an attempt to increase steric bulk, often showed excellent potency combined with comparable or improved LipE relative to <b>10</b>, but generally poor HLM stability. Metabolic stability could be improved by introducing fluorine substituents on the aliphatic appendage, although at the expense of lower potency against Na<sub>V</sub>1.7. An example is 1-fluorobicyclo[2.2.2]octane <b>20</b>, which was 16-fold less potent compared to <b>10</b> but considerably more stable in HLM.</div><div class="NLM_p">At this point, we considered triazole <b>13</b> to be the most promising lead, as it showed the best combination of high potency against Na<sub>V</sub>1.7, higher LipE, and increased stability in human liver microsomes compared to other adamantyl and cycloalkyl triazoles. Analogs such as <b>18</b> and <b>20</b> substantially improved HLM stability. However, the potency against Na<sub>V</sub>1.7 for these highly plasma protein bound acids (<i>vide infra</i>) was considered to be insufficient to provide <i>in vivo</i> efficacy at low plasma concentrations based on our experience with related acyl sulfonamides.</div><div class="NLM_p">In our search for highly potent, metabolically stable triazoles, we next turned our attention to aromatic replacements of the adamantane moiety<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> since this would allow us to probe a different chemical space compared to cycloalkyl groups (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). As a consequence of this strategy, <i>F</i><sub>sp<sup>3</sup></sub> would be reduced, and we were cognizant of the potential impact on the properties of the resultant compounds.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Initial studies were conducted using an isoxazole core for ease of synthesis. Replacing the adamantane in isoxazole <b>4</b> with 3,4-dichlorophenyl provided <b>21</b>, which retained the weak Na<sub>V</sub>1.7 potency of <b>4</b>. More importantly, <b>21</b> displayed excellent HLM stability and low lipophilicity. Encouraged by these results, we searched for opportunities to improve the potency against Na<sub>V</sub>1.7. Interestingly, inverting the oxymethylene linker in <b>21</b> to give its isomer <b>22</b> provided an 8-fold boost in potency. A similar difference in potency was observed when these compounds were tested for inhibition of Na<sub>V</sub>1.7 in a voltage-clamp assay (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). We hypothesized that the torsion angle preference of the linker affects the conformation of the compounds and inhibition of Na<sub>V</sub>1.7. Small molecule conformational preferences derived from analysis of data from the Cambridge Structural Database (CSD) and Protein Data Bank (PDB),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and global energy minimization of <b>21</b> and <b>22</b> using OMEGA<a onclick="showRef(event, 'cit21a cit21b'); return false;" href="javascript:void(0);" class="ref cit21a cit21b">(21a,b)</a> and SZYBKI<a onclick="showRef(event, 'cit21c'); return false;" href="javascript:void(0);" class="ref cit21c">(21c)</a> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B) supported our rationale. Thus, aryl methylene groups, such as the benzisoxazole core in <b>22</b>, preferentially adopt a perpendicular orientation (90° torsion angle), allowing the linker to orient the phenyl and the benzisoxazole ring into an optimal geometry for binding. In contrast, an alkoxy aryl linker as in <b>21</b> prefers a planar orientation (0° torsion angle).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Aryl Isoxazole and Triazole SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0017.gif" alt="" id="gr16" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Human Na<sub>V</sub>1.7 radioligand binding assay (LBA); IC<sub>50</sub> for displacement of [<sup>3</sup>H]GX-545, reported as mean value ± SD from at least two independent determinations.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">LogD measured at pH 7.4 (<i>n</i> = 1).</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Calculated from Na<sub>V</sub>1.7 LBA IC<sub>50</sub> and measured LogD.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Predicted hepatic clearance extrapolated from <i>in vitro</i> human liver microsome (HLM) experiments; SD not applicable.</p></div></div><div></div></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Torsional preference of the linker impacts potency. Torsion angle preferences are taken from ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>. LBA IC<sub>50</sub>: IC<sub>50</sub> for displacement of [<sup>3</sup>H]GX-545, reported as mean value from at least two independent determinations ± SD. PX IC<sub>50</sub> values ± SD were generated on a PatchXpress (PX) automated voltage-clamp platform using a protocol where the membrane potential was maintained at a voltage yielding full inactivation of the channel. (B) Global minimum energy conformations of <b>21</b> (green) and <b>22</b> (orange), calculated by OMEGA<a onclick="showRef(event, 'cit21a cit21b'); return false;" href="javascript:void(0);" class="ref cit21a cit21b">(21a,b)</a> followed by optimization with SZYBKI,<a onclick="showRef(event, 'cit21c'); return false;" href="javascript:void(0);" class="ref cit21c">(21c)</a> using system defaults.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Consistent with previous observations, replacing the chlorine at R<sup>1</sup> by cyclopropyl to give <b>23</b> further improved potency and LipE (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). The high potency in ligand binding was confirmed by voltage-clamp assay on human Na<sub>V</sub>1.7, with a measured IC<sub>50</sub> of 0.002 ± 0.001 μM. In addition, <b>23</b> demonstrated low clearance in human liver microsomes. We next replaced the isoxazole with the triazole core, as initial data shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> suggested that this core would provide compounds with improved lipophilicity. Indeed, replacing the isoxazole core of <b>23</b> with a triazole was tolerated and provided a considerable reduction in lipophilicity. Triazole <b>24</b> retained potency and metabolic stability of <b>23</b>, while increasing LipE. Finally, changing the 3,4-dichlorophenyl group to a 3,5-dichlorophenyl group provided compound <b>25</b>, which combined high potency against Na<sub>V</sub>1.7 (voltage-clamp IC<sub>50</sub> of 0.001 ± 0.001 μM) with excellent HLM stability and with low lipophilicity.</div><div class="NLM_p">In general, SAR trends observed in the acyl sulfonamide series were reflected in the triazole series. For instance, a cyclopropyl group at R<sup>1</sup> led to a marked improvement in potency in both series compared to other substituents. In comparison to their acyl sulfonamide counterparts, most triazole sulfonamides displayed lower ligand binding affinity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A), with decreases from 2- to 28-fold observed. Notable exceptions included compounds <b>10</b>, <b>24</b>, and <b>25</b>, for which the LBA potency was within 1–2 fold of the corresponding acyl sulfonamide analog. On the other hand, triazole sulfonamides typically showed better stability in HLM compared to acyl sulfonamides (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B), which may compensate for their reduced potency. As examples, <b>10</b>, <b>13</b>, and <b>25</b> were 1.5–2-fold more stable than the corresponding acyl sulfonamides (<b>10</b>, 14 vs 19 mL/min/kg; <b>13</b>, 12 vs 18 mL/min/kg; <b>25</b>, 3.9 vs 9.5 mL/min/kg).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Analysis of matched pairs of triazoles and acyl sulfonamides. (A) Na<sub>V</sub>1.7 LBA: 29 matched pairs. (B) HLM: 24 matched pairs. Selected compound numbers are shown. Colors: green, triazoles; orange, acyl sulfonamides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It should be noted that measured p<i>K</i><sub>a</sub> values indicated an increased acidic p<i>K</i><sub>a</sub> for triazoles with aliphatic substituents at R<sup>1</sup> compared to chloro substituted triazole <b>5</b>. As such, we measured p<i>K</i><sub>a</sub> values of 6.7 for <b>10</b> and <b>13</b>. Therefore, a small fraction of these compounds will remain nonionized at physiological pH 7.4, which will likely affect LogD values and possibly potency relative to the acyl sulfonamides that will be fully ionized at this pH.</div><div class="NLM_p">In addition to possible p<i>K</i><sub>a</sub> effects, we rationalized that the observed shift in potency between acyl and triazole sulfonamides (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) may be a consequence of a conformational constraint that negatively affects potential hydrogen bond donor/acceptor interactions of triazoles within the binding site versus the more flexible acyl sulfonamides. Although the latter bind to the same VSD4 site of Na<sub>V</sub>1.7 as aryl sulfonamides, little is known about the precise binding mode of acyl sulfonamides.<a onclick="showRef(event, 'cit9b'); return false;" href="javascript:void(0);" class="ref cit9b">(9b)</a> To gain further understanding of the binding modes of acyl and triazole sulfonamides, we conducted site directed mutagenesis of specific residues within the anion binding pocket of the VSD4 site. Three arginine residue mutations within the anion binding pocket were generated (R1602A, R1605A, and R1608A), as well as a mutation of the tyrosine side chain (Y1537A) that forms the floor of the binding pocket (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Effect of mutations in the anion binding pocket of Na<sub>V</sub>1.7 VSD4 on binding of acyl sulfonamide <b>1</b>. Voltage-clamp data were generated on a Qube automated voltage-clamp system: <i>n</i> ≥ 3, error bars indicate SEM. The corresponding IC<sub>50</sub> values are as follows: 0.004 μM (WT), 0.04 μM (Y1537A), 1.37 μM (R1602A), 8.87 μM (R1605A), 27.35 μM (R1608A). (B) Effect of mutations on binding of triazole sulfonamide <b>5</b>. Voltage-clamp data were generated on a Qube automated voltage-clamp system: <i>n</i> ≥ 3, error bars indicate SEM. The corresponding IC<sub>50</sub> values are as follows: 0.02 μM (WT), 0.15 μM (Y1537A), 7.33 μM (R1602A), 6.13 μM (R1605A), 30.69 μM (R1608A). (C) Amino acid sequence of the S1–S4 region of human Na<sub>V</sub>1.7 VSD4. Residues selected for mutagenesis studies are highlighted in yellow. Residue numbering is in accordance with ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>. For additional data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similar to aryl sulfonamides,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Na<sub>V</sub>1.7 inhibition potency for triazole and acyl sulfonamides is dominated by R1608. Thus, the R1608A mutation eradicated potency for all compounds tested (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B). Mutations of R1602 and R1605 had little impact on binding of aryl sulfonamides to VSD4 (up to 6-fold reduction in potency).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In contrast, the two arginine residues contributed substantially to binding of both acyl and triazole sulfonamides. Potency for chloro-substituted adamantane ethers <b>1</b> and <b>5</b> was reduced to a similar extent by replacement of either R1602 or R1605 by alanine, resulting in a >300-fold reduction.</div><div class="NLM_p">The mutagenesis data show notable similarities between acyl and triazole sulfonamide binding, thus supporting a similar binding mode between the two series. Nonetheless, differences in binding for acyl and triazole sulfonamides were also revealed. For instance, inhibitory potency for triazole <b>10</b> was impacted to a greater extent by R1602 and R1605 mutations in comparison to its acyl sulfonamide counterpart (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">Selected analogs were further profiled against multiple human sodium channel isoforms (Na<sub>V</sub>1.1, 1.2, 1.5, 1.6, and 1.7) using the PatchXpress automated voltage-clamp system (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). In general, the triazoles reported herein displayed high selectivity against the cardiac sodium channel Na<sub>V</sub>1.5, from 37-fold selectivity for <b>13</b> to >1300-fold for <b>25</b>. Lower isoform selectivity was observed against other sodium channels, in particular Na<sub>V</sub>1.2. Thus, while the triazoles showed 15- to >110-fold and 13- to 16-fold selectivity for Na<sub>V</sub>1.7 over Na<sub>V</sub>1.1 and Na<sub>V</sub>1.6, respectively, the selectivity for Na<sub>V</sub>1.7 over Na<sub>V</sub>1.2 was only 2–10-fold. Potency measurements on the Qube automated voltage-clamp platform provided 2–4-fold lower human Na<sub>V</sub>1.7 IC<sub>50</sub> values compared to the PatchXpress system.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Voltage-Clamp IC<sub>50</sub> Values for the Inhibition of Human Na<sub>V</sub>1.<i>x</i> Isoforms</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Na<sub>V</sub>1.1<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">Na<sub>V</sub>1.2<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">Na<sub>V</sub>1.5<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center">Na<sub>V</sub>1.6<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">Na<sub>V</sub>1.7 PX<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>/Qube<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">0.053 ± 0.008</td><td class="colsep0 rowsep0" align="char" char=".">0.014 ± 0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.265 ± 0.044</td><td class="colsep0 rowsep0" align="left">0.190</td><td class="colsep0 rowsep0" align="char" char=".">0.003 ± 0.002/0.012</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">0.045 ± 0.008</td><td class="colsep0 rowsep0" align="char" char=".">0.007 ± 0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.110 ± 0.018</td><td class="colsep0 rowsep0" align="left">0.092</td><td class="colsep0 rowsep0" align="char" char=".">0.003 ± 0.001/0.007</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">0.112 ± 0.019</td><td class="colsep0 rowsep0" align="char" char=".">0.010 ± 0.003</td><td class="colsep0 rowsep0" align="char" char=".">1.313 ± 0.460</td><td class="colsep0 rowsep0" align="left">−<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">0.001 ± 0.001/0.002</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values ± SD for human Na<sub>V</sub>1.<i>x</i> isoforms were generated on a PatchXpress automated voltage-clamp platform.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Data were collected using a protocol where the membrane potential was maintained at a voltage yielding full inactivation of the channel.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> values were from pooled data generated on QPatch or Qube automated voltage-clamp platforms; SD not applicable.</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last">Not determined.</p></div></div></div><div class="NLM_p">Compounds <b>13</b> and <b>25</b> were also evaluated for their effects on mouse Na<sub>V</sub>1.7 using the Qube automated electrophysiology platform, and IC<sub>50</sub> values of 0.007 μM (<b>13</b>) and 0.005 μM (<b>25</b>) were measured. Selected analogs were tested <i>in vitro</i> for effects on the hERG potassium channel by automated voltage clamp, and inhibition was generally low (11% ± 2% inhibition at 10 μM test concentration for compound <b>13</b>).</div><div class="NLM_p">The ADME profile for compounds <b>10</b>, <b>13</b>, and <b>25</b> is shown in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>. All compounds showed moderate to high metabolic stability in liver microsomes, and <b>13</b> and <b>25</b> also showed high stability in human, rat, and dog hepatocytes. Triazoles <b>10</b>, <b>13</b>, and <b>25</b> demonstrated moderate permeability in MDR1 transfected MDCK cells, with <b>25</b> showing high potential for P-glycoprotein (Pgp) mediated efflux. The compounds showed no appreciable inhibition of CYP isoforms 3A4, 1A2, 2C9, and 2D6, at concentrations of 10 μM. Plasma protein binding (PPB) was determined by rapid equilibrium dialysis and was generally very high (99.0–99.9% in human, mouse, and rat). Testing of <b>13</b> and <b>25</b> by equilibrium dialysis using HT Dialysis membranes indicated 99.8% and 99.7% PPB in mouse, respectively.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. AMDE Profile and Physical Properties for Triazoles <b>13</b> and <b>25</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><b>10</b></th><th class="colsep0 rowsep0" align="center"><b>13</b></th><th class="colsep0 rowsep0" align="center"><b>25</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HLM/MLM/RLM/DLM Cl<sub>hep</sub><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">14/40/15/7.7</td><td class="colsep0 rowsep0" align="left">12/39/19/18</td><td class="colsep0 rowsep0" align="left">3.9/8.2/5.7/7.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HH/MH/RH/DH Cl<sub>hep</sub><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a> (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">17/17/4.7/18</td><td class="colsep0 rowsep0" align="left">6.4/39/9.6/9.9</td><td class="colsep0 rowsep0" align="left">7.2/26/10/9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app,AB</sub><a class="ref internalNav" href="#t7fn3" aria-label="c">c</a><sup>,</sup><a class="ref internalNav" href="#t7fn4" aria-label="d">d</a> (10<sup>–6</sup> cm/s)/ER</td><td class="colsep0 rowsep0" align="left">3.2/3.2</td><td class="colsep0 rowsep0" align="left">7.2/1.2</td><td class="colsep0 rowsep0" align="left">4.0/15.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kinetic solubility<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a> (μM)</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LogD<sub>7.4</sub><a class="ref internalNav" href="#t7fn4" aria-label="d">d</a><sup>,</sup><a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP 3A4, 1A2, 2C9, 2D6 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a><sup>,</sup><a class="ref internalNav" href="#t7fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PXR % induction<a class="ref internalNav" href="#t7fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">12.1</td><td class="colsep0 rowsep0" align="left">9.9</td><td class="colsep0 rowsep0" align="left">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H/M/R PPB<a class="ref internalNav" href="#t7fn8" aria-label="h">h</a> (%)</td><td class="colsep0 rowsep0" align="left">99.8/99.9/99.8</td><td class="colsep0 rowsep0" align="left">99.9/99.9/99.9</td><td class="colsep0 rowsep0" align="left">99.6/99.0/99.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Predicted hepatic clearance extrapolated from <i>in vitro</i> liver microsome experiments; SD not applicable.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">Predicted hepatic clearance extrapolated from <i>in vitro</i> hepatocyte experiments; SD not applicable.</p></div><div class="footnote" id="t7fn3"><sup><sup>c</sup></sup><p class="last">Apparent permeability, apical to basolateral side, in MDR1 transfected MDCK cells and MDR1 efflux ratio, ER = AB/BA.</p></div><div class="footnote" id="t7fn4"><sup><sup>d</sup></sup><p class="last"><i>n</i> = 1.</p></div><div class="footnote" id="t7fn5"><sup><sup>e</sup></sup><p class="last">LogD measured at pH 7.4.</p></div><div class="footnote" id="t7fn6"><sup><sup>f</sup></sup><p class="last">IC<sub>50</sub> for the inhibition of cytochrome P450 isoforms.</p></div><div class="footnote" id="t7fn7"><sup><sup>g</sup></sup><p class="last">Expressed as percentage of activation seen with rifampicin when both compounds are used at a test concentration of 10 μM.</p></div><div class="footnote" id="t7fn8"><sup><sup>h</sup></sup><p class="last">Plasma protein binding for human, mouse, and rat as determined by equilibrium dialysis using the RED device.</p></div><div class="footnote" id="t7fn9"><sup><sup>i</sup></sup><p class="last">Not determined.</p></div></div></div><div class="NLM_p">The pharmacokinetic parameters for <b>10</b>, <b>13</b>, and <b>25</b> in mice, rats, and dogs after iv administration are shown in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>. All compounds show low total clearance (0.8–7 mL/min/kg), consistent with the low <i>in vitro</i> clearance inferred from stability testing with hepatocytes (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Volume of distribution was low (<0.7 L/kg) and within the range typically observed for acidic compounds.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Pharmacokinetic Parameters for Triazoles <b>10</b>, <b>13</b>, and <b>25</b> after iv Administration<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">3.1 ± 0.4</td><td class="colsep0 rowsep0" align="char" char=".">2.3 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.6 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">0.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">7.0 ± 1.3</td><td class="colsep0 rowsep0" align="char" char=".">0.4 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">4.8 ± 0.6</td><td class="colsep0 rowsep0" align="char" char=".">6.2 ± 1.2</td><td class="colsep0 rowsep0" align="char" char=".">0.7 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2.4 ± 0.9</td><td class="colsep0 rowsep0" align="char" char=".">1.7 ± 0.6</td><td class="colsep0 rowsep0" align="char" char=".">0.3 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">1.2 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">4.1 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.4 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">3.4 ± 0.3</td><td class="colsep0 rowsep0" align="char" char=".">0.8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.2 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2.4 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">3.2 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.6 ± 0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">Dose: 1 mg/kg for male Sprague–Dawley rats (age 9–11 weeks; <i>n</i> = 3) and male CF-1 mice (age 4–5 weeks; <i>n</i> = 3); 0.5 mg/kg for male Beagle dogs (age 6 months to 3 years; <i>n</i> = 3). Data are represented as mean ± SD.</p></div></div></div><div class="NLM_p">We next examined analogs <b>10</b>, <b>13</b>, and <b>25</b> for target engagement and analgesic activity <i>in vivo.</i> We previously reported on an acute pain and target engagement assay in rats utilizing aconitine, a strong neurotoxin and voltage-gated sodium channel activator.<a onclick="showRef(event, 'cit6b ref23'); return false;" href="javascript:void(0);" class="ref cit6b ref23">(6b,23)</a> However, rat Na<sub>V</sub>1.7 VSD4 has marked differences to the human form,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and VSD4 binders often show poor potency against rat Na<sub>V</sub>1.7 that typically requires evaluation of <i>in vivo</i> pharmacology in mice.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">In order to facilitate the <i>in vivo</i> characterization of our compounds, we employed a novel induced-pain model using transgenic FVB mice. In addition to endogenous mouse Na<sub>V</sub>1.7, these mice express human Na<sub>V</sub>1.7 with the same gain-of-function mutation (I848T) that causes IEM in humans. The transgenic FVB mice were generated by incorporation of a bacterial artificial chromosome (BAC) gene coding for the mutated human sodium channel. A pain response is then induced by injecting aconitine, similar to our rat pain model. Notably, using this study design, aconitine only affects transgenic mice carrying human Na<sub>V</sub>1.7 but not wild-type mice, and it is therefore felt that inhibition of the pain response represents block of human Na<sub>V</sub>1.7. We utilized the humanized IEM model throughout the program as the primary assay to evaluate compounds for efficacy and to quantify target engagement of human Na<sub>V</sub>1.7 <i>in vivo</i>.</div><div class="NLM_p">Aconitine was injected into a hindpaw to stimulate the nociceptive response 2 h following oral administration of test compound. Flinching and licking behavior were captured and manually quantified for 30 min post-acontine-injection as nociceptive behavior. At approximately 3 h post-treatment, animals were euthanized and plasma samples were collected. Triazole <b>10</b> displayed a dose-dependent reduction of the pain response (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A), with 31%, 66% and 93% reduction at 3, 10, and 30 mg/kg, relative to the aconitine vehicle. Plasma concentrations (mean ± SD) were measured as 2.7 ± 0.6, 12.2 ± 3.5, and 46.2 ± 12.5 μM, respectively. Similarly, cyclopropyl sulfonamide analog <b>13</b> showed significant reduction of nociceptive behavior at the doses tested, with up to 85% reduction at the 30 mg/kg dose and a plasma concentration of 2.8 ± 0.8 μM. The EC<sub>50</sub> values for the inhibition of nociceptive behavior by the two adamantyl triazoles <b>10</b> and <b>13</b> were calculated as 5.8 μM (<b>10</b>) and 0.5 μM (<b>13</b>), respectively (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Effect of compounds <b>10</b>, <b>13</b>, and <b>25</b> on aconitine-induced pain in transgenic IEM mice. Male 7–10 week old FVB hSCN9a Tg mice were used (<i>n</i> = 4 animals/group for no aconitine vehicle and all doses of test compounds; <i>n</i> = 8 animals for aconitine vehicle group). Nociceptive behavior is presented as mean ± SEM. Reduction of nociceptive behavior (flinching and licking after intraplantar injection of aconitine) relative to vehicle is listed above the bars (in %). Statistical analysis was performed by a one-way ANOVA, followed by a Dunnett’s test: *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, ****<i>p</i> < 0.0001. (B) Concentration–response relationships for inhibition of nociception by <b>10</b>, <b>13</b>, and <b>25</b> in the IEM assay. Data points are shown as mean relative response ± SD and represent the same data sets as in panel A, including the corresponding terminal plasma concentrations (mean values shown). The curves are fit to a 1:1 binding reaction. EC<sub>50</sub> values are calculated as 5.8 μM (<b>10</b>), 0.5 μM (<b>13</b>), and 21.2 μM (<b>25</b>). (C) Pharmacokinetic profiles of <b>10</b>, <b>13</b>, and <b>25</b> in plasma following 10 and 30 mg/kg oral doses to male FVB mice (solid line, <i>n</i> = 3 animals; age 6–7 weeks). Plasma concentrations are represented as mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In contrast, aryl substituted triazole sulfonamide <b>25</b> performed poorly in this induced pain model, with only 32% and 43% reduction of nociceptive behavior following 10 and 30 mg/kg oral administration, respectively. The two doses yielded plasma concentrations of 7.8 ± 2.6 and 18.8 ± 8.0 μM, respectively. The EC<sub>50</sub> for the inhibition of nociceptive behavior by <b>25</b> was estimated as 21.2 μM.</div><div class="NLM_p">The poor efficacy of <b>25</b> was surprising based on the <i>in vitro</i> profile of the compounds. All three compounds showed similar high potency against human Na<sub>V</sub>1.7 as measured on the PatchXpress platform. Triazole <b>25</b> was the most potent compound based on experiments on the Qube automated voltage-clamp system, while <b>10</b> was the least potent compound. Furthermore, all three compounds showed very high plasma protein binding in mice. However, <b>25</b> showed only poor efficacy, with >3-fold and >40-fold higher EC<sub>50</sub> values for the inhibition of nociceptive behavior compared to <b>10</b> and <b>13</b>, respectively.</div><div class="NLM_p">This apparent discrepancy between <i>in vivo</i> efficacy and <i>in vitro</i> potency for different chemotypes is not fully understood, although we consider the following as possibilities: (1) Inaccurate measurements of Na<sub>V</sub>1.7 IC<sub>50</sub> due to slow binding kinetics. Block develops slowly at concentrations comparable to the IC<sub>50</sub> for Na<sub>V</sub>1.7 and steady-state block may not be attained in the duration of a voltage clamp experiment. However, all three compounds have similar potency in the ligand binding assay. (2) Inaccurate determination of free fraction. In our experience, accurate quantification of free fraction for extensively bound compounds (i.e., when PPB > 99%) is often difficult. High compound lipophilicity and nonspecific binding of compounds may also play a role. Therefore, we cannot rule out that the observed <i>in vivo</i> effects could be correlated to differences of free compound concentrations. (3) Marked differences in free drug concentrations in the dorsal root ganglion (DRG), as has recently been suggested for aryl sulfonamides.<a onclick="showRef(event, 'cit6e'); return false;" href="javascript:void(0);" class="ref cit6e">(6e)</a> Na<sub>V</sub>1.7 is highly expressed in the DRG, and inhibition of channel function in this region may be responsible for the analgesic effect. It seems plausible that differences in permeability and possible interactions as transporter substrates may affect nerve penetration, although we were unable to quantify concentrations in mouse DRG. Compound lipophilicity may also play a role. Assuming similar properties for the perineurium and the blood–brain barrier, nerve penetration can be inferred from brain exposures, which is lower for <b>25</b> (B/P < 0.004) compared to <b>10</b> and <b>13</b> (B/P > 0.17). (4) Partitioning into the neuronal membrane. Adamantyl triazoles <b>10</b> and <b>13</b> showed markedly higher lipophilicity than <b>25</b>, which may lead to increased partitioning of these compounds into neuronal membranes and higher local concentrations in proximity of the binding site. (5) Differences in PK and <i>C</i><sub>max</sub>. It is possible that efficacy during the testing period (2–3 h after dosing) reflects the time integral of exposure rather than the plasma level only at the time of evaluation of nociceptive effect. The integrated exposure would be more relevant if the residence time of compounds is long, so that binding at <i>C</i><sub>max</sub> is maintained during the course of the experiment. As demonstrated in separate PK studies in FVB mice (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C), all three compounds maintained stable plasma concentrations over the time course of the IEM experiments. However, exposure for compound <b>13</b> peaked shortly after dosing (at 0.5 h), whereas <b>10</b> and <b>25</b> reached <i>C</i><sub>max</sub> 2 h after dosing. We reasoned that this early <i>C</i><sub>max</sub>, if combined with long residence time, may contribute to the analgesic effect of <b>13</b>. To test this hypothesis, we determined the association rate constants, <i>k</i><sub>on</sub>, by kinetic analysis of binding rates on the Qube platform (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">Supporting Information</a>) and then calculated the dissociation rate constants, <i>k</i><sub>off</sub>, and residence times. For compound <b>13</b>, the calculated residence time is >110 min. It is therefore possible that binding at <i>C</i><sub>max</sub> is maintained during the course of the experiment for <b>13</b>. However, this scenario does not account for the difference observed for <b>10</b> and <b>25</b>.</div><div class="NLM_p last">Additional studies on these and other classes of VSD4 binders are ongoing to elucidate the impact of each component on efficacy and will be reported in due course.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Benzisoxazoles <b>4</b> and <b>21</b> were synthesized in four steps starting from 5-chloro-2,4-difluorobenzonitrile (<b>26</b>) as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Coupling of <b>26</b> with 1-adamantanemethanol or (3,4-dichlorophenyl)methanol, respectively, provided S<sub>N</sub>Ar adducts <b>27</b> and <b>28</b>. Reaction of these 2-fluorobenzonitriles with <i>N</i>-hydroxyacetamide in the presence of KO<i>t</i>-Bu led to the formation of amino benzisoxazoles <b>29</b> and <b>30</b>. Treatment of the latter with methanesulfonyl chloride and subsequently with sodium hydroxide provided sulfonamides <b>4</b> and <b>21</b>, respectively.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Isoxazoles <b>4</b> and <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-adamantanemethanol or (3,4-dichlorophenyl)methanol, NaH, DMF, 0 °C to rt, 100%; (b) <i>N</i>-hydroxyacetamide, KO<i>t</i>-Bu, DMF, 40–51%; (c) MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (d) 1 M NaOH, THF, 68–72% over 2 steps.</p></p></figure><div class="NLM_p">The synthesis of the triazole sulfonamides initially followed a similar amine sulfonylation strategy. Starting with 3-bromo-4-chloropyridine (<b>31</b>), treatment of the latter with 1-adamantanemethanol afforded S<sub>N</sub>Ar adduct <b>32</b>. Regioselective chlorination at the 2-position was accomplished by a two-step sequence consisting of <i>N</i>-oxidation with <i>m</i>CPBA followed by POCl<sub>3</sub> induced rearrangement to give 2-chloropyridine <b>33</b>. Displacement of the chlorine by hydrazine provided 2-hydrazinylpyridine <b>34</b>, which was then converted into amino triazole <b>35</b> through treatment with cyanogen bromide. In most cases, the installment of R<sup>1</sup> substituents was performed at this stage through a Suzuki–Miyaura coupling with appropriate boronic acids in the presence of Pd(PPh<sub>3</sub>)<sub>4</sub>. As such, coupling of <b>35</b> with isopropenylboronic acid pinacol ester followed by reduction of the double bond using hydrogen gas and Pd/C provided isopropyl analog <b>36</b>. Cyclopropyl analog <b>37</b> was obtained from coupling of <b>35</b> with cyclopropylboronic acid. Reaction of amino triazoles <b>35</b>–<b>37</b> with alkyl sulfonyl chlorides followed by treatment with sodium hydroxide then afforded triazole sulfonamides <b>6</b>, <b>7</b>, <b>9</b>–<b>12</b>, and <b>15</b>. Compound <b>8</b> was synthesized in a similar fashion using vinylboronic acid followed by sulfonylation and hydrogenation. Chloro triazole <b>5</b> was prepared from 3,4-dichloropyridine following an analogous sequence as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Furthermore, compounds <b>18</b> and <b>19</b> were obtained via the amine sulfonylation route (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">Supporting Information</a> for <b>5</b>, <b>8</b>, <b>18</b>, and <b>19</b>).</div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Triazoles <b>6</b>, <b>7</b>, <b>9</b>–<b>12</b>, and <b>15</b> via Sulfonylation of [1,2,4]Triazolo[4,3-<i>a</i>]pyridin-3-amines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-adamantanemethanol, KO<i>t</i>-Bu, DMSO, 94%; (b) <i>m</i>CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 94%; (c) POCl<sub>3</sub>, reflux, 70%; (d) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, dioxane, 160 °C, μW, 92%; (e) BrCN, EtOH, CH<sub>2</sub>Cl<sub>2</sub>, 100%; (f) (1) isopropenylboronic acid pinacol ester, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 160 °C, μW, 78%; (2) Pd/C, H<sub>2</sub>, THF, MeOH, AcOH, 100%; (g) cyclopropylboronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 160 °C, μW, 67%; (h) R<sup>2</sup>SO<sub>2</sub>Cl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, then 1 M NaOH, THF, 8–29%; (i) cyclobutylzinc bromide, RuPhos, Pd(OAc)<sub>2</sub>, THF, 6–12%.</p></p></figure><div class="NLM_p">Isomeric 2-(methylsulfonyl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3(2<i>H</i>)-imines such as <b>38</b> were often observed as byproducts during the sulfonylation of amino triazole <b>35</b>–<b>37</b>. Although they were readily separated from the desired products by chromatography, we sought an alternative route for the synthesis of triazole sulfonamides that would avoid the formation of these byproducts. To this end, we envisioned that a Cu-mediated <i>N</i>-heteroarylation of primary sulfonamides with appropriate halogenated triazole precursors might provide a suitable alternative.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The required building blocks for this coupling approach were conveniently derived from 2-hydrazinylpyridine <b>34</b> in three steps (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Condensation of <b>34</b> with triethyl orthoformate to form intermediate <b>39</b>, ensuing Pd-catalyzed coupling with cyclopropylboronic acid, and subsequent regioselective bromination with NBS provided 3-bromo-[1,2,4]triazolo[4,3-<i>a</i>]pyridine <b>40</b>. With the latter compound in hand, we were set to attempt the coupling with primary sulfonamides. Gratifyingly, heating of <b>40</b> with primary sulfonamides in the presence of CuOTf and <i>trans</i>-<i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine afforded triazole sulfonamides <b>13</b> and <b>14</b> in 12–78% yield. This coupling protocol was also employed for the synthesis of compounds <b>16</b>, <b>17</b>, and <b>20</b> from the corresponding precursors (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Triazoles <b>13</b> and <b>14</b> via Cu-Mediated Coupling of Sulfonamides with 3-Bromo-[1,2,4]triazolo[4,3-<i>a</i>]pyridines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H(OEt)<sub>3</sub>, reflux, 84%; (b) cyclopropylboronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, reflux, 64%; (c) NBS, CH<sub>2</sub>Cl<sub>2</sub>, 78%; (d) RSO<sub>2</sub>NH<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, <i>trans</i>-<i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine, CuOTf, PhMe, DMSO, reflux, 12–78%.</p></p></figure><div class="NLM_p">The synthesis of dichlorophenyl substituted isoxazole <b>22</b> proceeded in a similar fashion as described for the cycloalkyl analogs <b>4</b> and <b>21</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Methyl 4-bromo-2-chloro-5-fluorobenzoate (<b>41</b>) was converted into phenyl benzyl ether <b>42</b> in a three-step sequence consisting of ester reduction by LiBH<sub>4</sub>, sulfonylation of the obtained primary alcohol with methanesulfonyl chloride, and subsequent displacement of the sulfonate leaving group with dichlorophenol. Heating of compound <b>42</b> in the presence of CuCN and CuI generated a 2-fluorobenzonitrile, which was converted into amino benzisoxazole <b>43</b> by treatment with <i>N</i>-hydroxyacetamide and KO<i>t</i>-Bu. Sulfonylation with methanesulfonyl chloride then afforded isoxazole <b>22</b>. Compound <b>23</b> was obtained via sulfonylation of the corresponding cyclopropyl substituted amino benzisoxazole (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Isoxazole <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LiBH<sub>4</sub>, THF, reflux, 100%; (b) MsCl, TEA, THF, 77%; (c) 3,4-dichlorophenol, K<sub>2</sub>CO<sub>3</sub>, DMF, 65%; (d) CuCN, CuI, NMP, 150 °C, μW, 52%; (e) <i>N</i>-hydroxyacetamide, KO<i>t</i>-Bu, DMF, 81%; (f) MsCl, pyridine, 0 °C to rt; 20%.</p></p></figure><div class="NLM_p">The synthesis of triazoles <b>24</b> and <b>25</b> started from 5-bromo-2-chloroisonicotinic acid (<b>44</b>) (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Esterification and ensuing reduction of the methyl ester with LiBH<sub>4</sub> afforded alcohol <b>45</b>. Sulfonylation with methanesulfonyl chloride, and subsequent displacement of the sulfonate by 3,4-dichlorophenol or 3,5-dichlorophenol, respectively, generated phenyl benzyl ethers <b>46</b> and <b>47</b>. Displacement of the 2-chloropyridine with hydrazine followed by condensation with triethyl orthoformate afforded benzotriazoles <b>48</b> and <b>49</b>. The cyclopropyl appendage at the 6-position was next installed through a Suzuki–Miyaura coupling, followed by regioselective bromination at the 3-position with NBS to give 3-bromo-[1,2,4]triazolo[4,3-<i>a</i>]pyridines <b>50</b> and <b>51</b>. We then employed the same copper-mediated coupling strategy described earlier using methanesulfonamide to obtain triazole sulfonamides <b>24</b> and <b>25</b>.</div><figure id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Triazoles <b>24</b> and <b>25</b> via Cu-Mediated Coupling of Sulfonamides with 3-Bromo-[1,2,4]triazolo[4,3-<i>a</i>]pyridines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SO<sub>2</sub>Cl, MeOH, reflux, 95%; (b) LiBH<sub>4</sub>, THF, MeOH, 0 °C to rt, 79%; (c) (1) MsCl, DIPEA, THF, 0 °C; (2) 3,4-dichlorophenol or 3,5-dichlorophenol, K<sub>2</sub>CO<sub>3</sub>, EtOAc, DMF, 69–86% over 2 steps; (d) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, dioxane, reflux, 91–100%; (e) H(OEt)<sub>3</sub>, reflux, 64–77%; (f) cyclopropylboronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, reflux, 55–69%; (g) NBS, CH<sub>2</sub>Cl<sub>2</sub>, 70–98%; (h) MeSO<sub>2</sub>NH<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, <i>trans</i>-<i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine, CuOTf, PhMe, DMSO, reflux, 10–12%.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65658" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65658" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Two series of highly isoform-selective Na<sub>V</sub>1.7 inhibitors have been disclosed in the literature, acyl and aryl sulfonamides, which bind to the VSD4 site of Na<sub>V</sub>1.7. We describe herein the discovery of novel triazole sulfonamides as a third series of selective Na<sub>V</sub>1.7 inhibitors that are structurally derived from acyl sulfonamides. We hypothesized that the small molecule crystal structure of acyl sulfonamide <b>1</b> would resemble the bioactive conformation and applied conformational restraints to validate our hypothesis. This strategy provided potent Na<sub>V</sub>1.7 inhibitors that bind to the same VSD4 site as acyl and aryl sulfonamides, as supported by ligand binding data. Additionally, SAR and data from site directed mutagenesis provided evidence that triazole and acyl sulfonamides adopt a similar general binding mode within the VSD4 site. Although triazole sulfonamides were generally weaker Na<sub>V</sub>1.7 inhibitors compared to their acyl counterparts, they markedly improved metabolic stability over the latter series. In particular, compounds <b>13</b> (GNE-131) and <b>25</b> combined excellent potency with moderate to high <i>in vitro</i> metabolic stability that corresponded to low clearance in mouse, rat, and dog. Despite high plasma protein binding, adamantyl triazole sulfonamide <b>13</b> displayed excellent efficacy in a transgenic mouse model of induced pain. In contrast, aryl triazole sulfonamide <b>25</b> performed poorly in this pain model, despite showing similar <i>in vitro</i> affinity for Na<sub>V</sub>1.7 as compound <b>13</b>.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14256" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14256" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Methods</h3><div class="NLM_p last">Unless otherwise stated, commercially available reagents and solvents were used without purification. Yields were not optimized. Melting points were determined on a Büchi hot-stage apparatus and are uncorrected. NMR experiments were performed on 300, 500, and 600 MHz spectrometers, respectively. <sup>1</sup>H, <sup>19</sup>F, and <sup>13</sup>C NMR data are reported with chemical shifts (δ) in parts-per-million (ppm) relative to the residual signal of the deuterated solvent as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, qn = quintet, m = multiplet, and br = broad), coupling constant in Hz, and number of protons, fluorine, or carbon atoms. Mass spectra were obtained using a Waters 2795/Micromass Quattro LC/MS system (Waters Corporation). Purity was determined by HPLC analysis on Agilent 1100, 1200, or 1260 systems (Agilent Technologies) using a XBridge C-18 column (5 μm, 4.6 mm × 50 mm, Waters Corporation) with a 5–95% gradient over 5 min of CH<sub>3</sub>CN in water containing 0.1% TFA at a flow rate of 1.0 mL/min at 25 °C. Peaks were detected at a wavelength of 254 or 280 nm with an Agilent photodiode array detector. All compounds reported herein with biological data exhibited spectral data consistent with their proposed structures and had purities >95% as determined by HPLC, except compound <b>5</b> (94% purity) and compound <b>12</b> (93% purity), see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">Supporting Information</a>. Preparative HPLC was performed on Waters HPLC systems using a XBridge Prep C18 column (5 μm, 30 mm × 50 mm, Waters Corporation), an XSelect CSH Prep column (5 μm, 30 mm × 50 mm, Waters Corporation), or a Gemini-NX C18 column (5 μm, 150 mm × 50 mm, Phenomenex) with a 5–95% gradient of CH<sub>3</sub>CN in water containing 0.1% TFA or formic acid, respectively.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>N</i>-[6-(Adamantan-1-ylmethoxy)-5-chloro-1,2-benzoxazol-3-yl]methanesulfonamide (<b>4</b>)</h3><div class="NLM_p last">To a solution of <b>29</b> (0.021 g, 0.06 mmol) and triethylamine (0.015 g, 0.14 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added methanesulfonyl chloride (0.008 g, 0.07 mmol) at 0 °C. After stirring at ambient temperature for 2 h, the solvent was removed <i>in vacuo</i>, and the residue was dissolved in THF (1 mL) and NaOH (1 M, 0.5 mL). The mixture was stirred at room temperature for 2 h, and 1 M HCl was added to adjust pH to 6. The reaction mixture was diluted with ethyl acetate (15 mL) and washed with water (3 mL) and brine (3 mL). The organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. Purification of the residue by reverse phase chromatography, eluting with a gradient of 20–50% of acetonitrile in water containing 0.1% NH<sub>4</sub>HCO<sub>3</sub>, provided <b>4</b> as a colorless solid (0.017 g, 72% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.80 (s, 1H), 7.13 (s, 1H), 3.68 (s, 2H), 3.20 (s, 3H), 2.06 (br s, 3H), 1.86–1.77 (m, 12H), {NH not observed}; LRMS (ESI) calculated for C<sub>19</sub>H<sub>24</sub>ClN<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 411.1, found 410.9.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-(7-(Adamantan-1-ylmethoxy)-6-chloro-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamide (<b>5</b>)</h3><div class="NLM_p last">Compound <b>5</b> was synthesized using procedures analogous to those described for compound <b>7</b>, starting from 3,4-dichloropyridine. See <a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">Supporting Information</a> for details. Colorless solid (0.034 g). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.14 (s, 1H), 6.92 (s, 1H), 3.71 (s, 2H), 2.95 (s, 3H), 2.00–1.95 (m, 3H), 1.76–1.62 (m, 12H), {NH not observed}; LRMS (ESI) calculated for C<sub>18</sub>H<sub>24</sub>ClN<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 411.1, found 411.3.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-(7-((Adamantan-1-yl)methoxy)-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamide (<b>6</b>)</h3><div class="NLM_p last">Compound <b>6</b> was isolated as a byproduct in the synthesis of compound <b>11</b> and obtained as an off-white solid (0.018 g, 12% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.76 (d, <i>J</i> = 7.7 Hz, 1H), 6.45 (dd, <i>J</i> = 7.7, 2.2 Hz, 1H), 6.36 (d, <i>J</i> = 2.0 Hz, 1H), 3.51 (s, 2H), 3.06 (s, 3H), 2.07–1.97 (m, 3H), 1.80–1.59 (m, 12H), {NH not observed}; LRMS (ESI) calculated for C<sub>18</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>S [M – H]<sup>−</sup> 375.2, found 375.3.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-(7-(Adamantan-1-ylmethoxy)-6-bromo-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamide (<b>7</b>)</h3><div class="NLM_p last">To a mixture of <b>35</b> (0.25 g, 0.66 mmol) and triethylamine (0.28 mL, 2.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (13 mL) was added methanesulfonyl chloride (0.08 mL, 1 mmol) dropwise at 0 °C. The reaction mixture was allowed to warm to ambient temperature and stirred for 0.5 h. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (50 mL), washed with saturated aqueous ammonium chloride (15 mL) and brine (20 mL), and dried over anhydrous MgSO<sub>4</sub>. Filtration and concentration of the filtrate <i>in vacuo</i> provided a residue, which was dissolved in THF (2 mL), and 1 M NaOH (1 mL) was added to it. The reaction mixture was stirred at ambient temperature for 0.5 h, acidified with 1 M HCl to pH 6, and diluted with EtOAc (80 mL). The mixture was washed with water (20 mL) and brine (20 mL), dried over anhydrous MgSO<sub>4</sub>, and filtered, and the filtrate was concentrated <i>in vacuo</i>. Purification of the residue by column chromatography eluting with a gradient of 0% to 5% of MeOH in CH<sub>2</sub>Cl<sub>2</sub> afforded <b>7</b> as a colorless solid (0.09 g, 29% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.50 (s, 1H), 8.21 (s, 1H), 6.89 (s, 1H), 3.71 (s, 2H), 2.96 (s, 3H), 2.04–1.96 (m, 3H), 1.78–1.61 (m, 12H); LRMS (ESI) calculated for C<sub>18</sub>H<sub>24</sub>BrN<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 455.1, found 455.1.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-(7-((Adamantan-1-yl)methoxy)-6-ethyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamide (<b>8</b>)</h3><div class="NLM_p last">Colorless solid (0.005 g). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.10 (s, 1H), 7.62 (s, 1H), 6.37 (s, 1H), 3.54 (s, 2H), 3.08 (s, 3H), 2.58 (q, <i>J</i> = 7.2 Hz, 2H), 2.05 (s, 3H), 1.81–1.66 (m, 12H), 1.25 (t, <i>J</i> = 7.4 Hz, 3H); LRMS (ESI) calculated for C<sub>20</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 405.2, found 405.3.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-(7-((Adamantan-1-yl)methoxy)-6-isopropyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamide (<b>9</b>)</h3><div class="NLM_p last">Following the procedure as described for <b>7</b>, reaction of <b>36</b> with methanesulfonyl chloride followed by purification by reverse-phase HPLC, eluting with a gradient of CH<sub>3</sub>CN in H<sub>2</sub>O containing 0.1% TFA, afforded <b>9</b> as a colorless solid (0.035 g, 8% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.59 (s, 1H), 6.38 (s, 1H), 3.53 (s, 2H), 3.07 (s, 3H), 2.09–1.99 (m, 3H), 1.84–1.61 (m, 13H), 1.23 (s, 6H), {NH not observed}; LRMS (ESI) calculated for C<sub>21</sub>H<sub>31</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 419.2, found 419.2.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-(7-(Adamantan-1-ylmethoxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamide (<b>10</b>)</h3><div class="NLM_p last">Following the procedure as described for <b>7</b>, reaction of <b>37</b> with methanesulfonyl chloride afforded <b>10</b> as a colorless solid (0.13 g, 27% yield). <sup>1</sup>H NMR (601 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.33 (br s, 1H), 7.43 (s, 1H), 6.73 (s, 1H), 3.69 (s, 2H), 2.95 (s, 3H), 2.01–1.98 (m, 3H), 1.92–1.86 (m, 1H), 1.75–1.71 (m, 3H), 1.68–1.66 (m, 9H), 0.93–0.90 (m, 2H), 0.68–0.65 (m, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.7, 144.1, 124.5, 119.0, 88.9, 78.4, 40.8, 38.7, 36.5, 33.3, 27.5, 8.6, 6.1; LRMS (ESI) calculated for C<sub>21</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 417.2, found 417.3.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-(7-((Adamantan-1-yl)methoxy)-6-cyclobutyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamide (<b>11</b>)</h3><div class="NLM_p last">To a mixture of <b>7</b> (0.19 g, 0.41 mmol), palladium(II) acetate (0.009 g, 0.004 mmol), and dicyclohexyl(2′,6′-diisopropoxy-[1,1′-biphenyl]-2-yl)phosphine (RuPhos, 0.039 g, 0.083 mmol) was added a 0.5 M solution of cyclobutylzinc bromide in THF (4.1 mL, 2.05 mmol). The reaction mixture was stirred at ambient temperature for 1 h, then treated with 1 M HCl (5 mL) and diluted with EtOAc (100 mL). The organic phase was washed with brine (5 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated <i>in vacuo</i>, and the residue was purified by reverse-phase HPLC to afford <b>6</b> as first eluting compound and <b>11</b> as second eluting compound. Compound <b>11</b> was obtained as a beige solid (0.010 g, 6% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.57 (s, 1H), 6.33 (s, 1H), 3.66–3.51 (m, 1H), 3.49 (s, 2H), 3.07 (s, 3H), 2.42–2.28 (m, 2H), 2.13–1.99 (m, 7H), 1.82–1.56 (m, 12H); {NH not observed}; LRMS (ESI) calculated for C<sub>22</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub>S [M – H]<sup>−</sup> 429.2, found 429.3.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-(7-(Adamantan-1-ylmethoxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)-1,1-difluoromethanesulfonamide (<b>12</b>)</h3><div class="NLM_p last">To a mixture of <b>37</b> (0.34 g, 1.0 mmol) and triethylamine (0.84 mL, 6.0 mmol) in anhydrous THF (5 mL) was added difluoromethanesulfonyl chloride (0.45 g, 3.0 mmol) at 0 °C. The reaction mixture was allowed to warm to ambient temperature and stirred for 5 h. To the reaction mixture were then added 1 M NaOH (10 mL) and MeOH (2 mL), and the resulting reaction mixture was stirred for 16 h. The reaction mixture was diluted with ethyl acetate (50 mL) and then adjusted to pH 2–3 with 1 M HCl. The organic phase was washed with brine (10 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. Concentration of the filtrate <i>in vacuo</i> and purification of the residue by reverse-phase HPLC afforded <b>12</b> as an off-white solid (0.041 g, 9% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.59 (s, 1H), 6.91 (s, 1H), 6.75 (t, <i>J</i><sub>H–F</sub><i>=</i> 53.8 Hz, 1H), 3.74 (s, 2H), 2.05–1.87 (m, 4H), 1.80–1.60 (m, 12H), 0.99–0.90 (m, 2H), 0.74–0.67 (m, 2H), {NH not observed}; LRMS (ESI) calculated for C<sub>21</sub>H<sub>25</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub>S [M – H]<sup>−</sup> 451.2, found 451.3.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-(7-(Adamantan-1-ylmethoxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-<i>a</i>]-pyridin-3-yl)cyclo-propanesulfonamide (<b>13</b>)</h3><div class="NLM_p last">To a mixture of cyclopropanesulfonamide (1.52 g, 12.5 mmol) in toluene (21 mL) and DMSO (2 mL) was added <b>40</b> (4.2 g, 10 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (7.45 g, 22.9 mmol. The suspension was stirred at ambient temperature for 5 min, and then <i>trans</i>-<i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine (0.44 g, 3.12 mmol) was added. The mixture was carefully degassed with nitrogen, and copper(I) trifluoromethanesulfonate benzene complex (0.74 g, 1.56 mmol) was added. The reaction mixture was stirred at ambient temperature for 10 min and then heated to reflux for 5 h. The reaction mixture was allowed to cool to ambient temperature, ammonium hydroxide (40 mL) and toluene (40 mL) were added, and the mixture was stirred at ambient temperature for 20 min. The organic phase was separated and diluted with toluene (100 mL). To this solution was added 6% aqueous EDTA (75 mL), and the mixture was stirred at ambient temperature for 30 min. The organic layer was separated, diluted with methanol (20 mL), and passed through a short silica column, eluting with 10% methanol in toluene (300 mL). The filtrate was concentrated <i>in vacuo</i> to the point of precipitation. The precipitate was filtered off to afford <b>13</b> as a colorless solid (3.90 g, 78% yield). <sup>1</sup>H NMR (601 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.27 (s, 1H), 7.43 (s, 1H), 6.71 (s, 1H), 3.68 (s, 2H), 2.67–2.61 (m, 1H), 2.01–1.97 (m, 3H), 1.90–1.86 (m, 1H), 1.75–1.70 (m, 3H), 1.66 (s, 9H), 0.99–0.95 (m, 2H), 0.93–0.89 (m, 2H), 0.87–0.82 (m, 2H), 0.68–0.66 (m, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.5, 144.1, 124.6, 119.0, 118.0, 89.1, 78.3, 38.8, 36.5, 33.3, 30.8, 27.5, 8.6, 6.0, 4.5; LRMS (ESI) calculated for C<sub>23</sub>H<sub>31</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 443.2, found 443.2.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(7-(Adamantan-1-ylmethoxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)cyclobutanesulfonamide (<b>14</b>)</h3><div class="NLM_p last">Following the procedure as described for <b>13</b>, reaction of <b>40</b> with cyclobutanesulfonamide afforded <b>14</b> as a colorless solid (0.033 g, 12% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.26 (s, 1H), 7.38 (s, 1H), 6.66 (s, 1H), 3.91–3.74 (m, 1H), 3.63 (s, 2H), 2.35–2.05 (m, 4H), 2.01–1.91 (m, 3H), 1.90–1.75 (m, 3H), 1.73–1.54 (m, 12H), 0.92–0.80 (m, 2H), 0.66–0.57 (m, 2H); LRMS (ESI) calculated for C<sub>24</sub>H<sub>33</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 457.2, found 457.3.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(7-(Adamantan-1-ylmethoxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)-<i>N</i>′-methylsulfuric Diamide (<b>15</b>)</h3><div class="NLM_p last">Following the procedure as described for <b>12</b>, reaction of <b>37</b> with methylsulfamoyl chloride provided <b>15</b> as a colorless solid (0.046 g, 12% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 10.83 (br s, 1H), 7.59 (s, 1H), 6.44 (s, 1H), 5.30–5.27 (m, 1H), 3.57 (s, 2H), 2.75 (s, 3H), 2.03 (s, 3H), 1.93–1.63 (m, 12H), 1.01–0.89 (m, 2H), 0.70–0.59 (m, 2H); LRMS (ESI) calculated for C<sub>21</sub>H<sub>30</sub>N<sub>5</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 432.2, found 432.2.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(7-((Adamantan-2-yl)oxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamide (<b>16</b>)</h3><div class="NLM_p last">Colorless solid (0.19 g). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.46 (s, 1H), 6.84 (s, 1H), 4.81–4.77 (m, 1H), 2.94 (s, 3H), 2.20–2.14 (m, 2H), 2.09–2.05 (m, 2H), 1.98–1.85 (m, 7H), 1.75–1.71 (m, 2H), 1.59–1.55 (m, 2H), 0.94–0.87 (m, 2H), 0.70–0.65 (m, 2H); LRMS (ESI) calculated for C<sub>20</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 403.2, found 403.3.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(7-(2-(Adamantan-2-yl)ethoxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamide (<b>17</b>)</h3><div class="NLM_p last">Colorless solid (0.11 g). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.35 (br s, 1H), 7.39 (s, 1H), 6.82 (s, 1H), 4.15 (t, <i>J</i> = 6.7 Hz, 2H), 2.94 (s, 3H), 1.93–1.81 (m, 4H), 1.70–1.58 (m, 14H), 0.90–0.84 (m, 2H), 0.68–0.63 (m, 2H); LRMS (ESI) calculated for C<sub>22</sub>H<sub>31</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 431.2, found 431.2.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-(7-(Cyclohexylmethoxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methane-sulfonamide (<b>18</b>)</h3><div class="NLM_p last">Beige solid (0.055 g). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.33 (br s, 1H), 7.41 (s, 1H), 6.75 (s, 1H), 3.93 (d, <i>J</i> = 5.5 Hz, 2H), 2.94 (s, 3H), 1.93–1.59 (m, 7H), 1.37–1.02 (m, 5H), 0.93–0.84 (m, 2H), 0.70–0.62 (m, 2H); LRMS (ESI) calculated for C<sub>17</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>S [M – H]<sup>−</sup> 363.2, found 363.3.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(6-Cyclopropyl-7-(((1<i>S</i>,2<i>S</i>,5<i>S</i>)-6,6-dimethylbicyclo[3.1.1]heptan-2-yl)methoxy)-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamide (<b>19</b>)</h3><div class="NLM_p last">Colorless solid (0.020 g). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.37 (br s, 1H), 7.40 (s, 1H), 6.75 (s, 1H), 3.98–3.88 (m, 2H), 2.93 (s, 3H), 2.12–2.05 (m, 1H), 1.96–1.67 (m, 7H), 1.55–1.41 (m, 2H), 1.22 (s, 3H), 0.91–0.84 (m, 5H), 0.67–0.62 (m, 2H); LRMS (ESI) calculated for C<sub>20</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 405.2, found 405.2.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(6-Cyclopropyl-7-((4-fluorobicyclo[2.2.2]octan-1-yl)methoxy)-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)cyclopropanesulfonamide (<b>20</b>)</h3><div class="NLM_p last">Colorless solid (0.028 g). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.54 (br s, 1H), 6.36 (br s, 1H), 3.65 (s, 2H), 2.66–2.52 (m, 1H), 1.97–1.69 (m, 12H), 1.31–1.16 (m, 3H), 1.04–0.90 (m, 4H), 0.71–0.58 (m, 2H), {NH not observed}; LRMS (ESI) calculated for C<sub>21</sub>H<sub>28</sub>FN<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 435.2, found 435.2.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(5-Chloro-6-((3,4-dichlorobenzyl)oxy)benzo[<i>d</i>]isoxazol-3-yl)methanesulfonamide (<b>21</b>)</h3><div class="NLM_p last">Following the procedure as described for <b>4</b>, reaction of <b>30</b> with methanesulfonyl chloride provided <b>21</b> as a colorless solid (0.017 g, 68% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.81 (s, 1H), 7.73 (d, <i>J</i> = 2.0 Hz, 1H), 7.59 (d, <i>J</i> = 8.0 Hz, 1H), 7.48 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.22 (s, 1H), 5.25 (s, 2H), 3.13 (s, 3H), {NH not observed}; LRMS (ESI) calculated for C<sub>15</sub>H<sub>12</sub>Cl<sub>3</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 421.0, found 420.9.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-(5-Chloro-6-((3,4-dichlorophenoxy)methyl)benzo[<i>d</i>]isoxazol-3-yl)methanesulfonamide (<b>22</b>)</h3><div class="NLM_p last">To a mixture of <b>43</b> (0.042 g, 0.12 mmol) in pyridine (2 mL) was slowly added methanesulfonyl chloride (0.016 g, 0.14 mmol) at 0 °C. The reaction mixture was stirred at ambient temperature for 16 h and then concentrated <i>in vacuo</i>. Purification of the residue by reverse phase chromatography, eluting with a gradient of 20–50% of acetonitrile in water containing 0.1% NH<sub>4</sub>HCO<sub>3</sub>, provided <b>22</b> as a colorless solid (0.014 g, 20% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.85 (s, 1H), 7.60 (s, 1H), 7.46 (d, <i>J</i> = 9.0 Hz, 1H), 7.27 (d, <i>J</i> = 3.0 Hz, 1H), 7.05–7.02 (m, 1H), 5.27 (s, 2H), 3.10 (s, 3H), {NH not observed}; LRMS (ESI) calculated for C<sub>15</sub>H<sub>12</sub>Cl<sub>3</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 421.0, found 420.9.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-(5-Cyclopropyl-6-((3,4-dichlorophenoxy)methyl)benzo[<i>d</i>]isoxazol-3-yl)methanesulfonamide (<b>23</b>)</h3><div class="NLM_p last">Colorless solid (0.064 g). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.56 (d, <i>J</i> = 9 Hz, 1H), 7.44–7.42 (m, 2H), 7.21 (s, 1H), 6.92–6.89 (m, 1H), 5.38 (s, 2H), 2.83 (s, 3H), 2.03 (m, 1H), 0.91 (m, 2H), 0.65 (m, 2H), NH not observed; LRMS (ESI) calculated for C<sub>18</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 427.0, found 427.0.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-(6-Cyclopropyl-7-((3,4-dichlorophenoxy)methyl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamide (<b>24</b>)</h3><div class="NLM_p last">Following the procedure as described for <b>13</b>, reaction of <b>50</b> with methanesulfonamide provided <b>24</b> as a colorless solid (0.026 g, 12% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.71 (br s, 1H), 7.57–7.45 (m, 4H), 7.13 (dd, <i>J</i> = 2.9, 8.9 Hz, 1H), 5.32 (s, 2H), 2.94 (s, 3H), 1.95–1.86 (m, 1H), 0.91–0.85 (m, 2H), 0.69–0.64 (m, 2H); LRMS (ESI) calculated for C<sub>17</sub>H<sub>15</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>3</sub>S [M – H]<sup>−</sup> 425.0, found 425.1.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-(6-Cyclopropyl-7-((3,5-dichlorophenoxy)methyl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamide (<b>25</b>)</h3><div class="NLM_p last">Following the procedure as described for <b>13</b>, reaction of <b>51</b> with methanesulfonamide provided <b>25</b> as a colorless solid (0.03 g, 10% yield). <sup>1</sup>H NMR (601 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.58 (s, 1H), 7.55 (s, 1H), 7.29 (d, <i>J</i> = 1.8 Hz, 2H), 7.22–7.21 (m, 1H), 5.37 (s, 2H), 2.99 (s, 3H), 1.98–1.93 (m, 1H), 0.94–0.91 (m, 2H), 0.72–0.69 (m, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.2, 144.0, 142.7, 141.7, 134.7, 127.0, 121.0, 119.3, 114.3, 111.3, 66.8, 41.0, 9.9, 5.8; LRMS (ESI) calculated for C<sub>17</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 427.0, found 427.1.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-(Adamantan-1-ylmethoxy)-5-chloro-2-fluorobenzonitrile (<b>27</b>)</h3><div class="NLM_p last">To a solution of 1-adamantanemethanol (0.192 g, 1.16 mmol) in anhydrous DMF (3 mL) was added sodium hydride (0.070 g of a 60% dispersion in mineral oil, 2.32 mmol) at 0 °C. After stirring at 0 °C for 30 min, a solution of 5-chloro-2,4-difluorobenzonitrile (<b>26</b>; 0.200 g, 1.16 mmol) in anhydrous DMF (1 mL) was added slowly. The reaction mixture was stirred at ambient temperature for 6 h, quenched by saturated NH<sub>4</sub>Cl (10 mL), and extracted with ethyl acetate (5 mL × 3). The combined organic layers were washed with brine, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i> to afford <b>27</b> as a yellowish solid. The residue was used in the next step without further purification. LRMS (ESI) calculated for C<sub>18</sub>H<sub>18</sub>ClFNO [M – H]<sup>−</sup> 318.1, found 318.0.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-Chloro-4-((3,4-dichlorobenzyl)oxy)-2-fluorobenzonitrile (<b>28</b>)</h3><div class="NLM_p last">Following the procedure as described for <b>27</b>, reaction of <b>26</b> with (3,4-dichlorophenyl)methanol afforded <b>28</b> as a yellowish solid. LRMS (ESI) calculated for C<sub>14</sub>H<sub>8</sub>Cl<sub>3</sub>FNO [M + H]<sup>+</sup> 330.0, found 329.9.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 6-(Adamantan-1-ylmethoxy)-5-chloro-1,2-benzoxazol-3-amine (<b>29</b>)</h3><div class="NLM_p last">To a mixture of <i>N</i>-hydroxyacetamide (0.036 g, 0.48 mmol) in anhydrous DMF (2 mL) was added potassium <i>tert</i>-butoxide (54 mg, 0.48 mmol). After stirring at ambient temperature for 30 min, <b>27</b> (0.050 g, 0.16 mmol) was added, and the reaction mixture was stirred at ambient temperature for 16 h. The reaction mixture was quenched by addition of water (5 mL) and extracted with ethyl acetate (5 mL × 3). The combined organic layers were dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. Purification of the residue by reverse phase chromatography, eluting with a gradient of 20–60% of acetonitrile in water containing 0.1% NH<sub>4</sub>HCO<sub>3</sub>, provided <b>29</b> as a colorless solid (0.021 g, 40% yield). LRMS (ESI) calculated for C<sub>18</sub>H<sub>20</sub>ClN<sub>2</sub>O<sub>2</sub> [M – H]<sup>−</sup> 331.1, found 331.0.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 5-Chloro-6-((3,4-dichlorobenzyl)oxy)benzo[<i>d</i>]isoxazol-3-amine (<b>30</b>)</h3><div class="NLM_p last">Following the procedure as described for <b>29</b>, reaction of <b>28</b> with <i>N</i>-hydroxyacetamide provided <b>30</b> as a colorless solid (0.027 g, 51% yield). LRMS (ESI) calculated for C<sub>14</sub>H<sub>10</sub>Cl<sub>3</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 343.0, found 342.9 (M + H).</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-(Adamantan-1-ylmethoxy)-3-bromopyridine (<b>32</b>)</h3><div class="NLM_p last">To a solution of 1-adamantanemethanol (87.6 g, 527 mmol) in anhydrous DMSO (800 mL) was added potassium <i>tert</i>-butoxide (59.4 g, 529 mmol) at ambient temperature. The reaction mixture was stirred for 45 min at ambient temperature and then a solution of 3-bromo-4-chloropyridine (<b>31</b>, 101.3 g, 527 mmol) in anhydrous DMSO (100 mL) was added to it. The resulting mixture was stirred for 3 h then poured onto ice cold water (2 L). The precipitate formed was filtered, washed with water (2 L), and air-dried to afford <b>32</b> as a beige solid (159 g, 94% yield): <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.55 (s, 1H), 8.35 (d, <i>J</i> = 5.6 Hz, 1H), 6.77 (d, <i>J</i> = 5.6 Hz, 1H), 3.60 (s, 2H), 2.04 (s, 3H), 1.82–1.65 (m, 12H). LRMS (ESI) calculated for C<sub>16</sub>H<sub>21</sub>BrNO [M + H]<sup>+</sup> 322.1, found 322.1.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 4-(Adamantan-1-ylmethoxy)-5-bromo-2-chloropyridine (<b>33</b>)</h3><div class="NLM_p last">Step 1, to a solution of <b>32</b> (50.0 g, 156 mmol) in dichloromethane (325 mL) was added <i>m</i>-chloroperoxybenzoic acid (29.6 g, 171 mmol) in portions over 10 min at ambient temperature. The resulting reaction mixture was stirred for 2 h, and then a further portion of <i>m</i>-chloroperoxybenzoic acid (10 g, 58 mmol) was added. The reaction mixture continued to stir for another 1.5 h, and another portion of <i>m</i>-chloroperoxybenzoic acid (10 g, 58 mmol) was added. At this time, all starting material was consumed. The reaction was quenched by slow addition of 1 M NaOH (300 mL) at 0 °C then diluted with diethyl ether (200 mL). The reaction mixture was stirred for 0.5 h at 0 °C, and a colorless precipitate was formed. The solid was filtered off, washed with water (2 L), and air-dried to afford 4-(adamantan-1-ylmethoxy)-3-bromopyridine 1-oxide as a colorless solid (48.5 g, 94% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.35 (d, <i>J</i> = 2.2 Hz, 1H), 8.09 (dd, <i>J</i> = 7.2, 2.2 Hz, 1H), 6.73 (d, <i>J</i> = 7.2 Hz, 1H), 3.58 (s, 2H), 2.09–1.99 (m, 3H), 1.82–1.64 (m, 12H); LRMS (ESI) calculated for C<sub>16</sub>H<sub>21</sub>BrNO<sub>2</sub> [M + H]<sup>+</sup> 338.1, found 338.1. Step 2, a solution of 4-(adamantan-1-ylmethoxy)-3-bromopyridine 1-oxide (50.0 g, 148 mmol) in phosphorus oxychloride (225 mL) was refluxed for 3 h. The reaction mixture was cooled to ambient temperature and concentrated <i>in vacuo</i>. The residue was dissolved in toluene (100 mL) and concentrated <i>in vacuo</i>. This process was repeated two times to remove any residual phosphorus oxychloride. To the residue was then added water (∼1 L) at 0 °C followed by addition of saturated aqueous sodium hydrogen carbonate (∼300 mL). The solid was filtered off, washed with water (∼1 L), and air-dried. The solid was crystallized from toluene to afford <b>33</b> as a colorless solid (46.2 g, 88% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.32 (s, 1H), 6.78 (s, 1H), 3.60 (s, 2H), 2.08–2.01 (m, 3H), 1.85–1.64 (m, 12H); LRMS (ESI) calculated for C<sub>16</sub>H<sub>20</sub>BrClNO [M + H]<sup>+</sup> 356.0, found 356.0.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 4-(Adamantan-1-ylmethoxy)-5-bromo-2-hydrazineylpyridine (<b>34</b>)</h3><div class="NLM_p last">To a microwave vial containing <b>33</b> (3.55 g, 10 mmol) and dioxane (6 mL) was added hydrazine monohydrate (4 mL). The vial was capped and heated in the microwave at 160 °C for 3 h. The reaction was repeated five times on the same scale. Each reaction vial was poured onto ice cold water (∼1 L) and stirred for 0.5 h. The solid was filtered off, washed with water (∼1 L), and dried under house vacuum to afford <b>34</b> as a colorless solid (19.5 g, 92% yield). LRMS (ESI) calculated for C<sub>16</sub>H<sub>23</sub>BrN<sub>3</sub>O [M + H]<sup>+</sup> 352.1, found 352.1.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 7-(Adamantan-1-ylmethoxy)-6-bromo-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-amine (<b>35</b>)</h3><div class="NLM_p last">To a mixture of <b>34</b> (1.04 g, 2.96 mmol) in anhydrous EtOH (60 mL) and CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added cyanogen bromide (0.33 g, 3.0 mmol). The reaction mixture was stirred at ambient temperature for 1 h and then refluxed for 15 min. After the reaction mixture was cooled to ambient temperature, another portion of cyanogen bromide (0.063 g, 0.59 mmol) was added. The reaction mixture was stirred at ambient temperature for 1 h and then refluxed for 0.5 h. The reaction mixture was allowed to cool to ambient temperature and concentrated <i>in vacuo</i>. Trituration of the residue in diethyl ether afforded <b>35</b> as a colorless solid (1.12 g, quantitative yield). LRMS (ESI) calculated for C<sub>17</sub>H<sub>22</sub>BrN<sub>4</sub>O [M + H]<sup>+</sup> 377.1, found 377.1.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 7-(Adamantan-1-ylmethoxy)-6-isopropyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-amine (<b>36</b>)</h3><div class="NLM_p last">Step 1, following the procedure as described for <b>37</b>, reaction of 2-isopropenylboronic acid pinacol ester with <b>36</b> provided 7-((adamantan-1-yl)methoxy)-6-(prop-1-en-2-yl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-amine as a yellowish solid (0.35 g, 78% yield). LRMS (ESI) calculated for C<sub>20</sub>H<sub>27</sub>N<sub>4</sub>O [M + H]<sup>+</sup> 339.2, found 339.3. Step 2, to a flask containing 10% palladium on charcoal (50% wetted powder, 0.35 g, 0.16 mmol) was added a degassed solution of 7-((adamantan-1-yl)methoxy)-6-(prop-1-en-2-yl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-amine (0.35 g, 1.03 mmol) in a mixture of THF (30 mL), MeOH (30 mL), and AcOH (2 mL). Hydrogen was bubbled through the mixture for 1 min, and the reaction was stirred under an atmosphere of hydrogen for 1.5 h. The reaction mixture was degassed with nitrogen and filtered through a pad of diatomaceous earth. Concentration of the filtrate <i>in vacuo</i> afforded <b>36</b> as an oil (0.35 g, quantative yield). LRMS (ESI) calculated for C<sub>20</sub>H<sub>29</sub>N<sub>4</sub>O [M + H]<sup>+</sup> 341.2, found 341.3.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 7-(Adamantan-1-ylmethoxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-amine (<b>37</b>)</h3><div class="NLM_p last">A microwave vial was charged with <b>35</b> (0.40 g, 1.1 mmol), cyclopropylboronic acid (0.55 g, 6.4 mmol), potassium triphosphate (0.90 g, 4.2 mmol), and 1,4-dioxane (7 mL). The reaction mixture was purged with argon for 10 min, and tetrakis(triphenylphosphine)palladium(0) (0.25 g, 0.22 mmol) was added to it. The reaction mixture was heated in a microwave at 160 °C for 30 min. The reaction mixture was allowed to cool to ambient temperature, diluted with ethyl acetate (150 mL), and saturated aqueous ammonium chloride solution (40 mL). The aqueous layer was extracted with ethyl acetate (2 × 50 mL), and the combined organic layers were washed with brine (50 mL), dried over anhydrous MgSO<sub>4</sub>, and filtered. Concentration of the filtrate and purification of the residue by column chromatography, eluting with 10% methanol in dichloromethane (with 2% NEt<sub>3</sub>), afforded <b>37</b> as a pale yellow solid (0.24 g, 67% yield). LRMS (ESI) calculated for C<sub>20</sub>H<sub>27</sub>N<sub>4</sub>O [M + H]<sup>+</sup> 339.2, found 339.3.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 7-(Adamantan-1-ylmethoxy)-6-cyclopropyl-2-(methylsulfonyl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3(2<i>H</i>)-imine (<b>38</b>)</h3><div class="NLM_p last">Compound <b>38</b> was isolated as a byproduct in the synthesis of compound <b>10</b>. Colorless solid (14 mg, 8% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.74 (s, 1H), 8.20 (s, 1H), 7.32 (s, 1H), 3.96 (s, 2H), 3.63 (s, 3H), 2.14–1.96 (m, 4H), 1.81–1.61 (m, 12H), 1.10–1.06 (m, 2H), 0.86–0.79 (m, 2H); LRMS (ESI) calculated for C<sub>21</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 417.2, found 417.2.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 7-(Adamantan-1-ylmethoxy)-6-bromo-[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>39</b>)</h3><div class="NLM_p last">A suspension of <b>34</b> (19.5 g, 55.6 mmol) in triethyl orthoformate (100 mL) was refluxed for 1 h. The reaction mixture initially became a clear solution upon heating, and then a precipitate was formed. After cooling of the reaction mixture to ambient temperature, the solid was filtered off and washed with cold Et<sub>2</sub>O to afford <b>39</b> as beige solid (16.8 g, 84% yield): LRMS (ESI) calculated for C<sub>17</sub>H<sub>21</sub>BrN<sub>3</sub>O [M + H]<sup>+</sup> 362.1, found 362.1.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 7-(Adamantan-1-ylmethoxy)-3-bromo-6-cyclopropyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>40</b>)</h3><div class="NLM_p last">Step 1, to a mixture of <b>39</b> (26.1 g, 72.2 mmol), cyclopropylboronic acid (37.8, 434 mmol), and K<sub>3</sub>PO<sub>4</sub> (61.2 g, 288 mmol) in 1,4-dioxane (500 mL) was added Pd(PPh<sub>3</sub>)<sub>4</sub> (16.7 g, 14.5 mmol), and the mixture was degassed by bubbling argon through it for 10 min. The reaction mixture was heated to reflux for 7 h, and then filtered hot through a pad of diatomaceous earth. The filter pad was washed with hot dioxane, and the combined filtrate was concentrated <i>in vacuo</i>. The residue was purified by column chromatography, eluting with EtOAc and then with 10% of MeOH in CH<sub>2</sub>Cl<sub>2</sub>, to afford 7-(adamantan-1-ylmethoxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridine as beige solid (24.4 g, 64% yield). LRMS (ESI) calculated for C<sub>20</sub>H<sub>26</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 324.2, found 324.2. Step 2, to a solution of 7-(adamantan-1-ylmethoxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridine (24.4 g, 75.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (500 mL) was added NBS (14.8 g, 83.0 mmol), and the reaction mixture was stirred at ambient temperature for 2.5 h. The reaction mixture was washed with saturated sodium thiosulfate solution (3 × 100 mL), saturated sodium hydrogen carbonate solution (3 × 100 mL), and brine (300 mL), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated <i>in vacuo</i>, and the residue was crystallized from ethyl acetate to afford <b>40</b> as a pale yellow solid (23.2 g, 78%). LRMS (ESI) calculated for C<sub>20</sub>H<sub>25</sub>BrN<sub>3</sub>O [M + H]<sup>+</sup> 402.1, found 402.1.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 1-Bromo-5-chloro-4-((3,4-dichlorophenoxy)methyl)-2-fluorobenzene (<b>42</b>)</h3><div class="NLM_p last">Step 1, to a solution of methyl 4-bromo-2-chloro-5-fluorobenzoate (<b>41</b>, 15.4 g, 57.6 mmol) and MeOH (3.70 g, 5.1 mL, 115.0 mmol) in THF was added a 1.0 M solution of lithium borohydride in THF (28.8 mL, 115.0 mmol), and the reaction solution was heated to reflux for 6 h. After cooling to ambient temperature, the reaction mixture was diluted with MeOH (50 mL) and EtOAc (500 mL). The mixture was washed with 10% HCl (3 × 100 mL) and brine (3 × 100 mL), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated <i>in vacuo</i>, and the residue was triturated with Et<sub>2</sub>O to afford (4-bromo-2-chloro-5-fluorophenyl)methanol as a colorless solid (12.9 g, quantitative yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.51 (d, <i>J</i> = 6.1 Hz, 1H), 7.30 (d, <i>J</i> = 8.9 Hz, 1H), 4.69 (s, 2H), 2.14 (br, 1H); LRMS (ESI) calculated for C<sub>7</sub>H<sub>4</sub>BrClFO [M – H]<sup>−</sup> 236.9, found 237.1. Step 2, to a solution of (4-bromo-2-chloro-5-fluorophenyl)methanol (6.50 g, 29.1 mmol) in THF was added TEA (46.1 mL, 43.7 mmol), followed by methanesulfonyl chloride (4.14 g, 36.1 mmol), and the reaction was stirred at ambient temperature for 16 h. The reaction mixture was diluted with EtOAc (200 mL), washed with 1 N HCl (3 × 50 mL) and brine (3 × 100 mL), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated <i>in vacuo</i> to afford 4-bromo-2-chloro-5-fluorobenzyl methanesulfonate as a colorless solid (7.1 g, 77% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.94 (dd, <i>J</i> = 6.3, 0.9 Hz, 1H), 7.64 (d, <i>J</i> = 9.0 Hz, 1H), 5.25 (s, 2H), 3.28 (s, 3H). Step 3, a mixture of 4-bromo-2-chloro-5-fluorobenzyl methanesulfonate (3.17 g, 10.0 mmol), 3,4-dichlorophenol (1.79 g, 11.0 mmol) and K<sub>2</sub>CO<sub>3</sub> (2.03 g, 15.0 mmol) in DMF (20 mL) was stirred at ambient temperature for 3 h. The reaction mixture was filtered, and the residue was washed with EtOAc (100 mL). The combined organic phase was washed with water, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated <i>in vacuo</i> to afford <b>42</b> as a colorless solid (2.50 g, 65% yield). LRMS (ESI) calculated for C<sub>13</sub>H<sub>8</sub>BrCl<sub>3</sub>FO [M + H]<sup>+</sup> 382.9, found 382.8.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-Chloro-6-((3,4-dichlorophenoxy)methyl)benzo[<i>d</i>]isoxazol-3-amine (<b>43</b>)</h3><div class="NLM_p last">Step 1, a microwave vial was charged with <b>42</b> (384 mg, 0.58 mmol), CuCN (0.104 g, 1.16 mmol), CuI (0.011 g, 0.058 mmol), and NMP (3 mL), and the reaction mixture was heated in a microwave to 150 °C for 4 h. After concentration <i>in vacuo</i>, the residue was purified by reverse phase chromatography, eluting with a gradient of 40–80% acetonitrile in water containing 0.1% NH<sub>4</sub>HCO<sub>3</sub>, to afford 5-chloro-4-((3,4-dichlorophenoxy)methyl)-2-fluorobenzonitrile as an off-white solid (0.090 g, 52% yield). Step 2, to a mixture of <i>N</i>-hydroxyacetamide (0.035 g, 0.45 mmol) in DMF (2 mL) was added KO<i>t</i>-Bu (0.050 g, 0.45 mmol), and the mixture was stirred at ambient temperature for 30 min. To this mixture was then added 5-chloro-4-((3,4-dichlorophenoxy)methyl)-2-fluorobenzonitrile (0.050 g, 0.15 mmol), and the reaction mixture was stirred at ambient temperature for 16 h. Concentration <i>in vacuo</i> and purification of the residue by reverse phase chromatography, eluting with a gradient of 20–60% acetonitrile in water containing 0.1% NH<sub>4</sub>HCO, provided <b>43</b> as a colorless solid (0.042 g, 81% yield). LRMS (ESI) calculated for C<sub>14</sub>H<sub>10</sub>Cl<sub>3</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 343.0, found 343.0.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (5-Bromo-2-chloropyridin-4-yl)methanol (<b>45</b>)</h3><div class="NLM_p last">Step 1, to a solution of 5-bromo-2-chloroisonicotinic acid (<b>44</b>, 50.0 g, 211 mmol) in MeOH (200 mL) was added thionyl chloride (50 mL) at 0 °C. The reaction was warmed to ambient temperature and then heated under reflux for 4 h. After cooling to ambient temperature, the reaction mixture was concentrated <i>in vacuo</i>. The residue was diluted with Et<sub>2</sub>O (100 mL), washed with saturated sodium hydrogen carbonate (3 × 50 mL) and brine (3 × 50 mL), and dried over anhydrous sodium sulfate. Filtration and concentration of the filtrate <i>in vacuo</i> afforded methyl 5-bromo-2-chloroisonicotinate as pale yellow liquid (50.2 g, 95% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.55 (s, 1H), 7.59 (s, 1H), 3.93 (s, 3H); LRMS (ESI) calculated for C<sub>7</sub>H<sub>6</sub>BrClNO<sub>2</sub> [M + H]<sup>+</sup> 249.9, found 249.5. Step 2, to a solution of methyl 5-bromo-2-chloroisonicotinate (50.2 g, 200 mmol) in THF (600 mL) and methanol (10.1 mL, 250 mmol) was added a 4 M solution of LiBH<sub>4</sub> in THF (62.5 mL, 250 mmol) at 0 °C. The reaction mixture was allowed to reach ambient temperature and stirred for 4 h. The reaction mixture was then cooled to 0 °C and quenched by slow addition of MeOH (200 mL). The reaction mixture was diluted with EtOAc (200 mL), washed with brine (3 × 100 mL), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated <i>in vacuo</i> to afford <b>45</b> as a colorless solid (35.2 g, 79% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.45 (s, 1H), 7.48 (s, 1H), 5.79 (t, <i>J</i> = 5.4 Hz, 1H), 4.47 (d, <i>J</i> = 4.5 Hz, 2H); LRMS (ESI) calculated for C<sub>6</sub>H<sub>6</sub>BrClNO [M + H]<sup>+</sup> 221.9, found 222.1.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 5-Bromo-2-chloro-4-((3,4-dichlorophenoxy)methyl)pyridine (<b>46</b>)</h3><div class="NLM_p last">To a solution of <b>45</b> (6.49 g, 29.2 mmol) in anhydrous THF (150 mL) was added DIPEA (12.7 mL, 72.9 mmol) and methanesulfonyl chloride (4.5 mL, 58.0 mmol) at 0 °C. The reaction mixture was stirred at the same temperature for 1.5 h and then diluted with EtOAc (300 mL). The organic layer was washed with a mixture of saturated ammonium chloride and water (3:1, 2 × 300 mL), dried over anhydrous magnesium sulfate, and filtered. Concentration of the filtrate <i>in vacuo</i> provided a residue, which was dissolved in a mixture of anhydrous EtOAc and anhydrous DMF (1:1, 80 mL). To this mixture was then added 3,4-dichlorophenol (6.43 g, 39.4 mmol) and K<sub>2</sub>CO<sub>3</sub> (8.07 g, 58.4 mmol), and the reaction mixture was stirred at ambient temperature for 17 h. The reaction mixture was diluted with EtOAc (400 mL) and washed with a mixture of saturated sodium bicarbonate and water (3:1, 2 × 400 mL). The organic phase was dried over anhydrous magnesium sulfate and filtered, and the filtrate was concentrated <i>in vacuo</i>. The residue was triturated in methanol (70 mL) to afford <b>46</b> as a colorless solid (9.03 g, 84% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.47 (s, 1H), 7.52 (s, 1H), 7.36 (d, <i>J</i> = 8.9 Hz, 1H), 7.08 (d, <i>J</i> = 2.9 Hz, 1H), 6.83 (dd, <i>J</i> = 2.9, 8.9 Hz, 1H), 5.01 (s, 2H); LRMS (ESI) calculated for C<sub>12</sub>H<sub>8</sub>BrCl<sub>3</sub>NO [M + H]<sup>+</sup> 365.9, found 365.9.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 5-Bromo-2-chloro-4-((3,5-dichlorophenoxy)methyl)pyridine (<b>47</b>)</h3><div class="NLM_p last">Following the procedure as described for <b>46</b>, reaction of <b>45</b> with 3,5-dichlorophenol provided <b>47</b> as a colorless solid (7.40 g, 69% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.64 (s, 1 H), 7.74 (s, 1 H), 7.28–7.26 (m, 2H), 7.24–7.22 (m, 1H), 5.22 (s, 2H); LRMS (ESI) calculated for C<sub>12</sub>H<sub>8</sub>BrCl<sub>3</sub>NO [M + H]<sup>+</sup> 365.9, found 365.9.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 6-Bromo-7-((3,4-dichlorophenoxy)methyl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>48</b>)</h3><div class="NLM_p last">Step 1, to a solution of <b>46</b> (2.03 g, 5.54 mmol) in anhydrous 1,4-dioxane (30 mL) was added hydrazine hydrate (20 mL), and the reaction mixture was heated under reflux for 21 h. After cooling to ambient temperature, the mixture was slowly added to water (200 mL) under vigorous stirring, and the resulting slurry was filtered. The obtained solid was washed with water (100 mL) and dried to afford 5-bromo-4-((3,4-dichlorophenoxy)methyl)-2-hydrazinylpyridine as a colorless solid (1.86 g, 93% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.04 (s, 1H), 7.73 (s, 1H), 7.52 (d, <i>J</i> = 8.9 Hz, 1H), 7.30 (d, <i>J</i> = 2.9 Hz, 1H), 6.99 (dd, <i>J</i> = 2.9, 8.9 Hz, 1H), 6.86 (s, 1H), 5.03 (s, 2H), 4.14 (s, 2H); LRMS (ESI) calculated for C<sub>12</sub>H<sub>11</sub>BrCl<sub>2</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 362.0, found 361.9. Step 2, following the procedure as described for <b>39</b>, reaction of 5-bromo-4-((3,4-dichlorophenoxy)methyl)-2-hydrazinylpyridine with triethyl orthoformate provided <b>48</b> as a light brown solid (2.84 g, 75% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.16 (s, 1H), 8.99 (s, 1H), 7.99 (s, 1H), 7.54 (d, <i>J</i> = 8.9 Hz, 1H), 7.42 (d, <i>J</i> = 2.9 Hz, 1H), 7.10 (dd, <i>J</i> = 2.9, 8.9 Hz, 1H), 5.17 (s, 2H); LRMS (ESI) calculated for C<sub>13</sub>H<sub>9</sub>BrCl<sub>2</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 371.9, found 372.0.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 6-Bromo-7-((3,5-dichlorophenoxy)methyl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>49</b>)</h3><div class="NLM_p last">Step 1, following the procedure as described for <b>48</b>, reaction of <b>47</b> with hydrazine hydrate provided 5-bromo-4-((3,5-dichlorophenoxy)methyl)-2-hydrazinylpyridine as a colorless solid (7.72 g, quantitative yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.08 (s, 1H), 7.78 (s, 1H), 7.22 (t, <i>J</i> = 1.8 Hz, 1H), 7.14 (d, <i>J</i> = 1.8 Hz, 2H), 6.90 (s, 1H), 5.09 (s, 2H), 4.12 (br s, 2H); LRMS (ESI) calculated for C<sub>12</sub>H<sub>11</sub>BrCl<sub>2</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 362.0, found 362.1. Step 2, following the procedure as described for <b>39</b>, reaction of 5-bromo-4-((3,5-dichlorophenoxy)methyl)-2-hydrazinylpyridine with triethyl orthoformate provided <b>49</b> as a light brown solid (5.10 g, 64% yield): <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.21 (s, 1H), 9.03 (s, 1H), 8.05 (s, 1H), 7.26 (d, <i>J</i> = 1.7 Hz, 2H), 7.22 (dd, <i>J</i> = 1.7, 1.7 Hz, 1H), 5.23 (s, 2H); LRMS (ESI) calculated for C<sub>13</sub>H<sub>9</sub>BrCl<sub>2</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 371.9, found 371.9.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 3-Bromo-6-cyclopropyl-7-((3,4-dichlorophenoxy)methyl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>50</b>)</h3><div class="NLM_p last">Step 1, following the procedure as described for <b>40</b>, reaction of <b>48</b> with cyclopropylboronic acid provided 6-cyclopropyl-7-((3,4-dichlorophenoxy)methyl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridine as a light brown solid (0.28 g, 55% yield):. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.06 (s, 1H), 8.32 (s, 1H), 7.78 (s, 1H), 7.54 (d, <i>J</i> = 8.9 Hz, 1H), 7.45 (d, <i>J</i> = 2.9 Hz, 1H), 7.13 (dd, <i>J</i> = 2.9, 8.9 Hz, 1H), 5.34 (s, 2H), 2.00–1.90 (m, 1H), 0.92–0.85 (m, 2H), 0.68–0.63 (m, 2H); LRMS (ESI) calculated for C<sub>16</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 334.1, found 334.1. Step 2, following the procedure as described for <b>40</b>, reaction of 6-cyclopropyl-7-((3,4-dichlorophenoxy)methyl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridine with NBS provided <b>50</b> as a yellow solid (0.58 g, 97% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.85 (s, 1H), 7.82 (s, 1H), 7.55 (d, <i>J</i> = 8.9 Hz, 1H), 7.47 (d, <i>J</i> = 2.9 Hz, 1H), 7.14 (dd, <i>J</i> = 2.9, 8.9 Hz, 1H), 5.37 (s, 2H), 2.04–1.95 (m, 1H), 0.94–0.88 (m, 2H), 0.79–0.74 (m, 2H); LRMS (ESI) calculated for C<sub>16</sub>H<sub>13</sub>BrCl<sub>2</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 412.0, found 412.0.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 3-Bromo-6-cyclopropyl-7-((3,5-dichlorophenoxy)methyl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>51</b>)</h3><div class="NLM_p last">Step 1, following the procedure as described for <b>40</b>, and using (PPh<sub>3</sub>)<sub>2</sub>PdCl<sub>2</sub> instead of Pd(PPh<sub>3</sub>)<sub>4</sub>, reaction of <b>49</b> with cyclopropylboronic acid provided 6-cyclopropyl-7-((3,5-dichlorophenoxy)methyl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridine as a beige solid (0.76 g, 65% yield). LRMS (ESI) calculated for C<sub>16</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 334.1, found 334.0. Step 2, following the procedure as described for <b>40</b>, reaction of 6-cyclopropyl-7-((3,5-dichlorophenoxy)methyl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridine with NBS provided <b>51</b> as a beige solid (0.66 g, 70% yield). LRMS (ESI) calculated for C<sub>16</sub>H<sub>13</sub>BrCl<sub>2</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 412.0, found 411.9.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Computational Methods</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Energy Minimizations</h4><div class="NLM_p last">5-Chloro-2-fluoro-4-methoxy-<i>N</i>-(methylsulfonyl)benzamide and <i>N</i>-(6-chloro-7-methoxy-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methanesulfonamide were used as simplified examples of the acyl sulfonamide and triazole core, respectively. The conformations of the two compounds were minimized in the gas phase using the MMFF94x force field in MOE 2016.08 and manually superimposed.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Calculated p<i>K</i><sub>a</sub> and LogP Values</h4><div class="NLM_p last">The p<i>K</i><sub>a</sub> and LogP values were calculated with the program MoKa, version 2.6.5.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Na<sub>V</sub>1.<i>x</i> Cell Lines</h3><div class="NLM_p last">Human embryonic kidney (HEK293) cell lines permanently transfected with an expression vector containing the full-length cDNA coding for the human Na<sub>V</sub>1.<i>x</i> sodium channel α-subunit was generated, and the human β1 subunit was coexpressed in this cell line. GenBank accession numbers for the α-subunit are hNa<sub>V</sub>1.1 (<a href="https://www.ncbi.nlm.nih.gov/gquery?Term=NM_006920">NM_006920</a>), hNa<sub>V</sub>1.2 (<a href="https://www.ncbi.nlm.nih.gov/gquery?Term=NM_021007">NM_021007</a>), hNa<sub>V</sub>1.5 (<a href="https://www.ncbi.nlm.nih.gov/gquery?Term=AC127597">AC127597</a>), hNa<sub>V</sub>1.6 (<a href="https://www.ncbi.nlm.nih.gov/gquery?Term=NM_014191">NM_014191</a>), and hNa<sub>V</sub>1.7 (<a href="https://www.ncbi.nlm.nih.gov/gquery?Term=NM_002977">NM_002977</a>).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Radioligand Binding Experiments<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></h3><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Preparation of Membranes</h4><div class="NLM_p last">The human Na<sub>V</sub>1.7 channel was coexpressed with the β1 subunit in a stable HEK293 cell line as described above. Frozen recombinant cell pellets were thawed on ice and diluted to 4 times the cell pellet weight with ice cold 50 mM Tris HCl, pH 7.4, buffer. The cell suspensions were homogenized on ice using a motorized glass dounce homogenizer. Homogenates were further diluted 8.4 times with ice cold 50 mM Tris HCl, pH 7.4, buffer and then centrifuged at 200<i>g</i> at 4 °C for 15 min. The supernatants were collected and centrifuged at 10000<i>g</i> at 4 °C for 50 min. The pellets were then resuspended in 100 mM NaCl, 20 mM Tris HCl, pH 7.4, buffer containing 1% (v/v) protease inhibitors (Calbiochem) and rehomogenized on ice. The homogenized membranes were then processed through a syringe equipped with a 26 gauge needle. Protein concentrations were determined by Bradford Assay, and the membranes were stored at −80 °C.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Competitive Binding Experiments</h4><div class="NLM_p last">Binding reactions were performed in 96-well polypropylene plates at room temperature for 18 h. In a 360 μL assay volume, membranes were incubated with 50 pM [<sup>3</sup>H]GX-545 and increasing concentrations of test compound (1% DMSO). Nonspecific binding was defined in the presence of 1 μM unlabeled GX-545. Total binding was determined in the presence of DMSO (1%). Reactions were transferred and filtered through 96-well glass fiber/C filter plates presoaked with 0.5% poly(ethylene imine). The filtered reactions were washed 5 times with 200 μL of ice cold buffer containing 0.25% BSA. Bound radioactivity was determined by liquid scintillation counting.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Data Analysis</h4><div class="NLM_p last">Percent inhibition was determined and IC<sub>50</sub> values were calculated using a 4-parameter logistic model (% inhibition = <i>A</i> + ((<i>B</i> – <i>A</i>)/(1 + ((<i>x</i>/<i>C</i>)<sup><i>D</i></sup>))) using IDBS XLfit, where <i>A</i> and <i>B</i> are the maximum and minimum inhibition, respectively, <i>C</i> is the IC<sub>50</sub> concentration, and <i>D</i> is the (Hill) slope.</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Voltage-Clamp Whole Cell Recordings</h3><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Inactivated State Block Protocol</h4><div class="NLM_p last">To determine inactivated state inhibition, the membrane potential was maintained at a holding voltage (<i>V</i><sub>hold</sub>) where inactivation of the channel subtype is complete. Specifically, holding voltages used were −60 mV (human Na<sub>V</sub>1.7 and human Na<sub>V</sub>1.5), −35 mV (human Na<sub>V</sub>1.2, and human Na<sub>V</sub>1.6), −40 mV (human Na<sub>V</sub>1.1), and −60 mV (mouse Na<sub>V</sub>1.7). Once every second, the voltage was then stepped back to a very negative (<i>V</i><sub>hold</sub> = −150 mV) voltage for 20 ms to recover fast inactivated channels but not compound bound channels, and then a test pulse to 0 mV is applied to quantify the fraction of channel bound with compound.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> PatchXpress (PX, Molecular Devices, Sunnyvale, CA) Automated Voltage Clamp Platform</h4><div class="NLM_p last">Macroscopic sodium currents were recorded in the whole-cell configuration. The intracellular solution comprised 5 mM NaCl, 10 mM CsCl, 120 mM CsF, 0.1 mM CaCl<sub>2</sub>, 2 mM MgCl<sub>2</sub>, 10 mM HEPES, and 10 mM EGTA (adjusted to pH 7.2 with CsOH), while the extracellular solution comprised 140 mM NaCl, 5 mM KCl, 2 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, and 10 mM HEPES (adjusted to pH 7.4 with NaOH). Generally, the external sodium was reduced by equimolar replacement with choline. Osmolarity in the internal and external solutions was adjusted to 300 and 310 mOsm/kg with glucose, respectively. Currents were recorded at 40 kHz sampling frequency, filtered at 5 Hz, and analyzed with DataXpress software (DX2, Molecular Devices, Sunnyvale, CA). Series resistance compensation was applied at 60–80%. Compound inhibition was fitted to the Hill equation <i>Y</i> = [C]<sup><i>h</i></sup>/(IC<sub>50</sub><sup><i>h</i></sup> + [C]<sup><i>h</i></sup>) to estimate the half maximal inhibition concentration (IC<sub>50</sub> value); where <i>Y</i> is the normalized inhibition relative to the control, [C] the test compound concentration, IC<sub>50</sub> the concentration of test compound to inhibit the currents 50%, and <i>h</i> the Hill coefficient. IC<sub>50</sub> values generated on the PatchXpress automated voltage-clamp platform are presented as mean ± SD.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> QPatch HT (Sophion A/S, Copenhagen, Denmark) Automated Voltage Clamp Device</h4><div class="NLM_p last">Intra- and extracellular solutions and osmolarity were used as described for the PatchXpress system. Data were analyzed with QPatch Assay Software (Sophion A/S, Copenhagen, Denmark). IC<sub>50</sub> values on the QPatch automated voltage-clamp platform were generated from pooled data, for which SD is not applicable.</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Qube384 (Sophion A/S, Copenhagen, Denmark) Automated Voltage Clamp System</h4><div class="NLM_p last">A reverse sodium gradient was used during electrophysiological recordings. Specifically, low sodium (1 mM) extracellular and high sodium (120 mM) intracellular solutions were used. These solutions contained the following (mM): low sodium, 1 NaCl, 139 choline chloride, 5 KCl, 2 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, and 10 HEPES; high sodium, 120 NaF, 10 CsCl<sub>2</sub>, 0.1 CaCl<sub>2</sub>, 2 MgCl<sub>2</sub>, 10 HEPES, and 10 EGTA. The external solution was titrated with sodium hydroxide to pH 7.4, while the intracellular solution was titrated with CsOH to pH 7.2. Currents were low pass filtered at 5 kHz and recorded at 25 kHz sampling frequency. Appropriate filters for minimum seal resistance and minimum current size were applied, and series resistance was compensated 100% (routinely membrane resistance >500 MΩ and current magnitude >1 nA at a 0 mV test pulse from a −120 holding potential). Data was collected at room temperature, which corresponds to 27 ± 2 °C at the recording chamber. Every experimental plate contained vehicle controls to quantify and correct for any compound independent “run-down” of currents. Baselines were established after 20 min in vehicle. Maximal inhibition was established by adding 300 nM tetrodotoxin (TTX) to each well at the end of the experiment. Fractional block was calculated from fractional reduction of current amplitude from baseline to maximal block after 20 min of exposure for IC<sub>50</sub> determinations or 26 min in kinetic experiments. Data analysis was performed using Analyzer (Sophion A/S, Copenhagen, Denmark) and Prism (GraphPad Software Inc., La Jolla, CA, USA) software. IC<sub>50</sub> values on the Qube automated voltage-clamp platform were generated from Hill equation fits to pooled data, for which SD is not applicable.</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Site Directed Mutagenesis of VSD4 Residues</h3><div class="NLM_p last">The human Na<sub>V</sub>1.7 channel was coexpressed with the β1 subunit in a stable HEK293 cell line as described above. Stable HEK293 cell lines with a permanently transfected Y1537A, R1602A, R1605A, or R1608A mutation of hNaV1.7 were also generated, each coexpressed the β1 subunit. hNa<sub>V</sub>1.7 VSD4 mutants were generated using Agilent’s QuikChange II XL site-directed mutagenesis kit, and all constructs were confirmed by full-length DNA sequencing. Whole-cell patch clamp recordings of mutant sodium currents were recorded using the Qube384 (Sophion A/S, Copenhagen, Denmark) automated voltage clamp system using conditions stated above unless otherwise stated. To determine inactivated state block, the membrane potential was maintained at −60 mV (Na<sub>V</sub>1.7<sup>WT</sup> and Na<sub>V</sub>1.7<sup>Y1537A</sup>) or −75 mV (Na<sub>V</sub>1.7<sup>R1602A</sup>, Na<sub>V</sub>1.7<sup>R1605A</sup>, and Na<sub>V</sub>1.7<sup>R1608A</sup>; see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">Supporting Information</a>). Once every 10 s, the voltage was stepped back to a very negative (<i>V</i><sub>hold</sub> = −150 mV) voltage for 20 ms and then a test pulse is applied to quantify the drug block. Normalized compound inhibition was fit to the Hill equation. Data analysis was performed using Analyzer (Sophion A/S, Copenhagen, Denmark) and Prism (GraphPad Software Inc., La Jolla, CA, USA) software. Results are presented as mean ± SEM. Statistical comparisons (Student’s <i>t</i> test, one-way ANOVA) were performed using Prism, and <i>P</i> values of <0.05 were considered statistically significant.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Kinetic Solubility, LogD, and p<i>K</i><sub>a</sub> Measurements</h3><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Kinetic Solubility Assay</h4><div class="NLM_p last">The kinetic solubility was determined as previously described.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Compounds were dissolved in DMSO to a concentration of 10 mM. Samples were prepared by diluting 4 μL of the DMSO stock solution with 196 μL of PBS buffer (pH 7.4) in 96-well filter plates, yielding a compound concentration of 200 μM and 2% DMSO. The filter plates were sealed and shaken at 1000 rpm for 24 h. Solutions were then filtered into a clean 96-well plate, diluted with PBS (pH 7.4) buffer, and transferred to a 384-well plate for analysis by LCMS-CLND (CLND, chemiluminescence nitrogen detector).</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Measured LogD<sub>7.4</sub></h4><div class="NLM_p last">The LogD values were determined as previously described.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Test compounds were prepared as 10 mM DMSO stock solutions. Two assay solutions were prepared: buffer saturated 1-octanol (20 mL of PBS, pH 7.4, and 200 mL of 1-octanol) and 1-octanol saturated PBS (1 mL of 1-octanol and 200 mL of PBS, pH 7.4). Test compounds (5 μL) and buffer saturated 1-octanol (250 μL) were dispensed into each well of a 96-well plate. The plates were sealed and shaken at 1000 rpm for 20 min, then 1-octanol saturated PBS (250 μL) was added to each well. The plates were resealed, shaken at 1000 rpm for 1 h, and centrifuged at 3000 rpm for 10 min. Samples of the phases were transferred to separate 384-well plates, and internal standard was added for analysis. The concentration of test compound in each phase was determined by LCMS/MS. The LogD<sub>7.4</sub> value was calculated as the log of ratio of the solute in the octanol and PBS phases.</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> p<i>K</i><sub>a</sub> Measurements</h4><div class="NLM_p last">p<i>K</i><sub>a</sub> values were determined on a Sirius T3 instrument using published UV-metric procedures.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> In Vitro Metabolic Stability Experiments</h3><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Metabolic Stability Studies in Liver Microsomes</h4><div class="NLM_p last">The oxidative metabolism was evaluated in pooled liver microsomes (Celsis, Chicago, IL) from CD-1 mice (<i>n</i> = 10), Sprague–Dawley rats (<i>n</i> = 20), cynomolgus monkeys (<i>n</i> = 4), beagle dogs (<i>n</i> = 3), and humans (<i>n</i> = 15; Invitrogen Corporation, Carlsbad, CA). The incubation mixture was prepared for each species in 0.1 M potassium phosphate buffer (pH 7.4) containing 0.5 mg/mL microsomal protein, 1 mM NADPH, and 1 μM of test compound. Reactions were initiated with the addition of NADPH. Samples were incubated at 37 °C, and aliquots were sampled at 0, 20, 40, and 60 min. Reactions were quenched with 95/5 acetonitrile/water (v/v) with internal standard at each time point. Samples were centrifuged at 3000<i>g</i> for 10 min. Supernatant was diluted with water (1:2 ratio), and the percentage of compound remaining was determined by LC–MS/MS using the <i>t</i> = 0 peak area ratio values as 100%. The <i>in vitro</i> Cl<sub>int</sub> and scaled hepatic Cl<sub>hep</sub> were determined as described by Obach et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Metabolic Stability Study in Cryopreserved Hepatocytes</h4><div class="NLM_p last">The oxidative and conjugative metabolism were evaluated in cryopreserved hepatocytes from CD-1 mice (<i>n</i> = 10), Sprague–Dawley rats (<i>n</i> = 3), cynomolgus monkey, beagle dog (Invitrogen Corporation, Carlsbad, CA), and humans (<i>n</i> = 10; Celsis, Baltimore, MD). The cells were seeded at a density of 0.5 × 10<sup>6</sup> cells/mL; reactions were initiated with the addition of test compound to make the final substrate concentration of 1 μM. Samples were incubated at 37 °C in 5% carbon dioxide with saturating humidity, and aliquots were sampled at 0, 1, 2, and 3 h. Reactions were quenched with acetonitrile containing internal standard at each time point. Samples were centrifuged at 2000<i>g</i> for 10 min. Supernatant was diluted with water (1:2 ratio), and the percentage of test compound remaining was determined by LC/MS/MS. Using the <i>t</i> = 0 peak area ratio values as 100%, the <i>in vitro</i> Cl<sub>int</sub> and scaled hepatic Cl<sub>hep</sub> were determined as previously described:<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27−29)</a><span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_m001.gif" alt="" id="_i86" /></img></span>, where <i>Q</i><sub>Liver</sub> is the liver blood flow; standard deviation is not applicable.</div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> <i>In Vitro</i> Pgp (MDR1) Transport Assays</h3><div class="NLM_p last">Madin–Darby canine kidney (MDCK) cells heterologously expressing human Pgp were used to determine if a compound was a substrate of these transporters. MDR1-MDCKI cells were licensed from the National Cancer Institute (Bethesda, MD). For transport studies, cells were seeded on 12-well Costar Transwell plates 4 days before use (polyester membrane, 0.4 μm pore size; Corning Life Sciences, Lowell, MA) at a seeding density of 1.3 × 10<sup>5</sup> cells/mL. Compounds were tested at 10 μM in the MDR1 assay in the apical-to-basolateral (A-B) and basolateral-to-apical (B-A) directions. The compound was dissolved in transport buffer consisting of Hank’s balanced salt solution and 10 mM HEPES (Invitrogen Corporation, Grand Island, NY). Lucifer Yellow (Sigma-Aldrich) was used as the paracellular marker. The efflux ratio (ER) was calculated as ER = <span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_m002.gif" alt="" id="_i88" /></img></span>; standard deviation is not available.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> <i>In Vitro</i> Plasma Protein Binding</h3><div id="sec5_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> RED Device</h4><div class="NLM_p last">The extent of protein binding was determined <i>in vitro</i> and in CD-1 mouse, Sprague–Dawley rat, cynomolgus monkey, beagle dog, and human plasma (Bioreclamation Inc., Hicksville, NY) by equilibrium dialysis using the RED (rapid equilibrium dialysis) device (Thermo Fisher Scientific, Rockford, IL). Test compounds were dissolved in dimethyl sulfoxide (DMSO) and added to plasma for a final concentration of 5 μM of test compound and 1% of DMSO in the plasma. Plasma samples (300 μL) were dialyzed against PBS buffer (500 μL) on a shaking platform in a humidified incubator for 4 h at 37 °C. Following dialysis, buffer and plasma samples were transferred to a 96-well plate. Plasma proteins were precipitated with acetonitrile containing an internal standard. The amount of the parent analyte in the plasma and buffer samples was quantified by LCMS/MS, and percent unbound fraction (fu) was calculated.</div></div><div id="sec5_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> HT Dialysis</h4><div class="NLM_p last">The extent of protein binding was determined at WuXi Apptec in CD-1 mouse plasma (BioreclamationIVT) by equilibrium dialysis using HT Dialysis plates (model HTD 96b, HT Dialysis LLC, Gales Ferry, CT) in a similar fashion as described above, except that a final concentration of 2 μM of test compound was used.</div></div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Cytochrome P450 (CYP) Inhibition Assays</h3><div class="NLM_p last">Test compounds were incubated with 0.2 mg/mL human liver microsomes (150 donor pool, BD Biosciences, San Jose, CA) together with NADPH cofactor and the specific probe substrate for each CYP tested: CYP1A2 (phenacetin), CYP2C9 (warfarin), CYP2C19 (mephenytoin), CYP2D6 (dextromethorphan), and CYP3A4 (testosterone and midazolam). The reactions were terminated after 30 min by addition of cold acetonitrile/formic acid (94:6 v/v) containing an internal standard. Inhibition was determined through conversion of the probe substrates by CYPs as determined by LCMS/MS analysis. Five concentrations of each test compound were tested (0.1, 1, 5, and 10 μM, as well as a solvent control) to generate IC<sub>50</sub> values. IC<sub>50</sub> values were obtained from single experiments; SD is not applicable.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Human Pregnane X Receptor (PXR) Activation Assay</h3><div class="NLM_p last">The ability of test compounds to activate PXR was determined by using DPX2 cells, a human HepG2-derived cell line stably integrated with a PXR expression vector plus a luciferase reporter gene. DPX2 cells were treated with test compounds at eight concentrations from 0.046 to 20 μM in duplicate for 24 h at 37 °C in a CO<sub>2</sub> incubator. Cell viability was assessed fluorimetrically with CellTiter-Fluor to obtain relative fluorescent units (RFUs). The luciferase activity, which was directly proportional to the extent of PXR activation and accompanying gene transcription in the DPX2 cells was measured using One-Glo to obtain relative luminescent units (RLUs). The PXR (luciferase) activity was normalized with cell viability by dividing the average RLU by the average RFU at each test compound concentration, as well as in the vehicle control. PXR receptor activation fold increase was calculated by dividing the normalized luciferase activity of individual doses by that of the normalized DMSO vehicle control. The final data was expressed as fold activation relative to the vehicle control. Rifampicin (RIF) was used as positive control. The use of eight concentrations of test compounds and RIF allowed for the derivation of EC<sub>50</sub> from nonlinear regression analysis of the log dose–response curves. Induction of PXR by test compound was expressed as percentage of activation seen with rifampicin when both compounds were used at a test concentration of 10 μM. Test compounds showing activation <15% of 10 μM RIF would be considered negative.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Use of Animal Subjects</h3><div class="NLM_p last">All studies involving animals were either approved by the Animal Care Committee of Xenon Pharmaceuticals (Burnaby, BC, Canada) and performed in compliance with the Canadian Council on Animal Care guidelines (mouse efficacy and mouse PK studies) or approved by and conformed to the guidelines and principles set by the Institutional Animal Care and Use Committee of Genentech (South San Francisco, CA, USA) (mouse, rat, and dog PK studies).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Pharmacokinetic Studies in Mice, Rats, and Dogs</h3><div id="sec5_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> FVB Mouse PK</h4><div class="NLM_p last">Male FVB mice between 6 and 7 weeks of age with body weight ranging from 23 to 30 g were obtained from Charles River Laboratories (Kingston, NY). Animals were divided into groups of 3 per route and dose, and were not fasted before dosing. Mice in each group received an oral dose of the test article at 30 mg/kg prepared in 0.5% methyl cellulose with 0.2% Tween 80 (MCT) at a dose volume of 5 mL/kg. Blood samples (15 μL) were collected via tail nick from each animal at 0.25, 0.5, 1, 2, 4, and 6 h postdose and added to 60 μL of EDTA (1.7 mg/mL) water. Test article concentration in each blood sample was determined by a nonvalidated LCMS/MS assay at Genentech. The study for compound <b>25</b> was performed at Xenon Pharmaceuticals at a dose of 10 mg/kg using otherwise similar conditions. Male FVB mice were 7 weeks old and obtained from the Jackson Laboratory (Bar Harbor (ME)).</div></div><div id="sec5_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> CF-1 Mouse PK</h4><div class="NLM_p last">Male CF-1 mice (4–5 weeks old) ranging from 30 to 40 g were obtained from Envigo RMS Inc. (Haslett, MI). Animals were given <i>ad libitum</i> food and water access prior to studies. For iv dosing, three mice were given a single iv dose in 50% poly(ethylene glycol) 400 in phosphate buffered saline and 50% 2-(hydroxpropyl)-β-cyclodextrin in phosphate buffered saline (40:60). Blood samples (approximately 0.04 mL per sample) were collected from each animal into tubes containing K<sub>2</sub>EDTA at 0.033, 0.167, 0.5, 1, 2, 4, 8, and 24 h after dose administration. For oral dosing, three mice were given a single po dose in 0.5% w/w methyl cellulose and 0.2% v/v tween 80 in deionized water. Blood samples (approximately 0.04 mL per sample) were collected from each animal into tubes containing K<sub>2</sub>EDTA at 0.25, 0.5, 1, 2, 4, 8, and 24 h after dose administration. Blood was centrifuged for 10 min to harvest plasma. The concentration of test compound in each plasma sample was determined by LCMS/MS assay at Xenon.</div></div><div id="sec5_14_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> Rat PK</h4><div class="NLM_p last">Male Sprague–Dawley (SD) rats (9–11 weeks old) ranging from 250 to 300 g were obtained from Charles River Laboratories (Hollister, CA). Animals were fasted 16 h before oral dose administration. Three rats were given a single iv dose in 10% DMSO, 50% poly(ethylene glycol) 400, and 40% phosphate buffered saline. Blood samples (approximately 0.2 mL per sample) were collected from each animal into tubes containing K<sub>2</sub>EDTA at 0.033, 0.083, 0.25, 0.5, 1, 2, 4, 6, and 8 h after dose administration. Blood was centrifuged for 10 min to harvest plasma. The concentration of test compound in each plasma sample was determined by a nonvalidated LCMS/MS assay at Genentech. Pharmacokinetic analysis was performed at Genentech using noncompartmental methods.</div></div><div id="sec5_14_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> Dog PK</h4><div class="NLM_p last">Pharmacokinetics of test compound was determined in male Beagle dogs following a single intravenous bolus (iv) administration. Non-naive male Beagle dogs ages ranging from 6 months to 3 years old and weighing between 6 and 12 kg were obtained from Marshall Bioresources (Beijing, China). Animals were not fasted before iv dosing. Blood samples were collected in tubes containing K<sub>2</sub>EDTA at predose and at 0.033, 0.083, 0.25, 0.5, 1, 3, 6, 9, and 24 h post-iv administration. Blood was centrifuged for 10 min to harvest plasma. The concentration of test compound in each plasma sample was determined by a nonvalidated LCMS/MS assay at Wuxi AppTech, Inc. Pharmacokinetic analysis was performed at Genentech using noncompartmental methods.</div></div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Generation of Transgenic Mice</h3><div class="NLM_p last">Four founder strains were generated at Taconic Laboratories using BAC transgenic methodology. The full-length BAC construct, RP11–458J20, contained exons 1–27 and included ∼85 kb of sequence upstream from exon 1 and ∼4 kb of sequence downstream from exon 27. The human Na<sub>V</sub>1.7 IEM mutation I848T (ATT to ACT) was incorporated into exon 16. The mutation was confirmed by sequencing a PCR product amplified from the final BAC construct. The final BAC was run on a pulse-field gel to evaluate its integrity and injected into FVB strain of mouse embryos for the production of integration positive founder animals. For genotyping, mouse tail biopsies were collected for DNA extraction. Genomic DNA was extracted and tested for the presence of BAC transgene DNA with PCR assays using primers specific for the human Na<sub>V</sub>1.7 sequence within exon 10. Each of the strains was evaluated for appropriate tissue-specific expression of human Na<sub>V</sub>1.7 using TaqMan RT-PCR assays. The founder strain chosen for use in the <i>in vivo</i> assays had the distribution of human Na<sub>V</sub>1.7 most consistent with the distribution of the mouse ortholog.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> Efficacy Studies in Human Na<sub>V</sub>1.7 I848T Transgenic Mice</h3><div class="NLM_p">Male FVB <i>hSCN9a</i> Tg used for the experiments were seven to 10 weeks old and weighed 19 to 27 g. The test compound was administered orally in 0.5% w/w methyl cellulose and 0.2% v/v tween 80 in deionized water at a dose volume of 10 mL/kg 2 h before injection of the pain agent. The mice were then acclimatized to the test chamber for 60 min prior to injection of the pain-inducing agent. A volume of 20 μL of 39 μM aconitine was injected subcutaneously into the dorsal region of the left hind paw to induce spontaneous pain. Video data acquisition begins immediately after injection of the pain agent and continues for a total duration of 70 min. The first 30 min of each acquired video was analyzed and scored for the time spent flicking, lifting, biting, or licking the injected paw. At approximately 3–4 h post treatment (dosing of test compound), terminal blood samples via cardiac puncture were collected upon euthanasia of animals in addition to brain tissue. Plasma prepared in EDTA and brain tissue were frozen in liquid nitrogen and stored at −80 °C for PK analysis.</div><div id="sec5_16_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Plasma Analysis</h4><div class="NLM_p last">Plasma samples (50 μL) obtained from centrifugation of blood samples collected were extracted by protein precipitation with CH<sub>3</sub>CN (300 μL) after addition of an appropriate internal standard (50 μL). Extracts were centrifuged for 20 min, and the supernatants were collected for analysis. All samples were analyzed by UHPLC/MS/MS at Xenon Pharmaceuticals. A detailed description of the I848T transgenic mice, including efficacy studies and correlation to traditional rodent pain models, will be provided in a separate manuscript (G. Bankar et al., manuscript submitted).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i103"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01826" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01826" class="ext-link">10.1021/acs.jmedchem.7b01826</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthetic schemes and procedures for the synthesis of compounds <b>5</b>, <b>8</b>, <b>16</b>–<b>20</b>, and <b>23</b>, including characterization data for intermediates, additional SAR, modeling and mutagenesis data, crystal structure data for <b>1</b>, determination of <i>k</i><sub>on</sub>, <i>k</i><sub>off</sub>, and residence times for <b>10</b>, <b>13</b>, and <b>25</b>, CEREP data for <b>13</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Crystallographic information for compound <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_002.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf">jm7b01826_si_001.pdf (1.0 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_002.cif">jm7b01826_si_002.cif (22.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_003.csv">jm7b01826_si_003.csv (2.23 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Full structural data for compound <b>1</b> were submitted to the CCDC as number 1590582. Authors will release the atomic coordinates and experimental data upon article publication. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via <a href="https://www.ccdc.cam.ac.uk/structures" class="extLink">https://www.ccdc.cam.ac.uk/structures</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01826" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thilo Focken</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1993-2476" title="Orcid link">http://orcid.org/0000-0003-1993-2476</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#16627079757d7378566e737879783b667e77647b773875797b"><span class="__cf_email__" data-cfemail="90e4f6fff3fbf5fed0e8f5fefffebde0f8f1e2fdf1bef3fffd">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian S. Safina</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span>Present Address:
                        B.S.S.: Bolt Biotherapeutics, 640 Galveston Drive, Redwood City, CA 94063, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8134-9949" title="Orcid link">http://orcid.org/0000-0001-8134-9949</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d0b2a3b1b6b9beb190b2bfbca4b2b9bffeb3bfbd"><span class="__cf_email__" data-cfemail="b4d6c7d5d2dddad5f4d6dbd8c0d6dddb9ad7dbd9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sultan Chowdhury</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alla Zenova</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael E. Grimwood</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Chabot</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Sheng</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span>; 
    <span>Present Address:
                        T.S.: Inception Sciences Canada, 887 Great Northern Way, Suite 210, Vancouver, BC V5T 4T5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ivan Hemeon</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shannon M. Decker</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Wilson</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Bichler</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Jia</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shaoyi Sun</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clint Young</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span>; 
    <span>Present Address:
                        C.Y.: GlaxoSmithKline, 1250 Collegeville Road, Collegeville, Pennsylvania 19426, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sophia Lin</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samuel J. Goodchild</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noah G. Shuart</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elaine Chang</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiwei Xie</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span>; 
    <span>Present Address:
                        Z.X.: SignalChem Lifesciences, 13120 Vanier Place, Suite 110, Richmond, BC, V6V 2J2, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bowen Li</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kuldip Khakh</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Girish Bankar</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Waldbrook</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rainbow Kwan</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Nelkenbrecher</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Parisa Karimi Tari</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Navjot Chahal</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luis Sojo</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">C. Lee Robinette</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew D. White</span> - <span class="hlFld-Affiliation affiliation">Chempartner, Building No. 5, 998 Halei Rd., Zhangjiang Hi-Tech
Park, Pudong New Area, Shanghai 201203, China</span>; 
    <span>Present Address:
                        A.D.W.: University of Michigan, College of Pharmacy, 428 Church St., Ann Arbor, MI 48109, USA</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chien-An Chen</span> - <span class="hlFld-Affiliation affiliation">Chempartner, Building No. 5, 998 Halei Rd., Zhangjiang Hi-Tech
Park, Pudong New Area, Shanghai 201203, China</span>; 
    <span>Present Address:
                        C.-A.C.: Wuxi Apptec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi Zhang</span> - <span class="hlFld-Affiliation affiliation">Chempartner, Building No. 5, 998 Halei Rd., Zhangjiang Hi-Tech
Park, Pudong New Area, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jodie Pang</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jae H. Chang</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David H. Hackos</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. P. Johnson</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles J. Cohen</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel F. Ortwine</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel P. Sutherlin</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christoph M. Dehnhardt</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals, Inc., 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i112">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85015" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85015" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Antonio Depasquale for determining the small molecule X-ray structure of compound <b>1</b>. We also thank Baiwei Lin and others in the Genentech Analytical Group for the p<i>K</i><sub>a</sub> and LogD determinations.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">B/P</td><td class="NLM_def"><p class="first last">brain-to-plasma ratio</p></td></tr><tr><td class="NLM_term">CIP</td><td class="NLM_def"><p class="first last">congenital insensitivity to pain</p></td></tr><tr><td class="NLM_term">Cl<sub>hep</sub></td><td class="NLM_def"><p class="first last">predicted hepatic clearance</p></td></tr><tr><td class="NLM_term">cLogP</td><td class="NLM_def"><p class="first last">calculated logarithm of partition coefficient</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum concentration</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">cp<i>K</i><sub>a</sub></td><td class="NLM_def"><p class="first last">calculated logarithmic acid dissociation constant</p></td></tr><tr><td class="NLM_term">DH</td><td class="NLM_def"><p class="first last">dog hepatocytes</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DLM</td><td class="NLM_def"><p class="first last">dog liver microsomes</p></td></tr><tr><td class="NLM_term">DRG</td><td class="NLM_def"><p class="first last">dorsal root ganglion</p></td></tr><tr><td class="NLM_term">HH</td><td class="NLM_def"><p class="first last">human hepatocytes</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">IEM</td><td class="NLM_def"><p class="first last">inherited erythromelalgia</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">LBA</td><td class="NLM_def"><p class="first last">ligand binding assay</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term">LRMS</td><td class="NLM_def"><p class="first last">low resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney cell line</p></td></tr><tr><td class="NLM_term">MDR1</td><td class="NLM_def"><p class="first last">multidrug resistance protein 1</p></td></tr><tr><td class="NLM_term">MH</td><td class="NLM_def"><p class="first last">mouse hepatocytes</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsomes</p></td></tr><tr><td class="NLM_term">mLogD</td><td class="NLM_def"><p class="first last">measured distribution coefficient at pH 7.2</p></td></tr><tr><td class="NLM_term">MsCl</td><td class="NLM_def"><p class="first last">methanesulfonyl chloride</p></td></tr><tr><td class="NLM_term">Na<sub>V</sub></td><td class="NLM_def"><p class="first last">voltage-gated sodium channel</p></td></tr><tr><td class="NLM_term">PEPD</td><td class="NLM_def"><p class="first last">paroxysmal extreme pain disorder</p></td></tr><tr><td class="NLM_term">PNS</td><td class="NLM_def"><p class="first last">peripheral nervous system</p></td></tr><tr><td class="NLM_term">PX</td><td class="NLM_def"><p class="first last">PatchXpress automated patch clamp system</p></td></tr><tr><td class="NLM_term">RH</td><td class="NLM_def"><p class="first last">rat hepatocytes</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsomes</p></td></tr><tr><td class="NLM_term"><i>SCN9A</i></td><td class="NLM_def"><p class="first last">gene encoding the sodium channel Na<sub>V</sub>1.7</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>max</sub></td><td class="NLM_def"><p class="first last">time of maximum concentration</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">VSD</td><td class="NLM_def"><p class="first last">voltage-sensor domain</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i114">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14077" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14077" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eijkelkamp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cregg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werdehausen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugiero, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span> <span> </span><span class="NLM_article-title">Neurological perspectives on voltage-gated sodium channels</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">2585</span>– <span class="NLM_lpage">2612</span>, <span class="refDoi"> DOI: 10.1093/brain/aws225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1093%2Fbrain%2Faws225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=22961543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2012&pages=2585-2612&author=N.+Eijkelkampauthor=J.+E.+Linleyauthor=M.+D.+Bakerauthor=M.+S.+Minettauthor=R.+Creggauthor=R.+Werdehausenauthor=F.+Rugieroauthor=J.+N.+Wood&title=Neurological+perspectives+on+voltage-gated+sodium+channels&doi=10.1093%2Fbrain%2Faws225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological perspectives on voltage-gated sodium channels</span></div><div class="casAuthors">Eijkelkamp Niels; Linley John E; Baker Mark D; Minett Michael S; Cregg Roman; Werdehausen Robert; Rugiero Francois; Wood John N</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">Pt 9</span>),
    <span class="NLM_cas:pages">2585-612</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The activity of voltage-gated sodium channels has long been linked to disorders of neuronal excitability such as epilepsy and chronic pain.  Recent genetic studies have now expanded the role of sodium channels in health and disease, to include autism, migraine, multiple sclerosis, cancer as well as muscle and immune system disorders.  Transgenic mouse models have proved useful in understanding the physiological role of individual sodium channels, and there has been significant progress in the development of subtype selective inhibitors of sodium channels.  This review will outline the functions and roles of specific sodium channels in electrical signalling and disease, focusing on neurological aspects.  We also discuss recent advances in the development of selective sodium channel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMaWmHsTCoQ3l8icjszYl0fW6udTcc2eYyBKyN_Mls4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D&md5=6f9b33df722a3c5831b8860d3fad1af2</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Faws225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Faws225%26sid%3Dliteratum%253Aachs%26aulast%3DEijkelkamp%26aufirst%3DN.%26aulast%3DLinley%26aufirst%3DJ.%2BE.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DMinett%26aufirst%3DM.%2BS.%26aulast%3DCregg%26aufirst%3DR.%26aulast%3DWerdehausen%26aufirst%3DR.%26aulast%3DRugiero%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26atitle%3DNeurological%2520perspectives%2520on%2520voltage-gated%2520sodium%2520channels%26jtitle%3DBrain%26date%3D2012%26volume%3D135%26spage%3D2585%26epage%3D2612%26doi%3D10.1093%2Fbrain%2Faws225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S.
D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">The Na<sub>V</sub>1.7 sodium channel: from molecule to man</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1038/nrn3404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1038%2Fnrn3404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=23232607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=49-62&author=S.%0AD.+Dib-Hajjauthor=Y.+Yangauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=The+NaV1.7+sodium+channel%3A+from+molecule+to+man&doi=10.1038%2Fnrn3404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The NaV1.7 sodium channel: from molecule to man</span></div><div class="casAuthors">Dib-Hajj, Sulayman D.; Yang, Yang; Black, Joel A.; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-62</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The voltage-gated sodium channel NaV1.7 is preferentially expressed in peripheral somatic and visceral sensory neurons, olfactory sensory neurons and sympathetic ganglion neurons.  NaV1.7 accumulates at nerve fiber endings and amplifies small subthreshold depolarizations, poising it to act as a threshold channel that regulates excitability.  Genetic and functional studies have added to the evidence that NaV1.7 is a major contributor to pain signaling in humans, and homol. modeling based on crystal structures of ion channels suggests an at.-level structural basis for the altered gating of mutant NaV1.7 that causes pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4lZH1L7XWLVg90H21EOLACvtfcHk0lj-O11qneBpTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ&md5=0e075d2c82d98774da1d316f4409d3eb</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnrn3404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3404%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DThe%2520NaV1.7%2520sodium%2520channel%253A%2520from%2520molecule%2520to%2520man%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D49%26epage%3D62%26doi%3D10.1038%2Fnrn3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">de Lera Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span> <span> </span><span class="NLM_article-title">Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7093</span>– <span class="NLM_lpage">7118</span>, <span class="refDoi"> DOI: 10.1021/jm501981g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501981g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7093-7118&author=M.+de+Lera+Ruizauthor=R.+L.+Kraus&title=Voltage-gated+sodium+channels%3A+structure%2C+function%2C+pharmacology%2C+and+clinical+indications&doi=10.1021%2Fjm501981g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span></div><div class="casAuthors">de Lera Ruiz, Manuel; Kraus, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7093-7118</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today.  Nav1.7 channels in particular have received much attention recently because of strong genetic validation of their involvement in nociception.  Here we summarize the current status of research in the Nav field and present the most relevant recent developments with respect to the mol. structure, general physiol., and pharmacol. of distinct Nav channel subtypes.  We discuss Nav channel ligands such as small mols., toxins isolated from animal venoms, and the recently identified Nav1.7-selective antibody.  Furthermore, we review eight characterized ligand binding sites on the Nav channel α subunit.  Finally, we examine possible therapeutic applications of Nav ligands and provide an update on current clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn2idyYye8oLVg90H21EOLACvtfcHk0lj-O11qneBpTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D&md5=a816fdf5b46e2e5727669bf17e2e4fd4</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1021%2Fjm501981g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501981g%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26atitle%3DVoltage-gated%2520sodium%2520channels%253A%2520structure%252C%2520function%252C%2520pharmacology%252C%2520and%2520clinical%2520indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7093%26epage%3D7118%26doi%3D10.1021%2Fjm501981g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span> <span> </span><span class="NLM_article-title">Mutations in <i>SCN9A</i>, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span>. <i>J. Med. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1136/jmg.2003.012153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1136%2Fjmg.2003.012153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=14985375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=171-174&author=Y.+Yangauthor=Y.+Wangauthor=S.+Liauthor=Z.+Xuauthor=H.+Liauthor=L.+Maauthor=J.+Fanauthor=D.+Buauthor=B.+Liuauthor=Z.+Fanauthor=G.+Wuauthor=J.+Jinauthor=B.+Dingauthor=X.+Zhuauthor=Y.+Shen&title=Mutations+in+SCN9A%2C+encoding+a+sodium+channel+alpha+subunit%2C+in+patients+with+primary+erythermalgia&doi=10.1136%2Fjmg.2003.012153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span></div><div class="casAuthors">Yang, Y.; Wang, Y.; Li, S.; Xu, Z.; Li, H.; Ma, L.; Fan, J.; Bu, D.; Liu, B.; Fan, Z.; Wu, G.; Jin, J.; Ding, B.; Zhu, X.; Shen, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-174</span>CODEN:
                <span class="NLM_cas:coden">JMDGAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-2593</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Primary erythermalgia is a rare autosomal dominant disease characterized by intermittent burning pain with redness and heat in the extremities.  A previous study established the linkage of primary erythermalgia to a 7.94 cM interval on chromosome 2q, but the causative gene was not identified.  We performed linkage anal. in a Chinese family with primary erythermalgia, and screened the mutations in the two candidate genes, SCN9A and GCA, in the family and a sporadic patient.  Linkage anal. yielded a max. lod score of 2.11 for both markers D2S2370 and D2S2330.  Based on crit. recombination events in two patients in the family, we further limited the genetic region to 5.98 cM between D2S2370 and D2S2345.  We then identified two missense mutations in SCN9A in the family (T2573A) and the sporadic patient (T2543C).  Our data suggest that mutations in SCN9A cause primary erythermalgia.  SCN9A, encoding a voltage-gated sodium channel alpha subunit predominantly expressed in sensory and sympathetic neurons, may play an important role in nociception and vasomotor regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBMPc9seMturVg90H21EOLACvtfcHk0ljxXkcJVgJ9IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D&md5=bf4ca6710278dd25a4de4ac5d8fdab2f</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2003.012153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2003.012153%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DMutations%2520in%2520SCN9A%252C%2520encoding%2520a%2520sodium%2520channel%2520alpha%2520subunit%252C%2520in%2520patients%2520with%2520primary%2520erythermalgia%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2004%26volume%3D41%26spage%3D171%26epage%3D174%26doi%3D10.1136%2Fjmg.2003.012153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S.</span></span> <span> </span><span class="NLM_article-title">Erythermalgia: molecular basis for an inherited pain syndrome</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">562</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2005.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.molmed.2005.10.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=555-562&author=S.+G.+Waxmanauthor=S.+Dib-Hajj&title=Erythermalgia%3A+molecular+basis+for+an+inherited+pain+syndrome&doi=10.1016%2Fj.molmed.2005.10.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2005.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2005.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DDib-Hajj%26aufirst%3DS.%26atitle%3DErythermalgia%253A%2520molecular%2520basis%2520for%2520an%2520inherited%2520pain%2520syndrome%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D555%26epage%3D562%26doi%3D10.1016%2Fj.molmed.2005.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fertleman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffatt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klugbauer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, M.</span></span> <span> </span><span class="NLM_article-title"><i>SCN9A</i> Mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2006.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.neuron.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=17145499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=767-774&author=C.+R.+Fertlemanauthor=M.+D.+Bakerauthor=K.+A.+Parkerauthor=S.+Moffattauthor=F.+V.+Elmslieauthor=B.+Abrahamsenauthor=J.+Ostmanauthor=N.+Klugbauerauthor=J.+N.+Woodauthor=R.+M.+Gardinerauthor=M.+Rees&title=SCN9A+Mutations+in+paroxysmal+extreme+pain+disorder%3A+allelic+variants+underlie+distinct+channel+defects+and+phenotypes&doi=10.1016%2Fj.neuron.2006.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">SCN9A mutations in paroxysmal clinical study extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span></div><div class="casAuthors">Fertleman, Caroline R.; Baker, Mark D.; Parker, Keith A.; Moffatt, Sarah; Elmslie, Frances V.; Abrahamsen, Bjarke; Ostman, Johan; Klugbauer, Norbert; Wood, John N.; Gardiner, R. Mark; Rees, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">767-774</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Paroxysmal extreme pain disorder (PEPD), previously known as familial rectal pain (FRP, or OMIM 167400), is an inherited condition characterized by paroxysms of rectal, ocular, or submandibular pain with flushing.  A genome-wide linkage search followed by mutational anal. of the candidate gene SCN9A, which encodes hNav1.7, identified eight missense mutations in 11 families and 2 sporadic cases.  Functional anal. in vitro of three of these mutant Nav1.7 channels revealed a redn. in fast inactivation, leading to persistent sodium current.  Other mutations in SCN9A assocd. with more neg. activation thresholds are known to cause primary erythermalgia (PE).  Carbamazepine, a drug that is effective in PEPD, but not PE, showed selective block of persistent current assocd. with PEPD mutants, but did not affect the neg. activation threshold of a PE mutant.  PEPD and PE are allelic variants with distinct underlying biophys. mechanisms and represent a sep. class of peripheral neuronal sodium channelopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2qhSqNNAvLVg90H21EOLACvtfcHk0ljxXkcJVgJ9IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ&md5=2f52e4722b3046d2bb0dc7af0901e952</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DFertleman%26aufirst%3DC.%2BR.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DK.%2BA.%26aulast%3DMoffatt%26aufirst%3DS.%26aulast%3DElmslie%26aufirst%3DF.%2BV.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DOstman%26aufirst%3DJ.%26aulast%3DKlugbauer%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGardiner%26aufirst%3DR.%2BM.%26aulast%3DRees%26aufirst%3DM.%26atitle%3DSCN9A%2520Mutations%2520in%2520paroxysmal%2520extreme%2520pain%2520disorder%253A%2520allelic%2520variants%2520underlie%2520distinct%2520channel%2520defects%2520and%2520phenotypes%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D767%26epage%3D774%26doi%3D10.1016%2Fj.neuron.2006.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fertleman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrie, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicardi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednarek, N. A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eeg-Olofsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griesemer, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goutières, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmros, I. N.O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollitzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roulet-Perez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, J. B.P.</span></span> <span> </span><span class="NLM_article-title">paroxysmal extreme pain disorder (previously familial rectal pain syndrome)</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">586</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1212/01.wnl.0000268065.16865.5f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1212%2F01.wnl.0000268065.16865.5f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2007&pages=586-595&author=C.+R.+Fertlemanauthor=C.+D.+Ferrieauthor=J.+Aicardiauthor=N.+A.+F.+Bednarekauthor=O.+Eeg-Olofssonauthor=F.+V.+Elmslieauthor=D.+A.+Griesemerauthor=F.+Gouti%C3%A8resauthor=M.+Kirkpatrickauthor=I.+N.O.+Malmrosauthor=M.+Pollitzerauthor=M.+Rossiterauthor=E.+Roulet-Perezauthor=R.+Schubertauthor=V.+V.+Smithauthor=H.+Testardauthor=V.+Wongauthor=J.+B.P.+Stephenson&title=paroxysmal+extreme+pain+disorder+%28previously+familial+rectal+pain+syndrome%29&doi=10.1212%2F01.wnl.0000268065.16865.5f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1212%2F01.wnl.0000268065.16865.5f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252F01.wnl.0000268065.16865.5f%26sid%3Dliteratum%253Aachs%26aulast%3DFertleman%26aufirst%3DC.%2BR.%26aulast%3DFerrie%26aufirst%3DC.%2BD.%26aulast%3DAicardi%26aufirst%3DJ.%26aulast%3DBednarek%26aufirst%3DN.%2BA.%2BF.%26aulast%3DEeg-Olofsson%26aufirst%3DO.%26aulast%3DElmslie%26aufirst%3DF.%2BV.%26aulast%3DGriesemer%26aufirst%3DD.%2BA.%26aulast%3DGouti%25C3%25A8res%26aufirst%3DF.%26aulast%3DKirkpatrick%26aufirst%3DM.%26aulast%3DMalmros%26aufirst%3DI.%2BN.O.%26aulast%3DPollitzer%26aufirst%3DM.%26aulast%3DRossiter%26aufirst%3DM.%26aulast%3DRoulet-Perez%26aufirst%3DE.%26aulast%3DSchubert%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DV.%2BV.%26aulast%3DTestard%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DV.%26aulast%3DStephenson%26aufirst%3DJ.%2BB.P.%26atitle%3Dparoxysmal%2520extreme%2520pain%2520disorder%2520%2528previously%2520familial%2520rectal%2520pain%2520syndrome%2529%26jtitle%3DNeurology%26date%3D2007%26volume%3D69%26spage%3D586%26epage%3D595%26doi%3D10.1212%2F01.wnl.0000268065.16865.5f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Faber, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeijmakers, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estacion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerrits, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drenth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkies, I. S.</span></span> <span> </span><span class="NLM_article-title">Gain of function Na<sub>V</sub>1.7 mutations in idiopathic small fiber neuropathy</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1002/ana.22485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1002%2Fana.22485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=21698661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=26-39&author=C.+G.+Faberauthor=J.+G.+Hoeijmakersauthor=H.+S.+Ahnauthor=X.+Chengauthor=C.+Hanauthor=J.+S.+Choiauthor=M.+Estacionauthor=G.+Lauriaauthor=E.+K.+Vanhoutteauthor=M.+M.+Gerritsauthor=S.+Dib-Hajjauthor=J.+P.+Drenthauthor=S.+G.+Waxmanauthor=I.+S.+Merkies&title=Gain+of+function+NaV1.7+mutations+in+idiopathic+small+fiber+neuropathy&doi=10.1002%2Fana.22485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2eR"><div class="casContent"><span class="casTitleNuber">2e</span><div class="casTitle"><span class="NLM_cas:atitle">Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy</span></div><div class="casAuthors">Faber, Catharina G.; Hoeijmakers, Janneke G. J.; Ahn, Hye-Sook; Cheng, Xiaoyang; Han, Chongyang; Choi, Jin-Sung; Estacion, Mark; Lauria, Giuseppe; Vanhoutte, Els K.; Gerrits, Monique M.; Dib-Hajj, Sulayman; Drenth, Joost P. H.; Waxman, Stephen G.; Merkies, Ingemar S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-39</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: : Small nerve fiber neuropathy (SFN) often occurs without apparent cause, but no systematic genetic studies have been performed in patients with idiopathic SFN (I-SFN).  We sought to identify a genetic basis for I-SFN by screening patients with biopsy-confirmed idiopathic SFN for mutations in the SCN9A gene, encoding voltage-gated sodium channel NaV1.7, which is preferentially expressed in small diam. peripheral axons.  Methods: : Patients referred with possible I-SFN, who met the criteria of ≥2 SFN-related symptoms, normal strength, tendon reflexes, vibration sense, and nerve conduction studies, and reduced intraepidermal nerve fiber d. (IENFD) plus abnormal quant. sensory testing (QST) and no underlying etiol. for SFN, were assessed clin. and by screening of SCN9A for mutations and functional analyses.  Results: : Twenty-eight patients who met stringent criteria for I-SFN including abnormal IENFD and QST underwent SCN9A gene analyses.  Of these 28 patients with biopsy-confirmed I-SFN, 8 were found to carry novel mutations in SCN9A.  Functional anal. revealed multiple gain of function changes in the mutant channels; each of the mutations rendered dorsal root ganglion neurons hyperexcitable.  Interpretation: : We show for the first time that gain of function mutations in sodium channel NaV1.7, which render dorsal root ganglion neurons hyperexcitable, are present in a substantial proportion (28.6%; 8 of 28) of patients meeting strict criteria for I-SFN.  These results point to a broader role of NaV1.7 mutations in neurol. disease than previously considered from studies on rare genetic syndromes, and suggest an etiol. basis for I-SFN, whereby expression of gain of function mutant sodium channels in small diam. peripheral axons may cause these fibers to degenerate.  ANN NEUROL 2012;71:26-39.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI5yt6a_BN-rVg90H21EOLACvtfcHk0ljraydICB_UHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqtr4%253D&md5=ea551234a6635b3fd70e3ea4bd68f96c</span></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=10.1002%2Fana.22485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22485%26sid%3Dliteratum%253Aachs%26aulast%3DFaber%26aufirst%3DC.%2BG.%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BG.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DC.%26aulast%3DChoi%26aufirst%3DJ.%2BS.%26aulast%3DEstacion%26aufirst%3DM.%26aulast%3DLauria%26aufirst%3DG.%26aulast%3DVanhoutte%26aufirst%3DE.%2BK.%26aulast%3DGerrits%26aufirst%3DM.%2BM.%26aulast%3DDib-Hajj%26aufirst%3DS.%26aulast%3DDrenth%26aufirst%3DJ.%2BP.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DMerkies%26aufirst%3DI.%2BS.%26atitle%3DGain%2520of%2520function%2520NaV1.7%2520mutations%2520in%2520idiopathic%2520small%2520fiber%2520neuropathy%26jtitle%3DAnn.%2520Neurol.%26date%3D2012%26volume%3D71%26spage%3D26%26epage%3D39%26doi%3D10.1002%2Fana.22485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholas, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raashid, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gazali, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHale, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span> <span> </span><span class="NLM_article-title">An SCN9A channelopathy causes congenital inability to experience pain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>444</i></span>,  <span class="NLM_fpage">894</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1038/nature05413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1038%2Fnature05413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=17167479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2006&pages=894-898&author=J.+J.+Coxauthor=F.+Reimannauthor=A.+K.+Nicholasauthor=G.+Thorntonauthor=E.+Robertsauthor=K.+Springellauthor=G.+Karbaniauthor=H.+Jafriauthor=J.+Mannanauthor=Y.+Raashidauthor=L.+Al-Gazaliauthor=H.+Hamamyauthor=E.+M.+Valenteauthor=S.+Gormanauthor=R.+Williamsauthor=D.+P.+McHaleauthor=J.+N.+Woodauthor=F.+M.+Gribbleauthor=C.+G.+Woods&title=An+SCN9A+channelopathy+causes+congenital+inability+to+experience+pain&doi=10.1038%2Fnature05413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">An SCN9A channelopathy causes congenital inability to experience pain</span></div><div class="casAuthors">Cox, James J.; Reimann, Frank; Nicholas, Adeline K.; Thornton, Gemma; Roberts, Emma; Springell, Kelly; Karbani, Gulshan; Jafri, Hussain; Mannan, Jovaria; Raashid, Yasmin; Al-Gazali, Lihadh; Hamamy, Henan; Valente, Enza Maria; Gorman, Shaun; Williams, Richard; McHale, Duncan P.; Wood, John N.; Gribble, Fiona M.; Woods, C. Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">7121</span>),
    <span class="NLM_cas:pages">894-898</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype.  In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3.  This region contains the gene SCN9A, encoding the α-subunit of the voltage-gated sodium channel, Nav1.7, which is strongly expressed in nociceptive neurons.  Sequence anal. of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X).  We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Nav1.7 with sodium channel β1 and β2 subunits in HEK293 cells.  In cells expressing mutant Nav1.7, the currents were no greater than background.  Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans.  These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWD3rCKSQEurVg90H21EOLACvtfcHk0ljraydICB_UHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM&md5=461e3a6abd6d3f4f8f7d896d8f62d882</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnature05413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05413%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BJ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DNicholas%26aufirst%3DA.%2BK.%26aulast%3DThornton%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DSpringell%26aufirst%3DK.%26aulast%3DKarbani%26aufirst%3DG.%26aulast%3DJafri%26aufirst%3DH.%26aulast%3DMannan%26aufirst%3DJ.%26aulast%3DRaashid%26aufirst%3DY.%26aulast%3DAl-Gazali%26aufirst%3DL.%26aulast%3DHamamy%26aufirst%3DH.%26aulast%3DValente%26aufirst%3DE.%2BM.%26aulast%3DGorman%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMcHale%26aufirst%3DD.%2BP.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26atitle%3DAn%2520SCN9A%2520channelopathy%2520causes%2520congenital%2520inability%2520to%2520experience%2520pain%26jtitle%3DNature%26date%3D2006%26volume%3D444%26spage%3D894%26epage%3D898%26doi%3D10.1038%2Fnature05413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattice, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radomski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaldson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ives, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younghusband, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boltshauser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinspan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerdraon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowsher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pimstone, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuels, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrington, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span> <span> </span><span class="NLM_article-title">Loss-of-function mutations in the Na<sub>V</sub>1.7 gene underlie congenital indifference to pain in multiple human populations</span>. <i>Clin. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1111/j.1399-0004.2007.00790.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1111%2Fj.1399-0004.2007.00790.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=17470132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=311-319&author=Y.+P.+Goldbergauthor=J.+MacFarlaneauthor=M.+L.+MacDonaldauthor=J.+Thompsonauthor=M.-P.+Dubeauthor=M.+Matticeauthor=R.+Fraserauthor=C.+Youngauthor=S.+Hossainauthor=T.+Papeauthor=B.+Payneauthor=C.+Radomskiauthor=G.+Donaldsonauthor=E.+Ivesauthor=J.+Coxauthor=H.+B.+Younghusbandauthor=R.+Greenauthor=A.+Duffauthor=E.+Boltshauserauthor=G.+A.+Grinspanauthor=J.+H.+Dimonauthor=B.+G.+Sibleyauthor=G.+Andriaauthor=E.+Toscanoauthor=J.+Kerdraonauthor=D.+Bowsherauthor=S.+N.+Pimstoneauthor=M.+E.+Samuelsauthor=R.+Sherringtonauthor=M.+R.+Hayden&title=Loss-of-function+mutations+in+the+NaV1.7+gene+underlie+congenital+indifference+to+pain+in+multiple+human+populations&doi=10.1111%2Fj.1399-0004.2007.00790.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations</span></div><div class="casAuthors">Goldberg Y P; MacFarlane J; MacDonald M L; Thompson J; Dube M-P; Mattice M; Fraser R; Young C; Hossain S; Pape T; Payne B; Radomski C; Donaldson G; Ives E; Cox J; Younghusband H B; Green R; Duff A; Boltshauser E; Grinspan G A; Dimon J H; Sibley B G; Andria G; Toscano E; Kerdraon J; Bowsher D; Pimstone S N; Samuels M E; Sherrington R; Hayden M R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-9</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal.  We identified and collected DNA from individuals from nine families of seven different nationalities in which the affected individuals meet the diagnostic criteria for CIP.  Using homozygosity mapping and haplotype sharing methods, we narrowed the CIP locus to chromosome 2q24-q31, a region known to contain a cluster of voltage-gated sodium channel genes.  From these prioritized candidate sodium channels, we identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7.  The mutations completely co-segregated with the disease phenotype, and nine of these SCN9A mutations resulted in truncation and loss-of-function of the Nav1.7 channel.  These genetic data further support the evidence that Nav1.7 plays an essential role in mediating pain in humans, and that SCN9A mutations identified in multiple different populations underlie CIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgEhjb_1oWGHqj_yg7twvpfW6udTcc2eZwQDc0MZX1Y7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D&md5=02ae3943bc678b3407d492e4a6298b74</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-0004.2007.00790.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-0004.2007.00790.x%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DY.%2BP.%26aulast%3DMacFarlane%26aufirst%3DJ.%26aulast%3DMacDonald%26aufirst%3DM.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DDube%26aufirst%3DM.-P.%26aulast%3DMattice%26aufirst%3DM.%26aulast%3DFraser%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DHossain%26aufirst%3DS.%26aulast%3DPape%26aufirst%3DT.%26aulast%3DPayne%26aufirst%3DB.%26aulast%3DRadomski%26aufirst%3DC.%26aulast%3DDonaldson%26aufirst%3DG.%26aulast%3DIves%26aufirst%3DE.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DYounghusband%26aufirst%3DH.%2BB.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DDuff%26aufirst%3DA.%26aulast%3DBoltshauser%26aufirst%3DE.%26aulast%3DGrinspan%26aufirst%3DG.%2BA.%26aulast%3DDimon%26aufirst%3DJ.%2BH.%26aulast%3DSibley%26aufirst%3DB.%2BG.%26aulast%3DAndria%26aufirst%3DG.%26aulast%3DToscano%26aufirst%3DE.%26aulast%3DKerdraon%26aufirst%3DJ.%26aulast%3DBowsher%26aufirst%3DD.%26aulast%3DPimstone%26aufirst%3DS.%2BN.%26aulast%3DSamuels%26aufirst%3DM.%2BE.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DLoss-of-function%2520mutations%2520in%2520the%2520NaV1.7%2520gene%2520underlie%2520congenital%2520indifference%2520to%2520pain%2520in%2520multiple%2520human%2520populations%26jtitle%3DClin.%2520Genet.%26date%3D2007%26volume%3D71%26spage%3D311%26epage%3D319%26doi%3D10.1111%2Fj.1399-0004.2007.00790.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">England, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D.</span></span> <span> </span><span class="NLM_article-title">Isoform-selective voltage-gated Na+ modulators as next-generation analgesics</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.4155/fmc.10.26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.4155%2Ffmc.10.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=21426202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslamtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=775-790&author=S.+Englandauthor=D.+Rawson&title=Isoform-selective+voltage-gated+Na%2B+modulators+as+next-generation+analgesics&doi=10.4155%2Ffmc.10.26"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-selective voltage-gated Na+ channel modulators as next-generation analgesics</span></div><div class="casAuthors">England, Steve; Rawson, David</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">775-790</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  For many patients the current therapies for controlling chronic pain are inadequate.  This has driven the search for analgesics with improved efficacy and side effect profiles.  Some anticonvulsants have voltage-gated Na+ channels (VGSCs) as their mol. targets and are used to treat pain, but the efficacy seen is marginal and the drugs are generally poorly tolerated.  The clin. used VGSC-modulating analgesics show no isoform selectivity, which probably limits their use.  Thus, focus has fallen on VGSCs expressed selectively by primary afferent neurons and the search for isoform-selective drugs.  In this review, we describe developments in our understanding of the biol. of VGSCs, screening technologies and the pharmacol. properties of VGSC modulators with promise as analgesics.  Also highlighted are the challenges assocd. with targeting isoform-selective VGSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHZcFRT0qRdbVg90H21EOLACvtfcHk0lgmVEmjZosH1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslamtLo%253D&md5=06b147bfe9141a4742ff4dcd2642b86c</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.26%26sid%3Dliteratum%253Aachs%26aulast%3DEngland%26aufirst%3DS.%26aulast%3DRawson%26aufirst%3DD.%26atitle%3DIsoform-selective%2520voltage-gated%2520Na%252B%2520modulators%2520as%2520next-generation%2520analgesics%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D775%26epage%3D790%26doi%3D10.4155%2Ffmc.10.26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertrampf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kless, A.</span></span> <span> </span><span class="NLM_article-title">Advances in targeting voltage gated sodium channels with small Molecules</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1712</span>– <span class="NLM_lpage">1740</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1002%2Fcmdc.201200298" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1712-1740&author=A.+Nardiauthor=N.+Damannauthor=T.+Hertrampfauthor=A.+Kless&title=Advances+in+targeting+voltage+gated+sodium+channels+with+small+Molecules&doi=10.1002%2Fcmdc.201200298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200298%26sid%3Dliteratum%253Aachs%26aulast%3DNardi%26aufirst%3DA.%26aulast%3DDamann%26aufirst%3DN.%26aulast%3DHertrampf%26aufirst%3DT.%26aulast%3DKless%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520targeting%2520voltage%2520gated%2520sodium%2520channels%2520with%2520small%2520Molecules%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1712%26epage%3D1740%26doi%3D10.1002%2Fcmdc.201200298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7: patent applications since 2010</span>. <i>Pharm. Pat. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.4155/ppa.14.39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.4155%2Fppa.14.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=25374320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=509-521&author=S.+Sunauthor=C.+J.+Cohenauthor=C.+M.+Dehnhardt&title=Inhibitors+of+voltage-gated+sodium+channel+NaV1.7%3A+patent+applications+since+2010&doi=10.4155%2Fppa.14.39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010</span></div><div class="casAuthors">Sun, Shaoyi; Cohen, Charles J.; Dehnhardt, Christoph M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Patent Analyst</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">509-521</span>CODEN:
                <span class="NLM_cas:coden">PPAHCN</span>;
        ISSN:<span class="NLM_cas:issn">2046-8954</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  There has been intense interest in developing inhibitors of the sodium channel Nav1.7 because genetic studies have established very strong validation for the efficacy to alleviate both inflammatory and neuropathic pain.  This review summarizes patent applications targeting Nav1.7 since 2010 until May, 2014.  We have classified the patents into three categories as follows: small mols. with well-defined mol. selectivity among sodium channel isoforms; biologicals with well-defined mol. selectivity; and, small mols. that inhibit Nav1.7 with unknown mol. selectivity.  Most of the review is dedicated to small mol. selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE50bQQ3wiFLVg90H21EOLACvtfcHk0lgmVEmjZosH1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL&md5=6986fe156f608706204b483207d2201c</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.4155%2Fppa.14.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fppa.14.39%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26atitle%3DInhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%253A%2520patent%2520applications%2520since%25202010%26jtitle%3DPharm.%2520Pat.%2520Anal.%26date%3D2014%26volume%3D3%26spage%3D509%26epage%3D521%26doi%3D10.4155%2Fppa.14.39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prime, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Recent progress in sodium channel modulators for pain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3690</span>– <span class="NLM_lpage">3699</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2014.06.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=25060923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3690-3699&author=S.+K.+Bagalauthor=M.+L.+Chapmanauthor=B.+E.+Marronauthor=R.+Primeauthor=R.+I.+Storerauthor=N.+A.+Swain&title=Recent+progress+in+sodium+channel+modulators+for+pain&doi=10.1016%2Fj.bmcl.2014.06.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in sodium channel modulators for pain</span></div><div class="casAuthors">Bagal, Sharan K.; Chapman, Mark L.; Marron, Brian E.; Prime, Rebecca; Storer, R. Ian; Swain, Nigel A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3690-3699</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels (Navs) are an important family of transmembrane ion channel proteins and Nav drug discovery is an exciting field.  Pharmaceutical investment in Navs for pain therapeutics has expanded exponentially due to genetic data such as SCN10A mutations and an improved ability to establish an effective screen sequence for example IonWorks Barracuda, Synchropatch and Qube.  Moreover, emerging clin. data (AZD-3161, XEN402, CNV1014802, PF-05089771, PF-04531083) combined with recent breakthroughs in Nav structural biol. pave the way for a future of fruitful prospective Nav drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbT6en4xkVxLVg90H21EOLACvtfcHk0lhEPCX7i-dTEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL&md5=c8bae40b70509e2aa3dce106e2c41677</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.038%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPrime%26aufirst%3DR.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26atitle%3DRecent%2520progress%2520in%2520sodium%2520channel%2520modulators%2520for%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3690%26epage%3D3699%26doi%3D10.1016%2Fj.bmcl.2014.06.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schott, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alshinawi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyndt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Probst, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoorntje, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulsbeek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilde, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escande, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannens, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Marec, H.</span></span> <span> </span><span class="NLM_article-title">Cardiac conduction defects associate with mutations in SCN5A</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1038/12618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1038%2F12618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10471492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFWhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=20-21&author=J.+J.+Schottauthor=C.+Alshinawiauthor=F.+Kyndtauthor=V.+Probstauthor=T.+M.+Hoorntjeauthor=M.+Hulsbeekauthor=A.+A.+Wildeauthor=D.+Escandeauthor=M.+M.+Mannensauthor=H.+Le+Marec&title=Cardiac+conduction+defects+associate+with+mutations+in+SCN5A&doi=10.1038%2F12618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac conduction defects associate with mutations in SCN5A</span></div><div class="casAuthors">Schott, Jean-Jacques; Alshinawi, Connie; Kyndt, Florence; Probst, Vincent; Hoorntje, Theo M.; Hulsbeek, Miriam; Wilde, Arthur A. M.; Escande, Denis; Mannens, Marcel M. A. M.; Le Marec, Herve</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-21</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Progressive cardiac conduction defect (PCCD) also called Lenegre or Lev disease, is one of the most common cardiac conduction disturbances.  Here, the authors report a mutation in the gene encoding the cardiac-specific sodium channel (SCN5A) that segregates with PCCD in an autosomal dominant manner in a large French family.  The authors also studied a Dutch family in which the proband presented after birth with asymptomatic first-degree atrio-ventricular block assocd. with right bundle branch block.  Sequencing the entire SCN5A coding region in the French family identified a T→C substitution in the highly conserved +2 donor splicing site of intron 22.  The abnormal transcript predicts in-frame skipping of exon 22 and an impaired gene product lacking the voltage-sensitive DIIIS4 segment.  SCN5A was directly sequenced in the Dutch family.  A deletion of a single nucleotide (G) at position 5280 resulting in a frameshift predicting a premature stop codon was identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsWjnnnqL4MbVg90H21EOLACvtfcHk0lhEPCX7i-dTEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFWhs7k%253D&md5=7cb11c78625c8e2fd7f21caa876de2ff</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2F12618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F12618%26sid%3Dliteratum%253Aachs%26aulast%3DSchott%26aufirst%3DJ.%2BJ.%26aulast%3DAlshinawi%26aufirst%3DC.%26aulast%3DKyndt%26aufirst%3DF.%26aulast%3DProbst%26aufirst%3DV.%26aulast%3DHoorntje%26aufirst%3DT.%2BM.%26aulast%3DHulsbeek%26aufirst%3DM.%26aulast%3DWilde%26aufirst%3DA.%2BA.%26aulast%3DEscande%26aufirst%3DD.%26aulast%3DMannens%26aufirst%3DM.%2BM.%26aulast%3DLe%2BMarec%26aufirst%3DH.%26atitle%3DCardiac%2520conduction%2520defects%2520associate%2520with%2520mutations%2520in%2520SCN5A%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D23%26spage%3D20%26epage%3D21%26doi%3D10.1038%2F12618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Royer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veen, T. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bouter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marionneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griol-Charhbili, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Léoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steenman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rijen, H. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demolombe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddard, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escoubet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarry-Guichard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colledge, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bakker, J. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grace, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escande, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charpentier, F.</span></span> <span> </span><span class="NLM_article-title">A mouse model of SCN5A-linked hereditary Lenègre’s disease: age-related conduction slowing and myocardial fibrosis</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1738</span>– <span class="NLM_lpage">1746</span>, <span class="refDoi"> DOI: 10.1161/01.CIR.0000160853.19867.61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1161%2F01.CIR.0000160853.19867.61" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=1738-1746&author=A.+Royerauthor=T.+A.+B.+van+Veenauthor=S.+Le+Bouterauthor=C.+Marionneauauthor=V.+Griol-Charhbiliauthor=A.+L%C3%A9oniauthor=M.+Steenmanauthor=H.+V.+M.+van+Rijenauthor=S.+Demolombeauthor=C.+A.+Goddardauthor=C.+Richerauthor=B.+Escoubetauthor=T.+Jarry-Guichardauthor=W.+H.+Colledgeauthor=D.+Grosauthor=J.+M.+T.+de+Bakkerauthor=A.+A.+Graceauthor=D.+Escandeauthor=F.+Charpentier&title=A+mouse+model+of+SCN5A-linked+hereditary+Len%C3%A8gre%E2%80%99s+disease%3A+age-related+conduction+slowing+and+myocardial+fibrosis&doi=10.1161%2F01.CIR.0000160853.19867.61"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.0000160853.19867.61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.0000160853.19867.61%26sid%3Dliteratum%253Aachs%26aulast%3DRoyer%26aufirst%3DA.%26aulast%3Dvan%2BVeen%26aufirst%3DT.%2BA.%2BB.%26aulast%3DLe%2BBouter%26aufirst%3DS.%26aulast%3DMarionneau%26aufirst%3DC.%26aulast%3DGriol-Charhbili%26aufirst%3DV.%26aulast%3DL%25C3%25A9oni%26aufirst%3DA.%26aulast%3DSteenman%26aufirst%3DM.%26aulast%3Dvan%2BRijen%26aufirst%3DH.%2BV.%2BM.%26aulast%3DDemolombe%26aufirst%3DS.%26aulast%3DGoddard%26aufirst%3DC.%2BA.%26aulast%3DRicher%26aufirst%3DC.%26aulast%3DEscoubet%26aufirst%3DB.%26aulast%3DJarry-Guichard%26aufirst%3DT.%26aulast%3DColledge%26aufirst%3DW.%2BH.%26aulast%3DGros%26aufirst%3DD.%26aulast%3Dde%2BBakker%26aufirst%3DJ.%2BM.%2BT.%26aulast%3DGrace%26aufirst%3DA.%2BA.%26aulast%3DEscande%26aufirst%3DD.%26aulast%3DCharpentier%26aufirst%3DF.%26atitle%3DA%2520mouse%2520model%2520of%2520SCN5A-linked%2520hereditary%2520Len%25C3%25A8gre%25E2%2580%2599s%2520disease%253A%2520age-related%2520conduction%2520slowing%2520and%2520myocardial%2520fibrosis%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D1738%26epage%3D1746%26doi%3D10.1161%2F01.CIR.0000160853.19867.61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenova, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafeev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel NaV1.7</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4401</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2014.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=25176194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWqsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4397-4401&author=S.+Sunauthor=Q.+Jiaauthor=A.+Y.+Zenovaauthor=M.+Chafeevauthor=Z.+Zhangauthor=S.+Linauthor=R.+Kwanauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=C.+Youngauthor=C.+J.+Cohenauthor=R.+M.+Oballa&title=The+discovery+of+benzenesulfonamide-based+potent+and+selective+inhibitors+of+voltage-gated+sodium+channel+NaV1.7&doi=10.1016%2Fj.bmcl.2014.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Nav1.7</span></div><div class="casAuthors">Sun, Shaoyi; Jia, Qi; Zenova, Alla Y.; Chafeev, Mikhail; Zhang, Zaihui; Lin, Sophia; Kwan, Rainbow; Grimwood, Mike E.; Chowdhury, Sultan; Young, Clint; Cohen, Charles J.; Oballa, Renata M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4397-4401</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage gated sodium channel Nav1.7 represents an interesting target for the treatment of pain.  Human genetic studies have identified the crucial role of Nav1.7 in pain signaling.  Herein, we report the design and synthesis of a novel series of benzenesulfonamide-based Nav1.7 inhibitors.  Structural-activity relationship (SAR) studies were undertaken towards improving Nav1.7 activity and minimizing CYP inhibition.  These efforts resulted in the identification of compd. I, a highly potent Nav1.7 inhibitor with a thousand-fold selectivity over Nav1.5 and negligible CYP inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjReDfVWQ9BbVg90H21EOLACvtfcHk0lhRzbAsJVP8sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWqsrfJ&md5=ac2bc2156d5bce18e8eb6027088edf27</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DZenova%26aufirst%3DA.%2BY.%26aulast%3DChafeev%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26atitle%3DThe%2520discovery%2520of%2520benzenesulfonamide-based%2520potent%2520and%2520selective%2520inhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4397%26epage%3D4401%26doi%3D10.1016%2Fj.bmcl.2014.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauphinais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogucki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of aryl sulfonamides as isoform-selective inhibitors of Na<sub>V</sub>1.7 with efficacy in rodent pain models</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=277-282&author=T.+Fockenauthor=S.+Liuauthor=N.+Chahalauthor=M.+Dauphinaisauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=I.+Hemeonauthor=P.+Bichlerauthor=D.+Boguckiauthor=M.+Waldbrookauthor=G.+Bankarauthor=L.+E.+Sojoauthor=C.+Youngauthor=S.+Linauthor=N.+Shuartauthor=R.+Kwanauthor=J.+Pangauthor=J.+H.+Changauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=J.+P.+Johnsonauthor=C.+M.+Dehnhardtauthor=T.+S.+Mansourauthor=R.+M.+Oballaauthor=C.+J.+Cohenauthor=C.+L.+Robinette&title=Discovery+of+aryl+sulfonamides+as+isoform-selective+inhibitors+of+NaV1.7+with+efficacy+in+rodent+pain+models&doi=10.1021%2Facsmedchemlett.5b00447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models</span></div><div class="casAuthors">Focken, Thilo; Liu, Shifeng; Chahal, Navjot; Dauphinais, Maxim; Grimwood, Michael E.; Chowdhury, Sultan; Hemeon, Ivan; Bichler, Paul; Bogucki, David; Waldbrook, Matthew; Bankar, Girish; Sojo, Luis E.; Young, Clint; Lin, Sophia; Shuart, Noah; Kwan, Rainbow; Pang, Jodie; Chang, Jae H.; Safina, Brian S.; Sutherlin, Daniel P.; Johnson, J. P., Jr.; Dehnhardt, Christoph M.; Mansour, Tarek S.; Oballa, Renata M.; Cohen, Charles J.; Robinette, C. Lee</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-282</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report on a novel series of aryl sulfonamides that act as nanomolar potent, isoform-selective inhibitors of the human sodium channel hNaV1.7.  The optimization of these inhibitors is described.  The authors aimed to improve potency against hNaV1.7 while minimizing off-target safety concerns and generated compd. I.  This agent displayed significant analgesic effects in rodent models of acute and inflammatory pain and demonstrated that binding to the voltage sensor domain 4 site of NaV1.7 leads to an analgesic effect in vivo.  The findings corroborate the importance of hNaV1.7 as a drug target for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpIxiu3ixqRLVg90H21EOLACvtfcHk0lhRzbAsJVP8sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D&md5=ae05f2c1ef6cf51d69a67a7b1ee7f8fa</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00447%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DDauphinais%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DSojo%26aufirst%3DL.%2BE.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DShuart%26aufirst%3DN.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520of%2520aryl%2520sulfonamides%2520as%2520isoform-selective%2520inhibitors%2520of%2520NaV1.7%2520with%2520efficacy%2520in%2520rodent%2520pain%2520models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D277%26epage%3D282%26doi%3D10.1021%2Facsmedchemlett.5b00447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrou, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estacion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mis, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilbrey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutteridge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castle, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hounshell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krafte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, E. B.</span></span> <span> </span><span class="NLM_article-title">Subtype-selective small molecule inhibitors reveal a fundamental role for Na<sub>V</sub>1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0152405</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0152405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1371%2Fjournal.pone.0152405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=27050761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1KqtL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0152405&author=A.+J.+Alexandrouauthor=A.+R.+Brownauthor=M.+L.+Chapmanauthor=M.+Estacionauthor=J.+Turnerauthor=M.+A.+Misauthor=A.+Wilbreyauthor=E.+C.+Payneauthor=A.+Gutteridgeauthor=P.+J.+Coxauthor=R.+Doyleauthor=D.+Printzenhoffauthor=Z.+Linauthor=B.+E.+Marronauthor=C.+Westauthor=N.+A.+Swainauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=N.+A.+Castleauthor=J.+A.+Hounshellauthor=M.+Rivaraauthor=A.+Randallauthor=S.+D.+Dib-Hajjauthor=D.+Krafteauthor=S.+G.+Waxmanauthor=M.+K.+Patelauthor=R.+P.+Buttauthor=E.+B.+Stevens&title=Subtype-selective+small+molecule+inhibitors+reveal+a+fundamental+role+for+NaV1.7+in+nociceptor+electrogenesis%2C+axonal+conduction+and+presynaptic+release&doi=10.1371%2Fjournal.pone.0152405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release</span></div><div class="casAuthors">Alexandrou, Aristos J.; Brown, Adam R.; Chapman, Mark L.; Estacion, Mark; Turner, Jamie; Mis, Malgorzata A.; Wilbrey, Anna; Payne, Elizabeth C.; Gutteridge, Alex; Cox, Peter J.; Doyle, Rachel; Printzenhoff, David; Lin, Zhixin; Marron, Brian E.; West, Christopher; Swain, Nigel A.; Storer, R. Ian; Stupple, Paul A.; Castle, Neil A.; Hounshell, James A.; Rivara, Mirko; Randall, Andrew; Dib-Hajj, Sulayman D.; Krafte, Douglas; Waxman, Stephen G.; Patel, Manoj K.; Butt, Richard P.; Stevens, Edward B.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0152405/1-e0152405/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Human genetic studies show that the voltage gated sodium channel 1.7 (Nav1.7) is a key mol. determinant of pain sensation.  However, defining the Nav1.7 contribution to nociceptive signalling has been hampered by a lack of selective inhibitors.  Here we report two potent and selective arylsulfonamide Nav1.7 inhibitors; PF-05198007 and PF-05089771, which we have used to directly interrogate Nav1.7's role in nociceptor physiol.  We report that Nav1.7 is the predominant functional TTX-sensitive Nav in mouse and human nociceptors and contributes to the initiation and the upstroke phase of the nociceptor action potential.  Moreover, we confirm a role for Nav1.7 in influencing synaptic transmission in the dorsal horn of the spinal cord as well as peripheral neuropeptide release in the skin.  These findings demonstrate multiple contributions of Nav1.7 to nociceptor signalling and shed new light on the relative functional contribution of this channel to peripheral and central noxious signal transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx6L5QNhpEg7Vg90H21EOLACvtfcHk0liMbd5sfEE5Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1KqtL3M&md5=41505ac1108ad830dec78c052655f6b0</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0152405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0152405%26sid%3Dliteratum%253Aachs%26aulast%3DAlexandrou%26aufirst%3DA.%2BJ.%26aulast%3DBrown%26aufirst%3DA.%2BR.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DEstacion%26aufirst%3DM.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DMis%26aufirst%3DM.%2BA.%26aulast%3DWilbrey%26aufirst%3DA.%26aulast%3DPayne%26aufirst%3DE.%2BC.%26aulast%3DGutteridge%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DP.%2BJ.%26aulast%3DDoyle%26aufirst%3DR.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DWest%26aufirst%3DC.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26aulast%3DHounshell%26aufirst%3DJ.%2BA.%26aulast%3DRivara%26aufirst%3DM.%26aulast%3DRandall%26aufirst%3DA.%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DKrafte%26aufirst%3DD.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DPatel%26aufirst%3DM.%2BK.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DStevens%26aufirst%3DE.%2BB.%26atitle%3DSubtype-selective%2520small%2520molecule%2520inhibitors%2520reveal%2520a%2520fundamental%2520role%2520for%2520NaV1.7%2520in%2520nociceptor%2520electrogenesis%252C%2520axonal%2520conduction%2520and%2520presynaptic%2520release%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0152405%26doi%3D10.1371%2Fjournal.pone.0152405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: optimizing potency and pharmacokinetics to enable in vivo target engagement</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1062-1067&author=I.+E.+Marxauthor=T.+A.+Dineenauthor=J.+Ableauthor=C.+Bodeauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+DiMauroauthor=B.+Duauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=B.+E.+Hallauthor=L.+Huangauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=M.-H.+J.+Linauthor=S.+Liuauthor=J.+S.+McDermottauthor=B.+D.+Moyerauthor=E.+A.+Petersonauthor=J.+T.+Robertsauthor=P.+E.+Roseauthor=J.+Wangauthor=B.+D.+Youngbloodauthor=V.+L.+Yuauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+optimizing+potency+and+pharmacokinetics+to+enable+in+vivo+target+engagement&doi=10.1021%2Facsmedchemlett.6b00243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement</span></div><div class="casAuthors">Marx, Isaac E.; Dineen, Thomas A.; Able, Jessica; Bode, Christiane; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Du, Bingfan; Foti, Robert S.; Fremeau, Robert T.; Gao, Hua; Gunaydin, Hakan; Hall, Brian E.; Huang, Liyue; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Lin, Min-Hwa Jasmine; Liu, Dong; McDermott, Jeff S.; Moyer, Bryan D.; Peterson, Emily A.; Roberts, Jonathan T.; Rose, Paul; Wang, Jean; Youngblood, Beth D.; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1062-1067</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human genetic evidence has identified the voltage-gated sodium channel NaV1.7 as an attractive target for the treatment of pain.  The authors initially identified naphthalene sulfonamide 5-(2-(1-methyl-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-N-(1,2,4-thiadiazol-5-yl)naphthalene-2-sulfonamide (compd. 3) as a potent and selective inhibitor of NaV1.7.  Optimization to reduce biliary clearance by balancing hydrophilicity and hydrophobicity (Log D) while maintaining NaV1.7 potency led to the identification of quinazoline 16 (AM-2099).  Compd. 16 demonstrated a favorable pharmacokinetic profile in rat and dog and demonstrated dose-dependent redn. of histamine-induced scratching bouts in a mouse behavioral model following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNi8X2t0EULVg90H21EOLACvtfcHk0liMbd5sfEE5Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE&md5=43c2ae357af90d6c6f56245c3114c016</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00243%26sid%3Dliteratum%253Aachs%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRoberts%26aufirst%3DJ.%2BT.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%2BL.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520optimizing%2520potency%2520and%2520pharmacokinetics%2520to%2520enable%2520in%2520vivo%2520target%2520engagement%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D1062%26epage%3D1067%26doi%3D10.1021%2Facsmedchemlett.6b00243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post-Munson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graef, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newberry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Development of new benzenesulfonamides as potent and selective Na<sub>V</sub>1.7 inhibitors for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2513</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01918</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2513-2525&author=Y.-J.+Wuauthor=J.+Guernonauthor=J.+Shiauthor=J.+Dittaauthor=K.+J.+Robbinsauthor=R.+Rajamaniauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=K.+Mosureauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=D.+J.+Post-Munsonauthor=S.+Wangauthor=J.+Herringtonauthor=J.+Graefauthor=K.+Newberryauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Development+of+new+benzenesulfonamides+as+potent+and+selective+NaV1.7+inhibitors+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.6b01918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Shi, Jianliang; Ditta, Jonathan; Robbins, Kevin J.; Rajamani, Ramkumar; Easton, Amy; Newton, Amy; Bourin, Clotilde; Mosure, Kathleen; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Post-Munson, Debra J.; Wang, Shuya; Herrington, James; Graef, John; Newberry, Kimberly; Bristow, Linda J.; Meanwell, Nicholas A.; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2513-2525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By taking advantage of certain features in piperidine (I), the authors developed a novel series of cyclohexylamine- and piperidine-based benzenesulfonamides as potent and selective Nav1.7 inhibitors.  However, 4-((((1S,4S)-4-aminocydohexyl)methyl)amino)-5-chloro-2-fluoro-N-(thiazol-2-yl)benzenesulfonamide (24), one of the early analogs, failed to reduce phase 2 flinching in the mouse formalin test even at a dose of 100 mpk PO due to insufficient DRG exposure attributed to poor membrane permeability.  Two analogs with improved membrane permeability showed much increased DRG concns. at doses of 30 mpk PO but, confoundingly, only one of these was effective in the formalin test.  More data are needed to understand the disconnect between efficacy and exposure relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVESOC2ks88bVg90H21EOLACvtfcHk0ljsZvxPJCj3CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D&md5=d320dedb1d61794445680d94dc2c7e48</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01918%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DDitta%26aufirst%3DJ.%26aulast%3DRobbins%26aufirst%3DK.%2BJ.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DPost-Munson%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DJ.%26aulast%3DNewberry%26aufirst%3DK.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520new%2520benzenesulfonamides%2520as%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2513%26epage%3D2525%26doi%3D10.1021%2Facs.jmedchem.6b01918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric
Boijic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: optimizing potency and pharmacokinetics while mitigating metabolic liabilities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5969</span>– <span class="NLM_lpage">5989</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01851</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01851" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5969-5989&author=M.+M.+Weissauthor=T.+A.+Dineenauthor=I.+E.+Marxauthor=S.+Altmannauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Y.+Chu-Moyerauthor=E.+F.+DiMauroauthor=E.+Feric%0ABoijicauthor=R.+S.+Fotiauthor=H.+Gaoauthor=R.+F.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=H.+Huangauthor=L.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=J.+Liguttiauthor=D.+S.+Laauthor=M.-H.+J.+Linauthor=D.+Liuauthor=B.+D.+Moyerauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=P.+E.+Roseauthor=K.+Tabornauthor=B.+D.+Youngbloodauthor=V.+L.+Yuauthor=R.+T.+Fremeau&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+optimizing+potency+and+pharmacokinetics+while+mitigating+metabolic+liabilities&doi=10.1021%2Facs.jmedchem.6b01851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6fR"><div class="casContent"><span class="casTitleNuber">6f</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities</span></div><div class="casAuthors">Weiss, Matthew M.; Dineen, Thomas A.; Marx, Isaac E.; Altmann, Steven; Boezio, Alessandro; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Feric Bojic, Elma; Foti, Robert S.; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Huang, Hongbing; Huang, Liyue; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; Ligutti, Joseph; La, Daniel S.; Lin, Min-Hwa Jasmine; Liu, Dong; Moyer, Bryan D.; Nguyen, Hanh N.; Peterson, Emily A.; Rose, Paul E.; Taborn, Kristin; Youngblood, Beth D.; Yu, Violeta; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5969-5989</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several reports have recently emerged regarding the identification of heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  The optimization of a series of internal NaV1.7 leads that address a no. of metabolic liabilities including bioactivation, PXR activation, as well as CYP3A4 induction and inhibition led to the identification of potent and selective inhibitors that demonstrated favorable pharmacokinetic profiles and were devoid of the aforementioned liabilities.  The key to achieving this within a series prone to transporter-mediated clearance was the identification of a small range of optimal cLogD values and the discovery of subtle PXR SAR that was not lipophilicity dependent.  This enabled the identification of compd. 20, which was advanced into a target engagement pharmacodynamic model where it exhibited robust reversal of histamine-induced scratching bouts in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovsPC2UZpxsbVg90H21EOLACvtfcHk0ljsZvxPJCj3CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D&md5=6333a6b936e48f9d18cf9df10ea12853</span></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01851%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%2BY.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DFeric%2BBoijic%26aufirst%3DE.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%2BL.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520optimizing%2520potency%2520and%2520pharmacokinetics%2520while%2520mitigating%2520metabolic%2520liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5969%26epage%3D5989%26doi%3D10.1021%2Facs.jmedchem.6b01851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span> <span> </span><span class="NLM_article-title">The discovery of tetrahydropyridine analogs as <i>h</i>Na<sub>V</sub>1.7 selective inhibitors for analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2210</span>– <span class="NLM_lpage">2215</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2017.03.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=28385504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2210-2215&author=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=M.+Tengauthor=J.+Qinauthor=Z.+Huauthor=L.+Houauthor=L.+Shenauthor=H.+Dongauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=J.+Zhangauthor=L.+Ye&title=The+discovery+of+tetrahydropyridine+analogs+as+hNaV1.7+selective+inhibitors+for+analgesia&doi=10.1016%2Fj.bmcl.2017.03.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6gR"><div class="casContent"><span class="casTitleNuber">6g</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia</span></div><div class="casAuthors">Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Teng, Mingxing; Qin, Jian; Hu, Zhijing; Hou, Lijuan; Shen, Liang; Dong, Haiheng; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Zhang, Jianzhao; Ye, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2210-2215</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 small mol. inhibitors have attracted lots of attention by its unique analgesic effect.  Herein, the design and synthesis of a novel series of tetrahydropyridine analogs as hNav1.7 inhibitors for analgesia is reported.  Detail structural-activity relationship (SAR) studies were undertaken towards improving hNav1.7 activity, in vitro ADME, and in vivo PK profiles.  These efforts resulted in the identification of compd. (-)-I, a highly potent and selective hNav1.7 inhibitor with good ADME and PK profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP6xx5fd4NYrVg90H21EOLACvtfcHk0ljsZvxPJCj3CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D&md5=ed0b99fa7611354124394c07bbf259ac</span></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.043%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26atitle%3DThe%2520discovery%2520of%2520tetrahydropyridine%2520analogs%2520as%2520hNaV1.7%2520selective%2520inhibitors%2520for%2520analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2210%26epage%3D2215%26doi%3D10.1016%2Fj.bmcl.2017.03.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric
Bojic, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milgram, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescourio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellwagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: optimizing potency, pharmacokinetics, and metabolic properties to obtain atropisomeric quinolinone (AM-0466) that affords robust in vivo activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5990</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5990-6017&author=R.+F.+Graceffaauthor=A.+A.+Boezioauthor=J.+Ableauthor=S.+Altmannauthor=L.+M.+Berryauthor=C.+Boezioauthor=J.+R.+Butlerauthor=M.+Chu-Moyerauthor=M.+Cookeauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=F.+Feric%0ABojicauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=A.+Guzman-Perezauthor=H.+Gaoauthor=H.+Gunaydinauthor=H.+Huangauthor=L.+Huangauthor=C.+Ilchauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=B.+C.+Milgramauthor=M.-H.+J.+Linauthor=I.+E.+Marxauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=G.+Rescourioauthor=J.+Robertsauthor=L.+Schenkelauthor=R.+Shimanovichauthor=B.+A.+Sparlingauthor=J.+Stellwagenauthor=K.+Tabornauthor=K.+R.+Vaidaauthor=J.+Wangauthor=J.+Yeomanauthor=V.+Yuauthor=D.+Zhuauthor=B.+D.+Moyerauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+optimizing+potency%2C+pharmacokinetics%2C+and+metabolic+properties+to+obtain+atropisomeric+quinolinone+%28AM-0466%29+that+affords+robust+in+vivo+activity&doi=10.1021%2Facs.jmedchem.6b01850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6hR"><div class="casContent"><span class="casTitleNuber">6h</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity</span></div><div class="casAuthors">Graceffa, Russell F.; Boezio, Alessandro A.; Able, Jessica; Altmann, Steven; Berry, Loren M.; Boezio, Christiane; Butler, John R.; Chu-Moyer, Margaret; Cooke, Melanie; DiMauro, Erin F.; Dineen, Thomas A.; Feric Bojic, Elma; Foti, Robert S.; Fremeau, Robert T.; Guzman-Perez, Angel; Gao, Hua; Gunaydin, Hakan; Huang, Hongbing; Huang, Liyue; Ilch, Christopher; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Milgram, Benjamin C.; Lin, Min-Hwa Jasmine; Marx, Isaac E.; Nguyen, Hanh N.; Peterson, Emily A.; Rescourio, Gwen; Roberts, John; Schenkel, Laurie; Shimanovich, Roman; Sparling, Brian A.; Stellwagen, John; Taborn, Kristin; Vaida, Karina R.; Wang, Jean; Yeoman, John; Yu, Violeta; Zhu, Dawn; Moyer, Bryan D.; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5990-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain.  We have previously reported on a no. of structurally distinct bicyclic heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  Herein, we report the discovery and optimization of a series of atropisomeric quinolinone sulfonamide inhibitors [Bicyclic sulfonamide compds. as sodium channel inhibitors and their prepn. WO 2014201206, 2014] of NaV1.7, which demonstrate nanomolar inhibition of NaV1.7 and exhibit high levels of selectivity over other sodium channel isoforms.  After optimization of metabolic and pharmacokinetic properties, including PXR activation, CYP2C9 inhibition, and CYP3A4 TDI, several compds. were advanced into in vivo target engagement and efficacy models.  When tested in mice, compd. 39 (AM-0466) demonstrated robust pharmacodynamic activity in a NaV1.7-dependent model of histamine-induced pruritus (itch) and addnl. in a capsaicin-induced nociception model of pain without any confounding effect in open-field activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ofeMhgMFqbVg90H21EOLACvtfcHk0ligNNOxvzTSmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D&md5=5b48afe24a97290ea5e44a71deaa0303</span></div><a href="/servlet/linkout?suffix=cit6h&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01850%26sid%3Dliteratum%253Aachs%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DJ.%2BR.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DFeric%2BBojic%26aufirst%3DF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DMilgram%26aufirst%3DB.%2BC.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRescourio%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DStellwagen%26aufirst%3DJ.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYeoman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520optimizing%2520potency%252C%2520pharmacokinetics%252C%2520and%2520metabolic%2520properties%2520to%2520obtain%2520atropisomeric%2520quinolinone%2520%2528AM-0466%2529%2520that%2520affords%2520robust%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5990%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.6b01850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6i"><span><span class="NLM_label">(i) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Roecker, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egbertson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koser, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective, orally bioavailable, <i>N</i>-linked arylsulfonamide Na<sub>V</sub>1.7 inhibitors with pain efficacy in mice</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2017.03.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6i&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=28389149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2087-2093&author=A.+J.+Roeckerauthor=M.+Egbertsonauthor=K.+L.+G.+Jonesauthor=R.+Gomezauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+J.+Koserauthor=M.+O.+Urbanauthor=R.+Kleinauthor=M.+Clementsauthor=J.+Panigelauthor=C.+Daleyauthor=J.+Wangauthor=E.+N.+Fingerauthor=J.+Majercakauthor=V.+Santarelliauthor=I.+Greganauthor=M.+Catoauthor=T.+Filzenauthor=A.+Jovanovskaauthor=Y.-H.+Wangauthor=D.+Wangauthor=L.+A.+Joyceauthor=E.+C.+Shererauthor=X.+Pengauthor=X.+Wangauthor=H.+Sunauthor=P.+J.+Colemanauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Discovery+of+selective%2C+orally+bioavailable%2C+N-linked+arylsulfonamide+NaV1.7+inhibitors+with+pain+efficacy+in+mice&doi=10.1016%2Fj.bmcl.2017.03.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6iR"><div class="casContent"><span class="casTitleNuber">6i</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice</span></div><div class="casAuthors">Roecker, Anthony J.; Egbertson, Melissa; Jones, Kristen L. G.; Gomez, Robert; Kraus, Richard L.; Li, Yuxing; Koser, Amy Jo; Urban, Mark O.; Klein, Rebecca; Clements, Michelle; Panigel, Jacqueline; Daley, Christopher; Wang, Jixin; Finger, Eleftheria N.; Majercak, John; Santarelli, Vincent; Gregan, Irene; Cato, Matthew; Filzen, Tracey; Jovanovska, Aneta; Wang, Ying-Hong; Wang, Deping; Joyce, Leo A.; Sherer, Edward C.; Peng, Xuanjia; Wang, Xiu; Sun, Haiyan; Coleman, Paul J.; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2087-2093</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel Nav1.7 is a genetically validated target for the treatment of pain with gain-of-function mutations in man eliciting a variety of painful disorders and loss-of-function mutations affording insensitivity to pain.  Unfortunately, drugs thought to garner efficacy via Nav1 inhibition have undesirable side effect profiles due to their lack of selectivity over channel isoforms.  Herein we report the discovery of a novel series of orally bioavailable arylsulfonamide Nav1.7 inhibitors with high levels of selectivity over Nav1.5, the Nav isoform responsible for cardiovascular side effects, through judicious use of parallel medicinal chem. and physicochem. property optimization.  This effort produced inhibitors such as compd. 5 with excellent potency, selectivity, behavioral efficacy in a rodent pain model, and efficacy in a mouse itch model suggestive of target modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNDA0s8NB86LVg90H21EOLACvtfcHk0lhFSBt148MpdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D&md5=5729efef8e3df4afe3f89c25472c9268</span></div><a href="/servlet/linkout?suffix=cit6i&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.085%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DEgbertson%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%2BL.%2BG.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKoser%26aufirst%3DA.%2BJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DClements%26aufirst%3DM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DDaley%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMajercak%26aufirst%3DJ.%26aulast%3DSantarelli%26aufirst%3DV.%26aulast%3DGregan%26aufirst%3DI.%26aulast%3DCato%26aufirst%3DM.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DL.%2BA.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%2520selective%252C%2520orally%2520bioavailable%252C%2520N-linked%2520arylsulfonamide%2520NaV1.7%2520inhibitors%2520with%2520pain%2520efficacy%2520in%2520mice%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2087%26epage%3D2093%26doi%3D10.1016%2Fj.bmcl.2017.03.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6j"><span><span class="NLM_label">(j) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pero, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehman, H. D. G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulhearn, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henze, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Benzoxazolinone aryl sulfonamides as potent, selective Na<sub>V</sub>1.7 inhibitors with in vivo efficacy in a preclinical pain model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2683</span>– <span class="NLM_lpage">2688</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6j&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2017.04.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6j&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=28465103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6j&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2683-2688&author=J.+E.+Peroauthor=M.+A.+Rossiauthor=H.+D.+G.+F.+Lehmanauthor=M.+J.+Kellyauthor=J.+J.+Mulhearnauthor=S.+E.+Wolkenbergauthor=M.+J.+Catoauthor=M.+K.+Clementsauthor=C.+J.+Daleyauthor=T.+Filzenauthor=E.+N.+Fingerauthor=Y.+Greganauthor=D.+A.+Henzeauthor=A.+Jovanovskaauthor=R.+Kleinauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+Liangauthor=J.+M.+Majercakauthor=J.+Panigelauthor=M.+O.+Urbanauthor=J.+Wangauthor=Y.-H.+Wangauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Benzoxazolinone+aryl+sulfonamides+as+potent%2C+selective+NaV1.7+inhibitors+with+in+vivo+efficacy+in+a+preclinical+pain+model&doi=10.1016%2Fj.bmcl.2017.04.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6jR"><div class="casContent"><span class="casTitleNuber">6j</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model</span></div><div class="casAuthors">Pero, Joseph E.; Rossi, Michael A.; Lehman, Hannah D. G. F.; Kelly, Michael J., III; Mulhearn, James J.; Wolkenberg, Scott E.; Cato, Matthew J.; Clements, Michelle K.; Daley, Christopher J.; Filzen, Tracey; Finger, Eleftheria N.; Gregan, Yun; Henze, Darrell A.; Jovanovska, Aneta; Klein, Rebecca; Kraus, Richard L.; Li, Yuxing; Liang, Annie; Majercak, John M.; Panigel, Jacqueline; Urban, Mark O.; Wang, Jixin; Wang, Ying-Hong; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2683-2688</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Studies on human genetics have suggested that inhibitors of the Nav1.7 voltage-gated sodium channel hold considerable promise as therapies for the treatment of chronic pain syndromes.  Herein, we report novel, peripherally-restricted benzoxazolinone aryl sulfonamides as potent Nav1.7 inhibitors with excellent selectivity against the Nav1.5 isoform, which is expressed in the heart muscle.  Elaboration of initial lead compd. 3d afforded exemplar 13, which featured attractive physicochem. properties, outstanding lipophilic ligand efficiency and pharmacol. selectivity against Nav1.5 exceeding 1000-fold.  Key structure-activity relationships assocd. with oral bioavailability were leveraged to discover compd. 17, which exhibited a comparable potency/selectivity profile as well as full efficacy following oral administration in a preclin. model indicative of antinociceptive behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGCg6OCYoM57Vg90H21EOLACvtfcHk0lhFSBt148MpdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D&md5=9ea2c021a2c76ffe0bb8c623d1eb7427</span></div><a href="/servlet/linkout?suffix=cit6j&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DJ.%2BE.%26aulast%3DRossi%26aufirst%3DM.%2BA.%26aulast%3DLehman%26aufirst%3DH.%2BD.%2BG.%2BF.%26aulast%3DKelly%26aufirst%3DM.%2BJ.%26aulast%3DMulhearn%26aufirst%3DJ.%2BJ.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DCato%26aufirst%3DM.%2BJ.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DDaley%26aufirst%3DC.%2BJ.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DGregan%26aufirst%3DY.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DMajercak%26aufirst%3DJ.%2BM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DBenzoxazolinone%2520aryl%2520sulfonamides%2520as%2520potent%252C%2520selective%2520NaV1.7%2520inhibitors%2520with%2520in%2520vivo%2520efficacy%2520in%2520a%2520preclinical%2520pain%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2683%26epage%3D2688%26doi%3D10.1016%2Fj.bmcl.2017.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6k"><span><span class="NLM_label">(k) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coats, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasmine Lin, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nho Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of benzoxazine sulfonamide inhibitors of Na<sub>V</sub>1.7: tools that bridge efficacy and target engagement</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3477</span>– <span class="NLM_lpage">3485</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.05.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6k&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2017.05.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6k&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=28629594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6k&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVeqsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=3477-3485&author=D.+S.+Laauthor=E.+A.+Petersonauthor=C.+Bodeauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Y.+Chu-Moyerauthor=J.+Coatsauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=B.+Duauthor=H.+Gaoauthor=R.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=R.+Fremeauauthor=X.+Huangauthor=C.+Ilchauthor=T.+J.+Kornecookauthor=C.+Kreimanauthor=J.+Liguttiauthor=M.-H.+Jasmine+Linauthor=J.+S.+McDermottauthor=I.+Marxauthor=D.+J.+Matsonauthor=S.+I.+McDonoughauthor=B.+D.+Moyerauthor=H.+Nho+Nguyenauthor=K.+Tabornauthor=V.+Yuauthor=M.+M.+Weiss&title=The+discovery+of+benzoxazine+sulfonamide+inhibitors+of+NaV1.7%3A+tools+that+bridge+efficacy+and+target+engagement&doi=10.1016%2Fj.bmcl.2017.05.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6kR"><div class="casContent"><span class="casTitleNuber">6k</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of benzoxazine sulfonamide inhibitors of NaV1.7: Tools that bridge efficacy and target engagement</span></div><div class="casAuthors">La, Daniel S.; Peterson, Emily A.; Bode, Christiane; Boezio, Alessandro A.; Bregman, Howard; Chu-Moyer, Margaret Y.; Coats, James; Di Mauro, Erin F.; Dineen, Thomas A.; Du, Bingfan; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Fremeau, Robert, Jr.; Huang, Xin; Ilch, Christopher; Kornecook, Thomas J.; Kreiman, Charles; Ligutti, Joseph; Jasmine Lin, Min-Hwa; McDermott, Jeff S.; Marx, Isaac; Matson, David J.; McDonough, Stefan I.; Moyer, Bryan D.; Nho Nguyen, Hanh; Taborn, Kristin; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3477-3485</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel NaV1.7 has received much attention from the scientific community due to compelling human genetic data linking gain- and loss-of-function mutations to pain phenotypes.  Despite this genetic validation of NaV1.7 as a target for pain, high quality pharmacol. tools facilitate further understanding of target biol., establishment of target coverage requirements and subsequent progression into the clinic.  Within the sulfonamide class of inhibitors, reduced potency on rat NaV1.7 vs. human NaV1.7 was obsd., rendering in vivo rat pharmacol. studies challenging.  Herein, the authors report the discovery and optimization of novel benzoxazine sulfonamide inhibitors of human, rat and mouse NaV1.7 which enabled pharmacol. assessment in traditional behavioral rodent models of pain and in turn, established a connection between formalin-induced pain and histamine-induced pruritus in mice.  The latter represents a simple and efficient means of measuring target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrephmJ2EoOv7Vg90H21EOLACvtfcHk0lhFSBt148MpdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVeqsb7K&md5=680ffa374194c12fd3705a7003bd572e</span></div><a href="/servlet/linkout?suffix=cit6k&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.05.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.05.070%26sid%3Dliteratum%253Aachs%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%2BY.%26aulast%3DCoats%26aufirst%3DJ.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DFremeau%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DKornecook%26aufirst%3DT.%2BJ.%26aulast%3DKreiman%26aufirst%3DC.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DJasmine%2BLin%26aufirst%3DM.-H.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMarx%26aufirst%3DI.%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNho%2BNguyen%26aufirst%3DH.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DThe%2520discovery%2520of%2520benzoxazine%2520sulfonamide%2520inhibitors%2520of%2520NaV1.7%253A%2520tools%2520that%2520bridge%2520efficacy%2520and%2520target%2520engagement%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D3477%26epage%3D3485%26doi%3D10.1016%2Fj.bmcl.2017.05.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6l"><span><span class="NLM_label">(l) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulier, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greener, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransley, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 4-[2-(5-Amino-1<i>H</i>-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-<i>N</i>-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): design and optimization of diaryl ether aryl sulfonamides as selective inhibitors of Na<sub>V</sub>1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7029</span>– <span class="NLM_lpage">7042</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6l&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7029-7042&author=N.+A.+Swainauthor=D.+Batchelorauthor=S.+Beaudoinauthor=B.+M.+Bechleauthor=P.+A.+Bradleyauthor=A.+D.+Brownauthor=B.+Brownauthor=K.+J.+Butcherauthor=R.+P.+Buttauthor=M.+L.+Chapmanauthor=S.+Dentonauthor=D.+Ellisauthor=S.+Galanauthor=S.+M.+Gaulierauthor=B.+S.+Greenerauthor=M.+J.+de+Grootauthor=M.+S.+Glossopauthor=I.+K.+Gurrellauthor=J.+Hannamauthor=M.+S.+Johnsonauthor=Z.+Linauthor=C.+J.+Markworthauthor=B.+E.+Marronauthor=D.+S.+Millanauthor=S.+Nakagawaauthor=A.+Pikeauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=S.+J.+Ransleyauthor=S.+M.+Reisterauthor=K.+Sasakiauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=C.+W.+West&title=Discovery+of+clinical+candidate+4-%5B2-%285-Amino-1H-pyrazol-4-yl%29-4-chlorophenoxy%5D-5-chloro-2-fluoro-N-1%2C3-thiazol-4-ylbenzenesulfonamide+%28PF-05089771%29%3A+design+and+optimization+of+diaryl+ether+aryl+sulfonamides+as+selective+inhibitors+of+NaV1.7&doi=10.1021%2Facs.jmedchem.7b00598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6lR"><div class="casContent"><span class="casTitleNuber">6l</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7</span></div><div class="casAuthors">Swain, Nigel. A.; Batchelor, Dave; Beaudoin, Serge; Bechle, Bruce M.; Bradley, Paul A.; Brown, Alan D.; Brown, Bruce; Butcher, Ken J.; Butt, Richard P.; Chapman, Mark L.; Denton, Stephen; Ellis, David; Galan, Sebastien R. G.; Gaulier, Steven M.; Greener, Ben S.; de Groot, Marcel J.; Glossop, Mel S.; Gurrell, Ian K.; Hannam, Jo; Johnson, Matthew S.; Lin, Zhixin; Markworth, Christopher J.; Marron, Brian E.; Millan, David S.; Nakagawa, Shoko; Pike, Andy; Printzenhoff, David; Rawson, David J.; Ransley, Sarah J.; Reister, Steven M.; Sasaki, Kosuke; Storer, R. Ian; Stupple, Paul A.; West, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7029-7042</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of acidic diaryl ether heterocyclic sulfonamides that are potent and sub-type selective NaV1.7 inhibitors is described.  Optimization of early lead matter focused on removal of structural alerts, improving metabolic stability and reducing cytochrome P 450 inhibition driven drug-drug interaction concerns to deliver the desired balance of preclin. in vitro properties.  Concerns over non-metabolic routes of clearance, variable clearance in pre-clin. species and subsequent low confidence human pharmacokinetic predictions led to the decision to conduct a human microdose study to det. clin. pharmacokinetics.  The design strategies and results from pre-clin. PK and clin. human microdose PK data are described leading to the discovery of the first sub-type selective NaV1.7 inhibitor clin. candidate PF-05089771 (34) which binds to a site in the voltage sensing domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpST6i8wDUALbVg90H21EOLACvtfcHk0ljfLnDNPqHXyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM&md5=93761c8e8e16cea4db2c9cff6e315e57</span></div><a href="/servlet/linkout?suffix=cit6l&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00598%26sid%3Dliteratum%253Aachs%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DBatchelor%26aufirst%3DD.%26aulast%3DBeaudoin%26aufirst%3DS.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBradley%26aufirst%3DP.%2BA.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DDenton%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DS.%26aulast%3DGaulier%26aufirst%3DS.%2BM.%26aulast%3DGreener%26aufirst%3DB.%2BS.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DGlossop%26aufirst%3DM.%2BS.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DHannam%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRansley%26aufirst%3DS.%2BJ.%26aulast%3DReister%26aufirst%3DS.%2BM.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWest%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25204-%255B2-%25285-Amino-1H-pyrazol-4-yl%2529-4-chlorophenoxy%255D-5-chloro-2-fluoro-N-1%252C3-thiazol-4-ylbenzenesulfonamide%2520%2528PF-05089771%2529%253A%2520design%2520and%2520optimization%2520of%2520diaryl%2520ether%2520aryl%2520sulfonamides%2520as%2520selective%2520inhibitors%2520of%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7029%26epage%3D7042%26doi%3D10.1021%2Facs.jmedchem.7b00598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6m"><span><span class="NLM_label">(m) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrou, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castle, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fengas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theile, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmus, J. S.</span></span> <span> </span><span class="NLM_article-title">Highly potent and selective Na<sub>V</sub>1.7 inhibitors for use as intravenous agents and chemical probes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4805</span>– <span class="NLM_lpage">4811</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.09.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6m&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2017.09.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6m&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=29029933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6m&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gmur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4805-4811&author=R.+I.+Storerauthor=A.+Pikeauthor=N.+A.+Swainauthor=A.+J.+Alexandrouauthor=B.+M.+Bechleauthor=D.+C.+Blakemoreauthor=A.+D.+Brownauthor=N.+A.+Castleauthor=M.+S.+Corbettauthor=N.+J.+Flanaganauthor=D.+Fengasauthor=M.+S.+Johnsonauthor=L.+H.+Jonesauthor=B.+E.+Marronauthor=C.+E.+Payneauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=C.+R.+Roseauthor=T.+Ryckmansauthor=J.+Sunauthor=J.+W.+Theileauthor=R.+Torellaauthor=E.+Tsengauthor=J.+S.+Warmus&title=Highly+potent+and+selective+NaV1.7+inhibitors+for+use+as+intravenous+agents+and+chemical+probes&doi=10.1016%2Fj.bmcl.2017.09.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6mR"><div class="casContent"><span class="casTitleNuber">6m</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes</span></div><div class="casAuthors">Storer, R. Ian; Pike, Andy; Swain, Nigel A.; Alexandrou, Aristos J.; Bechle, Bruce M.; Blakemore, David C.; Brown, Alan D.; Castle, Neil A.; Corbett, Matthew S.; Flanagan, Neil J.; Fengas, David; Johnson, M. Scott; Jones, Lyn H.; Marron, Brian E.; Payne, C. Elizabeth; Printzenhoff, David; Rawson, David J.; Rose, Colin R.; Ryckmans, Thomas; Sun, Jianmin; Theile, Jonathan W.; Torella, Rubben; Tseng, Elaine; Warmus, Joseph S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4805-4811</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and selection of a highly potent and selective NaV1.7 inhibitor PF-06456384, designed specifically for i.v. infusion, is disclosed.  Extensive in vitro pharmacol. and ADME profiling followed by in vivo preclin. PK and efficacy model data are discussed.  A proposed protein-ligand binding mode for this compd. is also provided to rationalize the high levels of potency and selectivity over inhibition of related sodium channels.  To further support the proposed binding mode, potent conjugates are described which illustrate the potential for development of chem. probes to enable further target evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA-67HTehcGLVg90H21EOLACvtfcHk0ljfLnDNPqHXyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gmur3L&md5=5be8e615ad061aa7cf06056de8b8682c</span></div><a href="/servlet/linkout?suffix=cit6m&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.09.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.09.056%26sid%3Dliteratum%253Aachs%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DAlexandrou%26aufirst%3DA.%2BJ.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26aulast%3DCorbett%26aufirst%3DM.%2BS.%26aulast%3DFlanagan%26aufirst%3DN.%2BJ.%26aulast%3DFengas%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPayne%26aufirst%3DC.%2BE.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DTheile%26aufirst%3DJ.%2BW.%26aulast%3DTorella%26aufirst%3DR.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26atitle%3DHighly%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520use%2520as%2520intravenous%2520agents%2520and%2520chemical%2520probes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4805%26epage%3D4811%26doi%3D10.1016%2Fj.bmcl.2017.09.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6n"><span><span class="NLM_label">(n) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of aminocyclohexene analogues as selective and orally bioavailable <i>h</i>Na<sub>V</sub>1.7 inhibitors for analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4979</span>– <span class="NLM_lpage">4984</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6n&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2017.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6n&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=29037948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6n&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4979-4984&author=M.+Tengauthor=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=J.+Qinauthor=Y.+Wangauthor=Z.+Huauthor=H.+Dongauthor=L.+Houauthor=G.+Huauthor=L.+Shenauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=L.+Yeauthor=J.+Zhangauthor=H.+Wang&title=Discovery+of+aminocyclohexene+analogues+as+selective+and+orally+bioavailable+hNaV1.7+inhibitors+for+analgesia&doi=10.1016%2Fj.bmcl.2017.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6nR"><div class="casContent"><span class="casTitleNuber">6n</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesia</span></div><div class="casAuthors">Teng, Mingxing; Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Qin, Jian; Wang, Yikai; Hu, Zhijing; Dong, Haiheng; Hou, Lijuan; Hu, Guoping; Shen, Liang; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Ye, Liang; Zhang, Jianzhao; Wang, Hongbo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4979-4984</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 receives a lot of attention owing to its attractive mechanism of action in pain processing pathway.  The authors have previously reported the design of a novel series of tetrahydropyridine analogs towards hNav1.7 selective inhibitors.  Herein, the authors disclose further efforts to the optimization of hit compd. (-)-6, which led to the identification of aminocyclohexene analogs (-)-9 and (-)-17 with good potency, high selectivity, and minimal CYP inhibition.  Both compds. (-)-9 and (-)-17 demonstrated improved pharmacokinetic profiles in rats, and robust efficacy in rat formalin-induced nociception and spinal nerve ligation (SNL) models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqawNCRE6H6rVg90H21EOLACvtfcHk0lgAgrl-7eibMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7J&md5=922146ec3e1c272e02af031be78dc06d</span></div><a href="/servlet/linkout?suffix=cit6n&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520aminocyclohexene%2520analogues%2520as%2520selective%2520and%2520orally%2520bioavailable%2520hNaV1.7%2520inhibitors%2520for%2520analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4979%26epage%3D4984%26doi%3D10.1016%2Fj.bmcl.2017.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krafte, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krambis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonio, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zellmer, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagoner, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castle, N. A.</span></span> <span> </span><span class="NLM_article-title">Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">E2724</span>– <span class="NLM_lpage">E2732</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220844110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1073%2Fpnas.1220844110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=23818614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1emu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E2724-E2732&author=K.+McCormackauthor=S.+Santosauthor=M.+L.+Chapmanauthor=D.+S.+Krafteauthor=B.+E.+Marronauthor=C.+W.+Westauthor=M.+J.+Krambisauthor=B.+M.+Antonioauthor=S.+G.+Zellmerauthor=D.+Printzenhoffauthor=K.+M.+Padillaauthor=Z.+Linauthor=P.+K.+Wagonerauthor=N.+A.+Swainauthor=P.+A.+Stuppleauthor=M.+de+Grootauthor=R.+P.+Buttauthor=N.+A.+Castle&title=Voltage+sensor+interaction+site+for+selective+small+molecule+inhibitors+of+voltage-gated+sodium+channels&doi=10.1073%2Fpnas.1220844110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels</span></div><div class="casAuthors">McCormack, Ken; Santos, Sonia; Chapman, Mark L.; Krafte, Douglas S.; Marron, Brian E.; West, Christopher W.; Krambis, Michael J.; Antonio, Brett M.; Zellmer, Shannon G.; Printzenhoff, David; Padilla, Karen M.; Lin, Zhixin; Wagoner, P. Kay; Swain, Nigel A.; Stupple, Paul A.; de Groot, Marcel; Butt, Richard P.; Castle, Neil A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">E2724-E2732,SE2724/1-SE2724/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Voltage-gated sodium (Nav) channels play a fundamental role in the generation and propagation of elec. impulses in excitable cells.  Here the authors describe two unique structurally related nanomolar potent small mol. Nav channel inhibitors that exhibit up to 1000-fold selectivity for human Nav1.3/Nav1.1 (ICA-121431, IC50, 19 nM) or Nav1.7 (PF-04856264, IC50, 28 nM) vs. other TTX-sensitive or resistant (i.e., Nav1.5) sodium channels.  Using both chimeras and single point mutations, the authors demonstrate that this unique class of sodium channel inhibitor interacts with the S1-S4 voltage sensor segment of homologous Domain 4.  Amino acid residues in the "extracellular" facing regions of the S2 and S3 transmembrane segments of Nav1.3 and Nav1.7 seem to be major determinants of Nav subtype selectivity and to confer differences in species sensitivity to these inhibitors.  The unique interaction region on the Domain 4 voltage sensor segment is distinct from the structural domains forming the channel pore, as well as previously characterized interaction sites for other small mol. inhibitors, including local anesthetics and TTX.  However, this interaction region does include at least one amino acid residue [E1559 (Nav1.3)/D1586 (Nav1.7)] that is important for Site 3 α-scorpion and anemone polypeptide toxin modulators of Nav channel inactivation.  The present study provides a potential framework for identifying subtype selective small mol. sodium channel inhibitors targeting interaction sites away from the pore region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW_9_BEDLPnbVg90H21EOLACvtfcHk0lgAgrl-7eibMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1emu7zK&md5=d970cc772ece1372fb0b427a240beb56</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220844110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220844110%26sid%3Dliteratum%253Aachs%26aulast%3DMcCormack%26aufirst%3DK.%26aulast%3DSantos%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DKrafte%26aufirst%3DD.%2BS.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DWest%26aufirst%3DC.%2BW.%26aulast%3DKrambis%26aufirst%3DM.%2BJ.%26aulast%3DAntonio%26aufirst%3DB.%2BM.%26aulast%3DZellmer%26aufirst%3DS.%2BG.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DPadilla%26aufirst%3DK.%2BM.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DWagoner%26aufirst%3DP.%2BK.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3Dde%2BGroot%26aufirst%3DM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26atitle%3DVoltage%2520sensor%2520interaction%2520site%2520for%2520selective%2520small%2520molecule%2520inhibitors%2520of%2520voltage-gated%2520sodium%2520channels%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE2724%26epage%3DE2732%26doi%3D10.1073%2Fpnas.1220844110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukund, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shriver, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillantes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koth, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payandeh, J.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Structural basis of Na<sub>V</sub>1.7 inhibition by an isoform-selective small molecule antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">aac5464</span>, <span class="refDoi"> DOI: 10.1126/science.aac5464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1126%2Fscience.aac5464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=26680203" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&pages=aac5464&author=S.+Ahujaauthor=S.+Mukundauthor=L.+Dengauthor=K.+Khakhauthor=E.+Changauthor=H.+Hoauthor=S.+Shriverauthor=C.+Youngauthor=S.+Linauthor=J.+P.+Johnsonauthor=P.+Wuauthor=J.+Liauthor=M.+Coonsauthor=C.+Tamauthor=B.+Brillantesauthor=H.+Sampangauthor=K.+Mortaraauthor=M.+Grimwoodauthor=C.+Dehnhardtauthor=J.-C.+Andrezauthor=T.+Fockenauthor=D.+P.+Sutherlinauthor=B.+S.+Safinaauthor=M.+A.+Starovasnikauthor=D.+F.+Ortwineauthor=Y.+Frankeauthor=C.+J.+Cohenauthor=D.+H.+Hackosauthor=C.+M.+Kothauthor=J.+Payandeh&title=Structural+basis+of+NaV1.7+inhibition+by+an+isoform-selective+small+molecule+antagonist&doi=10.1126%2Fscience.aac5464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac5464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac5464%26sid%3Dliteratum%253Aachs%26aulast%3DAhuja%26aufirst%3DS.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DShriver%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCoons%26aufirst%3DM.%26aulast%3DTam%26aufirst%3DC.%26aulast%3DBrillantes%26aufirst%3DB.%26aulast%3DSampang%26aufirst%3DH.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DGrimwood%26aufirst%3DM.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DAndrez%26aufirst%3DJ.-C.%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DFranke%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DKoth%26aufirst%3DC.%2BM.%26aulast%3DPayandeh%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520NaV1.7%2520inhibition%2520by%2520an%2520isoform-selective%2520small%2520molecule%2520antagonist%26jtitle%3DScience%26date%3D2015%26volume%3D350%26spage%3Daac5464%26doi%3D10.1126%2Fscience.aac5464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzygiel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segelbacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span> <span> </span><span class="NLM_article-title">Clinical micro-dose studies to explore the human pharmacokinetics of four selective inhibitors of human Na<sub>V</sub>1.7 voltage-dependent sodium channels</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1007/s40262-015-0365-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1007%2Fs40262-015-0365-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=26895021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=875-887&author=H.+M.+Jonesauthor=R.+P.+Buttauthor=R.+W.+Websterauthor=I.+Gurrellauthor=P.+Dzygielauthor=N.+Flanaganauthor=D.+Fraierauthor=T.+Hayauthor=L.+E.+Iavaroneauthor=J.+Luckwellauthor=H.+Pearceauthor=A.+Phippsauthor=J.+Segelbacherauthor=B.+Speedauthor=K.+Beaumont&title=Clinical+micro-dose+studies+to+explore+the+human+pharmacokinetics+of+four+selective+inhibitors+of+human+NaV1.7+voltage-dependent+sodium+channels&doi=10.1007%2Fs40262-015-0365-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels</span></div><div class="casAuthors">Jones, Hannah M.; Butt, Richard P.; Webster, Rob W.; Gurrell, Ian; Dzygiel, Pawel; Flanagan, Neil; Fraier, Daniela; Hay, Tanya; Iavarone, Laura Else; Luckwell, Jacquelynn; Pearce, Hannah; Phipps, Alex; Segelbacher, Jill; Speed, Bill; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">875-887</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background: The emergence of genetic data linking Nav1.7 sodium channel over- and under- expression to human pain signalling has led to an interest in the treatment of chronic pain through inhibition of Nav1.7 channels.  Objective: We describe the pharmacokinetic (PK) results of a clin. microdose study performed with four potent and selective Nav1.7 inhibitors and the subsequent modeling resulting in the selection of a single compd. to explore Nav1.7 pharmacol. at higher doses.  Methods: A clin. microdose study to investigate the i.v. and oral PK of four compds. (PF-05089771, PF-05150122, PF-05186462 and PF-05241328) was performed in healthy volunteers.  PK parameters were derived via noncompartmental anal.  A physiol.-based PK (PBPK) model was used to predict exposure and multiples of Nav1.7 50 % inhibitory concn. (IC50) for each compd. at higher doses.  Results: Plasma clearance, vol. of distribution and bioavailability ranged from 45 to 392 mL/min/kg, 13 to 36 L/kg and 38 to 110 %, resp.  The PBPK model for PF-05089771 predicted a 1 g oral dose would be required to achieve exposures of approx. 12× Nav1.7 IC50 at max. concn. (Cmax), and approx. 3× IC50 after 12 h (min. concn. [Cmin] for a twice-daily regimen).  Lower multiples of Nav1.7 IC50 were predicted with the same oral doses of PF-05150122, PF-05186462, and PF-05241328.  In a subsequent single ascending oral dose clin. study, the predictions for PF-05089771 compared well with obsd. data.  Conclusion: Based on the human PK data obtained from the microdose study and subsequent modeling, PF-05089771 provided the best opportunity to explore Nav1.7 blockade for the treatment of acute or chronic pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEQTEvITzd7Vg90H21EOLACvtfcHk0ljxrCJuk6zORA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D&md5=bf8dbccbbbbf25f52bf13f28bc995c18</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0365-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0365-0%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DWebster%26aufirst%3DR.%2BW.%26aulast%3DGurrell%26aufirst%3DI.%26aulast%3DDzygiel%26aufirst%3DP.%26aulast%3DFlanagan%26aufirst%3DN.%26aulast%3DFraier%26aufirst%3DD.%26aulast%3DHay%26aufirst%3DT.%26aulast%3DIavarone%26aufirst%3DL.%2BE.%26aulast%3DLuckwell%26aufirst%3DJ.%26aulast%3DPearce%26aufirst%3DH.%26aulast%3DPhipps%26aufirst%3DA.%26aulast%3DSegelbacher%26aufirst%3DJ.%26aulast%3DSpeed%26aufirst%3DB.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DClinical%2520micro-dose%2520studies%2520to%2520explore%2520the%2520human%2520pharmacokinetics%2520of%2520four%2520selective%2520inhibitors%2520of%2520human%2520NaV1.7%2520voltage-dependent%2520sodium%2520channels%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26spage%3D875%26epage%3D887%26doi%3D10.1007%2Fs40262-015-0365-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Application of a parallel synthetic strategy in the discovery of biaryl acyl sulfonamides as efficient and selective Na<sub>V</sub>1.7 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7818</span>– <span class="NLM_lpage">7839</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00425</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00425" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SktLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7818-7839&author=E.+F.+DiMauroauthor=S.+Altmannauthor=L.+M.+Berryauthor=H.+Bregmanauthor=N.+Chakkaauthor=M.+Chu-Moyerauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=B.+E.+Hallauthor=H.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=J.+Leeauthor=J.+Liguttiauthor=D.+Liuauthor=B.+D.+Moyerauthor=D.+Ortunoauthor=P.+E.+Roseauthor=L.+B.+Schenkelauthor=K.+Tabornauthor=J.+Wangauthor=Y.+Wangauthor=V.+Yuauthor=M.+M.+Weiss&title=Application+of+a+parallel+synthetic+strategy+in+the+discovery+of+biaryl+acyl+sulfonamides+as+efficient+and+selective+NaV1.7+inhibitors&doi=10.1021%2Facs.jmedchem.6b00425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors</span></div><div class="casAuthors">DiMauro, Erin F.; Altmann, Stephen; Berry, Loren M.; Bregman, Howard; Chakka, Nagasree; Chu-Moyer, Margaret; Bojic, Elma Feric; Foti, Robert S.; Fremeau, Robert; Gao, Hua; Gunaydin, Hakan; Guzman-Perez, Angel; Hall, Brian E.; Huang, Hongbing; Jarosh, Michael; Kornecook, Thomas; Lee, Josie; Ligutti, Joseph; Liu, Dong; Moyer, Bryan D.; Ortuno, Daniel; Rose, Paul E.; Schenkel, Laurie B.; Taborn, Kristin; Wang, Jean; Wang, Yan; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7818-7839</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of potent and selective hNaV1.7 inhibitors possess common pharmacophoric features that include a heteroaryl sulfonamide headgroup and a lipophilic arom. tail group.  Recently, reports of similar arom. tail groups in combination with an acyl sulfonamide headgroup have emerged, with the acyl sulfonamide bestowing levels of selectivity over hNaV1.5 comparable to the heteroaryl sulfonamide.  Beginning with com. available carboxylic acids that met selected pharmacophoric requirements in the lipophilic tail, a parallel synthetic approach was applied to rapidly generate the derived acyl sulfonamides.  A biaryl acyl sulfonamide hit from this library was elaborated, optimizing for potency and selectivity with attention to physicochem. properties.  The resulting novel leads are potent, ligand and lipophilic efficient, and selective over hNaV1.5.  Representative lead I demonstrates selectivity over other human NaV isoforms and good pharmacokinetics in rodents.  The biaryl acyl sulfonamides reported herein may also offer ADME advantages over known heteroaryl sulfonamide inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxffPzH1T1T7Vg90H21EOLACvtfcHk0ljxrCJuk6zORA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SktLjK&md5=8afa7437928f0d43a1327662674978ed</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00425%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DOrtuno%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DApplication%2520of%2520a%2520parallel%2520synthetic%2520strategy%2520in%2520the%2520discovery%2520of%2520biaryl%2520acyl%2520sulfonamides%2520as%2520efficient%2520and%2520selective%2520NaV1.7%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7818%26epage%3D7839%26doi%3D10.1021%2Facs.jmedchem.6b00425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J.-C.</span>; <span class="NLM_string-name">Chowdhury, S.</span>; <span class="NLM_string-name">Decker, S.</span>; <span class="NLM_string-name">Dehnhardt, C. M.</span>; <span class="NLM_string-name">Focken, T.</span>; <span class="NLM_string-name">Grimwood, M. E.</span>; <span class="NLM_string-name">Hemeon, I. W.</span>; <span class="NLM_string-name">Jia, Q.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Ortwine, D. F.</span>; <span class="NLM_string-name">Safina, B.</span>; <span class="NLM_string-name">Sheng, T.</span>; <span class="NLM_string-name">Sun, S.</span>; <span class="NLM_string-name">Sutherlin, D. P.</span>; <span class="NLM_string-name">Wilson, M. S.</span>; <span class="NLM_string-name">Zenova, A. Y.</span></span> <span> </span><span class="NLM_article-title">N-Substituted Benzamides and Their Use in the Treatment of Pain</span>. <span class="NLM_patent">WO2013177224A1</span>, Nov 28, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.-C.+Andrez&author=S.+Chowdhury&author=S.+Decker&author=C.+M.+Dehnhardt&author=T.+Focken&author=M.+E.+Grimwood&author=I.+W.+Hemeon&author=Q.+Jia&author=J.+Li&author=D.+F.+Ortwine&author=B.+Safina&author=T.+Sheng&author=S.+Sun&author=D.+P.+Sutherlin&author=M.+S.+Wilson&author=A.+Y.+Zenova&title=N-Substituted+Benzamides+and+Their+Use+in+the+Treatment+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAndrez%26aufirst%3DJ.-C.%26atitle%3DN-Substituted%2520Benzamides%2520and%2520Their%2520Use%2520in%2520the%2520Treatment%2520of%2520Pain%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafeev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadieux, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of XEN907, a spirooxindole blocker of NaV1.7 for the treatment of pain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3676</span>– <span class="NLM_lpage">3681</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2011.04.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=21570288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntFKhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3676-3681&author=S.+Chowdhuryauthor=M.+Chafeevauthor=S.+Liuauthor=J.+Sunauthor=V.+Rainaauthor=R.+Chuiauthor=W.+Youngauthor=R.+Kwanauthor=J.+Fuauthor=J.+A.+Cadieux&title=Discovery+of+XEN907%2C+a+spirooxindole+blocker+of+NaV1.7+for+the+treatment+of+pain&doi=10.1016%2Fj.bmcl.2011.04.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of XEN907, a spiro-oxindole blocker of Nav1.7 for the treatment of pain</span></div><div class="casAuthors">Chowdhury, Sultan; Chafeev, Mikhail; Liu, Shifeng; Sun, Jianyu; Raina, Vandna; Chui, Ray; Young, Wendy; Kwan, Rainbow; Fu, Jianmin; Cadieux, Jay A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3676-3681</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Starting from the oxindole I identified through a high-throughput screening (HTS) campaign, a series of Nav1.7 blockers were developed.  Following the elimination of undesirable structural features, preliminary optimization of the oxindole C-3 and N-1 substituents afforded the simplified analog II, which demonstrated a 10-fold increase in target potency vs. the original HTS hit.  A scaffold rigidification strategy then led to the discovery of XEN907, a novel spirooxindole Nav1.7 blocker.  This lead compd., which in turn showed a further 10-fold increase in potency, represents a promising structure for further optimization efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtYUA7aLTTk7Vg90H21EOLACvtfcHk0ljLzmM6IMzdrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntFKhsL0%253D&md5=ea3ccd821ed690b3ed67a7901e6a4df1</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.088%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DChafeev%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DRaina%26aufirst%3DV.%26aulast%3DChui%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DW.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DCadieux%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520XEN907%252C%2520a%2520spirooxindole%2520blocker%2520of%2520NaV1.7%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3676%26epage%3D3681%26doi%3D10.1016%2Fj.bmcl.2011.04.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namdari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winters, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verschoof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrington, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pimstone, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span> <span> </span><span class="NLM_article-title">Treatment of NaV1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2011.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.pain.2011.09.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2012&pages=80-85&author=Y.+P.+Goldbergauthor=N.+Priceauthor=R.+Namdariauthor=C.+J.+Cohenauthor=M.+H.+Lamersauthor=C.+Wintersauthor=J.+Priceauthor=C.+E.+Youngauthor=H.+Verschoofauthor=R.+Sherringtonauthor=S.+N.+Pimstoneauthor=M.+R.+Hayden&title=Treatment+of+NaV1.7-mediated+pain+in+inherited+erythromelalgia+using+a+novel+sodium+channel+blocker&doi=10.1016%2Fj.pain.2011.09.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2011.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2011.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DY.%2BP.%26aulast%3DPrice%26aufirst%3DN.%26aulast%3DNamdari%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DLamers%26aufirst%3DM.%2BH.%26aulast%3DWinters%26aufirst%3DC.%26aulast%3DPrice%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DC.%2BE.%26aulast%3DVerschoof%26aufirst%3DH.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DPimstone%26aufirst%3DS.%2BN.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DTreatment%2520of%2520NaV1.7-mediated%2520pain%2520in%2520inherited%2520erythromelalgia%2520using%2520a%2520novel%2520sodium%2520channel%2520blocker%26jtitle%3DPain%26date%3D2012%26volume%3D153%26spage%3D80%26epage%3D85%26doi%3D10.1016%2Fj.pain.2011.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadieux, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafeev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langille, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sviridov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajlic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verschoof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, W.</span></span> <span> </span><span class="NLM_article-title">Tetracyclic spirooxindole blockers of <i>h</i>NaV1.7: activity in vitro and in CFA-induced inflammatory pain model</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1825</span>– <span class="NLM_lpage">1836</span>, <span class="refDoi"> DOI: 10.1007/s00044-012-0180-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1007%2Fs00044-012-0180-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOgtrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=1825-1836&author=S.+Chowdhuryauthor=S.+Liuauthor=J.+A.+Cadieuxauthor=T.+Hsiehauthor=M.+Chafeevauthor=S.+Sunauthor=Q.+Jiaauthor=J.+Sunauthor=M.+Woodauthor=J.+Langilleauthor=S.+Sviridovauthor=J.+Fuauthor=Z.+Zhangauthor=R.+Chuiauthor=A.+Wangauthor=X.+Chengauthor=J.+Zhongauthor=S.+Hossainauthor=K.+Khakhauthor=I.+Rajlicauthor=H.+Verschoofauthor=R.+Kwanauthor=W.+Young&title=Tetracyclic+spirooxindole+blockers+of+hNaV1.7%3A+activity+in+vitro+and+in+CFA-induced+inflammatory+pain+model&doi=10.1007%2Fs00044-012-0180-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Tetracyclic spirooxindole blockers of hNaV1.7: activity in vitro and in CFA-induced inflammatory pain model</span></div><div class="casAuthors">Chowdhury, Sultan; Liu, Shifeng; Cadieux, Jay A.; Hsieh, Tom; Chafeev, Mikhail; Sun, Shaoyi; Jia, Qi; Sun, Jianyu; Wood, Mark; Langille, Jonathan; Sviridov, Serguei; Fu, Jianmin; Zhang, Zaihui; Chui, Ray; Wang, Audrey; Cheng, Xing; Zhong, Jing; Hossain, Sazzad; Khakh, Kuldip; Rajlic, Ivana; Verschoof, Henry; Kwan, Rainbow; Young, Wendy</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1825-1836</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">The structure-activity relationship of a new series of tetracyclic spirooxindoles led to the discovery of compd. 25a, a potent hNaV1.7 blocker with improved ADME properties and in vivo efficacy in the CFA-induced inflammatory pain model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjPSR-hOyPHrVg90H21EOLACvtfcHk0ljLzmM6IMzdrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOgtrrO&md5=de6f7da4cf7b773fc50bee110c751d9c</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1007%2Fs00044-012-0180-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-012-0180-1%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCadieux%26aufirst%3DJ.%2BA.%26aulast%3DHsieh%26aufirst%3DT.%26aulast%3DChafeev%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DSviridov%26aufirst%3DS.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DChui%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DHossain%26aufirst%3DS.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DRajlic%26aufirst%3DI.%26aulast%3DVerschoof%26aufirst%3DH.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DW.%26atitle%3DTetracyclic%2520spirooxindole%2520blockers%2520of%2520hNaV1.7%253A%2520activity%2520in%2520vitro%2520and%2520in%2520CFA-induced%2520inflammatory%2520pain%2520model%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2013%26volume%3D22%26spage%3D1825%26epage%3D1836%26doi%3D10.1007%2Fs00044-012-0180-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from flatland: increasing saturation as an approach to improving clinical success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0ljqdT0nKxPjCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Milletti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storchi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sforna, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span> <span> </span><span class="NLM_article-title">New and original pKa prediction method using grid molecular interaction fields</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2172</span>– <span class="NLM_lpage">2181</span>, <span class="refDoi"> DOI: 10.1021/ci700018y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci700018y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2172-2181&author=F.+Millettiauthor=L.+Storchiauthor=G.+Sfornaauthor=G.+Cruciani&title=New+and+original+pKa+prediction+method+using+grid+molecular+interaction+fields&doi=10.1021%2Fci700018y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">New and Original pKa Prediction Method Using Grid Molecular Interaction Fields</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Sforna, Gianluca; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2172-2181</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the most important physicochem. properties of a mol. is pKa.  It is known that two parameters imperative in ADME profiling, soly., and lipophilicity are governed by pKa, and receptor binding can be influenced by pKa.  Because most drugs are ionized in physiol. conditions, pKa is particularly relevant to medicinal chem.  Despite the numerous advances in high-throughput measurements, in silico detn. is still the fastest and cheapest way of obtaining pKa.  This paper presents a new original computational method for pKa prediction of org. compds.  Descriptors were generated using the program GRID, and these descriptors are based on mol. interaction fields precomputed on a set of mol. fragments.  The new method was developed, trained, and cross-validated by using a large and diverse data set of 24 617 pKa values.  This paper presents the results for a class of 421 acidic nitrogen compds. (RMSE = 0.41, r2 = 0.97, q2 = 0.87) and for a class of 947 six-membered N-heterocyclic bases (RMSE = 0.60, r2 = 0.93, q2 = 0.85).  For external validation 28 novel compds. were selected that covered nine different ionizable groups, and 39 pKa values could be exptl. detd. by spectral gradient anal. (SGA).  Comparison of exptl. pKa with calcd. pKa demonstrated that the predictive ability of the method is good (external set, r2 = 0.85, RMSE = 0.90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzEk0uiS1E6rVg90H21EOLACvtfcHk0ljqdT0nKxPjCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF&md5=f2b1dec853ccb0ef1a40540d234232fb</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Fci700018y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700018y%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DSforna%26aufirst%3DG.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DNew%2520and%2520original%2520pKa%2520prediction%2520method%2520using%2520grid%2520molecular%2520interaction%2520fields%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2172%26epage%3D2181%26doi%3D10.1021%2Fci700018y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Milletti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storchi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goracci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span> <span> </span><span class="NLM_article-title">Extending pKa prediction accuracy: high-throughput pKa measurements to understand pKa modulation of new chemical series</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4270</span>– <span class="NLM_lpage">4279</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2010.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.ejmech.2010.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=20633962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4270-4279&author=F.+Millettiauthor=L.+Storchiauthor=L.+Goracciauthor=S.+Bendelsauthor=B.+Wagnerauthor=M.+Kansyauthor=G.+Cruciani&title=Extending+pKa+prediction+accuracy%3A+high-throughput+pKa+measurements+to+understand+pKa+modulation+of+new+chemical+series&doi=10.1016%2Fj.ejmech.2010.06.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Extending pKa prediction accuracy: High-throughput pKa measurements to understand pKa modulation of new chemical series</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Goracci, Laura; Bendels, Stefanie; Wagner, Bjoern; Kansy, Manfred; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4270-4279</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We have recently developed a tool, MoKα, to predict the pKa of org. compds. using a large dataset of over 26,500 literature pKa values as a training set.  However, predicting accurately pKa (<0.5 pH units) remains challenging for novel series, and this can be a drawback in the optimization of activity and ADME properties of lead compds.  To address this issue it is important to expand our knowledge of pKa determinants, therefore we have conducted high-throughput pKa measurements by using Spectral Gradient Anal. (SGA) on novel series of compds. selected from vendor databases.  Here we report our findings on the effect of specific chem. groups and steric constraints on the pKa of common functionalities in medicinal chem., such as amines, sulfonamides, and amides.  Furthermore, we report the pKa of ionizable groups that were not well represented in the database of literature pKa of MoKα, such as hydrazide derivs.  These findings helped us to enhance MoKα, which is here benchmarked on a set of exptl. pKa values from the Roche inhouse library (N = 5581; RMSE = 1.09; R2 = 0.82).  The accuracy of the predictions was greatly improved (RMSE = 0.49, R2 = 0.96) after training the software by using the automated tool Kibitzer with 6226 pK a values taken from a different set of Roche compds. appropriately selected, and this demonstrates the value of using high-throughput pKa measurements to expand the training set of pKa values used by the software MoKα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxQ9UJOAhB-rVg90H21EOLACvtfcHk0ljqdT0nKxPjCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLo%253D&md5=e4c579032df7fa37ec3551c69a09257a</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DGoracci%26aufirst%3DL.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DExtending%2520pKa%2520prediction%2520accuracy%253A%2520high-throughput%2520pKa%2520measurements%2520to%2520understand%2520pKa%2520modulation%2520of%2520new%2520chemical%2520series%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4270%26epage%3D4279%26doi%3D10.1016%2Fj.ejmech.2010.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span> <i>MoKa 2.6.5</i>; <span class="NLM_publisher-name">Molecular
Discovery</span>: <span class="NLM_publisher-loc">Borehamwood, Hertfordshire,
UK</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MoKa+2.6.5%3B+Molecular%0ADiscovery%3A+Borehamwood%2C+Hertfordshire%2C%0AUK%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMoKa%25202.6.5%26pub%3DMolecular%250ADiscovery%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Improving drug candidates by design: A focus on physicochemical properties as a means of improving compound disposition and safety</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1420</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1021/tx200211v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200211v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1420-1456&author=N.+A.+Meanwell&title=Improving+drug+candidates+by+design%3A+A+focus+on+physicochemical+properties+as+a+means+of+improving+compound+disposition+and+safety&doi=10.1021%2Ftx200211v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1420-1456</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of small mol. drug candidates from the discovery phase to a marketed product continues to be a challenging enterprise with very low success rates that have fostered the perception of poor productivity by the pharmaceutical industry.  Although there have been significant advances in preclin. profiling that have improved compd. triaging and altered the underlying reasons for compd. attrition, the failure rates have not appreciably changed.  As part of an effort to more deeply understand the reasons for candidate failure, there has been considerable interest in analyzing the physicochem. properties of marketed drugs for the purpose of comparing with drugs in discovery and development as a means capturing recent trends in drug design.  The scenario that has emerged is one in which contemporary drug discovery is thought to be focused too heavily on advancing candidates with profiles that are most easily satisfied by mols. with increased mol. wt. and higher overall lipophilicity.  The preponderance of mols. expressing these properties is frequently a function of increased arom. ring count when compared with that of the drugs launched in the latter half of the 20th century and may reflect a preoccupation with maximizing target affinity rather than taking a more holistic approach to drug design.  These attributes not only present challenges for formulation and absorption but also may influence the manifestation of toxicity during development.  By providing some definition around the optimal physicochem. properties assocd. with marketed drugs, guidelines for drug design have been developed that are based largely on calcd. parameters and which may readily be applied by medicinal chemists as an aid to understanding candidate quality.  The physicochem. properties of a mol. that are consistent with the potential for good oral absorption were initially defined by Lipinski, with addnl. insights allowing further refinement, while deeper analyses have explored the correlation with metabolic stability and toxicity.  These insights have been augmented by careful analyses of physicochem. aspects of drug-target interactions, with thermodn. profiling indicating that the signature of best-in-class drugs is a dependence on enthalpy to drive binding energetics rather than entropy, which is dependent on lipophilicity.  Optimization of the entropic contribution to the binding energy of a ligand to its target is generally much easier than refining the enthalpic element.  Consequently, in the absence of a fundamental understanding of the thermodn. complexion of an interaction, the design of mols. with increased lipophilicity becomes almost inevitable.  The application of ligand efficiency, a measure of affinity per heavy atom, group efficiency, which assesses affinity in the context of structural changes, and lipophilic ligand efficiency, which relates potency to lipophilicity, offer less sophisticated but practically useful anal. algorithms to assess the quality of drug-target interactions.  These parameters are readily calcd. and can be applied to lead optimization programs in a fashion that helps to maximize potency while minimizing the kind of lipophilic burden that has been dubbed "mol. obesity".  Several recently described lead optimization campaigns provide illustrative, informative, and productive examples of the effect of paying close attention to carefully controlling physicochem. properties by monitoring ligand efficiency and lipophilic ligand efficiency.  However, to be successful during the lead optimization phase, drug candidate identification programs will need to adopt a holistic approach that integrates multiple parameters, many of which will have unique dependencies on both the drug target and the specific chemotype under prosecution.  Nevertheless, there are many important drug targets that necessitate working in space beyond that which has been defined by the retrospective analyses of marketed drugs and which will require adaptation of some of the guideposts that are useful in directing lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQrUfIwZiIR7Vg90H21EOLACvtfcHk0ljGk4Y73ZSHfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D&md5=9ddcf6dc81bf8ab0441df5037979ff4e</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Ftx200211v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200211v%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520drug%2520candidates%2520by%2520design%253A%2520A%2520focus%2520on%2520physicochemical%2520properties%2520as%2520a%2520means%2520of%2520improving%2520compound%2520disposition%2520and%2520safety%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1420%26epage%3D1456%26doi%3D10.1021%2Ftx200211v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kormos, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Will, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stedman, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekaran, R. Y.</span></span> <span> </span><span class="NLM_article-title">Improving the odds of success in drug discovery: choosing the best compounds for in vivo toxicology studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9771</span>– <span class="NLM_lpage">9779</span>, <span class="refDoi"> DOI: 10.1021/jm401485p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401485p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslOms7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9771-9779&author=T.+T.+Wagerauthor=B.+L.+Kormosauthor=J.+T.+Bradyauthor=Y.+Willauthor=M.+D.+Aleoauthor=D.+B.+Stedmanauthor=M.+Kuhnauthor=R.+Y.+Chandrasekaran&title=Improving+the+odds+of+success+in+drug+discovery%3A+choosing+the+best+compounds+for+in+vivo+toxicology+studies&doi=10.1021%2Fjm401485p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the Odds of Success in Drug Discovery: Choosing the Best Compounds for in Vivo Toxicology Studies</span></div><div class="casAuthors">Wager, Travis T.; Kormos, Bethany L.; Brady, Joseph T.; Will, Yvonne; Aleo, Michael D.; Stedman, Donald B.; Kuhn, Max; Chandrasekaran, Ramalakshmi Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9771-9779</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of mols. that advanced into exploratory animal toxicol. studies (two species) was examd. to det. what properties contributed to success in these safety studies.  Compds. were rigorously evaluated across numerous safety end points and classified as "pass" if a suitable in vivo therapeutic index (TI) was achieved for advancement into regulatory toxicol. studies.  The most predictive end point contributing to compd. survival was a predicted human efficacious concn. (Ceff) of ≤250 nM (total drug) and ≤40 nM (free drug).  This trend held across a wide range of CNS modes of action, encompassing targets such as enzymes, G-protein-coupled receptors, ion channels, and transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpartARg68zVrVg90H21EOLACvtfcHk0ljGk4Y73ZSHfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslOms7%252FL&md5=7efd1be4dbede3e4d3201154929bd641</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm401485p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401485p%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DBrady%26aufirst%3DJ.%2BT.%26aulast%3DWill%26aufirst%3DY.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26aulast%3DStedman%26aufirst%3DD.%2BB.%26aulast%3DKuhn%26aufirst%3DM.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26atitle%3DImproving%2520the%2520odds%2520of%2520success%2520in%2520drug%2520discovery%253A%2520choosing%2520the%2520best%2520compounds%2520for%2520in%2520vivo%2520toxicology%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9771%26epage%3D9779%26doi%3D10.1021%2Fjm401485p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span> <i>Molecular Operating
Environment (MOE)</i>, version 2016.08; <span class="NLM_publisher-name">Chemical
Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal,
QC, Canada</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Molecular+Operating%0AEnvironment+%28MOE%29%2C+version+2016.08%3B+Chemical%0AComputing+Group+Inc.%3A+Montreal%2C%0AQC%2C+Canada%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%250AEnvironment%2520%2528MOE%2529%26pub%3DChemical%250AComputing%2520Group%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Touré, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller-Moslin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusuff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doré, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPietro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Plas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorilla, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulathila, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herlihy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, M.</span></span> <span> </span><span class="NLM_article-title">The role of the acidity of <i>N</i>-heteroaryl sulfonamides as inhibitors of Bcl-2 family protein-protein interactions</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1021/ml300321d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300321d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=186-190&author=B.+B.+Tour%C3%A9author=K.+Miller-Moslinauthor=N.+Yusuffauthor=L.+Perezauthor=M.+Dor%C3%A9author=C.+Joudauthor=W.+Michaelauthor=L.+DiPietroauthor=S.+van+der%0APlasauthor=M.+McEwanauthor=F.+Lenoirauthor=M.+Hoeauthor=R.+Karkiauthor=C.+Springerauthor=J.+Sullivanauthor=K.+Levineauthor=C.+Fiorillaauthor=X.+Xieauthor=R.+Kulathilaauthor=K.+Herlihyauthor=D.+Porterauthor=M.+Visser&title=The+role+of+the+acidity+of+N-heteroaryl+sulfonamides+as+inhibitors+of+Bcl-2+family+protein-protein+interactions&doi=10.1021%2Fml300321d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml300321d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300321d%26sid%3Dliteratum%253Aachs%26aulast%3DTour%25C3%25A9%26aufirst%3DB.%2BB.%26aulast%3DMiller-Moslin%26aufirst%3DK.%26aulast%3DYusuff%26aufirst%3DN.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DDor%25C3%25A9%26aufirst%3DM.%26aulast%3DJoud%26aufirst%3DC.%26aulast%3DMichael%26aufirst%3DW.%26aulast%3DDiPietro%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BPlas%26aufirst%3DS.%26aulast%3DMcEwan%26aufirst%3DM.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DHoe%26aufirst%3DM.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DSullivan%26aufirst%3DJ.%26aulast%3DLevine%26aufirst%3DK.%26aulast%3DFiorilla%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DKulathila%26aufirst%3DR.%26aulast%3DHerlihy%26aufirst%3DK.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DVisser%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520the%2520acidity%2520of%2520N-heteroaryl%2520sulfonamides%2520as%2520inhibitors%2520of%2520Bcl-2%2520family%2520protein-protein%2520interactions%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D186%26epage%3D190%26doi%3D10.1021%2Fml300321d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, J. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, S. J.</span></span> <span> </span><span class="NLM_article-title">pH-Metric log P. 3. Glass electrode calibration in methanol-water, applied to pKa determination of water-insoluble substances</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1021/ac00049a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac00049a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADyaK3sXislGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1993&pages=42-49&author=A.+Avdeefauthor=J.+E.+A.+Comerauthor=S.+J.+Thomson&title=pH-Metric+log+P.+3.+Glass+electrode+calibration+in+methanol-water%2C+applied+to+pKa+determination+of+water-insoluble+substances&doi=10.1021%2Fac00049a010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">pH-Metric log P.  3.  Glass electrode calibration in methanol-water, applied to pKa determination of water-insoluble substances</span></div><div class="casAuthors">Avdeef, Alex; Comer, John E. A.; Thomson, Simon J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-9</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    </div><div class="casAbstract">A series of semiaq. HCl solns. of known concn., contg. 0.1 M KNO3 (as ionic strength adjuster) and 0-70 wt % methanol, was titrated at 21, 25, and 37° with standardized KOH, pH 2-12.  The pH measuring circuit (Ross-type electrode) was calibrated with an aq. pH buffer (Nernst slope assumed).  The operational pH readings were related to PcH (=-log [H+]) by the four-parameter equation: pH = α + SpcH + jH[H+] + jOH[OH-].  The parameters were detd. by a weighted nonlinear least squares procedure, which allows for CO2 corrections.  This calibration procedure was applied at 25° in titrns. to det. the pKa values of acetic acid, benzoic acid, 4-n-butoxyphenol, 4-ethoxyphenol, 1-benzylimidazole, (±)-propranolol, and N-methyl-D-glucamine and of two water-insol. highly lipophilic benzoic acid derivs. of pharmaceutical interest, with the aim of detg. their octanol-water partition coeffs.  Yasuda-Shedlovsky plots were used to extrapolate semiaq. apparent pKa's to zero methanol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJa9rxYvhsjbVg90H21EOLACvtfcHk0lgNiNsN1uQgtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXislGktg%253D%253D&md5=2ff4251abce9438cceae0c9990b25c0d</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fac00049a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac00049a010%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DComer%26aufirst%3DJ.%2BE.%2BA.%26aulast%3DThomson%26aufirst%3DS.%2BJ.%26atitle%3DpH-Metric%2520log%2520P.%25203.%2520Glass%2520electrode%2520calibration%2520in%2520methanol-water%252C%2520applied%2520to%2520pKa%2520determination%2520of%2520water-insoluble%2520substances%26jtitle%3DAnal.%2520Chem.%26date%3D1993%26volume%3D65%26spage%3D42%26epage%3D49%26doi%3D10.1021%2Fac00049a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Takács-Novák, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span> <span> </span><span class="NLM_article-title">Potentiometric pKa determination of water-insoluble compounds: validation study in methanol/water mixtures</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1016/S0378-5173(97)04907-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2FS0378-5173%2897%2904907-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADyaK2sXktFWnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1997&pages=235-248&author=K.+Tak%C3%A1cs-Nov%C3%A1kauthor=K.+J.+Boxauthor=A.+Avdeef&title=Potentiometric+pKa+determination+of+water-insoluble+compounds%3A+validation+study+in+methanol%2Fwater+mixtures&doi=10.1016%2FS0378-5173%2897%2904907-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiometric pKa determination of water-insoluble compounds: validation study in methanol/water mixtures</span></div><div class="casAuthors">Takacs-Novak, Krisztina; Box, Karl J.; Avdeef, Alex</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The apparent ionization consts. (psKa) of 25 mols., based on 431 sep. potentiometric titrns., were detd. in methanol/water mixts. of 15-65 wt% methanol content.  The Yasuda-Shedlovsky extrapolation (psKa+log[H2O] = a/ε+b) was used to obtain the pKa values in zero methanol%.  In the case of water-sol. drugs the extrapolated data were in very good agreement with pKa values measured in aq. solns. under the same exptl. conditions (av. deviation = 0.05).  The water-insol. mols. showed acceptable accordance with spectroscopically measured or with literature pKa values.  Concn. dependence between 1-5 mM was not obsd. while the range of extrapolation (water-rich: R=15-35 wt%, or methanol-rich: R=40-65 wt%) significantly influenced the accuracy of pKa values.  Remarkable changes in the solvation structure of weak acids in methanol-rich mixts. (>35 wt%) were suggested from analyzing the slopes of Yasuda-Shedlovsky equations.  Recommendations for the proper application of a mixed-solvent procedure in order to gain the most reliable aq. pKa values are suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIltgu3Cu3GbVg90H21EOLACvtfcHk0lgNiNsN1uQgtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktFWnu7o%253D&md5=4efcc572c3b9f4c5b2de1890d22b7970</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1016%2FS0378-5173%2897%2904907-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-5173%252897%252904907-7%26sid%3Dliteratum%253Aachs%26aulast%3DTak%25C3%25A1cs-Nov%25C3%25A1k%26aufirst%3DK.%26aulast%3DBox%26aufirst%3DK.%2BJ.%26aulast%3DAvdeef%26aufirst%3DA.%26atitle%3DPotentiometric%2520pKa%2520determination%2520of%2520water-insoluble%2520compounds%253A%2520validation%2520study%2520in%2520methanol%252Fwater%2520mixtures%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D1997%26volume%3D151%26spage%3D235%26epage%3D248%26doi%3D10.1016%2FS0378-5173%2897%2904907-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obando, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codd, R.</span></span> <span> </span><span class="NLM_article-title">The many faces of the adamantly group in drug design</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1949</span>– <span class="NLM_lpage">1963</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.01.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.ejmech.2011.01.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=1949-1963&author=J.+Liuauthor=D.+Obandoauthor=V.+Liaoauthor=T.+Lifaauthor=R.+Codd&title=The+many+faces+of+the+adamantly+group+in+drug+design&doi=10.1016%2Fj.ejmech.2011.01.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.01.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.01.047%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DObando%26aufirst%3DD.%26aulast%3DLiao%26aufirst%3DV.%26aulast%3DLifa%26aufirst%3DT.%26aulast%3DCodd%26aufirst%3DR.%26atitle%3DThe%2520many%2520faces%2520of%2520the%2520adamantly%2520group%2520in%2520drug%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D1949%26epage%3D1963%26doi%3D10.1016%2Fj.ejmech.2011.01.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barron, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien-Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werry, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chishty, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skarratt, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hibbs, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vugts, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windhorst, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span> <span> </span><span class="NLM_article-title">Pharmacological evaluation of novel bioisosteres of an admantanyl benzamide P2X<sub>7</sub> receptor antagonist</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2374</span>– <span class="NLM_lpage">2380</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00272</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00272" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlyhtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=2374-2380&author=S.+M.+Wilkinsonauthor=M.+L.+Barronauthor=J.+O%E2%80%99Brien-Brownauthor=B.+Janssenauthor=L.+Stokesauthor=E.+L.+Werryauthor=M.+Chishtyauthor=K.+K.+Skarrattauthor=J.+A.+Ongauthor=D.+E.+Hibbsauthor=D.+J.+Vugtsauthor=S.+Fullerauthor=A.+D.+Windhorstauthor=M.+Kassiou&title=Pharmacological+evaluation+of+novel+bioisosteres+of+an+admantanyl+benzamide+P2X7+receptor+antagonist&doi=10.1021%2Facschemneuro.7b00272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Evaluation of Novel Bioisosteres of an Adamantanyl Benzamide P2X7 Receptor Antagonist</span></div><div class="casAuthors">Wilkinson, Shane M.; Barron, Melissa L.; O'Brien-Brown, James; Janssen, Bieneke; Stokes, Leanne; Werry, Eryn L.; Chishty, Mansoor; Skarratt, Kristen K.; Ong, Jennifer A.; Hibbs, David E.; Vugts, Danielle J.; Fuller, Stephen; Windhorst, Albert D.; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2374-2380</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adamantanyl benzamide 1 was identified as a potent P2X7R antagonist but failed to progress further due to poor metabolic stability.  We describe the synthesis and SAR of a series of bioisosteres of benzamide 1 to explore improvements in the pharmacol. properties of this lead.  Initial efforts investigated a series of heteroarom. bioisosteres, which demonstrated improved physicochem. properties but reduced P2X7R antagonism.  Installation of bioisosteric fluorine on the adamantane bridgeheads was well tolerated and led to a series of bioisosteres with improved physicochem. properties and metabolic stability.  Trifluorinated benzamide 34 demonstrated optimal physicochem. parameters, superior metabolic stability (ten times longer than lead benzamide 1), and an improved physicokinetic profile and proved effective in the presence of several known P2X7R polymorphisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo77pXNGe3iy7Vg90H21EOLACvtfcHk0lgNiNsN1uQgtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlyhtr7L&md5=6f1ee1daa1cccebc6859efde186eb39d</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00272%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DS.%2BM.%26aulast%3DBarron%26aufirst%3DM.%2BL.%26aulast%3DO%25E2%2580%2599Brien-Brown%26aufirst%3DJ.%26aulast%3DJanssen%26aufirst%3DB.%26aulast%3DStokes%26aufirst%3DL.%26aulast%3DWerry%26aufirst%3DE.%2BL.%26aulast%3DChishty%26aufirst%3DM.%26aulast%3DSkarratt%26aufirst%3DK.%2BK.%26aulast%3DOng%26aufirst%3DJ.%2BA.%26aulast%3DHibbs%26aufirst%3DD.%2BE.%26aulast%3DVugts%26aufirst%3DD.%2BJ.%26aulast%3DFuller%26aufirst%3DS.%26aulast%3DWindhorst%26aufirst%3DA.%2BD.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DPharmacological%2520evaluation%2520of%2520novel%2520bioisosteres%2520of%2520an%2520admantanyl%2520benzamide%2520P2X7%2520receptor%2520antagonist%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D2374%26epage%3D2380%26doi%3D10.1021%2Facschemneuro.7b00272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wanka, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiner, P. R.</span></span> <span> </span><span class="NLM_article-title">The lipophilic bullet hits the targets: medicinal chemistry of admantane derivatives</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">3516</span>– <span class="NLM_lpage">3604</span>, <span class="refDoi"> DOI: 10.1021/cr100264t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr100264t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=3516-3604&author=L.+Wankaauthor=K.+Iqbalauthor=P.+R.+Schreiner&title=The+lipophilic+bullet+hits+the+targets%3A+medicinal+chemistry+of+admantane+derivatives&doi=10.1021%2Fcr100264t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Fcr100264t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr100264t%26sid%3Dliteratum%253Aachs%26aulast%3DWanka%26aufirst%3DL.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DSchreiner%26aufirst%3DP.%2BR.%26atitle%3DThe%2520lipophilic%2520bullet%2520hits%2520the%2520targets%253A%2520medicinal%2520chemistry%2520of%2520admantane%2520derivatives%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3D3516%26epage%3D3604%26doi%3D10.1021%2Fcr100264t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knerr, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selmi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinàs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindqvist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ståhlberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorstensson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullah, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Mahony, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Högberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindhardt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Åstrand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duker, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Ca<sub>V</sub>3.2) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5557</span>– <span class="NLM_lpage">5561</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.06.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2011.06.092" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5557-5561&author=F.+Giordanettoauthor=L.+Knerrauthor=N.+Selmiauthor=A.+Llin%C3%A0sauthor=A.+Lindqvistauthor=Q.+D.+Wangauthor=P.+St%C3%A5hlbergauthor=F.+Thorstenssonauthor=V.+Ullahauthor=K.+Nilssonauthor=G.+O%E2%80%99Mahonyauthor=G.+H%C3%B6gbergauthor=E.+Lindhardtauthor=A.+%C3%85strandauthor=G.+Duker&title=Discovery+of+N-%281-adamantyl%29-2-%284-alkylpiperazin-1-yl%29acetamide+derivatives+as+T-type+calcium+channel+%28CaV3.2%29+inhibitors&doi=10.1016%2Fj.bmcl.2011.06.092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.06.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.06.092%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DKnerr%26aufirst%3DL.%26aulast%3DSelmi%26aufirst%3DN.%26aulast%3DLlin%25C3%25A0s%26aufirst%3DA.%26aulast%3DLindqvist%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%2BD.%26aulast%3DSt%25C3%25A5hlberg%26aufirst%3DP.%26aulast%3DThorstensson%26aufirst%3DF.%26aulast%3DUllah%26aufirst%3DV.%26aulast%3DNilsson%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DG.%26aulast%3DH%25C3%25B6gberg%26aufirst%3DG.%26aulast%3DLindhardt%26aufirst%3DE.%26aulast%3D%25C3%2585strand%26aufirst%3DA.%26aulast%3DDuker%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520N-%25281-adamantyl%2529-2-%25284-alkylpiperazin-1-yl%2529acetamide%2520derivatives%2520as%2520T-type%2520calcium%2520channel%2520%2528CaV3.2%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5557%26epage%3D5561%26doi%3D10.1016%2Fj.bmcl.2011.06.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brameld, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1021/ci7002494</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci7002494" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksV2isA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1-24&author=K.+A.+Brameldauthor=B.+Kuhnauthor=D.+C.+Reuterauthor=M.+Stahl&title=Small+molecule+conformational+preferences+derived+from+crystal+structure+data.+A+medicinal+chemistry+focused+analysis&doi=10.1021%2Fci7002494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule conformational preferences derived from crystal structure data. a medicinal chemistry focused analysis</span></div><div class="casAuthors">Brameld, Ken A.; Kuhn, Bernd; Reuter, Deborah C.; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-24</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Based on torsion angle distributions of frequently occurring substructures, conformation preferences of druglike mols. are presented, accompanied by a review of the relevant literature.  First, the relevance of the Cambridge Structural Database (CSD) for drug design is demonstrated by comparing substructures present in compds. entering clin. trials with those found in the CSD and protein-bound ligands in the Protein Data Bank (PDB).  Next, we briefly highlight preferred conformations of elementary acyclic systems, followed by a discussion of sulfonamide conformations.  Due to their central role in medicinal chem., we discuss properties of aryl ring substituents in depth, including biaryl systems and systems of two aryl rings connected by two acyclic bonds.  For a subset of torsion motifs, we also compare torsion angle histograms derived from CSD structures with those derived from ligands in the PDB.  Furthermore, selected properties of some six- and seven-membered ring systems are discussed.  The article closes with a section on attractive sulfur-oxygen contacts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBrdvMrRvKirVg90H21EOLACvtfcHk0li3Ez2yWbA3fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksV2isA%253D%253D&md5=289969338dcb94a145ce736d19d05cf4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fci7002494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci7002494%26sid%3Dliteratum%253Aachs%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DReuter%26aufirst%3DD.%2BC.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DSmall%2520molecule%2520conformational%2520preferences%2520derived%2520from%2520crystal%2520structure%2520data.%2520A%2520medicinal%2520chemistry%2520focused%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D1%26epage%3D24%26doi%3D10.1021%2Fci7002494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P.
C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellingson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M. T.</span></span> <span> </span><span class="NLM_article-title">Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and the Cambridge Structural Database</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1021/ci100031x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100031x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=572-584&author=P.%0AC.+D.+Hawkinsauthor=A.+G.+Skillmanauthor=G.+L.+Warrenauthor=B.+A.+Ellingsonauthor=M.+T.+Stahl&title=Conformer+Generation+with+OMEGA%3A+Algorithm+and+Validation+Using+High+Quality+Structures+from+the+Protein+Databank+and+the+Cambridge+Structural+Database&doi=10.1021%2Fci100031x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Warren, Gregory L.; Ellingson, Benjamin A.; Stahl, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">572-584</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here, we present the algorithm and validation for OMEGA, a systematic, knowledge-based conformer generator.  The algorithm consists of three phases: assembly of an initial 3D structure from a library of fragments; exhaustive enumeration of all rotatable torsions using values drawn from a knowledge-based list of angles, thereby generating a large set of conformations; and sampling of this set by geometric and energy criteria.  Validation of conformer generators like OMEGA has often been undertaken by comparing computed conformer sets to exptl. mol. conformations from crystallog., usually from the Protein Databank (PDB).  Such an approach is fraught with difficulty due to the systematic problems with small mol. structures in the PDB.  Methods are presented to identify a diverse set of small mol. structures from cocomplexes in the PDB that has maximal reliability.  A challenging set of 197 high quality, carefully selected ligand structures from well-solved models was obtained using these methods.  This set will provide a sound basis for comparison and validation of conformer generators in the future.  Validation results from this set are compared to the results using structures of a set of druglike mols. extd. from the Cambridge Structural Database (CSD).  OMEGA is found to perform very well in reproducing the crystallog. conformations from both these data sets using two complementary metrics of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1SOwPH1NzrVg90H21EOLACvtfcHk0li3Ez2yWbA3fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D&md5=fb87ecc9c51eddef63b41fffcd9babee</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fci100031x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100031x%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%2BD.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26aulast%3DEllingson%26aufirst%3DB.%2BA.%26aulast%3DStahl%26aufirst%3DM.%2BT.%26atitle%3DConformer%2520Generation%2520with%2520OMEGA%253A%2520Algorithm%2520and%2520Validation%2520Using%2520High%2520Quality%2520Structures%2520from%2520the%2520Protein%2520Databank%2520and%2520the%2520Cambridge%2520Structural%2520Database%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D572%26epage%3D584%26doi%3D10.1021%2Fci100031x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span> <i>OMEGA</i>, 2.5.1.4; <span class="NLM_publisher-name">OpenEye Scientific Software</span>: <span class="NLM_publisher-loc">Santa Fe, NM</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+OMEGA%2C+2.5.1.4%3B+OpenEye+Scientific+Software%3A+Santa+Fe%2C+NM%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DOMEGA%26pub%3DOpenEye%2520Scientific%2520Software%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span> <i>SZYBKI</i>, 1.9.0.3; <span class="NLM_publisher-name">OpenEye Scientific
Software</span>: <span class="NLM_publisher-loc">Santa Fe, NM</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+SZYBKI%2C+1.9.0.3%3B+OpenEye+Scientific%0ASoftware%3A+Santa+Fe%2C+NM%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSZYBKI%26pub%3DOpenEye%2520Scientific%250ASoftware%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Volume of distribution in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5691</span>– <span class="NLM_lpage">5698</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00201</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00201" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFSlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5691-5698&author=D.+A.+Smithauthor=K.+Beaumontauthor=T.+S.+Maurerauthor=L.+Di&title=Volume+of+distribution+in+drug+design&doi=10.1021%2Facs.jmedchem.5b00201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Volume of Distribution in Drug Design</span></div><div class="casAuthors">Smith, Dennis A.; Beaumont, Kevin; Maurer, Tristan S.; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5691-5698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Vol. of distribution is one of the most important pharmacokinetic properties of a drug candidate.  It is a major determinant of half-life and dosing frequency of a drug.  For a similar log P, a basic mol. will tend to exhibit higher vol. of distribution than a neutral mol.  Acids often exhibit low vols. of distribution.  Although a design strategy against vol. of distribution can be advantageous in achieving desirable dosing regimen, it must be well-directed in order to avoid detrimental effects to other important properties.  Strategies to increase vol. of distribution include adding lipophilicity and introducing basic functional groups in a way that does not increase metabolic clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP7QwgPahf4bVg90H21EOLACvtfcHk0lgaa-paJh5fow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFSlsb0%253D&md5=2c7289b3602a8edef2d9ef0e6a82e483</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00201%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DVolume%2520of%2520distribution%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5691%26epage%3D5698%26doi%3D10.1021%2Facs.jmedchem.5b00201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Catterall, W.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cestèle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarov-Yarovoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheuer, T.</span></span> <span> </span><span class="NLM_article-title">Voltage-gated ion channels and gating modifier toxins</span>. <i>Toxicon</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1016/j.toxicon.2006.09.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.toxicon.2006.09.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=17239913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD2sXps1emuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2007&pages=124-141&author=W.%0AA.+Catterallauthor=S.+Cest%C3%A8leauthor=V.+Yarov-Yarovoyauthor=F.+H.+Yuauthor=K.+Konokiauthor=T.+Scheuer&title=Voltage-gated+ion+channels+and+gating+modifier+toxins&doi=10.1016%2Fj.toxicon.2006.09.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated ion channels and gating modifier toxins</span></div><div class="casAuthors">Catterall, William A.; Cestele, Sandrine; Yarov-Yarovoy, Vladimir; Yu, Frank H.; Konoki, Keiichi; Scheuer, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Toxicon</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-141</span>CODEN:
                <span class="NLM_cas:coden">TOXIA6</span>;
        ISSN:<span class="NLM_cas:issn">0041-0101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium, calcium, and potassium channels generate elec. signals required for action potential generation and conduction and are the mol. targets for a broad range of potent neurotoxins.  These channels are built on a common structural motif contg. six transmembrane segments and a pore loop.  Their pores are formed by the S5/S6 segments and the pore loop between them, and they are gated by bending of the S6 segments at a hinge glycine or proline residue.  The voltage sensor domain consists of the S1-S4 segments, with pos. charged residues in the S4 segment serving as gating charges.  The diversity of toxin action on these channels is illustrated by sodium channels, which are the mol. targets for toxins that act at six or more distinct receptor sites on the channel protein.  Both hydrophilic low mol. wt. toxins and larger polypeptide toxins phys. block the pore and prevent sodium conductance.  Hydrophobic alkaloid toxins and related lipid-sol. toxins act at intramembrane sites and alter voltage-dependent gating of sodium channels via an allosteric mechanism.  In contrast, polypeptide toxins alter channel gating by voltage-sensor trapping through binding to extracellular receptor sites, and this toxin interaction has now been modeled at the at. level for a β-scorpion toxin.  The voltage-sensor trapping mechanism may be a common mode of action for polypeptide gating modifier toxins acting on all of the voltage-gated ion channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvR2ly__UVIbVg90H21EOLACvtfcHk0lgaa-paJh5fow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXps1emuw%253D%253D&md5=23e334d91f54cb73375c1d3d6ab8b888</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2Fj.toxicon.2006.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxicon.2006.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26aulast%3DCest%25C3%25A8le%26aufirst%3DS.%26aulast%3DYarov-Yarovoy%26aufirst%3DV.%26aulast%3DYu%26aufirst%3DF.%2BH.%26aulast%3DKonoki%26aufirst%3DK.%26aulast%3DScheuer%26aufirst%3DT.%26atitle%3DVoltage-gated%2520ion%2520channels%2520and%2520gating%2520modifier%2520toxins%26jtitle%3DToxicon%26date%3D2007%26volume%3D49%26spage%3D124%26epage%3D141%26doi%3D10.1016%2Fj.toxicon.2006.09.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Deuis, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I.</span></span> <span> </span><span class="NLM_article-title">The pharmacology of voltage-gated sodium channel activators</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.neuropharm.2017.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=28416444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvF2jtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=87-108&author=J.+R.+Deuisauthor=A.+Muellerauthor=M.+R.+Israelauthor=I.+Vetter&title=The+pharmacology+of+voltage-gated+sodium+channel+activators&doi=10.1016%2Fj.neuropharm.2017.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology of voltage-gated sodium channel activators</span></div><div class="casAuthors">Deuis, Jennifer R.; Mueller, Alexander; Israel, Mathilde R.; Vetter, Irina</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-108</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Toxins and venom components that target voltage-gated sodium (NaV) channels have evolved numerous times due to the importance of this class of ion channels in the normal physiol. function of peripheral and central neurons as well as cardiac and skeletal muscle.  NaV channel activators in particular have been isolated from the venom of spiders, wasps, snakes, scorpions, cone snails and sea anemone and are also produced by plants, bacteria and algae.  These compds. have provided key insight into the mol. structure, function and pathophysiol. roles of NaV channels and are important tools due to their at times exquisite subtype-selectivity.  We review the pharmacol. of NaV channel activators with particular emphasis on mammalian isoforms and discuss putative applications for these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIVcjid2xGK7Vg90H21EOLACvtfcHk0lgZ3Ty4dgrelQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvF2jtb0%253D&md5=aabb844d2e8992b42ec6ddc53d43bf72</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DDeuis%26aufirst%3DJ.%2BR.%26aulast%3DMueller%26aufirst%3DA.%26aulast%3DIsrael%26aufirst%3DM.%2BR.%26aulast%3DVetter%26aufirst%3DI.%26atitle%3DThe%2520pharmacology%2520of%2520voltage-gated%2520sodium%2520channel%2520activators%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D127%26spage%3D87%26epage%3D108%26doi%3D10.1016%2Fj.neuropharm.2017.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baffoe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoe, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touré, B. B.</span></span> <span> </span><span class="NLM_article-title">Copper-mediated <i>N</i>-heteroarylation of primary sulfonamides: synthesis of mono-<i>N</i>-heteroaryl sulfonamides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1532</span>– <span class="NLM_lpage">1535</span>, <span class="refDoi"> DOI: 10.1021/ol100263r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol100263r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1Whu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1532-1535&author=J.+Baffoeauthor=M.+Y.+Hoeauthor=B.+B.+Tour%C3%A9&title=Copper-mediated+N-heteroarylation+of+primary+sulfonamides%3A+synthesis+of+mono-N-heteroaryl+sulfonamides&doi=10.1021%2Fol100263r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-Mediated N-Heteroarylation of Primary Sulfonamides: Synthesis of Mono-N-heteroaryl Sulfonamides</span></div><div class="casAuthors">Baffoe, Jonathan; Hoe, Madelene Y.; Toure, B. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1532-1535</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein is described the coupling of primary sulfonamides and various halogenated heterocyclic cores, with an emphasis on 2-heteroaryl halides, via copper catalysis.  These studies enabled the synthesis of many new mono-N-heteroaryl sulfonamides.  The electronic factors that influence the course of the reaction have also been investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxsqgu-eozA7Vg90H21EOLACvtfcHk0lgZ3Ty4dgrelQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1Whu7k%253D&md5=7f9c065b12a456c79e59a2020ff29d4a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fol100263r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol100263r%26sid%3Dliteratum%253Aachs%26aulast%3DBaffoe%26aufirst%3DJ.%26aulast%3DHoe%26aufirst%3DM.%2BY.%26aulast%3DTour%25C3%25A9%26aufirst%3DB.%2BB.%26atitle%3DCopper-mediated%2520N-heteroarylation%2520of%2520primary%2520sulfonamides%253A%2520synthesis%2520of%2520mono-N-heteroaryl%2520sulfonamides%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D1532%26epage%3D1535%26doi%3D10.1021%2Fol100263r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pease, J. H.</span></span> <span> </span><span class="NLM_article-title">A high throughput solubility assay for drug discovery using microscale shake-flask and rapid UHPLC–UV–CLND quantification</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2016.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.jpba.2016.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=26855285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGhurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2016&pages=126-140&author=B.+Linauthor=J.+H.+Pease&title=A+high+throughput+solubility+assay+for+drug+discovery+using+microscale+shake-flask+and+rapid+UHPLC%E2%80%93UV%E2%80%93CLND+quantification&doi=10.1016%2Fj.jpba.2016.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A high throughput solubility assay for drug discovery using microscale shake-flask and rapid UHPLC-UV-CLND quantification</span></div><div class="casAuthors">Lin, Baiwei; Pease, Joseph H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">126-140</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The rapid detn. of key phys. properties of lead compds. is essential to the drug discovery process.  Soly. is one of the most important properties since good soly. is needed not only for obtaining reliable in vitro and in vivo assay results in early discovery but also to ensure sufficient concn. of the drug being in circulation to get the desired therapeutic exposure at the target of interest.  In order for medicinal chemists to tune soly. of lead compds., a rapid assay is needed to provide soly. data that is accurate and predictive so that it can be reliably used for designing the next generation of compds. with improved properties.  To ensure speed and data quality, we developed a high throughput soly. assay that utilizes a single calibration UHPLC-UV-CLND method and a 24 h shake-flask format for rapid quantification.  A set of 46 model compds. was used to demonstrate that the method is accurate, reproducible and predictive.  Here we present development of the assay, including evaluation of quantification method, filtration membranes, equil. times, DMSO concns., and buffer conditions.  A comparison of thermodn. soly. results to our high throughput 24 h shake-flask soly. assay results is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpojPpYm9G6NrVg90H21EOLACvtfcHk0lg2rQQvOhlFFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGhurg%253D&md5=98415728ed8254d173301d5f2c85e3f8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2016.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2016.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DB.%26aulast%3DPease%26aufirst%3DJ.%2BH.%26atitle%3DA%2520high%2520throughput%2520solubility%2520assay%2520for%2520drug%2520discovery%2520using%2520microscale%2520shake-flask%2520and%2520rapid%2520UHPLC%25E2%2580%2593UV%25E2%2580%2593CLND%2520quantification%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2016%26volume%3D122%26spage%3D126%26epage%3D140%26doi%3D10.1016%2Fj.jpba.2016.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pease, J. H.</span></span> <span> </span><span class="NLM_article-title">A novel method for high throughput lipophilicity determination by microscale shake flask and liquid chromatography tandem mass spectrometry</span>. <i>Comb. Chem. High Throughput Screening</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">825</span>, <span class="refDoi"> DOI: 10.2174/1386207311301010007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.2174%2F1386207311301010007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=24168238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWktLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=817-825&author=B.+Linauthor=J.+H.+Pease&title=A+novel+method+for+high+throughput+lipophilicity+determination+by+microscale+shake+flask+and+liquid+chromatography+tandem+mass+spectrometry&doi=10.2174%2F1386207311301010007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Method for High Throughput Lipophilicity Determination by Microscale Shake Flask and Liquid Chromatography Tandem Mass Spectrometry</span></div><div class="casAuthors">Lin, Baiwei; Pease, Joseph H.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">817-825</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Modern small mol. drug design requires the optimization of not only the binding characteristics of the mol. but also its physicochem. properties for ADMET performance.  A key phys. property is lipophilicity and medicinal chemists need rapid access to high quality data in order to drive their decision making.  Traditionally lipophilicity (log D) measurements are performed with a shake flask method and UV detn.  This method suffers from low sensitivity and is not easily converted to a high throughput format.  Over the past decade, several groups have taken different approaches to improve this assay, including replacing the shake flask method with one that utilizes reverse phase HPLC.  Here we describe a new microscale shake flask method that utilizes UPLC-MS/MS to achieve increased throughput, sensitivity and accuracy.  Approaches for assessing data quality are also described.  This platform technol. only requires micrograms of compd. and is routinely used by most small mol. drug discovery project teams at Genentech.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS0kv3IN4lnLVg90H21EOLACvtfcHk0lg2rQQvOhlFFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWktLbO&md5=1d863747144615780be712cc329ab344</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F1386207311301010007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207311301010007%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DB.%26aulast%3DPease%26aufirst%3DJ.%2BH.%26atitle%3DA%2520novel%2520method%2520for%2520high%2520throughput%2520lipophilicity%2520determination%2520by%2520microscale%2520shake%2520flask%2520and%2520liquid%2520chromatography%2520tandem%2520mass%2520spectrometry%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2013%26volume%3D16%26spage%3D817%26epage%3D825%26doi%3D10.2174%2F1386207311301010007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silber, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rance, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wastall, P.</span></span> <span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lg2rQQvOhlFFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, Y.</span></span> <span> </span><span class="NLM_article-title">Prediction of hepatic clearance in human from in vitro data for successful drug development</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1208/s12248-009-9103-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1208%2Fs12248-009-9103-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=19408130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=262-276&author=M.+Chibaauthor=Y.+Ishiiauthor=Y.+Sugiyama&title=Prediction+of+hepatic+clearance+in+human+from+in+vitro+data+for+successful+drug+development&doi=10.1208%2Fs12248-009-9103-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of hepatic clearance in human from in vitro data for successful drug development</span></div><div class="casAuthors">Chiba, Masato; Ishii, Yasuyuki; Sugiyama, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-276</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The in vivo metabolic clearance in human has been successfully predicted by using in vitro data of metabolic stability in cryopreserved prepns. of human hepatocytes.  In the predictions by human hepatocytes, the systematic underpredictions of in vivo clearance have been commonly obsd. among different datasets.  The regression-based scaling factor for the in vitro-to-in vivo extrapolation has mitigated discrepancy between in vitro prediction and in vivo observation.  In addn. to the elimination by metabolic degrdn., the important roles of transporter-mediated hepatic uptake and canalicular excretion have been increasingly recognized as a rate-detg. step in the hepatic clearance.  It has been, therefore, proposed that the in vitro assessment should allow the evaluation of clearances for both transporter(s)-mediated uptake/excretion and metabolic degrdn.  This review first outlines the limited ability of subcellular fractions such as liver microsomes to predict hepatic clearance in vivo.  It highlights the advantages of cryopreserved human hepatocytes as one of the versatile in vitro systems for the prediction of in vivo metabolic clearance in human at the early development state.  The following section discusses the mechanisms underlying the systematic underprediction of in vivo intrinsic clearance by hepatocytes.  It leads to the proposal for the assessment of hepatic uptake clearance as one of the kinetically important determinants for accurate predictions of hepatic clearance in human.  The judicious combination of advanced technologies and understandings for the drug disposition allows us to rationally optimize new chem. entities to the drug candidate with higher probability of success during the clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC52lEOUdlKLVg90H21EOLACvtfcHk0lg2rQQvOhlFFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqs7rI&md5=8c2b3366285c690ba1055d46f52f0b6b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1208%2Fs12248-009-9103-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-009-9103-6%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26atitle%3DPrediction%2520of%2520hepatic%2520clearance%2520in%2520human%2520from%2520in%2520vitro%2520data%2520for%2520successful%2520drug%2520development%26jtitle%3DAAPS%2520J.%26date%3D2009%26volume%3D11%26spage%3D262%26epage%3D276%26doi%3D10.1208%2Fs12248-009-9103-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGinnity, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbanowicz, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of fresh and cryopreseved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance</span>. <i>Drug. Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1253</span>, <span class="refDoi"> DOI: 10.1124/dmd.104.000026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1124%2Fdmd.104.000026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=1247-1253&author=D.+F.+McGinnityauthor=M.+G.+Soarsauthor=R.+A.+Urbanowiczauthor=R.+J.+Riley&title=Evaluation+of+fresh+and+cryopreseved+hepatocytes+as+in+vitro+drug+metabolism+tools+for+the+prediction+of+metabolic+clearance&doi=10.1124%2Fdmd.104.000026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.000026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.000026%26sid%3Dliteratum%253Aachs%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DUrbanowicz%26aufirst%3DR.%2BA.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DEvaluation%2520of%2520fresh%2520and%2520cryopreseved%2520hepatocytes%2520as%2520in%2520vitro%2520drug%2520metabolism%2520tools%2520for%2520the%2520prediction%2520of%2520metabolic%2520clearance%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D1247%26epage%3D1253%26doi%3D10.1124%2Fdmd.104.000026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b','cit2c','cit2d','cit2e'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b','cit4c','cit4d'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e','cit6f','cit6g','cit6h','cit6i','cit6j','cit6k','cit6l','cit6m','cit6n'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':['cit18a','cit18b','cit18c'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b','cit21c'],'ref22':['cit22'],'ref23':['cit23a','cit23b'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yanyun Zhang, Ke Wang, <span class="NLM_string-name hlFld-ContribAuthor">Zhiyi Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Development in Channelopathies: Allosteric Modulation of Ligand-Gated and Voltage-Gated Ion Channels. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15258-15278. <a href="https://doi.org/10.1021/acs.jmedchem.0c01304" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01304%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDrug%252BDevelopment%252Bin%252BChannelopathies%25253A%252BAllosteric%252BModulation%252Bof%252BLigand-Gated%252Band%252BVoltage-Gated%252BIon%252BChannels%26aulast%3DZhang%26aufirst%3DYanyun%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27072020%26date%3D30112020%26volume%3D63%26issue%3D24%26spage%3D15258%26epage%3D15278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tsuyoshi Shinozuka, Hiroyuki Kobayashi, Sayaka Suzuki, Kyosuke Tanaka, Narayan Karanjule, Noriyuki Hayashi, Toshifumi Tsuda, Eri Tokumaru, Masahiro Inoue, Kiyono Ueda, Hiroko Kimoto, Yuki Domon, Sakiko Takahashi, Kazufumi Kubota, Tomihisa Yokoyama, Akiko Shimizugawa, Ryuta Koishi, Chie Fujiwara, Daigo Asano, Tomoko Sakakura, Kiyoshi Takasuna, Yasuyuki Abe, Toshiyuki Watanabe, <span class="NLM_string-name hlFld-ContribAuthor">Yutaka Kitano</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of DS-1971a, a Potent, Selective NaV1.7 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10204-10220. <a href="https://doi.org/10.1021/acs.jmedchem.0c00259" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00259%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BDS-1971a%25252C%252Ba%252BPotent%25252C%252BSelective%252BNaV1.7%252BInhibitor%26aulast%3DShinozuka%26aufirst%3DTsuyoshi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12022020%26date%3D26052020%26date%3D11052020%26volume%3D63%26issue%3D18%26spage%3D10204%26epage%3D10220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Weikaixin Kong, Xinyu Tu, Weiran Huang, Yang Yang, Zhengwei Xie, <span class="NLM_string-name hlFld-ContribAuthor">Zhuo Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Prediction and Optimization of NaV1.7 Sodium Channel Inhibitors Based on Machine Learning and Simulated Annealing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (6)
                                     , 2739-2753. <a href="https://doi.org/10.1021/acs.jcim.9b01180" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b01180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b01180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b01180%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPrediction%252Band%252BOptimization%252Bof%252BNaV1.7%252BSodium%252BChannel%252BInhibitors%252BBased%252Bon%252BMachine%252BLearning%252Band%252BSimulated%252BAnnealing%26aulast%3DKong%26aufirst%3DWeikaixin%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D21122019%26date%3D04062020%26date%3D18052020%26volume%3D60%26issue%3D6%26spage%3D2739%26epage%3D2753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Roman
S. Malykhin, Aleksandr O. Kokuev, Valentin S. Dorokhov, Yulia V. Nelyubina, Vladimir A. Tartakovsky, Andrey A. Tabolin, Sema L. Ioffe, <span class="NLM_string-name hlFld-ContribAuthor">Alexey Yu. Sukhorukov</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleophilic Halogenation of Cyclic Nitronates: A General Access to 3-Halo-1,2-Oxazines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (21)
                                     , 13794-13806. <a href="https://doi.org/10.1021/acs.joc.9b02010" title="DOI URL">https://doi.org/10.1021/acs.joc.9b02010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b02010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b02010%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DNucleophilic%252BHalogenation%252Bof%252BCyclic%252BNitronates%25253A%252BA%252BGeneral%252BAccess%252Bto%252B3-Halo-1%25252C2-Oxazines%26aulast%3DMalykhin%26aufirst%3DRoman%2BS.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D23072019%26date%3D24102019%26date%3D09102019%26volume%3D84%26issue%3D21%26spage%3D13794%26epage%3D13806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">John V. Mulcahy, Hassan Pajouhesh, Jacob T. Beckley, Anton Delwig, J. Du Bois, <span class="NLM_string-name hlFld-ContribAuthor">John C. Hunter</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (19)
                                     , 8695-8710. <a href="https://doi.org/10.1021/acs.jmedchem.8b01906" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01906%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChallenges%252Band%252BOpportunities%252Bfor%252BTherapeutics%252BTargeting%252Bthe%252BVoltage-Gated%252BSodium%252BChannel%252BIsoform%252BNaV1.7%26aulast%3DMulcahy%26aufirst%3DJohn%2BV.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D04122018%26date%3D07052019%26date%3D23042019%26volume%3D62%26issue%3D19%26spage%3D8695%26epage%3D8710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Steven J. McKerrall, Teresa Nguyen, Kwong Wah Lai, Philippe Bergeron, Lunbin Deng, Antonio DiPasquale, Jae H. Chang, Jun Chen, Tania Chernov-Rogan, David H. Hackos, Jonathan Maher, Daniel F. Ortwine, Jodie Pang, Jian Payandeh, William R. Proctor, Shannon D. Shields, Jennifer Vogt, Pengfei Ji, Wenfeng Liu, Elisa Ballini, Lilia Schumann, Glauco Tarozzo, Girish Bankar, Sultan Chowdhury, Abid Hasan, J. P. Johnson, Jr., Kuldip Khakh, Sophia Lin, Charles J. Cohen, Christoph M. Dehnhardt, Brian S. Safina, <span class="NLM_string-name hlFld-ContribAuthor">Daniel P. Sutherlin</span>. </span><span class="cited-content_cbyCitation_article-title">Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Nav1.7 Inhibitors for the Treatment of Chronic Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 4091-4109. <a href="https://doi.org/10.1021/acs.jmedchem.9b00141" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00141%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-%252Band%252BLigand-Based%252BDiscovery%252Bof%252BChromane%252BArylsulfonamide%252BNav1.7%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BPain%26aulast%3DMcKerrall%26aufirst%3DSteven%2BJ.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D23012019%26date%3D16042019%26date%3D03042019%26volume%3D62%26issue%3D8%26spage%3D4091%26epage%3D4109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Guanglin Luo, Ling Chen, Amy Easton, Amy Newton, Clotilde Bourin, Eric Shields, Kathy Mosure, Matthew G. Soars, Ronald J. Knox, Michele Matchett, Rick L. Pieschl, Debra J. Post-Munson, Shuya Wang, James Herrington, John Graef, Kimberly Newberry, Digavalli V. Sivarao, Arun Senapati, Linda J. Bristow, Nicholas A. Meanwell, Lorin A. Thompson, <span class="NLM_string-name hlFld-ContribAuthor">Carolyn Dzierba</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 831-856. <a href="https://doi.org/10.1021/acs.jmedchem.8b01550" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01550%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BIndole-%252Band%252BIndazole-acylsulfonamides%252Bas%252BPotent%252Band%252BSelective%252BNaV1.7%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BPain%26aulast%3DLuo%26aufirst%3DGuanglin%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D04102018%26date%3D08012019%26date%3D21122018%26volume%3D62%26issue%3D2%26spage%3D831%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shaoyi Sun, Qi Jia, Alla Y. Zenova, Michael S. Wilson, Sultan Chowdhury, Thilo Focken, Jun Li, Shannon Decker, Michael E. Grimwood, Jean-Christophe Andrez, Ivan Hemeon, Tao Sheng, Chien-An Chen, Andy White, David H. Hackos, Lunbin Deng, Girish Bankar, Kuldip Khakh, Elaine Chang, Rainbow Kwan, Sophia Lin, Karen Nelkenbrecher, Benjamin D. Sellers, Antonio G. DiPasquale, Jae Chang, Jodie Pang, Luis Sojo, Andrea Lindgren, Matthew Waldbrook, Zhiwei Xie, Clint Young, James P. Johnson, C. Lee Robinette, Charles J. Cohen, Brian S. Safina, Daniel P. Sutherlin, Daniel F. Ortwine, <span class="NLM_string-name hlFld-ContribAuthor">Christoph M. Dehnhardt</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Selective Acyl Sulfonamide–Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (NaV) 1.7 with Potent Analgesic Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 908-927. <a href="https://doi.org/10.1021/acs.jmedchem.8b01621" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01621</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01621%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BSelective%252BAcyl%252BSulfonamide%2525E2%252580%252593Cycloalkylether%252BInhibitors%252Bof%252Bthe%252BVoltage-Gated%252BSodium%252BChannel%252B%252528NaV%252529%252B1.7%252Bwith%252BPotent%252BAnalgesic%252BActivity%26aulast%3DSun%26aufirst%3DShaoyi%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D18102018%26date%3D21122018%26date%3D30112018%26volume%3D62%26issue%3D2%26spage%3D908%26epage%3D927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karol R.  Francisco</span>, <span class="hlFld-ContribAuthor ">Carmine  Varricchio</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Paniak</span>, <span class="hlFld-ContribAuthor ">Marisa C.  Kozlowski</span>, <span class="hlFld-ContribAuthor ">Andrea  Brancale</span>, <span class="hlFld-ContribAuthor ">Carlo  Ballatore</span>. </span><span class="cited-content_cbyCitation_article-title">Structure property relationships of N-acylsulfonamides and related bioisosteres. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113399. <a href="https://doi.org/10.1016/j.ejmech.2021.113399" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113399</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113399%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%252Bproperty%252Brelationships%252Bof%252BN-acylsulfonamides%252Band%252Brelated%252Bbioisosteres%26aulast%3DFrancisco%26aufirst%3DKarol%2BR.%26date%3D2021%26volume%3D218%26spage%3D113399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaista  Amin</span>, <span class="hlFld-ContribAuthor ">M. Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">A. K.  Najmi</span>, <span class="hlFld-ContribAuthor ">Nadeem  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Asif  Husain</span>, <span class="hlFld-ContribAuthor ">M.  Shaquiquzzaman</span>. </span><span class="cited-content_cbyCitation_article-title">A review on synthetic procedures and applications of phosphorus oxychloride (POCl
              3
              ) in the last biennial period (2018–19). </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2021,</strong> <em>196 </em>
                                    (3)
                                     , 211-274. <a href="https://doi.org/10.1080/10426507.2020.1831499" title="DOI URL">https://doi.org/10.1080/10426507.2020.1831499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2020.1831499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2020.1831499%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DA%252Breview%252Bon%252Bsynthetic%252Bprocedures%252Band%252Bapplications%252Bof%252Bphosphorus%252Boxychloride%252B%252528POCl%252B3%252B%252529%252Bin%252Bthe%252Blast%252Bbiennial%252Bperiod%252B%2525282018%2525E2%252580%25259319%252529%26aulast%3DAmin%26aufirst%3DShaista%26date%3D2021%26date%3D2020%26volume%3D196%26issue%3D3%26spage%3D211%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tahir  Farooq</span>. </span><span class="cited-content_cbyCitation_article-title">Triazoles as Bioisosteres in Medicinal Chemistry: A Recent Update. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 31-47. <a href="https://doi.org/10.1016/B978-0-12-817113-4.00010-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-817113-4.00010-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-817113-4.00010-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-817113-4.00010-X%26sid%3Dliteratum%253Aachs%26atitle%3DTriazoles%252Bas%252BBioisosteres%252Bin%252BMedicinal%252BChemistry%25253A%252BA%252BRecent%252BUpdate%26aulast%3DFarooq%26aufirst%3DTahir%26date%3D2021%26spage%3D31%26epage%3D47%26pub%3DElsevier%26atitle%3DAdvances%252Bin%252BTriazole%252BChemistry%26date%3D2021%26volume%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sooyeon  Jo</span>, <span class="hlFld-ContribAuthor ">Bruce P.  Bean</span>. </span><span class="cited-content_cbyCitation_article-title">Lidocaine Binding Enhances Inhibition of Nav1.7 Channels by the Sulfonamide PF-05089771. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2020,</strong> <em>97 </em>
                                    (6)
                                     , 377-383. <a href="https://doi.org/10.1124/mol.119.118380" title="DOI URL">https://doi.org/10.1124/mol.119.118380</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.119.118380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.119.118380%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DLidocaine%252BBinding%252BEnhances%252BInhibition%252Bof%252BNav1.7%252BChannels%252Bby%252Bthe%252BSulfonamide%252BPF-05089771%26aulast%3DJo%26aufirst%3DSooyeon%26date%3D2020%26date%3D2020%26volume%3D97%26issue%3D6%26spage%3D377%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiwen  Xu</span>, <span class="hlFld-ContribAuthor ">Bei  Shen</span>, <span class="hlFld-ContribAuthor ">Lingfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Chunhua  Qiao</span>. </span><span class="cited-content_cbyCitation_article-title">Metal free [4+1] and [5+1] annulation reactions to prepare heterocycles using DMF and its derivatives as one-carbon source. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (19)
                                     , 151844. <a href="https://doi.org/10.1016/j.tetlet.2020.151844" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151844%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DMetal%252Bfree%252B%25255B4%25252B1%25255D%252Band%252B%25255B5%25252B1%25255D%252Bannulation%252Breactions%252Bto%252Bprepare%252Bheterocycles%252Busing%252BDMF%252Band%252Bits%252Bderivatives%252Bas%252Bone-carbon%252Bsource%26aulast%3DXu%26aufirst%3DYiwen%26date%3D2020%26volume%3D61%26issue%3D19%26spage%3D151844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-tao  Wang</span>, <span class="hlFld-ContribAuthor ">Yue-ming  Zheng</span>, <span class="hlFld-ContribAuthor ">Yue-ting  Chen</span>, <span class="hlFld-ContribAuthor ">Min  Gu</span>, <span class="hlFld-ContribAuthor ">Zhao-bing  Gao</span>, <span class="hlFld-ContribAuthor ">Fa-jun  Nan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2020,</strong> <em>41 </em>
                                    (3)
                                     , 293-302. <a href="https://doi.org/10.1038/s41401-019-0267-z" title="DOI URL">https://doi.org/10.1038/s41401-019-0267-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-019-0267-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-019-0267-z%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DDiscovery%252Bof%252Baryl%252Bsulfonamide-selective%252BNav1.7%252Binhibitors%252Bwith%252Ba%252Bhighly%252Bhydrophobic%252Bethanoanthracene%252Bcore%26aulast%3DWang%26aufirst%3DJin-tao%26date%3D2020%26date%3D2019%26volume%3D41%26issue%3D3%26spage%3D293%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heike  Wulff</span>, <span class="hlFld-ContribAuthor ">Palle  Christophersen</span>, <span class="hlFld-ContribAuthor ">Paul  Colussi</span>, <span class="hlFld-ContribAuthor ">K. George  Chandy</span>, <span class="hlFld-ContribAuthor ">Vladimir  Yarov-Yarovoy</span>. </span><span class="cited-content_cbyCitation_article-title">Antibodies and venom peptides: new modalities for ion channels. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2019,</strong> <em>18 </em>
                                    (5)
                                     , 339-357. <a href="https://doi.org/10.1038/s41573-019-0013-8" title="DOI URL">https://doi.org/10.1038/s41573-019-0013-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-019-0013-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-019-0013-8%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DAntibodies%252Band%252Bvenom%252Bpeptides%25253A%252Bnew%252Bmodalities%252Bfor%252Bion%252Bchannels%26aulast%3DWulff%26aufirst%3DHeike%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D5%26spage%3D339%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun-kai  Chen</span>, <span class="hlFld-ContribAuthor ">Ye  Tao</span>, <span class="hlFld-ContribAuthor ">Yu-qi  Ma</span>, <span class="hlFld-ContribAuthor ">Xu-hong  Pang</span>, <span class="hlFld-ContribAuthor ">He-dong  Bian</span>, <span class="hlFld-ContribAuthor ">Han-Fu  Liu</span>, <span class="hlFld-ContribAuthor ">Fu-ping  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">The positional isomeric effect and structural difference in coordination assemblies system of CoII with 3/4-pmpt ligands. </span><span class="cited-content_cbyCitation_journal-name">Polyhedron</span><span> <strong>2018,</strong> <em>156 </em>, 231-244. <a href="https://doi.org/10.1016/j.poly.2018.09.018" title="DOI URL">https://doi.org/10.1016/j.poly.2018.09.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.poly.2018.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.poly.2018.09.018%26sid%3Dliteratum%253Aachs%26jtitle%3DPolyhedron%26atitle%3DThe%252Bpositional%252Bisomeric%252Beffect%252Band%252Bstructural%252Bdifference%252Bin%252Bcoordination%252Bassemblies%252Bsystem%252Bof%252BCoII%252Bwith%252B3%25252F4-pmpt%252Bligands%26aulast%3DChen%26aufirst%3DYun-kai%26date%3D2018%26volume%3D156%26spage%3D231%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven J.  McKerrall</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>. </span><span class="cited-content_cbyCitation_article-title">Nav1.7 inhibitors for the treatment of chronic pain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (19)
                                     , 3141-3149. <a href="https://doi.org/10.1016/j.bmcl.2018.08.007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.08.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.08.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNav1.7%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bchronic%252Bpain%26aulast%3DMcKerrall%26aufirst%3DSteven%2BJ.%26date%3D2018%26volume%3D28%26issue%3D19%26spage%3D3141%26epage%3D3149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Girish  Bankar</span>, <span class="hlFld-ContribAuthor ">Samuel J.  Goodchild</span>, <span class="hlFld-ContribAuthor ">Sarah  Howard</span>, <span class="hlFld-ContribAuthor ">Karen  Nelkenbrecher</span>, <span class="hlFld-ContribAuthor ">Matthew  Waldbrook</span>, <span class="hlFld-ContribAuthor ">Michelle  Dourado</span>, <span class="hlFld-ContribAuthor ">Noah G.  Shuart</span>, <span class="hlFld-ContribAuthor ">Sophia  Lin</span>, <span class="hlFld-ContribAuthor ">Clint  Young</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Xie</span>, <span class="hlFld-ContribAuthor ">Kuldip  Khakh</span>, <span class="hlFld-ContribAuthor ">Elaine  Chang</span>, <span class="hlFld-ContribAuthor ">Luis E.  Sojo</span>, <span class="hlFld-ContribAuthor ">Andrea  Lindgren</span>, <span class="hlFld-ContribAuthor ">Sultan  Chowdhury</span>, <span class="hlFld-ContribAuthor ">Shannon  Decker</span>, <span class="hlFld-ContribAuthor ">Michael  Grimwood</span>, <span class="hlFld-ContribAuthor ">Jean-Christophe  Andrez</span>, <span class="hlFld-ContribAuthor ">Christoph M.  Dehnhardt</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Jae H.  Chang</span>, <span class="hlFld-ContribAuthor ">Brian S.  Safina</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>, <span class="hlFld-ContribAuthor ">James P.  Johnson</span>, <span class="hlFld-ContribAuthor ">David H.  Hackos</span>, <span class="hlFld-ContribAuthor ">C. Lee  Robinette</span>, <span class="hlFld-ContribAuthor ">Charles J.  Cohen</span>. </span><span class="cited-content_cbyCitation_article-title">Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2018,</strong> <em>24 </em>
                                    (12)
                                     , 3133-3145. <a href="https://doi.org/10.1016/j.celrep.2018.08.063" title="DOI URL">https://doi.org/10.1016/j.celrep.2018.08.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2018.08.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2018.08.063%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DSelective%252BNaV1.7%252BAntagonists%252Bwith%252BLong%252BResidence%252BTime%252BShow%252BImproved%252BEfficacy%252Bagainst%252BInflammatory%252Band%252BNeuropathic%252BPain%26aulast%3DBankar%26aufirst%3DGirish%26date%3D2018%26volume%3D24%26issue%3D12%26spage%3D3133%26epage%3D3145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Acyl sulfonamide Na<sub>V</sub>1.7 inhibitors.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a><sup><i>a</i></sup>IC<sub>50</sub> values ± SD were generated on a PatchXpress automated voltage-clamp platform. <sup><i>b</i></sup>Published voltage-clamp data, which were derived on various voltage-clamp platforms. <sup><i>c</i></sup>cLogP was calculated using MoKa, version 2.6.5.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of triazole sulfonamides. (A) ORTEP plot of a small molecule crystal structure of <b>1</b> (CCDC 1590582) and restriction of conformational flexibility of acyl sulfonamides by cyclization. (B) Overlay of minimized version of the acyl sulfonamide and triazole cores (gray and orange, respectively). The conformations were minimized in the gas phase using the MMFF94x force field in MOE<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and manually superimposed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Torsional preference of the linker impacts potency. Torsion angle preferences are taken from ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>. LBA IC<sub>50</sub>: IC<sub>50</sub> for displacement of [<sup>3</sup>H]GX-545, reported as mean value from at least two independent determinations ± SD. PX IC<sub>50</sub> values ± SD were generated on a PatchXpress (PX) automated voltage-clamp platform using a protocol where the membrane potential was maintained at a voltage yielding full inactivation of the channel. (B) Global minimum energy conformations of <b>21</b> (green) and <b>22</b> (orange), calculated by OMEGA<a onclick="showRef(event, 'cit21a cit21b'); return false;" href="javascript:void(0);" class="ref cit21a cit21b">(21a,b)</a> followed by optimization with SZYBKI,<a onclick="showRef(event, 'cit21c'); return false;" href="javascript:void(0);" class="ref cit21c">(21c)</a> using system defaults.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Analysis of matched pairs of triazoles and acyl sulfonamides. (A) Na<sub>V</sub>1.7 LBA: 29 matched pairs. (B) HLM: 24 matched pairs. Selected compound numbers are shown. Colors: green, triazoles; orange, acyl sulfonamides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Effect of mutations in the anion binding pocket of Na<sub>V</sub>1.7 VSD4 on binding of acyl sulfonamide <b>1</b>. Voltage-clamp data were generated on a Qube automated voltage-clamp system: <i>n</i> ≥ 3, error bars indicate SEM. The corresponding IC<sub>50</sub> values are as follows: 0.004 μM (WT), 0.04 μM (Y1537A), 1.37 μM (R1602A), 8.87 μM (R1605A), 27.35 μM (R1608A). (B) Effect of mutations on binding of triazole sulfonamide <b>5</b>. Voltage-clamp data were generated on a Qube automated voltage-clamp system: <i>n</i> ≥ 3, error bars indicate SEM. The corresponding IC<sub>50</sub> values are as follows: 0.02 μM (WT), 0.15 μM (Y1537A), 7.33 μM (R1602A), 6.13 μM (R1605A), 30.69 μM (R1608A). (C) Amino acid sequence of the S1–S4 region of human Na<sub>V</sub>1.7 VSD4. Residues selected for mutagenesis studies are highlighted in yellow. Residue numbering is in accordance with ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>. For additional data, see the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Effect of compounds <b>10</b>, <b>13</b>, and <b>25</b> on aconitine-induced pain in transgenic IEM mice. Male 7–10 week old FVB hSCN9a Tg mice were used (<i>n</i> = 4 animals/group for no aconitine vehicle and all doses of test compounds; <i>n</i> = 8 animals for aconitine vehicle group). Nociceptive behavior is presented as mean ± SEM. Reduction of nociceptive behavior (flinching and licking after intraplantar injection of aconitine) relative to vehicle is listed above the bars (in %). Statistical analysis was performed by a one-way ANOVA, followed by a Dunnett’s test: *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, ****<i>p</i> < 0.0001. (B) Concentration–response relationships for inhibition of nociception by <b>10</b>, <b>13</b>, and <b>25</b> in the IEM assay. Data points are shown as mean relative response ± SD and represent the same data sets as in panel A, including the corresponding terminal plasma concentrations (mean values shown). The curves are fit to a 1:1 binding reaction. EC<sub>50</sub> values are calculated as 5.8 μM (<b>10</b>), 0.5 μM (<b>13</b>), and 21.2 μM (<b>25</b>). (C) Pharmacokinetic profiles of <b>10</b>, <b>13</b>, and <b>25</b> in plasma following 10 and 30 mg/kg oral doses to male FVB mice (solid line, <i>n</i> = 3 animals; age 6–7 weeks). Plasma concentrations are represented as mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Isoxazoles <b>4</b> and <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-adamantanemethanol or (3,4-dichlorophenyl)methanol, NaH, DMF, 0 °C to rt, 100%; (b) <i>N</i>-hydroxyacetamide, KO<i>t</i>-Bu, DMF, 40–51%; (c) MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (d) 1 M NaOH, THF, 68–72% over 2 steps.</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Triazoles <b>6</b>, <b>7</b>, <b>9</b>–<b>12</b>, and <b>15</b> via Sulfonylation of [1,2,4]Triazolo[4,3-<i>a</i>]pyridin-3-amines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-adamantanemethanol, KO<i>t</i>-Bu, DMSO, 94%; (b) <i>m</i>CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 94%; (c) POCl<sub>3</sub>, reflux, 70%; (d) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, dioxane, 160 °C, μW, 92%; (e) BrCN, EtOH, CH<sub>2</sub>Cl<sub>2</sub>, 100%; (f) (1) isopropenylboronic acid pinacol ester, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 160 °C, μW, 78%; (2) Pd/C, H<sub>2</sub>, THF, MeOH, AcOH, 100%; (g) cyclopropylboronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 160 °C, μW, 67%; (h) R<sup>2</sup>SO<sub>2</sub>Cl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, then 1 M NaOH, THF, 8–29%; (i) cyclobutylzinc bromide, RuPhos, Pd(OAc)<sub>2</sub>, THF, 6–12%.</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Triazoles <b>13</b> and <b>14</b> via Cu-Mediated Coupling of Sulfonamides with 3-Bromo-[1,2,4]triazolo[4,3-<i>a</i>]pyridines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H(OEt)<sub>3</sub>, reflux, 84%; (b) cyclopropylboronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, reflux, 64%; (c) NBS, CH<sub>2</sub>Cl<sub>2</sub>, 78%; (d) RSO<sub>2</sub>NH<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, <i>trans</i>-<i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine, CuOTf, PhMe, DMSO, reflux, 12–78%.</p></p></figure><figure data-id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Isoxazole <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LiBH<sub>4</sub>, THF, reflux, 100%; (b) MsCl, TEA, THF, 77%; (c) 3,4-dichlorophenol, K<sub>2</sub>CO<sub>3</sub>, DMF, 65%; (d) CuCN, CuI, NMP, 150 °C, μW, 52%; (e) <i>N</i>-hydroxyacetamide, KO<i>t</i>-Bu, DMF, 81%; (f) MsCl, pyridine, 0 °C to rt; 20%.</p></p></figure><figure data-id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/medium/jm-2017-01826q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Triazoles <b>24</b> and <b>25</b> via Cu-Mediated Coupling of Sulfonamides with 3-Bromo-[1,2,4]triazolo[4,3-<i>a</i>]pyridines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.7b01826/20180608/images/large/jm-2017-01826q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01826&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SO<sub>2</sub>Cl, MeOH, reflux, 95%; (b) LiBH<sub>4</sub>, THF, MeOH, 0 °C to rt, 79%; (c) (1) MsCl, DIPEA, THF, 0 °C; (2) 3,4-dichlorophenol or 3,5-dichlorophenol, K<sub>2</sub>CO<sub>3</sub>, EtOAc, DMF, 69–86% over 2 steps; (d) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, dioxane, reflux, 91–100%; (e) H(OEt)<sub>3</sub>, reflux, 64–77%; (f) cyclopropylboronic acid, K<sub>3</sub>PO<sub>4</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, reflux, 55–69%; (g) NBS, CH<sub>2</sub>Cl<sub>2</sub>, 70–98%; (h) MeSO<sub>2</sub>NH<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, <i>trans</i>-<i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine, CuOTf, PhMe, DMSO, reflux, 10–12%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i114">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01288" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01288" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eijkelkamp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cregg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werdehausen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugiero, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span> <span> </span><span class="NLM_article-title">Neurological perspectives on voltage-gated sodium channels</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">2585</span>– <span class="NLM_lpage">2612</span>, <span class="refDoi"> DOI: 10.1093/brain/aws225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1093%2Fbrain%2Faws225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=22961543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2012&pages=2585-2612&author=N.+Eijkelkampauthor=J.+E.+Linleyauthor=M.+D.+Bakerauthor=M.+S.+Minettauthor=R.+Creggauthor=R.+Werdehausenauthor=F.+Rugieroauthor=J.+N.+Wood&title=Neurological+perspectives+on+voltage-gated+sodium+channels&doi=10.1093%2Fbrain%2Faws225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological perspectives on voltage-gated sodium channels</span></div><div class="casAuthors">Eijkelkamp Niels; Linley John E; Baker Mark D; Minett Michael S; Cregg Roman; Werdehausen Robert; Rugiero Francois; Wood John N</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">Pt 9</span>),
    <span class="NLM_cas:pages">2585-612</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The activity of voltage-gated sodium channels has long been linked to disorders of neuronal excitability such as epilepsy and chronic pain.  Recent genetic studies have now expanded the role of sodium channels in health and disease, to include autism, migraine, multiple sclerosis, cancer as well as muscle and immune system disorders.  Transgenic mouse models have proved useful in understanding the physiological role of individual sodium channels, and there has been significant progress in the development of subtype selective inhibitors of sodium channels.  This review will outline the functions and roles of specific sodium channels in electrical signalling and disease, focusing on neurological aspects.  We also discuss recent advances in the development of selective sodium channel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMaWmHsTCoQ3l8icjszYl0fW6udTcc2eZC_4MSv42clrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D&md5=6f9b33df722a3c5831b8860d3fad1af2</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Faws225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Faws225%26sid%3Dliteratum%253Aachs%26aulast%3DEijkelkamp%26aufirst%3DN.%26aulast%3DLinley%26aufirst%3DJ.%2BE.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DMinett%26aufirst%3DM.%2BS.%26aulast%3DCregg%26aufirst%3DR.%26aulast%3DWerdehausen%26aufirst%3DR.%26aulast%3DRugiero%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26atitle%3DNeurological%2520perspectives%2520on%2520voltage-gated%2520sodium%2520channels%26jtitle%3DBrain%26date%3D2012%26volume%3D135%26spage%3D2585%26epage%3D2612%26doi%3D10.1093%2Fbrain%2Faws225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S.
D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">The Na<sub>V</sub>1.7 sodium channel: from molecule to man</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1038/nrn3404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1038%2Fnrn3404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=23232607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=49-62&author=S.%0AD.+Dib-Hajjauthor=Y.+Yangauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=The+NaV1.7+sodium+channel%3A+from+molecule+to+man&doi=10.1038%2Fnrn3404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The NaV1.7 sodium channel: from molecule to man</span></div><div class="casAuthors">Dib-Hajj, Sulayman D.; Yang, Yang; Black, Joel A.; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-62</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The voltage-gated sodium channel NaV1.7 is preferentially expressed in peripheral somatic and visceral sensory neurons, olfactory sensory neurons and sympathetic ganglion neurons.  NaV1.7 accumulates at nerve fiber endings and amplifies small subthreshold depolarizations, poising it to act as a threshold channel that regulates excitability.  Genetic and functional studies have added to the evidence that NaV1.7 is a major contributor to pain signaling in humans, and homol. modeling based on crystal structures of ion channels suggests an at.-level structural basis for the altered gating of mutant NaV1.7 that causes pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4lZH1L7XWLVg90H21EOLACvtfcHk0lierLBHisu25Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ&md5=0e075d2c82d98774da1d316f4409d3eb</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnrn3404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3404%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DThe%2520NaV1.7%2520sodium%2520channel%253A%2520from%2520molecule%2520to%2520man%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D49%26epage%3D62%26doi%3D10.1038%2Fnrn3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">de Lera Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span> <span> </span><span class="NLM_article-title">Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7093</span>– <span class="NLM_lpage">7118</span>, <span class="refDoi"> DOI: 10.1021/jm501981g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501981g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7093-7118&author=M.+de+Lera+Ruizauthor=R.+L.+Kraus&title=Voltage-gated+sodium+channels%3A+structure%2C+function%2C+pharmacology%2C+and+clinical+indications&doi=10.1021%2Fjm501981g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span></div><div class="casAuthors">de Lera Ruiz, Manuel; Kraus, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7093-7118</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today.  Nav1.7 channels in particular have received much attention recently because of strong genetic validation of their involvement in nociception.  Here we summarize the current status of research in the Nav field and present the most relevant recent developments with respect to the mol. structure, general physiol., and pharmacol. of distinct Nav channel subtypes.  We discuss Nav channel ligands such as small mols., toxins isolated from animal venoms, and the recently identified Nav1.7-selective antibody.  Furthermore, we review eight characterized ligand binding sites on the Nav channel α subunit.  Finally, we examine possible therapeutic applications of Nav ligands and provide an update on current clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn2idyYye8oLVg90H21EOLACvtfcHk0lierLBHisu25Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D&md5=a816fdf5b46e2e5727669bf17e2e4fd4</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1021%2Fjm501981g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501981g%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26atitle%3DVoltage-gated%2520sodium%2520channels%253A%2520structure%252C%2520function%252C%2520pharmacology%252C%2520and%2520clinical%2520indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7093%26epage%3D7118%26doi%3D10.1021%2Fjm501981g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span> <span> </span><span class="NLM_article-title">Mutations in <i>SCN9A</i>, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span>. <i>J. Med. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1136/jmg.2003.012153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1136%2Fjmg.2003.012153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=14985375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=171-174&author=Y.+Yangauthor=Y.+Wangauthor=S.+Liauthor=Z.+Xuauthor=H.+Liauthor=L.+Maauthor=J.+Fanauthor=D.+Buauthor=B.+Liuauthor=Z.+Fanauthor=G.+Wuauthor=J.+Jinauthor=B.+Dingauthor=X.+Zhuauthor=Y.+Shen&title=Mutations+in+SCN9A%2C+encoding+a+sodium+channel+alpha+subunit%2C+in+patients+with+primary+erythermalgia&doi=10.1136%2Fjmg.2003.012153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span></div><div class="casAuthors">Yang, Y.; Wang, Y.; Li, S.; Xu, Z.; Li, H.; Ma, L.; Fan, J.; Bu, D.; Liu, B.; Fan, Z.; Wu, G.; Jin, J.; Ding, B.; Zhu, X.; Shen, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-174</span>CODEN:
                <span class="NLM_cas:coden">JMDGAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-2593</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Primary erythermalgia is a rare autosomal dominant disease characterized by intermittent burning pain with redness and heat in the extremities.  A previous study established the linkage of primary erythermalgia to a 7.94 cM interval on chromosome 2q, but the causative gene was not identified.  We performed linkage anal. in a Chinese family with primary erythermalgia, and screened the mutations in the two candidate genes, SCN9A and GCA, in the family and a sporadic patient.  Linkage anal. yielded a max. lod score of 2.11 for both markers D2S2370 and D2S2330.  Based on crit. recombination events in two patients in the family, we further limited the genetic region to 5.98 cM between D2S2370 and D2S2345.  We then identified two missense mutations in SCN9A in the family (T2573A) and the sporadic patient (T2543C).  Our data suggest that mutations in SCN9A cause primary erythermalgia.  SCN9A, encoding a voltage-gated sodium channel alpha subunit predominantly expressed in sensory and sympathetic neurons, may play an important role in nociception and vasomotor regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBMPc9seMturVg90H21EOLACvtfcHk0lhGEUR7tdhxlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D&md5=bf4ca6710278dd25a4de4ac5d8fdab2f</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2003.012153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2003.012153%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DMutations%2520in%2520SCN9A%252C%2520encoding%2520a%2520sodium%2520channel%2520alpha%2520subunit%252C%2520in%2520patients%2520with%2520primary%2520erythermalgia%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2004%26volume%3D41%26spage%3D171%26epage%3D174%26doi%3D10.1136%2Fjmg.2003.012153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S.</span></span> <span> </span><span class="NLM_article-title">Erythermalgia: molecular basis for an inherited pain syndrome</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">562</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2005.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.molmed.2005.10.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=555-562&author=S.+G.+Waxmanauthor=S.+Dib-Hajj&title=Erythermalgia%3A+molecular+basis+for+an+inherited+pain+syndrome&doi=10.1016%2Fj.molmed.2005.10.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2005.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2005.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DDib-Hajj%26aufirst%3DS.%26atitle%3DErythermalgia%253A%2520molecular%2520basis%2520for%2520an%2520inherited%2520pain%2520syndrome%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D555%26epage%3D562%26doi%3D10.1016%2Fj.molmed.2005.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fertleman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffatt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klugbauer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, M.</span></span> <span> </span><span class="NLM_article-title"><i>SCN9A</i> Mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2006.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.neuron.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=17145499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=767-774&author=C.+R.+Fertlemanauthor=M.+D.+Bakerauthor=K.+A.+Parkerauthor=S.+Moffattauthor=F.+V.+Elmslieauthor=B.+Abrahamsenauthor=J.+Ostmanauthor=N.+Klugbauerauthor=J.+N.+Woodauthor=R.+M.+Gardinerauthor=M.+Rees&title=SCN9A+Mutations+in+paroxysmal+extreme+pain+disorder%3A+allelic+variants+underlie+distinct+channel+defects+and+phenotypes&doi=10.1016%2Fj.neuron.2006.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">SCN9A mutations in paroxysmal clinical study extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span></div><div class="casAuthors">Fertleman, Caroline R.; Baker, Mark D.; Parker, Keith A.; Moffatt, Sarah; Elmslie, Frances V.; Abrahamsen, Bjarke; Ostman, Johan; Klugbauer, Norbert; Wood, John N.; Gardiner, R. Mark; Rees, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">767-774</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Paroxysmal extreme pain disorder (PEPD), previously known as familial rectal pain (FRP, or OMIM 167400), is an inherited condition characterized by paroxysms of rectal, ocular, or submandibular pain with flushing.  A genome-wide linkage search followed by mutational anal. of the candidate gene SCN9A, which encodes hNav1.7, identified eight missense mutations in 11 families and 2 sporadic cases.  Functional anal. in vitro of three of these mutant Nav1.7 channels revealed a redn. in fast inactivation, leading to persistent sodium current.  Other mutations in SCN9A assocd. with more neg. activation thresholds are known to cause primary erythermalgia (PE).  Carbamazepine, a drug that is effective in PEPD, but not PE, showed selective block of persistent current assocd. with PEPD mutants, but did not affect the neg. activation threshold of a PE mutant.  PEPD and PE are allelic variants with distinct underlying biophys. mechanisms and represent a sep. class of peripheral neuronal sodium channelopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2qhSqNNAvLVg90H21EOLACvtfcHk0lhGEUR7tdhxlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ&md5=2f52e4722b3046d2bb0dc7af0901e952</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DFertleman%26aufirst%3DC.%2BR.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DK.%2BA.%26aulast%3DMoffatt%26aufirst%3DS.%26aulast%3DElmslie%26aufirst%3DF.%2BV.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DOstman%26aufirst%3DJ.%26aulast%3DKlugbauer%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGardiner%26aufirst%3DR.%2BM.%26aulast%3DRees%26aufirst%3DM.%26atitle%3DSCN9A%2520Mutations%2520in%2520paroxysmal%2520extreme%2520pain%2520disorder%253A%2520allelic%2520variants%2520underlie%2520distinct%2520channel%2520defects%2520and%2520phenotypes%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D767%26epage%3D774%26doi%3D10.1016%2Fj.neuron.2006.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fertleman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrie, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicardi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednarek, N. A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eeg-Olofsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griesemer, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goutières, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmros, I. N.O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollitzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roulet-Perez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, J. B.P.</span></span> <span> </span><span class="NLM_article-title">paroxysmal extreme pain disorder (previously familial rectal pain syndrome)</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">586</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1212/01.wnl.0000268065.16865.5f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1212%2F01.wnl.0000268065.16865.5f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2007&pages=586-595&author=C.+R.+Fertlemanauthor=C.+D.+Ferrieauthor=J.+Aicardiauthor=N.+A.+F.+Bednarekauthor=O.+Eeg-Olofssonauthor=F.+V.+Elmslieauthor=D.+A.+Griesemerauthor=F.+Gouti%C3%A8resauthor=M.+Kirkpatrickauthor=I.+N.O.+Malmrosauthor=M.+Pollitzerauthor=M.+Rossiterauthor=E.+Roulet-Perezauthor=R.+Schubertauthor=V.+V.+Smithauthor=H.+Testardauthor=V.+Wongauthor=J.+B.P.+Stephenson&title=paroxysmal+extreme+pain+disorder+%28previously+familial+rectal+pain+syndrome%29&doi=10.1212%2F01.wnl.0000268065.16865.5f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1212%2F01.wnl.0000268065.16865.5f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252F01.wnl.0000268065.16865.5f%26sid%3Dliteratum%253Aachs%26aulast%3DFertleman%26aufirst%3DC.%2BR.%26aulast%3DFerrie%26aufirst%3DC.%2BD.%26aulast%3DAicardi%26aufirst%3DJ.%26aulast%3DBednarek%26aufirst%3DN.%2BA.%2BF.%26aulast%3DEeg-Olofsson%26aufirst%3DO.%26aulast%3DElmslie%26aufirst%3DF.%2BV.%26aulast%3DGriesemer%26aufirst%3DD.%2BA.%26aulast%3DGouti%25C3%25A8res%26aufirst%3DF.%26aulast%3DKirkpatrick%26aufirst%3DM.%26aulast%3DMalmros%26aufirst%3DI.%2BN.O.%26aulast%3DPollitzer%26aufirst%3DM.%26aulast%3DRossiter%26aufirst%3DM.%26aulast%3DRoulet-Perez%26aufirst%3DE.%26aulast%3DSchubert%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DV.%2BV.%26aulast%3DTestard%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DV.%26aulast%3DStephenson%26aufirst%3DJ.%2BB.P.%26atitle%3Dparoxysmal%2520extreme%2520pain%2520disorder%2520%2528previously%2520familial%2520rectal%2520pain%2520syndrome%2529%26jtitle%3DNeurology%26date%3D2007%26volume%3D69%26spage%3D586%26epage%3D595%26doi%3D10.1212%2F01.wnl.0000268065.16865.5f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Faber, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeijmakers, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estacion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerrits, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drenth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkies, I. S.</span></span> <span> </span><span class="NLM_article-title">Gain of function Na<sub>V</sub>1.7 mutations in idiopathic small fiber neuropathy</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1002/ana.22485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1002%2Fana.22485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=21698661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=26-39&author=C.+G.+Faberauthor=J.+G.+Hoeijmakersauthor=H.+S.+Ahnauthor=X.+Chengauthor=C.+Hanauthor=J.+S.+Choiauthor=M.+Estacionauthor=G.+Lauriaauthor=E.+K.+Vanhoutteauthor=M.+M.+Gerritsauthor=S.+Dib-Hajjauthor=J.+P.+Drenthauthor=S.+G.+Waxmanauthor=I.+S.+Merkies&title=Gain+of+function+NaV1.7+mutations+in+idiopathic+small+fiber+neuropathy&doi=10.1002%2Fana.22485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2eR"><div class="casContent"><span class="casTitleNuber">2e</span><div class="casTitle"><span class="NLM_cas:atitle">Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy</span></div><div class="casAuthors">Faber, Catharina G.; Hoeijmakers, Janneke G. J.; Ahn, Hye-Sook; Cheng, Xiaoyang; Han, Chongyang; Choi, Jin-Sung; Estacion, Mark; Lauria, Giuseppe; Vanhoutte, Els K.; Gerrits, Monique M.; Dib-Hajj, Sulayman; Drenth, Joost P. H.; Waxman, Stephen G.; Merkies, Ingemar S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-39</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: : Small nerve fiber neuropathy (SFN) often occurs without apparent cause, but no systematic genetic studies have been performed in patients with idiopathic SFN (I-SFN).  We sought to identify a genetic basis for I-SFN by screening patients with biopsy-confirmed idiopathic SFN for mutations in the SCN9A gene, encoding voltage-gated sodium channel NaV1.7, which is preferentially expressed in small diam. peripheral axons.  Methods: : Patients referred with possible I-SFN, who met the criteria of ≥2 SFN-related symptoms, normal strength, tendon reflexes, vibration sense, and nerve conduction studies, and reduced intraepidermal nerve fiber d. (IENFD) plus abnormal quant. sensory testing (QST) and no underlying etiol. for SFN, were assessed clin. and by screening of SCN9A for mutations and functional analyses.  Results: : Twenty-eight patients who met stringent criteria for I-SFN including abnormal IENFD and QST underwent SCN9A gene analyses.  Of these 28 patients with biopsy-confirmed I-SFN, 8 were found to carry novel mutations in SCN9A.  Functional anal. revealed multiple gain of function changes in the mutant channels; each of the mutations rendered dorsal root ganglion neurons hyperexcitable.  Interpretation: : We show for the first time that gain of function mutations in sodium channel NaV1.7, which render dorsal root ganglion neurons hyperexcitable, are present in a substantial proportion (28.6%; 8 of 28) of patients meeting strict criteria for I-SFN.  These results point to a broader role of NaV1.7 mutations in neurol. disease than previously considered from studies on rare genetic syndromes, and suggest an etiol. basis for I-SFN, whereby expression of gain of function mutant sodium channels in small diam. peripheral axons may cause these fibers to degenerate.  ANN NEUROL 2012;71:26-39.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI5yt6a_BN-rVg90H21EOLACvtfcHk0liVMx9dS-6tgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqtr4%253D&md5=ea551234a6635b3fd70e3ea4bd68f96c</span></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=10.1002%2Fana.22485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22485%26sid%3Dliteratum%253Aachs%26aulast%3DFaber%26aufirst%3DC.%2BG.%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BG.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DC.%26aulast%3DChoi%26aufirst%3DJ.%2BS.%26aulast%3DEstacion%26aufirst%3DM.%26aulast%3DLauria%26aufirst%3DG.%26aulast%3DVanhoutte%26aufirst%3DE.%2BK.%26aulast%3DGerrits%26aufirst%3DM.%2BM.%26aulast%3DDib-Hajj%26aufirst%3DS.%26aulast%3DDrenth%26aufirst%3DJ.%2BP.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DMerkies%26aufirst%3DI.%2BS.%26atitle%3DGain%2520of%2520function%2520NaV1.7%2520mutations%2520in%2520idiopathic%2520small%2520fiber%2520neuropathy%26jtitle%3DAnn.%2520Neurol.%26date%3D2012%26volume%3D71%26spage%3D26%26epage%3D39%26doi%3D10.1002%2Fana.22485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholas, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raashid, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gazali, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHale, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span> <span> </span><span class="NLM_article-title">An SCN9A channelopathy causes congenital inability to experience pain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>444</i></span>,  <span class="NLM_fpage">894</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1038/nature05413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1038%2Fnature05413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=17167479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2006&pages=894-898&author=J.+J.+Coxauthor=F.+Reimannauthor=A.+K.+Nicholasauthor=G.+Thorntonauthor=E.+Robertsauthor=K.+Springellauthor=G.+Karbaniauthor=H.+Jafriauthor=J.+Mannanauthor=Y.+Raashidauthor=L.+Al-Gazaliauthor=H.+Hamamyauthor=E.+M.+Valenteauthor=S.+Gormanauthor=R.+Williamsauthor=D.+P.+McHaleauthor=J.+N.+Woodauthor=F.+M.+Gribbleauthor=C.+G.+Woods&title=An+SCN9A+channelopathy+causes+congenital+inability+to+experience+pain&doi=10.1038%2Fnature05413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">An SCN9A channelopathy causes congenital inability to experience pain</span></div><div class="casAuthors">Cox, James J.; Reimann, Frank; Nicholas, Adeline K.; Thornton, Gemma; Roberts, Emma; Springell, Kelly; Karbani, Gulshan; Jafri, Hussain; Mannan, Jovaria; Raashid, Yasmin; Al-Gazali, Lihadh; Hamamy, Henan; Valente, Enza Maria; Gorman, Shaun; Williams, Richard; McHale, Duncan P.; Wood, John N.; Gribble, Fiona M.; Woods, C. Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">7121</span>),
    <span class="NLM_cas:pages">894-898</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype.  In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3.  This region contains the gene SCN9A, encoding the α-subunit of the voltage-gated sodium channel, Nav1.7, which is strongly expressed in nociceptive neurons.  Sequence anal. of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X).  We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Nav1.7 with sodium channel β1 and β2 subunits in HEK293 cells.  In cells expressing mutant Nav1.7, the currents were no greater than background.  Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans.  These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWD3rCKSQEurVg90H21EOLACvtfcHk0liVMx9dS-6tgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM&md5=461e3a6abd6d3f4f8f7d896d8f62d882</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnature05413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05413%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BJ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DNicholas%26aufirst%3DA.%2BK.%26aulast%3DThornton%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DSpringell%26aufirst%3DK.%26aulast%3DKarbani%26aufirst%3DG.%26aulast%3DJafri%26aufirst%3DH.%26aulast%3DMannan%26aufirst%3DJ.%26aulast%3DRaashid%26aufirst%3DY.%26aulast%3DAl-Gazali%26aufirst%3DL.%26aulast%3DHamamy%26aufirst%3DH.%26aulast%3DValente%26aufirst%3DE.%2BM.%26aulast%3DGorman%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMcHale%26aufirst%3DD.%2BP.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26atitle%3DAn%2520SCN9A%2520channelopathy%2520causes%2520congenital%2520inability%2520to%2520experience%2520pain%26jtitle%3DNature%26date%3D2006%26volume%3D444%26spage%3D894%26epage%3D898%26doi%3D10.1038%2Fnature05413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattice, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radomski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaldson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ives, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younghusband, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boltshauser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinspan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerdraon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowsher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pimstone, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuels, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrington, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span> <span> </span><span class="NLM_article-title">Loss-of-function mutations in the Na<sub>V</sub>1.7 gene underlie congenital indifference to pain in multiple human populations</span>. <i>Clin. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1111/j.1399-0004.2007.00790.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1111%2Fj.1399-0004.2007.00790.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=17470132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=311-319&author=Y.+P.+Goldbergauthor=J.+MacFarlaneauthor=M.+L.+MacDonaldauthor=J.+Thompsonauthor=M.-P.+Dubeauthor=M.+Matticeauthor=R.+Fraserauthor=C.+Youngauthor=S.+Hossainauthor=T.+Papeauthor=B.+Payneauthor=C.+Radomskiauthor=G.+Donaldsonauthor=E.+Ivesauthor=J.+Coxauthor=H.+B.+Younghusbandauthor=R.+Greenauthor=A.+Duffauthor=E.+Boltshauserauthor=G.+A.+Grinspanauthor=J.+H.+Dimonauthor=B.+G.+Sibleyauthor=G.+Andriaauthor=E.+Toscanoauthor=J.+Kerdraonauthor=D.+Bowsherauthor=S.+N.+Pimstoneauthor=M.+E.+Samuelsauthor=R.+Sherringtonauthor=M.+R.+Hayden&title=Loss-of-function+mutations+in+the+NaV1.7+gene+underlie+congenital+indifference+to+pain+in+multiple+human+populations&doi=10.1111%2Fj.1399-0004.2007.00790.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations</span></div><div class="casAuthors">Goldberg Y P; MacFarlane J; MacDonald M L; Thompson J; Dube M-P; Mattice M; Fraser R; Young C; Hossain S; Pape T; Payne B; Radomski C; Donaldson G; Ives E; Cox J; Younghusband H B; Green R; Duff A; Boltshauser E; Grinspan G A; Dimon J H; Sibley B G; Andria G; Toscano E; Kerdraon J; Bowsher D; Pimstone S N; Samuels M E; Sherrington R; Hayden M R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-9</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal.  We identified and collected DNA from individuals from nine families of seven different nationalities in which the affected individuals meet the diagnostic criteria for CIP.  Using homozygosity mapping and haplotype sharing methods, we narrowed the CIP locus to chromosome 2q24-q31, a region known to contain a cluster of voltage-gated sodium channel genes.  From these prioritized candidate sodium channels, we identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7.  The mutations completely co-segregated with the disease phenotype, and nine of these SCN9A mutations resulted in truncation and loss-of-function of the Nav1.7 channel.  These genetic data further support the evidence that Nav1.7 plays an essential role in mediating pain in humans, and that SCN9A mutations identified in multiple different populations underlie CIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgEhjb_1oWGHqj_yg7twvpfW6udTcc2eYYzGgETjpEDLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D&md5=02ae3943bc678b3407d492e4a6298b74</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-0004.2007.00790.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-0004.2007.00790.x%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DY.%2BP.%26aulast%3DMacFarlane%26aufirst%3DJ.%26aulast%3DMacDonald%26aufirst%3DM.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DDube%26aufirst%3DM.-P.%26aulast%3DMattice%26aufirst%3DM.%26aulast%3DFraser%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DHossain%26aufirst%3DS.%26aulast%3DPape%26aufirst%3DT.%26aulast%3DPayne%26aufirst%3DB.%26aulast%3DRadomski%26aufirst%3DC.%26aulast%3DDonaldson%26aufirst%3DG.%26aulast%3DIves%26aufirst%3DE.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DYounghusband%26aufirst%3DH.%2BB.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DDuff%26aufirst%3DA.%26aulast%3DBoltshauser%26aufirst%3DE.%26aulast%3DGrinspan%26aufirst%3DG.%2BA.%26aulast%3DDimon%26aufirst%3DJ.%2BH.%26aulast%3DSibley%26aufirst%3DB.%2BG.%26aulast%3DAndria%26aufirst%3DG.%26aulast%3DToscano%26aufirst%3DE.%26aulast%3DKerdraon%26aufirst%3DJ.%26aulast%3DBowsher%26aufirst%3DD.%26aulast%3DPimstone%26aufirst%3DS.%2BN.%26aulast%3DSamuels%26aufirst%3DM.%2BE.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DLoss-of-function%2520mutations%2520in%2520the%2520NaV1.7%2520gene%2520underlie%2520congenital%2520indifference%2520to%2520pain%2520in%2520multiple%2520human%2520populations%26jtitle%3DClin.%2520Genet.%26date%3D2007%26volume%3D71%26spage%3D311%26epage%3D319%26doi%3D10.1111%2Fj.1399-0004.2007.00790.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">England, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D.</span></span> <span> </span><span class="NLM_article-title">Isoform-selective voltage-gated Na+ modulators as next-generation analgesics</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.4155/fmc.10.26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.4155%2Ffmc.10.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=21426202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslamtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=775-790&author=S.+Englandauthor=D.+Rawson&title=Isoform-selective+voltage-gated+Na%2B+modulators+as+next-generation+analgesics&doi=10.4155%2Ffmc.10.26"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-selective voltage-gated Na+ channel modulators as next-generation analgesics</span></div><div class="casAuthors">England, Steve; Rawson, David</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">775-790</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  For many patients the current therapies for controlling chronic pain are inadequate.  This has driven the search for analgesics with improved efficacy and side effect profiles.  Some anticonvulsants have voltage-gated Na+ channels (VGSCs) as their mol. targets and are used to treat pain, but the efficacy seen is marginal and the drugs are generally poorly tolerated.  The clin. used VGSC-modulating analgesics show no isoform selectivity, which probably limits their use.  Thus, focus has fallen on VGSCs expressed selectively by primary afferent neurons and the search for isoform-selective drugs.  In this review, we describe developments in our understanding of the biol. of VGSCs, screening technologies and the pharmacol. properties of VGSC modulators with promise as analgesics.  Also highlighted are the challenges assocd. with targeting isoform-selective VGSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHZcFRT0qRdbVg90H21EOLACvtfcHk0lhKVqqA_O5yGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslamtLo%253D&md5=06b147bfe9141a4742ff4dcd2642b86c</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.26%26sid%3Dliteratum%253Aachs%26aulast%3DEngland%26aufirst%3DS.%26aulast%3DRawson%26aufirst%3DD.%26atitle%3DIsoform-selective%2520voltage-gated%2520Na%252B%2520modulators%2520as%2520next-generation%2520analgesics%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D775%26epage%3D790%26doi%3D10.4155%2Ffmc.10.26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertrampf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kless, A.</span></span> <span> </span><span class="NLM_article-title">Advances in targeting voltage gated sodium channels with small Molecules</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1712</span>– <span class="NLM_lpage">1740</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1002%2Fcmdc.201200298" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1712-1740&author=A.+Nardiauthor=N.+Damannauthor=T.+Hertrampfauthor=A.+Kless&title=Advances+in+targeting+voltage+gated+sodium+channels+with+small+Molecules&doi=10.1002%2Fcmdc.201200298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200298%26sid%3Dliteratum%253Aachs%26aulast%3DNardi%26aufirst%3DA.%26aulast%3DDamann%26aufirst%3DN.%26aulast%3DHertrampf%26aufirst%3DT.%26aulast%3DKless%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520targeting%2520voltage%2520gated%2520sodium%2520channels%2520with%2520small%2520Molecules%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1712%26epage%3D1740%26doi%3D10.1002%2Fcmdc.201200298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7: patent applications since 2010</span>. <i>Pharm. Pat. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.4155/ppa.14.39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.4155%2Fppa.14.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=25374320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=509-521&author=S.+Sunauthor=C.+J.+Cohenauthor=C.+M.+Dehnhardt&title=Inhibitors+of+voltage-gated+sodium+channel+NaV1.7%3A+patent+applications+since+2010&doi=10.4155%2Fppa.14.39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010</span></div><div class="casAuthors">Sun, Shaoyi; Cohen, Charles J.; Dehnhardt, Christoph M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Patent Analyst</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">509-521</span>CODEN:
                <span class="NLM_cas:coden">PPAHCN</span>;
        ISSN:<span class="NLM_cas:issn">2046-8954</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  There has been intense interest in developing inhibitors of the sodium channel Nav1.7 because genetic studies have established very strong validation for the efficacy to alleviate both inflammatory and neuropathic pain.  This review summarizes patent applications targeting Nav1.7 since 2010 until May, 2014.  We have classified the patents into three categories as follows: small mols. with well-defined mol. selectivity among sodium channel isoforms; biologicals with well-defined mol. selectivity; and, small mols. that inhibit Nav1.7 with unknown mol. selectivity.  Most of the review is dedicated to small mol. selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE50bQQ3wiFLVg90H21EOLACvtfcHk0lhKVqqA_O5yGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL&md5=6986fe156f608706204b483207d2201c</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.4155%2Fppa.14.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fppa.14.39%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26atitle%3DInhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%253A%2520patent%2520applications%2520since%25202010%26jtitle%3DPharm.%2520Pat.%2520Anal.%26date%3D2014%26volume%3D3%26spage%3D509%26epage%3D521%26doi%3D10.4155%2Fppa.14.39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prime, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Recent progress in sodium channel modulators for pain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3690</span>– <span class="NLM_lpage">3699</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2014.06.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=25060923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3690-3699&author=S.+K.+Bagalauthor=M.+L.+Chapmanauthor=B.+E.+Marronauthor=R.+Primeauthor=R.+I.+Storerauthor=N.+A.+Swain&title=Recent+progress+in+sodium+channel+modulators+for+pain&doi=10.1016%2Fj.bmcl.2014.06.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in sodium channel modulators for pain</span></div><div class="casAuthors">Bagal, Sharan K.; Chapman, Mark L.; Marron, Brian E.; Prime, Rebecca; Storer, R. Ian; Swain, Nigel A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3690-3699</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels (Navs) are an important family of transmembrane ion channel proteins and Nav drug discovery is an exciting field.  Pharmaceutical investment in Navs for pain therapeutics has expanded exponentially due to genetic data such as SCN10A mutations and an improved ability to establish an effective screen sequence for example IonWorks Barracuda, Synchropatch and Qube.  Moreover, emerging clin. data (AZD-3161, XEN402, CNV1014802, PF-05089771, PF-04531083) combined with recent breakthroughs in Nav structural biol. pave the way for a future of fruitful prospective Nav drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbT6en4xkVxLVg90H21EOLACvtfcHk0lgvAPWTpKWSCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL&md5=c8bae40b70509e2aa3dce106e2c41677</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.038%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPrime%26aufirst%3DR.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26atitle%3DRecent%2520progress%2520in%2520sodium%2520channel%2520modulators%2520for%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3690%26epage%3D3699%26doi%3D10.1016%2Fj.bmcl.2014.06.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schott, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alshinawi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyndt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Probst, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoorntje, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulsbeek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilde, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escande, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannens, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Marec, H.</span></span> <span> </span><span class="NLM_article-title">Cardiac conduction defects associate with mutations in SCN5A</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1038/12618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1038%2F12618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10471492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFWhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=20-21&author=J.+J.+Schottauthor=C.+Alshinawiauthor=F.+Kyndtauthor=V.+Probstauthor=T.+M.+Hoorntjeauthor=M.+Hulsbeekauthor=A.+A.+Wildeauthor=D.+Escandeauthor=M.+M.+Mannensauthor=H.+Le+Marec&title=Cardiac+conduction+defects+associate+with+mutations+in+SCN5A&doi=10.1038%2F12618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac conduction defects associate with mutations in SCN5A</span></div><div class="casAuthors">Schott, Jean-Jacques; Alshinawi, Connie; Kyndt, Florence; Probst, Vincent; Hoorntje, Theo M.; Hulsbeek, Miriam; Wilde, Arthur A. M.; Escande, Denis; Mannens, Marcel M. A. M.; Le Marec, Herve</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-21</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Progressive cardiac conduction defect (PCCD) also called Lenegre or Lev disease, is one of the most common cardiac conduction disturbances.  Here, the authors report a mutation in the gene encoding the cardiac-specific sodium channel (SCN5A) that segregates with PCCD in an autosomal dominant manner in a large French family.  The authors also studied a Dutch family in which the proband presented after birth with asymptomatic first-degree atrio-ventricular block assocd. with right bundle branch block.  Sequencing the entire SCN5A coding region in the French family identified a T→C substitution in the highly conserved +2 donor splicing site of intron 22.  The abnormal transcript predicts in-frame skipping of exon 22 and an impaired gene product lacking the voltage-sensitive DIIIS4 segment.  SCN5A was directly sequenced in the Dutch family.  A deletion of a single nucleotide (G) at position 5280 resulting in a frameshift predicting a premature stop codon was identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsWjnnnqL4MbVg90H21EOLACvtfcHk0lgvAPWTpKWSCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFWhs7k%253D&md5=7cb11c78625c8e2fd7f21caa876de2ff</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2F12618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F12618%26sid%3Dliteratum%253Aachs%26aulast%3DSchott%26aufirst%3DJ.%2BJ.%26aulast%3DAlshinawi%26aufirst%3DC.%26aulast%3DKyndt%26aufirst%3DF.%26aulast%3DProbst%26aufirst%3DV.%26aulast%3DHoorntje%26aufirst%3DT.%2BM.%26aulast%3DHulsbeek%26aufirst%3DM.%26aulast%3DWilde%26aufirst%3DA.%2BA.%26aulast%3DEscande%26aufirst%3DD.%26aulast%3DMannens%26aufirst%3DM.%2BM.%26aulast%3DLe%2BMarec%26aufirst%3DH.%26atitle%3DCardiac%2520conduction%2520defects%2520associate%2520with%2520mutations%2520in%2520SCN5A%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D23%26spage%3D20%26epage%3D21%26doi%3D10.1038%2F12618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Royer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veen, T. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bouter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marionneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griol-Charhbili, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Léoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steenman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rijen, H. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demolombe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddard, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escoubet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarry-Guichard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colledge, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bakker, J. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grace, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escande, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charpentier, F.</span></span> <span> </span><span class="NLM_article-title">A mouse model of SCN5A-linked hereditary Lenègre’s disease: age-related conduction slowing and myocardial fibrosis</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1738</span>– <span class="NLM_lpage">1746</span>, <span class="refDoi"> DOI: 10.1161/01.CIR.0000160853.19867.61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1161%2F01.CIR.0000160853.19867.61" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=1738-1746&author=A.+Royerauthor=T.+A.+B.+van+Veenauthor=S.+Le+Bouterauthor=C.+Marionneauauthor=V.+Griol-Charhbiliauthor=A.+L%C3%A9oniauthor=M.+Steenmanauthor=H.+V.+M.+van+Rijenauthor=S.+Demolombeauthor=C.+A.+Goddardauthor=C.+Richerauthor=B.+Escoubetauthor=T.+Jarry-Guichardauthor=W.+H.+Colledgeauthor=D.+Grosauthor=J.+M.+T.+de+Bakkerauthor=A.+A.+Graceauthor=D.+Escandeauthor=F.+Charpentier&title=A+mouse+model+of+SCN5A-linked+hereditary+Len%C3%A8gre%E2%80%99s+disease%3A+age-related+conduction+slowing+and+myocardial+fibrosis&doi=10.1161%2F01.CIR.0000160853.19867.61"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.0000160853.19867.61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.0000160853.19867.61%26sid%3Dliteratum%253Aachs%26aulast%3DRoyer%26aufirst%3DA.%26aulast%3Dvan%2BVeen%26aufirst%3DT.%2BA.%2BB.%26aulast%3DLe%2BBouter%26aufirst%3DS.%26aulast%3DMarionneau%26aufirst%3DC.%26aulast%3DGriol-Charhbili%26aufirst%3DV.%26aulast%3DL%25C3%25A9oni%26aufirst%3DA.%26aulast%3DSteenman%26aufirst%3DM.%26aulast%3Dvan%2BRijen%26aufirst%3DH.%2BV.%2BM.%26aulast%3DDemolombe%26aufirst%3DS.%26aulast%3DGoddard%26aufirst%3DC.%2BA.%26aulast%3DRicher%26aufirst%3DC.%26aulast%3DEscoubet%26aufirst%3DB.%26aulast%3DJarry-Guichard%26aufirst%3DT.%26aulast%3DColledge%26aufirst%3DW.%2BH.%26aulast%3DGros%26aufirst%3DD.%26aulast%3Dde%2BBakker%26aufirst%3DJ.%2BM.%2BT.%26aulast%3DGrace%26aufirst%3DA.%2BA.%26aulast%3DEscande%26aufirst%3DD.%26aulast%3DCharpentier%26aufirst%3DF.%26atitle%3DA%2520mouse%2520model%2520of%2520SCN5A-linked%2520hereditary%2520Len%25C3%25A8gre%25E2%2580%2599s%2520disease%253A%2520age-related%2520conduction%2520slowing%2520and%2520myocardial%2520fibrosis%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D1738%26epage%3D1746%26doi%3D10.1161%2F01.CIR.0000160853.19867.61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenova, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafeev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel NaV1.7</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4401</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2014.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=25176194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWqsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4397-4401&author=S.+Sunauthor=Q.+Jiaauthor=A.+Y.+Zenovaauthor=M.+Chafeevauthor=Z.+Zhangauthor=S.+Linauthor=R.+Kwanauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=C.+Youngauthor=C.+J.+Cohenauthor=R.+M.+Oballa&title=The+discovery+of+benzenesulfonamide-based+potent+and+selective+inhibitors+of+voltage-gated+sodium+channel+NaV1.7&doi=10.1016%2Fj.bmcl.2014.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Nav1.7</span></div><div class="casAuthors">Sun, Shaoyi; Jia, Qi; Zenova, Alla Y.; Chafeev, Mikhail; Zhang, Zaihui; Lin, Sophia; Kwan, Rainbow; Grimwood, Mike E.; Chowdhury, Sultan; Young, Clint; Cohen, Charles J.; Oballa, Renata M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4397-4401</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage gated sodium channel Nav1.7 represents an interesting target for the treatment of pain.  Human genetic studies have identified the crucial role of Nav1.7 in pain signaling.  Herein, we report the design and synthesis of a novel series of benzenesulfonamide-based Nav1.7 inhibitors.  Structural-activity relationship (SAR) studies were undertaken towards improving Nav1.7 activity and minimizing CYP inhibition.  These efforts resulted in the identification of compd. I, a highly potent Nav1.7 inhibitor with a thousand-fold selectivity over Nav1.5 and negligible CYP inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjReDfVWQ9BbVg90H21EOLACvtfcHk0lgvAPWTpKWSCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWqsrfJ&md5=ac2bc2156d5bce18e8eb6027088edf27</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DZenova%26aufirst%3DA.%2BY.%26aulast%3DChafeev%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26atitle%3DThe%2520discovery%2520of%2520benzenesulfonamide-based%2520potent%2520and%2520selective%2520inhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4397%26epage%3D4401%26doi%3D10.1016%2Fj.bmcl.2014.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauphinais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogucki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of aryl sulfonamides as isoform-selective inhibitors of Na<sub>V</sub>1.7 with efficacy in rodent pain models</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=277-282&author=T.+Fockenauthor=S.+Liuauthor=N.+Chahalauthor=M.+Dauphinaisauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=I.+Hemeonauthor=P.+Bichlerauthor=D.+Boguckiauthor=M.+Waldbrookauthor=G.+Bankarauthor=L.+E.+Sojoauthor=C.+Youngauthor=S.+Linauthor=N.+Shuartauthor=R.+Kwanauthor=J.+Pangauthor=J.+H.+Changauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=J.+P.+Johnsonauthor=C.+M.+Dehnhardtauthor=T.+S.+Mansourauthor=R.+M.+Oballaauthor=C.+J.+Cohenauthor=C.+L.+Robinette&title=Discovery+of+aryl+sulfonamides+as+isoform-selective+inhibitors+of+NaV1.7+with+efficacy+in+rodent+pain+models&doi=10.1021%2Facsmedchemlett.5b00447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models</span></div><div class="casAuthors">Focken, Thilo; Liu, Shifeng; Chahal, Navjot; Dauphinais, Maxim; Grimwood, Michael E.; Chowdhury, Sultan; Hemeon, Ivan; Bichler, Paul; Bogucki, David; Waldbrook, Matthew; Bankar, Girish; Sojo, Luis E.; Young, Clint; Lin, Sophia; Shuart, Noah; Kwan, Rainbow; Pang, Jodie; Chang, Jae H.; Safina, Brian S.; Sutherlin, Daniel P.; Johnson, J. P., Jr.; Dehnhardt, Christoph M.; Mansour, Tarek S.; Oballa, Renata M.; Cohen, Charles J.; Robinette, C. Lee</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-282</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report on a novel series of aryl sulfonamides that act as nanomolar potent, isoform-selective inhibitors of the human sodium channel hNaV1.7.  The optimization of these inhibitors is described.  The authors aimed to improve potency against hNaV1.7 while minimizing off-target safety concerns and generated compd. I.  This agent displayed significant analgesic effects in rodent models of acute and inflammatory pain and demonstrated that binding to the voltage sensor domain 4 site of NaV1.7 leads to an analgesic effect in vivo.  The findings corroborate the importance of hNaV1.7 as a drug target for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpIxiu3ixqRLVg90H21EOLACvtfcHk0lhwpWYbfXfEUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D&md5=ae05f2c1ef6cf51d69a67a7b1ee7f8fa</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00447%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DDauphinais%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DSojo%26aufirst%3DL.%2BE.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DShuart%26aufirst%3DN.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520of%2520aryl%2520sulfonamides%2520as%2520isoform-selective%2520inhibitors%2520of%2520NaV1.7%2520with%2520efficacy%2520in%2520rodent%2520pain%2520models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D277%26epage%3D282%26doi%3D10.1021%2Facsmedchemlett.5b00447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrou, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estacion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mis, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilbrey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutteridge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castle, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hounshell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krafte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, E. B.</span></span> <span> </span><span class="NLM_article-title">Subtype-selective small molecule inhibitors reveal a fundamental role for Na<sub>V</sub>1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0152405</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0152405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1371%2Fjournal.pone.0152405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=27050761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1KqtL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0152405&author=A.+J.+Alexandrouauthor=A.+R.+Brownauthor=M.+L.+Chapmanauthor=M.+Estacionauthor=J.+Turnerauthor=M.+A.+Misauthor=A.+Wilbreyauthor=E.+C.+Payneauthor=A.+Gutteridgeauthor=P.+J.+Coxauthor=R.+Doyleauthor=D.+Printzenhoffauthor=Z.+Linauthor=B.+E.+Marronauthor=C.+Westauthor=N.+A.+Swainauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=N.+A.+Castleauthor=J.+A.+Hounshellauthor=M.+Rivaraauthor=A.+Randallauthor=S.+D.+Dib-Hajjauthor=D.+Krafteauthor=S.+G.+Waxmanauthor=M.+K.+Patelauthor=R.+P.+Buttauthor=E.+B.+Stevens&title=Subtype-selective+small+molecule+inhibitors+reveal+a+fundamental+role+for+NaV1.7+in+nociceptor+electrogenesis%2C+axonal+conduction+and+presynaptic+release&doi=10.1371%2Fjournal.pone.0152405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release</span></div><div class="casAuthors">Alexandrou, Aristos J.; Brown, Adam R.; Chapman, Mark L.; Estacion, Mark; Turner, Jamie; Mis, Malgorzata A.; Wilbrey, Anna; Payne, Elizabeth C.; Gutteridge, Alex; Cox, Peter J.; Doyle, Rachel; Printzenhoff, David; Lin, Zhixin; Marron, Brian E.; West, Christopher; Swain, Nigel A.; Storer, R. Ian; Stupple, Paul A.; Castle, Neil A.; Hounshell, James A.; Rivara, Mirko; Randall, Andrew; Dib-Hajj, Sulayman D.; Krafte, Douglas; Waxman, Stephen G.; Patel, Manoj K.; Butt, Richard P.; Stevens, Edward B.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0152405/1-e0152405/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Human genetic studies show that the voltage gated sodium channel 1.7 (Nav1.7) is a key mol. determinant of pain sensation.  However, defining the Nav1.7 contribution to nociceptive signalling has been hampered by a lack of selective inhibitors.  Here we report two potent and selective arylsulfonamide Nav1.7 inhibitors; PF-05198007 and PF-05089771, which we have used to directly interrogate Nav1.7's role in nociceptor physiol.  We report that Nav1.7 is the predominant functional TTX-sensitive Nav in mouse and human nociceptors and contributes to the initiation and the upstroke phase of the nociceptor action potential.  Moreover, we confirm a role for Nav1.7 in influencing synaptic transmission in the dorsal horn of the spinal cord as well as peripheral neuropeptide release in the skin.  These findings demonstrate multiple contributions of Nav1.7 to nociceptor signalling and shed new light on the relative functional contribution of this channel to peripheral and central noxious signal transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx6L5QNhpEg7Vg90H21EOLACvtfcHk0lhwpWYbfXfEUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1KqtL3M&md5=41505ac1108ad830dec78c052655f6b0</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0152405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0152405%26sid%3Dliteratum%253Aachs%26aulast%3DAlexandrou%26aufirst%3DA.%2BJ.%26aulast%3DBrown%26aufirst%3DA.%2BR.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DEstacion%26aufirst%3DM.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DMis%26aufirst%3DM.%2BA.%26aulast%3DWilbrey%26aufirst%3DA.%26aulast%3DPayne%26aufirst%3DE.%2BC.%26aulast%3DGutteridge%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DP.%2BJ.%26aulast%3DDoyle%26aufirst%3DR.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DWest%26aufirst%3DC.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26aulast%3DHounshell%26aufirst%3DJ.%2BA.%26aulast%3DRivara%26aufirst%3DM.%26aulast%3DRandall%26aufirst%3DA.%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DKrafte%26aufirst%3DD.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DPatel%26aufirst%3DM.%2BK.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DStevens%26aufirst%3DE.%2BB.%26atitle%3DSubtype-selective%2520small%2520molecule%2520inhibitors%2520reveal%2520a%2520fundamental%2520role%2520for%2520NaV1.7%2520in%2520nociceptor%2520electrogenesis%252C%2520axonal%2520conduction%2520and%2520presynaptic%2520release%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0152405%26doi%3D10.1371%2Fjournal.pone.0152405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: optimizing potency and pharmacokinetics to enable in vivo target engagement</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1062-1067&author=I.+E.+Marxauthor=T.+A.+Dineenauthor=J.+Ableauthor=C.+Bodeauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+DiMauroauthor=B.+Duauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=B.+E.+Hallauthor=L.+Huangauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=M.-H.+J.+Linauthor=S.+Liuauthor=J.+S.+McDermottauthor=B.+D.+Moyerauthor=E.+A.+Petersonauthor=J.+T.+Robertsauthor=P.+E.+Roseauthor=J.+Wangauthor=B.+D.+Youngbloodauthor=V.+L.+Yuauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+optimizing+potency+and+pharmacokinetics+to+enable+in+vivo+target+engagement&doi=10.1021%2Facsmedchemlett.6b00243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement</span></div><div class="casAuthors">Marx, Isaac E.; Dineen, Thomas A.; Able, Jessica; Bode, Christiane; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Du, Bingfan; Foti, Robert S.; Fremeau, Robert T.; Gao, Hua; Gunaydin, Hakan; Hall, Brian E.; Huang, Liyue; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Lin, Min-Hwa Jasmine; Liu, Dong; McDermott, Jeff S.; Moyer, Bryan D.; Peterson, Emily A.; Roberts, Jonathan T.; Rose, Paul; Wang, Jean; Youngblood, Beth D.; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1062-1067</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human genetic evidence has identified the voltage-gated sodium channel NaV1.7 as an attractive target for the treatment of pain.  The authors initially identified naphthalene sulfonamide 5-(2-(1-methyl-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-N-(1,2,4-thiadiazol-5-yl)naphthalene-2-sulfonamide (compd. 3) as a potent and selective inhibitor of NaV1.7.  Optimization to reduce biliary clearance by balancing hydrophilicity and hydrophobicity (Log D) while maintaining NaV1.7 potency led to the identification of quinazoline 16 (AM-2099).  Compd. 16 demonstrated a favorable pharmacokinetic profile in rat and dog and demonstrated dose-dependent redn. of histamine-induced scratching bouts in a mouse behavioral model following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNi8X2t0EULVg90H21EOLACvtfcHk0lgLxLswEOWp1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE&md5=43c2ae357af90d6c6f56245c3114c016</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00243%26sid%3Dliteratum%253Aachs%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRoberts%26aufirst%3DJ.%2BT.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%2BL.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520optimizing%2520potency%2520and%2520pharmacokinetics%2520to%2520enable%2520in%2520vivo%2520target%2520engagement%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D1062%26epage%3D1067%26doi%3D10.1021%2Facsmedchemlett.6b00243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post-Munson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graef, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newberry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Development of new benzenesulfonamides as potent and selective Na<sub>V</sub>1.7 inhibitors for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2513</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01918</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2513-2525&author=Y.-J.+Wuauthor=J.+Guernonauthor=J.+Shiauthor=J.+Dittaauthor=K.+J.+Robbinsauthor=R.+Rajamaniauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=K.+Mosureauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=D.+J.+Post-Munsonauthor=S.+Wangauthor=J.+Herringtonauthor=J.+Graefauthor=K.+Newberryauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Development+of+new+benzenesulfonamides+as+potent+and+selective+NaV1.7+inhibitors+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.6b01918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Shi, Jianliang; Ditta, Jonathan; Robbins, Kevin J.; Rajamani, Ramkumar; Easton, Amy; Newton, Amy; Bourin, Clotilde; Mosure, Kathleen; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Post-Munson, Debra J.; Wang, Shuya; Herrington, James; Graef, John; Newberry, Kimberly; Bristow, Linda J.; Meanwell, Nicholas A.; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2513-2525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By taking advantage of certain features in piperidine (I), the authors developed a novel series of cyclohexylamine- and piperidine-based benzenesulfonamides as potent and selective Nav1.7 inhibitors.  However, 4-((((1S,4S)-4-aminocydohexyl)methyl)amino)-5-chloro-2-fluoro-N-(thiazol-2-yl)benzenesulfonamide (24), one of the early analogs, failed to reduce phase 2 flinching in the mouse formalin test even at a dose of 100 mpk PO due to insufficient DRG exposure attributed to poor membrane permeability.  Two analogs with improved membrane permeability showed much increased DRG concns. at doses of 30 mpk PO but, confoundingly, only one of these was effective in the formalin test.  More data are needed to understand the disconnect between efficacy and exposure relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVESOC2ks88bVg90H21EOLACvtfcHk0lgLxLswEOWp1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D&md5=d320dedb1d61794445680d94dc2c7e48</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01918%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DDitta%26aufirst%3DJ.%26aulast%3DRobbins%26aufirst%3DK.%2BJ.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DPost-Munson%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DJ.%26aulast%3DNewberry%26aufirst%3DK.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520new%2520benzenesulfonamides%2520as%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2513%26epage%3D2525%26doi%3D10.1021%2Facs.jmedchem.6b01918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric
Boijic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: optimizing potency and pharmacokinetics while mitigating metabolic liabilities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5969</span>– <span class="NLM_lpage">5989</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01851</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01851" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5969-5989&author=M.+M.+Weissauthor=T.+A.+Dineenauthor=I.+E.+Marxauthor=S.+Altmannauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Y.+Chu-Moyerauthor=E.+F.+DiMauroauthor=E.+Feric%0ABoijicauthor=R.+S.+Fotiauthor=H.+Gaoauthor=R.+F.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=H.+Huangauthor=L.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=J.+Liguttiauthor=D.+S.+Laauthor=M.-H.+J.+Linauthor=D.+Liuauthor=B.+D.+Moyerauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=P.+E.+Roseauthor=K.+Tabornauthor=B.+D.+Youngbloodauthor=V.+L.+Yuauthor=R.+T.+Fremeau&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+optimizing+potency+and+pharmacokinetics+while+mitigating+metabolic+liabilities&doi=10.1021%2Facs.jmedchem.6b01851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6fR"><div class="casContent"><span class="casTitleNuber">6f</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities</span></div><div class="casAuthors">Weiss, Matthew M.; Dineen, Thomas A.; Marx, Isaac E.; Altmann, Steven; Boezio, Alessandro; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Feric Bojic, Elma; Foti, Robert S.; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Huang, Hongbing; Huang, Liyue; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; Ligutti, Joseph; La, Daniel S.; Lin, Min-Hwa Jasmine; Liu, Dong; Moyer, Bryan D.; Nguyen, Hanh N.; Peterson, Emily A.; Rose, Paul E.; Taborn, Kristin; Youngblood, Beth D.; Yu, Violeta; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5969-5989</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several reports have recently emerged regarding the identification of heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  The optimization of a series of internal NaV1.7 leads that address a no. of metabolic liabilities including bioactivation, PXR activation, as well as CYP3A4 induction and inhibition led to the identification of potent and selective inhibitors that demonstrated favorable pharmacokinetic profiles and were devoid of the aforementioned liabilities.  The key to achieving this within a series prone to transporter-mediated clearance was the identification of a small range of optimal cLogD values and the discovery of subtle PXR SAR that was not lipophilicity dependent.  This enabled the identification of compd. 20, which was advanced into a target engagement pharmacodynamic model where it exhibited robust reversal of histamine-induced scratching bouts in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovsPC2UZpxsbVg90H21EOLACvtfcHk0lhDqiPDRf6NBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D&md5=6333a6b936e48f9d18cf9df10ea12853</span></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01851%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%2BY.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DFeric%2BBoijic%26aufirst%3DE.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%2BL.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520optimizing%2520potency%2520and%2520pharmacokinetics%2520while%2520mitigating%2520metabolic%2520liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5969%26epage%3D5989%26doi%3D10.1021%2Facs.jmedchem.6b01851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span> <span> </span><span class="NLM_article-title">The discovery of tetrahydropyridine analogs as <i>h</i>Na<sub>V</sub>1.7 selective inhibitors for analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2210</span>– <span class="NLM_lpage">2215</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2017.03.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=28385504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2210-2215&author=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=M.+Tengauthor=J.+Qinauthor=Z.+Huauthor=L.+Houauthor=L.+Shenauthor=H.+Dongauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=J.+Zhangauthor=L.+Ye&title=The+discovery+of+tetrahydropyridine+analogs+as+hNaV1.7+selective+inhibitors+for+analgesia&doi=10.1016%2Fj.bmcl.2017.03.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6gR"><div class="casContent"><span class="casTitleNuber">6g</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia</span></div><div class="casAuthors">Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Teng, Mingxing; Qin, Jian; Hu, Zhijing; Hou, Lijuan; Shen, Liang; Dong, Haiheng; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Zhang, Jianzhao; Ye, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2210-2215</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 small mol. inhibitors have attracted lots of attention by its unique analgesic effect.  Herein, the design and synthesis of a novel series of tetrahydropyridine analogs as hNav1.7 inhibitors for analgesia is reported.  Detail structural-activity relationship (SAR) studies were undertaken towards improving hNav1.7 activity, in vitro ADME, and in vivo PK profiles.  These efforts resulted in the identification of compd. (-)-I, a highly potent and selective hNav1.7 inhibitor with good ADME and PK profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP6xx5fd4NYrVg90H21EOLACvtfcHk0lhDqiPDRf6NBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D&md5=ed0b99fa7611354124394c07bbf259ac</span></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.043%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26atitle%3DThe%2520discovery%2520of%2520tetrahydropyridine%2520analogs%2520as%2520hNaV1.7%2520selective%2520inhibitors%2520for%2520analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2210%26epage%3D2215%26doi%3D10.1016%2Fj.bmcl.2017.03.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric
Bojic, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milgram, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescourio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellwagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: optimizing potency, pharmacokinetics, and metabolic properties to obtain atropisomeric quinolinone (AM-0466) that affords robust in vivo activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5990</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5990-6017&author=R.+F.+Graceffaauthor=A.+A.+Boezioauthor=J.+Ableauthor=S.+Altmannauthor=L.+M.+Berryauthor=C.+Boezioauthor=J.+R.+Butlerauthor=M.+Chu-Moyerauthor=M.+Cookeauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=F.+Feric%0ABojicauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=A.+Guzman-Perezauthor=H.+Gaoauthor=H.+Gunaydinauthor=H.+Huangauthor=L.+Huangauthor=C.+Ilchauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=B.+C.+Milgramauthor=M.-H.+J.+Linauthor=I.+E.+Marxauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=G.+Rescourioauthor=J.+Robertsauthor=L.+Schenkelauthor=R.+Shimanovichauthor=B.+A.+Sparlingauthor=J.+Stellwagenauthor=K.+Tabornauthor=K.+R.+Vaidaauthor=J.+Wangauthor=J.+Yeomanauthor=V.+Yuauthor=D.+Zhuauthor=B.+D.+Moyerauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+optimizing+potency%2C+pharmacokinetics%2C+and+metabolic+properties+to+obtain+atropisomeric+quinolinone+%28AM-0466%29+that+affords+robust+in+vivo+activity&doi=10.1021%2Facs.jmedchem.6b01850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6hR"><div class="casContent"><span class="casTitleNuber">6h</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity</span></div><div class="casAuthors">Graceffa, Russell F.; Boezio, Alessandro A.; Able, Jessica; Altmann, Steven; Berry, Loren M.; Boezio, Christiane; Butler, John R.; Chu-Moyer, Margaret; Cooke, Melanie; DiMauro, Erin F.; Dineen, Thomas A.; Feric Bojic, Elma; Foti, Robert S.; Fremeau, Robert T.; Guzman-Perez, Angel; Gao, Hua; Gunaydin, Hakan; Huang, Hongbing; Huang, Liyue; Ilch, Christopher; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Milgram, Benjamin C.; Lin, Min-Hwa Jasmine; Marx, Isaac E.; Nguyen, Hanh N.; Peterson, Emily A.; Rescourio, Gwen; Roberts, John; Schenkel, Laurie; Shimanovich, Roman; Sparling, Brian A.; Stellwagen, John; Taborn, Kristin; Vaida, Karina R.; Wang, Jean; Yeoman, John; Yu, Violeta; Zhu, Dawn; Moyer, Bryan D.; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5990-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain.  We have previously reported on a no. of structurally distinct bicyclic heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  Herein, we report the discovery and optimization of a series of atropisomeric quinolinone sulfonamide inhibitors [Bicyclic sulfonamide compds. as sodium channel inhibitors and their prepn. WO 2014201206, 2014] of NaV1.7, which demonstrate nanomolar inhibition of NaV1.7 and exhibit high levels of selectivity over other sodium channel isoforms.  After optimization of metabolic and pharmacokinetic properties, including PXR activation, CYP2C9 inhibition, and CYP3A4 TDI, several compds. were advanced into in vivo target engagement and efficacy models.  When tested in mice, compd. 39 (AM-0466) demonstrated robust pharmacodynamic activity in a NaV1.7-dependent model of histamine-induced pruritus (itch) and addnl. in a capsaicin-induced nociception model of pain without any confounding effect in open-field activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ofeMhgMFqbVg90H21EOLACvtfcHk0lgaA-A5Ca5D7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D&md5=5b48afe24a97290ea5e44a71deaa0303</span></div><a href="/servlet/linkout?suffix=cit6h&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01850%26sid%3Dliteratum%253Aachs%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DJ.%2BR.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DFeric%2BBojic%26aufirst%3DF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DMilgram%26aufirst%3DB.%2BC.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRescourio%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DStellwagen%26aufirst%3DJ.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYeoman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520optimizing%2520potency%252C%2520pharmacokinetics%252C%2520and%2520metabolic%2520properties%2520to%2520obtain%2520atropisomeric%2520quinolinone%2520%2528AM-0466%2529%2520that%2520affords%2520robust%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5990%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.6b01850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6i"><span><span class="NLM_label">(i) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Roecker, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egbertson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koser, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective, orally bioavailable, <i>N</i>-linked arylsulfonamide Na<sub>V</sub>1.7 inhibitors with pain efficacy in mice</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2017.03.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6i&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=28389149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2087-2093&author=A.+J.+Roeckerauthor=M.+Egbertsonauthor=K.+L.+G.+Jonesauthor=R.+Gomezauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+J.+Koserauthor=M.+O.+Urbanauthor=R.+Kleinauthor=M.+Clementsauthor=J.+Panigelauthor=C.+Daleyauthor=J.+Wangauthor=E.+N.+Fingerauthor=J.+Majercakauthor=V.+Santarelliauthor=I.+Greganauthor=M.+Catoauthor=T.+Filzenauthor=A.+Jovanovskaauthor=Y.-H.+Wangauthor=D.+Wangauthor=L.+A.+Joyceauthor=E.+C.+Shererauthor=X.+Pengauthor=X.+Wangauthor=H.+Sunauthor=P.+J.+Colemanauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Discovery+of+selective%2C+orally+bioavailable%2C+N-linked+arylsulfonamide+NaV1.7+inhibitors+with+pain+efficacy+in+mice&doi=10.1016%2Fj.bmcl.2017.03.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6iR"><div class="casContent"><span class="casTitleNuber">6i</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice</span></div><div class="casAuthors">Roecker, Anthony J.; Egbertson, Melissa; Jones, Kristen L. G.; Gomez, Robert; Kraus, Richard L.; Li, Yuxing; Koser, Amy Jo; Urban, Mark O.; Klein, Rebecca; Clements, Michelle; Panigel, Jacqueline; Daley, Christopher; Wang, Jixin; Finger, Eleftheria N.; Majercak, John; Santarelli, Vincent; Gregan, Irene; Cato, Matthew; Filzen, Tracey; Jovanovska, Aneta; Wang, Ying-Hong; Wang, Deping; Joyce, Leo A.; Sherer, Edward C.; Peng, Xuanjia; Wang, Xiu; Sun, Haiyan; Coleman, Paul J.; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2087-2093</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel Nav1.7 is a genetically validated target for the treatment of pain with gain-of-function mutations in man eliciting a variety of painful disorders and loss-of-function mutations affording insensitivity to pain.  Unfortunately, drugs thought to garner efficacy via Nav1 inhibition have undesirable side effect profiles due to their lack of selectivity over channel isoforms.  Herein we report the discovery of a novel series of orally bioavailable arylsulfonamide Nav1.7 inhibitors with high levels of selectivity over Nav1.5, the Nav isoform responsible for cardiovascular side effects, through judicious use of parallel medicinal chem. and physicochem. property optimization.  This effort produced inhibitors such as compd. 5 with excellent potency, selectivity, behavioral efficacy in a rodent pain model, and efficacy in a mouse itch model suggestive of target modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNDA0s8NB86LVg90H21EOLACvtfcHk0lgaA-A5Ca5D7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D&md5=5729efef8e3df4afe3f89c25472c9268</span></div><a href="/servlet/linkout?suffix=cit6i&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.085%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DEgbertson%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%2BL.%2BG.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKoser%26aufirst%3DA.%2BJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DClements%26aufirst%3DM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DDaley%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMajercak%26aufirst%3DJ.%26aulast%3DSantarelli%26aufirst%3DV.%26aulast%3DGregan%26aufirst%3DI.%26aulast%3DCato%26aufirst%3DM.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DL.%2BA.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%2520selective%252C%2520orally%2520bioavailable%252C%2520N-linked%2520arylsulfonamide%2520NaV1.7%2520inhibitors%2520with%2520pain%2520efficacy%2520in%2520mice%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2087%26epage%3D2093%26doi%3D10.1016%2Fj.bmcl.2017.03.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6j"><span><span class="NLM_label">(j) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pero, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehman, H. D. G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulhearn, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henze, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Benzoxazolinone aryl sulfonamides as potent, selective Na<sub>V</sub>1.7 inhibitors with in vivo efficacy in a preclinical pain model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2683</span>– <span class="NLM_lpage">2688</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6j&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2017.04.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6j&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=28465103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6j&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2683-2688&author=J.+E.+Peroauthor=M.+A.+Rossiauthor=H.+D.+G.+F.+Lehmanauthor=M.+J.+Kellyauthor=J.+J.+Mulhearnauthor=S.+E.+Wolkenbergauthor=M.+J.+Catoauthor=M.+K.+Clementsauthor=C.+J.+Daleyauthor=T.+Filzenauthor=E.+N.+Fingerauthor=Y.+Greganauthor=D.+A.+Henzeauthor=A.+Jovanovskaauthor=R.+Kleinauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+Liangauthor=J.+M.+Majercakauthor=J.+Panigelauthor=M.+O.+Urbanauthor=J.+Wangauthor=Y.-H.+Wangauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Benzoxazolinone+aryl+sulfonamides+as+potent%2C+selective+NaV1.7+inhibitors+with+in+vivo+efficacy+in+a+preclinical+pain+model&doi=10.1016%2Fj.bmcl.2017.04.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6jR"><div class="casContent"><span class="casTitleNuber">6j</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model</span></div><div class="casAuthors">Pero, Joseph E.; Rossi, Michael A.; Lehman, Hannah D. G. F.; Kelly, Michael J., III; Mulhearn, James J.; Wolkenberg, Scott E.; Cato, Matthew J.; Clements, Michelle K.; Daley, Christopher J.; Filzen, Tracey; Finger, Eleftheria N.; Gregan, Yun; Henze, Darrell A.; Jovanovska, Aneta; Klein, Rebecca; Kraus, Richard L.; Li, Yuxing; Liang, Annie; Majercak, John M.; Panigel, Jacqueline; Urban, Mark O.; Wang, Jixin; Wang, Ying-Hong; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2683-2688</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Studies on human genetics have suggested that inhibitors of the Nav1.7 voltage-gated sodium channel hold considerable promise as therapies for the treatment of chronic pain syndromes.  Herein, we report novel, peripherally-restricted benzoxazolinone aryl sulfonamides as potent Nav1.7 inhibitors with excellent selectivity against the Nav1.5 isoform, which is expressed in the heart muscle.  Elaboration of initial lead compd. 3d afforded exemplar 13, which featured attractive physicochem. properties, outstanding lipophilic ligand efficiency and pharmacol. selectivity against Nav1.5 exceeding 1000-fold.  Key structure-activity relationships assocd. with oral bioavailability were leveraged to discover compd. 17, which exhibited a comparable potency/selectivity profile as well as full efficacy following oral administration in a preclin. model indicative of antinociceptive behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGCg6OCYoM57Vg90H21EOLACvtfcHk0lgaA-A5Ca5D7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D&md5=9ea2c021a2c76ffe0bb8c623d1eb7427</span></div><a href="/servlet/linkout?suffix=cit6j&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DJ.%2BE.%26aulast%3DRossi%26aufirst%3DM.%2BA.%26aulast%3DLehman%26aufirst%3DH.%2BD.%2BG.%2BF.%26aulast%3DKelly%26aufirst%3DM.%2BJ.%26aulast%3DMulhearn%26aufirst%3DJ.%2BJ.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DCato%26aufirst%3DM.%2BJ.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DDaley%26aufirst%3DC.%2BJ.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DGregan%26aufirst%3DY.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DMajercak%26aufirst%3DJ.%2BM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DBenzoxazolinone%2520aryl%2520sulfonamides%2520as%2520potent%252C%2520selective%2520NaV1.7%2520inhibitors%2520with%2520in%2520vivo%2520efficacy%2520in%2520a%2520preclinical%2520pain%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2683%26epage%3D2688%26doi%3D10.1016%2Fj.bmcl.2017.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6k"><span><span class="NLM_label">(k) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coats, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasmine Lin, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nho Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of benzoxazine sulfonamide inhibitors of Na<sub>V</sub>1.7: tools that bridge efficacy and target engagement</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3477</span>– <span class="NLM_lpage">3485</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.05.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6k&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2017.05.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6k&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=28629594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6k&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVeqsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=3477-3485&author=D.+S.+Laauthor=E.+A.+Petersonauthor=C.+Bodeauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Y.+Chu-Moyerauthor=J.+Coatsauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=B.+Duauthor=H.+Gaoauthor=R.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=R.+Fremeauauthor=X.+Huangauthor=C.+Ilchauthor=T.+J.+Kornecookauthor=C.+Kreimanauthor=J.+Liguttiauthor=M.-H.+Jasmine+Linauthor=J.+S.+McDermottauthor=I.+Marxauthor=D.+J.+Matsonauthor=S.+I.+McDonoughauthor=B.+D.+Moyerauthor=H.+Nho+Nguyenauthor=K.+Tabornauthor=V.+Yuauthor=M.+M.+Weiss&title=The+discovery+of+benzoxazine+sulfonamide+inhibitors+of+NaV1.7%3A+tools+that+bridge+efficacy+and+target+engagement&doi=10.1016%2Fj.bmcl.2017.05.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6kR"><div class="casContent"><span class="casTitleNuber">6k</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of benzoxazine sulfonamide inhibitors of NaV1.7: Tools that bridge efficacy and target engagement</span></div><div class="casAuthors">La, Daniel S.; Peterson, Emily A.; Bode, Christiane; Boezio, Alessandro A.; Bregman, Howard; Chu-Moyer, Margaret Y.; Coats, James; Di Mauro, Erin F.; Dineen, Thomas A.; Du, Bingfan; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Fremeau, Robert, Jr.; Huang, Xin; Ilch, Christopher; Kornecook, Thomas J.; Kreiman, Charles; Ligutti, Joseph; Jasmine Lin, Min-Hwa; McDermott, Jeff S.; Marx, Isaac; Matson, David J.; McDonough, Stefan I.; Moyer, Bryan D.; Nho Nguyen, Hanh; Taborn, Kristin; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3477-3485</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel NaV1.7 has received much attention from the scientific community due to compelling human genetic data linking gain- and loss-of-function mutations to pain phenotypes.  Despite this genetic validation of NaV1.7 as a target for pain, high quality pharmacol. tools facilitate further understanding of target biol., establishment of target coverage requirements and subsequent progression into the clinic.  Within the sulfonamide class of inhibitors, reduced potency on rat NaV1.7 vs. human NaV1.7 was obsd., rendering in vivo rat pharmacol. studies challenging.  Herein, the authors report the discovery and optimization of novel benzoxazine sulfonamide inhibitors of human, rat and mouse NaV1.7 which enabled pharmacol. assessment in traditional behavioral rodent models of pain and in turn, established a connection between formalin-induced pain and histamine-induced pruritus in mice.  The latter represents a simple and efficient means of measuring target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrephmJ2EoOv7Vg90H21EOLACvtfcHk0lj_hiS4PHwGwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVeqsb7K&md5=680ffa374194c12fd3705a7003bd572e</span></div><a href="/servlet/linkout?suffix=cit6k&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.05.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.05.070%26sid%3Dliteratum%253Aachs%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%2BY.%26aulast%3DCoats%26aufirst%3DJ.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DFremeau%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DKornecook%26aufirst%3DT.%2BJ.%26aulast%3DKreiman%26aufirst%3DC.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DJasmine%2BLin%26aufirst%3DM.-H.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMarx%26aufirst%3DI.%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNho%2BNguyen%26aufirst%3DH.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DThe%2520discovery%2520of%2520benzoxazine%2520sulfonamide%2520inhibitors%2520of%2520NaV1.7%253A%2520tools%2520that%2520bridge%2520efficacy%2520and%2520target%2520engagement%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D3477%26epage%3D3485%26doi%3D10.1016%2Fj.bmcl.2017.05.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6l"><span><span class="NLM_label">(l) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulier, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greener, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransley, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 4-[2-(5-Amino-1<i>H</i>-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-<i>N</i>-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): design and optimization of diaryl ether aryl sulfonamides as selective inhibitors of Na<sub>V</sub>1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7029</span>– <span class="NLM_lpage">7042</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6l&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7029-7042&author=N.+A.+Swainauthor=D.+Batchelorauthor=S.+Beaudoinauthor=B.+M.+Bechleauthor=P.+A.+Bradleyauthor=A.+D.+Brownauthor=B.+Brownauthor=K.+J.+Butcherauthor=R.+P.+Buttauthor=M.+L.+Chapmanauthor=S.+Dentonauthor=D.+Ellisauthor=S.+Galanauthor=S.+M.+Gaulierauthor=B.+S.+Greenerauthor=M.+J.+de+Grootauthor=M.+S.+Glossopauthor=I.+K.+Gurrellauthor=J.+Hannamauthor=M.+S.+Johnsonauthor=Z.+Linauthor=C.+J.+Markworthauthor=B.+E.+Marronauthor=D.+S.+Millanauthor=S.+Nakagawaauthor=A.+Pikeauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=S.+J.+Ransleyauthor=S.+M.+Reisterauthor=K.+Sasakiauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=C.+W.+West&title=Discovery+of+clinical+candidate+4-%5B2-%285-Amino-1H-pyrazol-4-yl%29-4-chlorophenoxy%5D-5-chloro-2-fluoro-N-1%2C3-thiazol-4-ylbenzenesulfonamide+%28PF-05089771%29%3A+design+and+optimization+of+diaryl+ether+aryl+sulfonamides+as+selective+inhibitors+of+NaV1.7&doi=10.1021%2Facs.jmedchem.7b00598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6lR"><div class="casContent"><span class="casTitleNuber">6l</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7</span></div><div class="casAuthors">Swain, Nigel. A.; Batchelor, Dave; Beaudoin, Serge; Bechle, Bruce M.; Bradley, Paul A.; Brown, Alan D.; Brown, Bruce; Butcher, Ken J.; Butt, Richard P.; Chapman, Mark L.; Denton, Stephen; Ellis, David; Galan, Sebastien R. G.; Gaulier, Steven M.; Greener, Ben S.; de Groot, Marcel J.; Glossop, Mel S.; Gurrell, Ian K.; Hannam, Jo; Johnson, Matthew S.; Lin, Zhixin; Markworth, Christopher J.; Marron, Brian E.; Millan, David S.; Nakagawa, Shoko; Pike, Andy; Printzenhoff, David; Rawson, David J.; Ransley, Sarah J.; Reister, Steven M.; Sasaki, Kosuke; Storer, R. Ian; Stupple, Paul A.; West, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7029-7042</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of acidic diaryl ether heterocyclic sulfonamides that are potent and sub-type selective NaV1.7 inhibitors is described.  Optimization of early lead matter focused on removal of structural alerts, improving metabolic stability and reducing cytochrome P 450 inhibition driven drug-drug interaction concerns to deliver the desired balance of preclin. in vitro properties.  Concerns over non-metabolic routes of clearance, variable clearance in pre-clin. species and subsequent low confidence human pharmacokinetic predictions led to the decision to conduct a human microdose study to det. clin. pharmacokinetics.  The design strategies and results from pre-clin. PK and clin. human microdose PK data are described leading to the discovery of the first sub-type selective NaV1.7 inhibitor clin. candidate PF-05089771 (34) which binds to a site in the voltage sensing domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpST6i8wDUALbVg90H21EOLACvtfcHk0ljUxedaHbrfdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM&md5=93761c8e8e16cea4db2c9cff6e315e57</span></div><a href="/servlet/linkout?suffix=cit6l&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00598%26sid%3Dliteratum%253Aachs%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DBatchelor%26aufirst%3DD.%26aulast%3DBeaudoin%26aufirst%3DS.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBradley%26aufirst%3DP.%2BA.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DDenton%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DS.%26aulast%3DGaulier%26aufirst%3DS.%2BM.%26aulast%3DGreener%26aufirst%3DB.%2BS.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DGlossop%26aufirst%3DM.%2BS.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DHannam%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRansley%26aufirst%3DS.%2BJ.%26aulast%3DReister%26aufirst%3DS.%2BM.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWest%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25204-%255B2-%25285-Amino-1H-pyrazol-4-yl%2529-4-chlorophenoxy%255D-5-chloro-2-fluoro-N-1%252C3-thiazol-4-ylbenzenesulfonamide%2520%2528PF-05089771%2529%253A%2520design%2520and%2520optimization%2520of%2520diaryl%2520ether%2520aryl%2520sulfonamides%2520as%2520selective%2520inhibitors%2520of%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7029%26epage%3D7042%26doi%3D10.1021%2Facs.jmedchem.7b00598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6m"><span><span class="NLM_label">(m) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrou, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castle, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fengas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theile, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmus, J. S.</span></span> <span> </span><span class="NLM_article-title">Highly potent and selective Na<sub>V</sub>1.7 inhibitors for use as intravenous agents and chemical probes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4805</span>– <span class="NLM_lpage">4811</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.09.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6m&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2017.09.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6m&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=29029933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6m&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gmur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4805-4811&author=R.+I.+Storerauthor=A.+Pikeauthor=N.+A.+Swainauthor=A.+J.+Alexandrouauthor=B.+M.+Bechleauthor=D.+C.+Blakemoreauthor=A.+D.+Brownauthor=N.+A.+Castleauthor=M.+S.+Corbettauthor=N.+J.+Flanaganauthor=D.+Fengasauthor=M.+S.+Johnsonauthor=L.+H.+Jonesauthor=B.+E.+Marronauthor=C.+E.+Payneauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=C.+R.+Roseauthor=T.+Ryckmansauthor=J.+Sunauthor=J.+W.+Theileauthor=R.+Torellaauthor=E.+Tsengauthor=J.+S.+Warmus&title=Highly+potent+and+selective+NaV1.7+inhibitors+for+use+as+intravenous+agents+and+chemical+probes&doi=10.1016%2Fj.bmcl.2017.09.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6mR"><div class="casContent"><span class="casTitleNuber">6m</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes</span></div><div class="casAuthors">Storer, R. Ian; Pike, Andy; Swain, Nigel A.; Alexandrou, Aristos J.; Bechle, Bruce M.; Blakemore, David C.; Brown, Alan D.; Castle, Neil A.; Corbett, Matthew S.; Flanagan, Neil J.; Fengas, David; Johnson, M. Scott; Jones, Lyn H.; Marron, Brian E.; Payne, C. Elizabeth; Printzenhoff, David; Rawson, David J.; Rose, Colin R.; Ryckmans, Thomas; Sun, Jianmin; Theile, Jonathan W.; Torella, Rubben; Tseng, Elaine; Warmus, Joseph S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4805-4811</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and selection of a highly potent and selective NaV1.7 inhibitor PF-06456384, designed specifically for i.v. infusion, is disclosed.  Extensive in vitro pharmacol. and ADME profiling followed by in vivo preclin. PK and efficacy model data are discussed.  A proposed protein-ligand binding mode for this compd. is also provided to rationalize the high levels of potency and selectivity over inhibition of related sodium channels.  To further support the proposed binding mode, potent conjugates are described which illustrate the potential for development of chem. probes to enable further target evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA-67HTehcGLVg90H21EOLACvtfcHk0ljUxedaHbrfdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gmur3L&md5=5be8e615ad061aa7cf06056de8b8682c</span></div><a href="/servlet/linkout?suffix=cit6m&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.09.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.09.056%26sid%3Dliteratum%253Aachs%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DAlexandrou%26aufirst%3DA.%2BJ.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26aulast%3DCorbett%26aufirst%3DM.%2BS.%26aulast%3DFlanagan%26aufirst%3DN.%2BJ.%26aulast%3DFengas%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPayne%26aufirst%3DC.%2BE.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DTheile%26aufirst%3DJ.%2BW.%26aulast%3DTorella%26aufirst%3DR.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26atitle%3DHighly%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520use%2520as%2520intravenous%2520agents%2520and%2520chemical%2520probes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4805%26epage%3D4811%26doi%3D10.1016%2Fj.bmcl.2017.09.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6n"><span><span class="NLM_label">(n) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of aminocyclohexene analogues as selective and orally bioavailable <i>h</i>Na<sub>V</sub>1.7 inhibitors for analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4979</span>– <span class="NLM_lpage">4984</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6n&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2017.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6n&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=29037948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6n&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4979-4984&author=M.+Tengauthor=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=J.+Qinauthor=Y.+Wangauthor=Z.+Huauthor=H.+Dongauthor=L.+Houauthor=G.+Huauthor=L.+Shenauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=L.+Yeauthor=J.+Zhangauthor=H.+Wang&title=Discovery+of+aminocyclohexene+analogues+as+selective+and+orally+bioavailable+hNaV1.7+inhibitors+for+analgesia&doi=10.1016%2Fj.bmcl.2017.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6nR"><div class="casContent"><span class="casTitleNuber">6n</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesia</span></div><div class="casAuthors">Teng, Mingxing; Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Qin, Jian; Wang, Yikai; Hu, Zhijing; Dong, Haiheng; Hou, Lijuan; Hu, Guoping; Shen, Liang; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Ye, Liang; Zhang, Jianzhao; Wang, Hongbo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4979-4984</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 receives a lot of attention owing to its attractive mechanism of action in pain processing pathway.  The authors have previously reported the design of a novel series of tetrahydropyridine analogs towards hNav1.7 selective inhibitors.  Herein, the authors disclose further efforts to the optimization of hit compd. (-)-6, which led to the identification of aminocyclohexene analogs (-)-9 and (-)-17 with good potency, high selectivity, and minimal CYP inhibition.  Both compds. (-)-9 and (-)-17 demonstrated improved pharmacokinetic profiles in rats, and robust efficacy in rat formalin-induced nociception and spinal nerve ligation (SNL) models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqawNCRE6H6rVg90H21EOLACvtfcHk0ljUxedaHbrfdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7J&md5=922146ec3e1c272e02af031be78dc06d</span></div><a href="/servlet/linkout?suffix=cit6n&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520aminocyclohexene%2520analogues%2520as%2520selective%2520and%2520orally%2520bioavailable%2520hNaV1.7%2520inhibitors%2520for%2520analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4979%26epage%3D4984%26doi%3D10.1016%2Fj.bmcl.2017.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krafte, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krambis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonio, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zellmer, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagoner, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castle, N. A.</span></span> <span> </span><span class="NLM_article-title">Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">E2724</span>– <span class="NLM_lpage">E2732</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220844110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1073%2Fpnas.1220844110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=23818614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1emu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E2724-E2732&author=K.+McCormackauthor=S.+Santosauthor=M.+L.+Chapmanauthor=D.+S.+Krafteauthor=B.+E.+Marronauthor=C.+W.+Westauthor=M.+J.+Krambisauthor=B.+M.+Antonioauthor=S.+G.+Zellmerauthor=D.+Printzenhoffauthor=K.+M.+Padillaauthor=Z.+Linauthor=P.+K.+Wagonerauthor=N.+A.+Swainauthor=P.+A.+Stuppleauthor=M.+de+Grootauthor=R.+P.+Buttauthor=N.+A.+Castle&title=Voltage+sensor+interaction+site+for+selective+small+molecule+inhibitors+of+voltage-gated+sodium+channels&doi=10.1073%2Fpnas.1220844110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels</span></div><div class="casAuthors">McCormack, Ken; Santos, Sonia; Chapman, Mark L.; Krafte, Douglas S.; Marron, Brian E.; West, Christopher W.; Krambis, Michael J.; Antonio, Brett M.; Zellmer, Shannon G.; Printzenhoff, David; Padilla, Karen M.; Lin, Zhixin; Wagoner, P. Kay; Swain, Nigel A.; Stupple, Paul A.; de Groot, Marcel; Butt, Richard P.; Castle, Neil A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">E2724-E2732,SE2724/1-SE2724/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Voltage-gated sodium (Nav) channels play a fundamental role in the generation and propagation of elec. impulses in excitable cells.  Here the authors describe two unique structurally related nanomolar potent small mol. Nav channel inhibitors that exhibit up to 1000-fold selectivity for human Nav1.3/Nav1.1 (ICA-121431, IC50, 19 nM) or Nav1.7 (PF-04856264, IC50, 28 nM) vs. other TTX-sensitive or resistant (i.e., Nav1.5) sodium channels.  Using both chimeras and single point mutations, the authors demonstrate that this unique class of sodium channel inhibitor interacts with the S1-S4 voltage sensor segment of homologous Domain 4.  Amino acid residues in the "extracellular" facing regions of the S2 and S3 transmembrane segments of Nav1.3 and Nav1.7 seem to be major determinants of Nav subtype selectivity and to confer differences in species sensitivity to these inhibitors.  The unique interaction region on the Domain 4 voltage sensor segment is distinct from the structural domains forming the channel pore, as well as previously characterized interaction sites for other small mol. inhibitors, including local anesthetics and TTX.  However, this interaction region does include at least one amino acid residue [E1559 (Nav1.3)/D1586 (Nav1.7)] that is important for Site 3 α-scorpion and anemone polypeptide toxin modulators of Nav channel inactivation.  The present study provides a potential framework for identifying subtype selective small mol. sodium channel inhibitors targeting interaction sites away from the pore region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW_9_BEDLPnbVg90H21EOLACvtfcHk0lgqx39eTG9Q_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1emu7zK&md5=d970cc772ece1372fb0b427a240beb56</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220844110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220844110%26sid%3Dliteratum%253Aachs%26aulast%3DMcCormack%26aufirst%3DK.%26aulast%3DSantos%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DKrafte%26aufirst%3DD.%2BS.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DWest%26aufirst%3DC.%2BW.%26aulast%3DKrambis%26aufirst%3DM.%2BJ.%26aulast%3DAntonio%26aufirst%3DB.%2BM.%26aulast%3DZellmer%26aufirst%3DS.%2BG.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DPadilla%26aufirst%3DK.%2BM.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DWagoner%26aufirst%3DP.%2BK.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3Dde%2BGroot%26aufirst%3DM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26atitle%3DVoltage%2520sensor%2520interaction%2520site%2520for%2520selective%2520small%2520molecule%2520inhibitors%2520of%2520voltage-gated%2520sodium%2520channels%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE2724%26epage%3DE2732%26doi%3D10.1073%2Fpnas.1220844110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukund, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shriver, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillantes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koth, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payandeh, J.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Structural basis of Na<sub>V</sub>1.7 inhibition by an isoform-selective small molecule antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">aac5464</span>, <span class="refDoi"> DOI: 10.1126/science.aac5464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1126%2Fscience.aac5464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=26680203" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&pages=aac5464&author=S.+Ahujaauthor=S.+Mukundauthor=L.+Dengauthor=K.+Khakhauthor=E.+Changauthor=H.+Hoauthor=S.+Shriverauthor=C.+Youngauthor=S.+Linauthor=J.+P.+Johnsonauthor=P.+Wuauthor=J.+Liauthor=M.+Coonsauthor=C.+Tamauthor=B.+Brillantesauthor=H.+Sampangauthor=K.+Mortaraauthor=M.+Grimwoodauthor=C.+Dehnhardtauthor=J.-C.+Andrezauthor=T.+Fockenauthor=D.+P.+Sutherlinauthor=B.+S.+Safinaauthor=M.+A.+Starovasnikauthor=D.+F.+Ortwineauthor=Y.+Frankeauthor=C.+J.+Cohenauthor=D.+H.+Hackosauthor=C.+M.+Kothauthor=J.+Payandeh&title=Structural+basis+of+NaV1.7+inhibition+by+an+isoform-selective+small+molecule+antagonist&doi=10.1126%2Fscience.aac5464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac5464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac5464%26sid%3Dliteratum%253Aachs%26aulast%3DAhuja%26aufirst%3DS.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DShriver%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCoons%26aufirst%3DM.%26aulast%3DTam%26aufirst%3DC.%26aulast%3DBrillantes%26aufirst%3DB.%26aulast%3DSampang%26aufirst%3DH.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DGrimwood%26aufirst%3DM.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DAndrez%26aufirst%3DJ.-C.%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DFranke%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DKoth%26aufirst%3DC.%2BM.%26aulast%3DPayandeh%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520NaV1.7%2520inhibition%2520by%2520an%2520isoform-selective%2520small%2520molecule%2520antagonist%26jtitle%3DScience%26date%3D2015%26volume%3D350%26spage%3Daac5464%26doi%3D10.1126%2Fscience.aac5464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzygiel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segelbacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span> <span> </span><span class="NLM_article-title">Clinical micro-dose studies to explore the human pharmacokinetics of four selective inhibitors of human Na<sub>V</sub>1.7 voltage-dependent sodium channels</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1007/s40262-015-0365-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1007%2Fs40262-015-0365-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=26895021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=875-887&author=H.+M.+Jonesauthor=R.+P.+Buttauthor=R.+W.+Websterauthor=I.+Gurrellauthor=P.+Dzygielauthor=N.+Flanaganauthor=D.+Fraierauthor=T.+Hayauthor=L.+E.+Iavaroneauthor=J.+Luckwellauthor=H.+Pearceauthor=A.+Phippsauthor=J.+Segelbacherauthor=B.+Speedauthor=K.+Beaumont&title=Clinical+micro-dose+studies+to+explore+the+human+pharmacokinetics+of+four+selective+inhibitors+of+human+NaV1.7+voltage-dependent+sodium+channels&doi=10.1007%2Fs40262-015-0365-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels</span></div><div class="casAuthors">Jones, Hannah M.; Butt, Richard P.; Webster, Rob W.; Gurrell, Ian; Dzygiel, Pawel; Flanagan, Neil; Fraier, Daniela; Hay, Tanya; Iavarone, Laura Else; Luckwell, Jacquelynn; Pearce, Hannah; Phipps, Alex; Segelbacher, Jill; Speed, Bill; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">875-887</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background: The emergence of genetic data linking Nav1.7 sodium channel over- and under- expression to human pain signalling has led to an interest in the treatment of chronic pain through inhibition of Nav1.7 channels.  Objective: We describe the pharmacokinetic (PK) results of a clin. microdose study performed with four potent and selective Nav1.7 inhibitors and the subsequent modeling resulting in the selection of a single compd. to explore Nav1.7 pharmacol. at higher doses.  Methods: A clin. microdose study to investigate the i.v. and oral PK of four compds. (PF-05089771, PF-05150122, PF-05186462 and PF-05241328) was performed in healthy volunteers.  PK parameters were derived via noncompartmental anal.  A physiol.-based PK (PBPK) model was used to predict exposure and multiples of Nav1.7 50 % inhibitory concn. (IC50) for each compd. at higher doses.  Results: Plasma clearance, vol. of distribution and bioavailability ranged from 45 to 392 mL/min/kg, 13 to 36 L/kg and 38 to 110 %, resp.  The PBPK model for PF-05089771 predicted a 1 g oral dose would be required to achieve exposures of approx. 12× Nav1.7 IC50 at max. concn. (Cmax), and approx. 3× IC50 after 12 h (min. concn. [Cmin] for a twice-daily regimen).  Lower multiples of Nav1.7 IC50 were predicted with the same oral doses of PF-05150122, PF-05186462, and PF-05241328.  In a subsequent single ascending oral dose clin. study, the predictions for PF-05089771 compared well with obsd. data.  Conclusion: Based on the human PK data obtained from the microdose study and subsequent modeling, PF-05089771 provided the best opportunity to explore Nav1.7 blockade for the treatment of acute or chronic pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEQTEvITzd7Vg90H21EOLACvtfcHk0lgqx39eTG9Q_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D&md5=bf8dbccbbbbf25f52bf13f28bc995c18</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0365-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0365-0%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DWebster%26aufirst%3DR.%2BW.%26aulast%3DGurrell%26aufirst%3DI.%26aulast%3DDzygiel%26aufirst%3DP.%26aulast%3DFlanagan%26aufirst%3DN.%26aulast%3DFraier%26aufirst%3DD.%26aulast%3DHay%26aufirst%3DT.%26aulast%3DIavarone%26aufirst%3DL.%2BE.%26aulast%3DLuckwell%26aufirst%3DJ.%26aulast%3DPearce%26aufirst%3DH.%26aulast%3DPhipps%26aufirst%3DA.%26aulast%3DSegelbacher%26aufirst%3DJ.%26aulast%3DSpeed%26aufirst%3DB.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DClinical%2520micro-dose%2520studies%2520to%2520explore%2520the%2520human%2520pharmacokinetics%2520of%2520four%2520selective%2520inhibitors%2520of%2520human%2520NaV1.7%2520voltage-dependent%2520sodium%2520channels%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26spage%3D875%26epage%3D887%26doi%3D10.1007%2Fs40262-015-0365-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Application of a parallel synthetic strategy in the discovery of biaryl acyl sulfonamides as efficient and selective Na<sub>V</sub>1.7 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7818</span>– <span class="NLM_lpage">7839</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00425</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00425" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SktLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7818-7839&author=E.+F.+DiMauroauthor=S.+Altmannauthor=L.+M.+Berryauthor=H.+Bregmanauthor=N.+Chakkaauthor=M.+Chu-Moyerauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=B.+E.+Hallauthor=H.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=J.+Leeauthor=J.+Liguttiauthor=D.+Liuauthor=B.+D.+Moyerauthor=D.+Ortunoauthor=P.+E.+Roseauthor=L.+B.+Schenkelauthor=K.+Tabornauthor=J.+Wangauthor=Y.+Wangauthor=V.+Yuauthor=M.+M.+Weiss&title=Application+of+a+parallel+synthetic+strategy+in+the+discovery+of+biaryl+acyl+sulfonamides+as+efficient+and+selective+NaV1.7+inhibitors&doi=10.1021%2Facs.jmedchem.6b00425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors</span></div><div class="casAuthors">DiMauro, Erin F.; Altmann, Stephen; Berry, Loren M.; Bregman, Howard; Chakka, Nagasree; Chu-Moyer, Margaret; Bojic, Elma Feric; Foti, Robert S.; Fremeau, Robert; Gao, Hua; Gunaydin, Hakan; Guzman-Perez, Angel; Hall, Brian E.; Huang, Hongbing; Jarosh, Michael; Kornecook, Thomas; Lee, Josie; Ligutti, Joseph; Liu, Dong; Moyer, Bryan D.; Ortuno, Daniel; Rose, Paul E.; Schenkel, Laurie B.; Taborn, Kristin; Wang, Jean; Wang, Yan; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7818-7839</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of potent and selective hNaV1.7 inhibitors possess common pharmacophoric features that include a heteroaryl sulfonamide headgroup and a lipophilic arom. tail group.  Recently, reports of similar arom. tail groups in combination with an acyl sulfonamide headgroup have emerged, with the acyl sulfonamide bestowing levels of selectivity over hNaV1.5 comparable to the heteroaryl sulfonamide.  Beginning with com. available carboxylic acids that met selected pharmacophoric requirements in the lipophilic tail, a parallel synthetic approach was applied to rapidly generate the derived acyl sulfonamides.  A biaryl acyl sulfonamide hit from this library was elaborated, optimizing for potency and selectivity with attention to physicochem. properties.  The resulting novel leads are potent, ligand and lipophilic efficient, and selective over hNaV1.5.  Representative lead I demonstrates selectivity over other human NaV isoforms and good pharmacokinetics in rodents.  The biaryl acyl sulfonamides reported herein may also offer ADME advantages over known heteroaryl sulfonamide inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxffPzH1T1T7Vg90H21EOLACvtfcHk0lgs4yOzi2HlWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SktLjK&md5=8afa7437928f0d43a1327662674978ed</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00425%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DOrtuno%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DApplication%2520of%2520a%2520parallel%2520synthetic%2520strategy%2520in%2520the%2520discovery%2520of%2520biaryl%2520acyl%2520sulfonamides%2520as%2520efficient%2520and%2520selective%2520NaV1.7%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7818%26epage%3D7839%26doi%3D10.1021%2Facs.jmedchem.6b00425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J.-C.</span>; <span class="NLM_string-name">Chowdhury, S.</span>; <span class="NLM_string-name">Decker, S.</span>; <span class="NLM_string-name">Dehnhardt, C. M.</span>; <span class="NLM_string-name">Focken, T.</span>; <span class="NLM_string-name">Grimwood, M. E.</span>; <span class="NLM_string-name">Hemeon, I. W.</span>; <span class="NLM_string-name">Jia, Q.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Ortwine, D. F.</span>; <span class="NLM_string-name">Safina, B.</span>; <span class="NLM_string-name">Sheng, T.</span>; <span class="NLM_string-name">Sun, S.</span>; <span class="NLM_string-name">Sutherlin, D. P.</span>; <span class="NLM_string-name">Wilson, M. S.</span>; <span class="NLM_string-name">Zenova, A. Y.</span></span> <span> </span><span class="NLM_article-title">N-Substituted Benzamides and Their Use in the Treatment of Pain</span>. <span class="NLM_patent">WO2013177224A1</span>, Nov 28, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.-C.+Andrez&author=S.+Chowdhury&author=S.+Decker&author=C.+M.+Dehnhardt&author=T.+Focken&author=M.+E.+Grimwood&author=I.+W.+Hemeon&author=Q.+Jia&author=J.+Li&author=D.+F.+Ortwine&author=B.+Safina&author=T.+Sheng&author=S.+Sun&author=D.+P.+Sutherlin&author=M.+S.+Wilson&author=A.+Y.+Zenova&title=N-Substituted+Benzamides+and+Their+Use+in+the+Treatment+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAndrez%26aufirst%3DJ.-C.%26atitle%3DN-Substituted%2520Benzamides%2520and%2520Their%2520Use%2520in%2520the%2520Treatment%2520of%2520Pain%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafeev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadieux, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of XEN907, a spirooxindole blocker of NaV1.7 for the treatment of pain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3676</span>– <span class="NLM_lpage">3681</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2011.04.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=21570288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntFKhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3676-3681&author=S.+Chowdhuryauthor=M.+Chafeevauthor=S.+Liuauthor=J.+Sunauthor=V.+Rainaauthor=R.+Chuiauthor=W.+Youngauthor=R.+Kwanauthor=J.+Fuauthor=J.+A.+Cadieux&title=Discovery+of+XEN907%2C+a+spirooxindole+blocker+of+NaV1.7+for+the+treatment+of+pain&doi=10.1016%2Fj.bmcl.2011.04.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of XEN907, a spiro-oxindole blocker of Nav1.7 for the treatment of pain</span></div><div class="casAuthors">Chowdhury, Sultan; Chafeev, Mikhail; Liu, Shifeng; Sun, Jianyu; Raina, Vandna; Chui, Ray; Young, Wendy; Kwan, Rainbow; Fu, Jianmin; Cadieux, Jay A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3676-3681</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Starting from the oxindole I identified through a high-throughput screening (HTS) campaign, a series of Nav1.7 blockers were developed.  Following the elimination of undesirable structural features, preliminary optimization of the oxindole C-3 and N-1 substituents afforded the simplified analog II, which demonstrated a 10-fold increase in target potency vs. the original HTS hit.  A scaffold rigidification strategy then led to the discovery of XEN907, a novel spirooxindole Nav1.7 blocker.  This lead compd., which in turn showed a further 10-fold increase in potency, represents a promising structure for further optimization efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtYUA7aLTTk7Vg90H21EOLACvtfcHk0lgs4yOzi2HlWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntFKhsL0%253D&md5=ea3ccd821ed690b3ed67a7901e6a4df1</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.088%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DChafeev%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DRaina%26aufirst%3DV.%26aulast%3DChui%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DW.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DCadieux%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520XEN907%252C%2520a%2520spirooxindole%2520blocker%2520of%2520NaV1.7%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3676%26epage%3D3681%26doi%3D10.1016%2Fj.bmcl.2011.04.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namdari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winters, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verschoof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrington, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pimstone, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span> <span> </span><span class="NLM_article-title">Treatment of NaV1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2011.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.pain.2011.09.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2012&pages=80-85&author=Y.+P.+Goldbergauthor=N.+Priceauthor=R.+Namdariauthor=C.+J.+Cohenauthor=M.+H.+Lamersauthor=C.+Wintersauthor=J.+Priceauthor=C.+E.+Youngauthor=H.+Verschoofauthor=R.+Sherringtonauthor=S.+N.+Pimstoneauthor=M.+R.+Hayden&title=Treatment+of+NaV1.7-mediated+pain+in+inherited+erythromelalgia+using+a+novel+sodium+channel+blocker&doi=10.1016%2Fj.pain.2011.09.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2011.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2011.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DY.%2BP.%26aulast%3DPrice%26aufirst%3DN.%26aulast%3DNamdari%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DLamers%26aufirst%3DM.%2BH.%26aulast%3DWinters%26aufirst%3DC.%26aulast%3DPrice%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DC.%2BE.%26aulast%3DVerschoof%26aufirst%3DH.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DPimstone%26aufirst%3DS.%2BN.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DTreatment%2520of%2520NaV1.7-mediated%2520pain%2520in%2520inherited%2520erythromelalgia%2520using%2520a%2520novel%2520sodium%2520channel%2520blocker%26jtitle%3DPain%26date%3D2012%26volume%3D153%26spage%3D80%26epage%3D85%26doi%3D10.1016%2Fj.pain.2011.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadieux, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafeev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langille, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sviridov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajlic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verschoof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, W.</span></span> <span> </span><span class="NLM_article-title">Tetracyclic spirooxindole blockers of <i>h</i>NaV1.7: activity in vitro and in CFA-induced inflammatory pain model</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1825</span>– <span class="NLM_lpage">1836</span>, <span class="refDoi"> DOI: 10.1007/s00044-012-0180-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1007%2Fs00044-012-0180-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOgtrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=1825-1836&author=S.+Chowdhuryauthor=S.+Liuauthor=J.+A.+Cadieuxauthor=T.+Hsiehauthor=M.+Chafeevauthor=S.+Sunauthor=Q.+Jiaauthor=J.+Sunauthor=M.+Woodauthor=J.+Langilleauthor=S.+Sviridovauthor=J.+Fuauthor=Z.+Zhangauthor=R.+Chuiauthor=A.+Wangauthor=X.+Chengauthor=J.+Zhongauthor=S.+Hossainauthor=K.+Khakhauthor=I.+Rajlicauthor=H.+Verschoofauthor=R.+Kwanauthor=W.+Young&title=Tetracyclic+spirooxindole+blockers+of+hNaV1.7%3A+activity+in+vitro+and+in+CFA-induced+inflammatory+pain+model&doi=10.1007%2Fs00044-012-0180-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Tetracyclic spirooxindole blockers of hNaV1.7: activity in vitro and in CFA-induced inflammatory pain model</span></div><div class="casAuthors">Chowdhury, Sultan; Liu, Shifeng; Cadieux, Jay A.; Hsieh, Tom; Chafeev, Mikhail; Sun, Shaoyi; Jia, Qi; Sun, Jianyu; Wood, Mark; Langille, Jonathan; Sviridov, Serguei; Fu, Jianmin; Zhang, Zaihui; Chui, Ray; Wang, Audrey; Cheng, Xing; Zhong, Jing; Hossain, Sazzad; Khakh, Kuldip; Rajlic, Ivana; Verschoof, Henry; Kwan, Rainbow; Young, Wendy</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1825-1836</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">The structure-activity relationship of a new series of tetracyclic spirooxindoles led to the discovery of compd. 25a, a potent hNaV1.7 blocker with improved ADME properties and in vivo efficacy in the CFA-induced inflammatory pain model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjPSR-hOyPHrVg90H21EOLACvtfcHk0lhURLqsgOPq2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOgtrrO&md5=de6f7da4cf7b773fc50bee110c751d9c</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1007%2Fs00044-012-0180-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-012-0180-1%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCadieux%26aufirst%3DJ.%2BA.%26aulast%3DHsieh%26aufirst%3DT.%26aulast%3DChafeev%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DSviridov%26aufirst%3DS.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DChui%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DHossain%26aufirst%3DS.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DRajlic%26aufirst%3DI.%26aulast%3DVerschoof%26aufirst%3DH.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DW.%26atitle%3DTetracyclic%2520spirooxindole%2520blockers%2520of%2520hNaV1.7%253A%2520activity%2520in%2520vitro%2520and%2520in%2520CFA-induced%2520inflammatory%2520pain%2520model%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2013%26volume%3D22%26spage%3D1825%26epage%3D1836%26doi%3D10.1007%2Fs00044-012-0180-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from flatland: increasing saturation as an approach to improving clinical success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lhURLqsgOPq2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Milletti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storchi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sforna, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span> <span> </span><span class="NLM_article-title">New and original pKa prediction method using grid molecular interaction fields</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2172</span>– <span class="NLM_lpage">2181</span>, <span class="refDoi"> DOI: 10.1021/ci700018y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci700018y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2172-2181&author=F.+Millettiauthor=L.+Storchiauthor=G.+Sfornaauthor=G.+Cruciani&title=New+and+original+pKa+prediction+method+using+grid+molecular+interaction+fields&doi=10.1021%2Fci700018y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">New and Original pKa Prediction Method Using Grid Molecular Interaction Fields</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Sforna, Gianluca; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2172-2181</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the most important physicochem. properties of a mol. is pKa.  It is known that two parameters imperative in ADME profiling, soly., and lipophilicity are governed by pKa, and receptor binding can be influenced by pKa.  Because most drugs are ionized in physiol. conditions, pKa is particularly relevant to medicinal chem.  Despite the numerous advances in high-throughput measurements, in silico detn. is still the fastest and cheapest way of obtaining pKa.  This paper presents a new original computational method for pKa prediction of org. compds.  Descriptors were generated using the program GRID, and these descriptors are based on mol. interaction fields precomputed on a set of mol. fragments.  The new method was developed, trained, and cross-validated by using a large and diverse data set of 24 617 pKa values.  This paper presents the results for a class of 421 acidic nitrogen compds. (RMSE = 0.41, r2 = 0.97, q2 = 0.87) and for a class of 947 six-membered N-heterocyclic bases (RMSE = 0.60, r2 = 0.93, q2 = 0.85).  For external validation 28 novel compds. were selected that covered nine different ionizable groups, and 39 pKa values could be exptl. detd. by spectral gradient anal. (SGA).  Comparison of exptl. pKa with calcd. pKa demonstrated that the predictive ability of the method is good (external set, r2 = 0.85, RMSE = 0.90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzEk0uiS1E6rVg90H21EOLACvtfcHk0ljQqtLXhJ5pPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF&md5=f2b1dec853ccb0ef1a40540d234232fb</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Fci700018y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700018y%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DSforna%26aufirst%3DG.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DNew%2520and%2520original%2520pKa%2520prediction%2520method%2520using%2520grid%2520molecular%2520interaction%2520fields%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2172%26epage%3D2181%26doi%3D10.1021%2Fci700018y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Milletti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storchi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goracci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span> <span> </span><span class="NLM_article-title">Extending pKa prediction accuracy: high-throughput pKa measurements to understand pKa modulation of new chemical series</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4270</span>– <span class="NLM_lpage">4279</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2010.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.ejmech.2010.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=20633962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4270-4279&author=F.+Millettiauthor=L.+Storchiauthor=L.+Goracciauthor=S.+Bendelsauthor=B.+Wagnerauthor=M.+Kansyauthor=G.+Cruciani&title=Extending+pKa+prediction+accuracy%3A+high-throughput+pKa+measurements+to+understand+pKa+modulation+of+new+chemical+series&doi=10.1016%2Fj.ejmech.2010.06.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Extending pKa prediction accuracy: High-throughput pKa measurements to understand pKa modulation of new chemical series</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Goracci, Laura; Bendels, Stefanie; Wagner, Bjoern; Kansy, Manfred; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4270-4279</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We have recently developed a tool, MoKα, to predict the pKa of org. compds. using a large dataset of over 26,500 literature pKa values as a training set.  However, predicting accurately pKa (<0.5 pH units) remains challenging for novel series, and this can be a drawback in the optimization of activity and ADME properties of lead compds.  To address this issue it is important to expand our knowledge of pKa determinants, therefore we have conducted high-throughput pKa measurements by using Spectral Gradient Anal. (SGA) on novel series of compds. selected from vendor databases.  Here we report our findings on the effect of specific chem. groups and steric constraints on the pKa of common functionalities in medicinal chem., such as amines, sulfonamides, and amides.  Furthermore, we report the pKa of ionizable groups that were not well represented in the database of literature pKa of MoKα, such as hydrazide derivs.  These findings helped us to enhance MoKα, which is here benchmarked on a set of exptl. pKa values from the Roche inhouse library (N = 5581; RMSE = 1.09; R2 = 0.82).  The accuracy of the predictions was greatly improved (RMSE = 0.49, R2 = 0.96) after training the software by using the automated tool Kibitzer with 6226 pK a values taken from a different set of Roche compds. appropriately selected, and this demonstrates the value of using high-throughput pKa measurements to expand the training set of pKa values used by the software MoKα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxQ9UJOAhB-rVg90H21EOLACvtfcHk0ljQqtLXhJ5pPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLo%253D&md5=e4c579032df7fa37ec3551c69a09257a</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DGoracci%26aufirst%3DL.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DExtending%2520pKa%2520prediction%2520accuracy%253A%2520high-throughput%2520pKa%2520measurements%2520to%2520understand%2520pKa%2520modulation%2520of%2520new%2520chemical%2520series%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4270%26epage%3D4279%26doi%3D10.1016%2Fj.ejmech.2010.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span> <i>MoKa 2.6.5</i>; <span class="NLM_publisher-name">Molecular
Discovery</span>: <span class="NLM_publisher-loc">Borehamwood, Hertfordshire,
UK</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MoKa+2.6.5%3B+Molecular%0ADiscovery%3A+Borehamwood%2C+Hertfordshire%2C%0AUK%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMoKa%25202.6.5%26pub%3DMolecular%250ADiscovery%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Improving drug candidates by design: A focus on physicochemical properties as a means of improving compound disposition and safety</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1420</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1021/tx200211v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200211v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1420-1456&author=N.+A.+Meanwell&title=Improving+drug+candidates+by+design%3A+A+focus+on+physicochemical+properties+as+a+means+of+improving+compound+disposition+and+safety&doi=10.1021%2Ftx200211v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1420-1456</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of small mol. drug candidates from the discovery phase to a marketed product continues to be a challenging enterprise with very low success rates that have fostered the perception of poor productivity by the pharmaceutical industry.  Although there have been significant advances in preclin. profiling that have improved compd. triaging and altered the underlying reasons for compd. attrition, the failure rates have not appreciably changed.  As part of an effort to more deeply understand the reasons for candidate failure, there has been considerable interest in analyzing the physicochem. properties of marketed drugs for the purpose of comparing with drugs in discovery and development as a means capturing recent trends in drug design.  The scenario that has emerged is one in which contemporary drug discovery is thought to be focused too heavily on advancing candidates with profiles that are most easily satisfied by mols. with increased mol. wt. and higher overall lipophilicity.  The preponderance of mols. expressing these properties is frequently a function of increased arom. ring count when compared with that of the drugs launched in the latter half of the 20th century and may reflect a preoccupation with maximizing target affinity rather than taking a more holistic approach to drug design.  These attributes not only present challenges for formulation and absorption but also may influence the manifestation of toxicity during development.  By providing some definition around the optimal physicochem. properties assocd. with marketed drugs, guidelines for drug design have been developed that are based largely on calcd. parameters and which may readily be applied by medicinal chemists as an aid to understanding candidate quality.  The physicochem. properties of a mol. that are consistent with the potential for good oral absorption were initially defined by Lipinski, with addnl. insights allowing further refinement, while deeper analyses have explored the correlation with metabolic stability and toxicity.  These insights have been augmented by careful analyses of physicochem. aspects of drug-target interactions, with thermodn. profiling indicating that the signature of best-in-class drugs is a dependence on enthalpy to drive binding energetics rather than entropy, which is dependent on lipophilicity.  Optimization of the entropic contribution to the binding energy of a ligand to its target is generally much easier than refining the enthalpic element.  Consequently, in the absence of a fundamental understanding of the thermodn. complexion of an interaction, the design of mols. with increased lipophilicity becomes almost inevitable.  The application of ligand efficiency, a measure of affinity per heavy atom, group efficiency, which assesses affinity in the context of structural changes, and lipophilic ligand efficiency, which relates potency to lipophilicity, offer less sophisticated but practically useful anal. algorithms to assess the quality of drug-target interactions.  These parameters are readily calcd. and can be applied to lead optimization programs in a fashion that helps to maximize potency while minimizing the kind of lipophilic burden that has been dubbed "mol. obesity".  Several recently described lead optimization campaigns provide illustrative, informative, and productive examples of the effect of paying close attention to carefully controlling physicochem. properties by monitoring ligand efficiency and lipophilic ligand efficiency.  However, to be successful during the lead optimization phase, drug candidate identification programs will need to adopt a holistic approach that integrates multiple parameters, many of which will have unique dependencies on both the drug target and the specific chemotype under prosecution.  Nevertheless, there are many important drug targets that necessitate working in space beyond that which has been defined by the retrospective analyses of marketed drugs and which will require adaptation of some of the guideposts that are useful in directing lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQrUfIwZiIR7Vg90H21EOLACvtfcHk0ljQqtLXhJ5pPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D&md5=9ddcf6dc81bf8ab0441df5037979ff4e</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Ftx200211v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200211v%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520drug%2520candidates%2520by%2520design%253A%2520A%2520focus%2520on%2520physicochemical%2520properties%2520as%2520a%2520means%2520of%2520improving%2520compound%2520disposition%2520and%2520safety%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1420%26epage%3D1456%26doi%3D10.1021%2Ftx200211v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kormos, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Will, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stedman, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekaran, R. Y.</span></span> <span> </span><span class="NLM_article-title">Improving the odds of success in drug discovery: choosing the best compounds for in vivo toxicology studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9771</span>– <span class="NLM_lpage">9779</span>, <span class="refDoi"> DOI: 10.1021/jm401485p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401485p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslOms7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9771-9779&author=T.+T.+Wagerauthor=B.+L.+Kormosauthor=J.+T.+Bradyauthor=Y.+Willauthor=M.+D.+Aleoauthor=D.+B.+Stedmanauthor=M.+Kuhnauthor=R.+Y.+Chandrasekaran&title=Improving+the+odds+of+success+in+drug+discovery%3A+choosing+the+best+compounds+for+in+vivo+toxicology+studies&doi=10.1021%2Fjm401485p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the Odds of Success in Drug Discovery: Choosing the Best Compounds for in Vivo Toxicology Studies</span></div><div class="casAuthors">Wager, Travis T.; Kormos, Bethany L.; Brady, Joseph T.; Will, Yvonne; Aleo, Michael D.; Stedman, Donald B.; Kuhn, Max; Chandrasekaran, Ramalakshmi Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9771-9779</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of mols. that advanced into exploratory animal toxicol. studies (two species) was examd. to det. what properties contributed to success in these safety studies.  Compds. were rigorously evaluated across numerous safety end points and classified as "pass" if a suitable in vivo therapeutic index (TI) was achieved for advancement into regulatory toxicol. studies.  The most predictive end point contributing to compd. survival was a predicted human efficacious concn. (Ceff) of ≤250 nM (total drug) and ≤40 nM (free drug).  This trend held across a wide range of CNS modes of action, encompassing targets such as enzymes, G-protein-coupled receptors, ion channels, and transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpartARg68zVrVg90H21EOLACvtfcHk0liPvADGX46LRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslOms7%252FL&md5=7efd1be4dbede3e4d3201154929bd641</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm401485p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401485p%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DBrady%26aufirst%3DJ.%2BT.%26aulast%3DWill%26aufirst%3DY.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26aulast%3DStedman%26aufirst%3DD.%2BB.%26aulast%3DKuhn%26aufirst%3DM.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26atitle%3DImproving%2520the%2520odds%2520of%2520success%2520in%2520drug%2520discovery%253A%2520choosing%2520the%2520best%2520compounds%2520for%2520in%2520vivo%2520toxicology%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9771%26epage%3D9779%26doi%3D10.1021%2Fjm401485p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span> <i>Molecular Operating
Environment (MOE)</i>, version 2016.08; <span class="NLM_publisher-name">Chemical
Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal,
QC, Canada</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Molecular+Operating%0AEnvironment+%28MOE%29%2C+version+2016.08%3B+Chemical%0AComputing+Group+Inc.%3A+Montreal%2C%0AQC%2C+Canada%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%250AEnvironment%2520%2528MOE%2529%26pub%3DChemical%250AComputing%2520Group%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Touré, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller-Moslin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusuff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doré, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPietro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Plas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorilla, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulathila, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herlihy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, M.</span></span> <span> </span><span class="NLM_article-title">The role of the acidity of <i>N</i>-heteroaryl sulfonamides as inhibitors of Bcl-2 family protein-protein interactions</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1021/ml300321d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300321d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=186-190&author=B.+B.+Tour%C3%A9author=K.+Miller-Moslinauthor=N.+Yusuffauthor=L.+Perezauthor=M.+Dor%C3%A9author=C.+Joudauthor=W.+Michaelauthor=L.+DiPietroauthor=S.+van+der%0APlasauthor=M.+McEwanauthor=F.+Lenoirauthor=M.+Hoeauthor=R.+Karkiauthor=C.+Springerauthor=J.+Sullivanauthor=K.+Levineauthor=C.+Fiorillaauthor=X.+Xieauthor=R.+Kulathilaauthor=K.+Herlihyauthor=D.+Porterauthor=M.+Visser&title=The+role+of+the+acidity+of+N-heteroaryl+sulfonamides+as+inhibitors+of+Bcl-2+family+protein-protein+interactions&doi=10.1021%2Fml300321d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml300321d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300321d%26sid%3Dliteratum%253Aachs%26aulast%3DTour%25C3%25A9%26aufirst%3DB.%2BB.%26aulast%3DMiller-Moslin%26aufirst%3DK.%26aulast%3DYusuff%26aufirst%3DN.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DDor%25C3%25A9%26aufirst%3DM.%26aulast%3DJoud%26aufirst%3DC.%26aulast%3DMichael%26aufirst%3DW.%26aulast%3DDiPietro%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BPlas%26aufirst%3DS.%26aulast%3DMcEwan%26aufirst%3DM.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DHoe%26aufirst%3DM.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DSullivan%26aufirst%3DJ.%26aulast%3DLevine%26aufirst%3DK.%26aulast%3DFiorilla%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DKulathila%26aufirst%3DR.%26aulast%3DHerlihy%26aufirst%3DK.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DVisser%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520the%2520acidity%2520of%2520N-heteroaryl%2520sulfonamides%2520as%2520inhibitors%2520of%2520Bcl-2%2520family%2520protein-protein%2520interactions%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D186%26epage%3D190%26doi%3D10.1021%2Fml300321d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, J. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, S. J.</span></span> <span> </span><span class="NLM_article-title">pH-Metric log P. 3. Glass electrode calibration in methanol-water, applied to pKa determination of water-insoluble substances</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1021/ac00049a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac00049a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADyaK3sXislGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1993&pages=42-49&author=A.+Avdeefauthor=J.+E.+A.+Comerauthor=S.+J.+Thomson&title=pH-Metric+log+P.+3.+Glass+electrode+calibration+in+methanol-water%2C+applied+to+pKa+determination+of+water-insoluble+substances&doi=10.1021%2Fac00049a010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">pH-Metric log P.  3.  Glass electrode calibration in methanol-water, applied to pKa determination of water-insoluble substances</span></div><div class="casAuthors">Avdeef, Alex; Comer, John E. A.; Thomson, Simon J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-9</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    </div><div class="casAbstract">A series of semiaq. HCl solns. of known concn., contg. 0.1 M KNO3 (as ionic strength adjuster) and 0-70 wt % methanol, was titrated at 21, 25, and 37° with standardized KOH, pH 2-12.  The pH measuring circuit (Ross-type electrode) was calibrated with an aq. pH buffer (Nernst slope assumed).  The operational pH readings were related to PcH (=-log [H+]) by the four-parameter equation: pH = α + SpcH + jH[H+] + jOH[OH-].  The parameters were detd. by a weighted nonlinear least squares procedure, which allows for CO2 corrections.  This calibration procedure was applied at 25° in titrns. to det. the pKa values of acetic acid, benzoic acid, 4-n-butoxyphenol, 4-ethoxyphenol, 1-benzylimidazole, (±)-propranolol, and N-methyl-D-glucamine and of two water-insol. highly lipophilic benzoic acid derivs. of pharmaceutical interest, with the aim of detg. their octanol-water partition coeffs.  Yasuda-Shedlovsky plots were used to extrapolate semiaq. apparent pKa's to zero methanol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJa9rxYvhsjbVg90H21EOLACvtfcHk0liPvADGX46LRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXislGktg%253D%253D&md5=2ff4251abce9438cceae0c9990b25c0d</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fac00049a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac00049a010%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DComer%26aufirst%3DJ.%2BE.%2BA.%26aulast%3DThomson%26aufirst%3DS.%2BJ.%26atitle%3DpH-Metric%2520log%2520P.%25203.%2520Glass%2520electrode%2520calibration%2520in%2520methanol-water%252C%2520applied%2520to%2520pKa%2520determination%2520of%2520water-insoluble%2520substances%26jtitle%3DAnal.%2520Chem.%26date%3D1993%26volume%3D65%26spage%3D42%26epage%3D49%26doi%3D10.1021%2Fac00049a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Takács-Novák, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span> <span> </span><span class="NLM_article-title">Potentiometric pKa determination of water-insoluble compounds: validation study in methanol/water mixtures</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1016/S0378-5173(97)04907-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2FS0378-5173%2897%2904907-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADyaK2sXktFWnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1997&pages=235-248&author=K.+Tak%C3%A1cs-Nov%C3%A1kauthor=K.+J.+Boxauthor=A.+Avdeef&title=Potentiometric+pKa+determination+of+water-insoluble+compounds%3A+validation+study+in+methanol%2Fwater+mixtures&doi=10.1016%2FS0378-5173%2897%2904907-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiometric pKa determination of water-insoluble compounds: validation study in methanol/water mixtures</span></div><div class="casAuthors">Takacs-Novak, Krisztina; Box, Karl J.; Avdeef, Alex</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The apparent ionization consts. (psKa) of 25 mols., based on 431 sep. potentiometric titrns., were detd. in methanol/water mixts. of 15-65 wt% methanol content.  The Yasuda-Shedlovsky extrapolation (psKa+log[H2O] = a/ε+b) was used to obtain the pKa values in zero methanol%.  In the case of water-sol. drugs the extrapolated data were in very good agreement with pKa values measured in aq. solns. under the same exptl. conditions (av. deviation = 0.05).  The water-insol. mols. showed acceptable accordance with spectroscopically measured or with literature pKa values.  Concn. dependence between 1-5 mM was not obsd. while the range of extrapolation (water-rich: R=15-35 wt%, or methanol-rich: R=40-65 wt%) significantly influenced the accuracy of pKa values.  Remarkable changes in the solvation structure of weak acids in methanol-rich mixts. (>35 wt%) were suggested from analyzing the slopes of Yasuda-Shedlovsky equations.  Recommendations for the proper application of a mixed-solvent procedure in order to gain the most reliable aq. pKa values are suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIltgu3Cu3GbVg90H21EOLACvtfcHk0liPvADGX46LRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktFWnu7o%253D&md5=4efcc572c3b9f4c5b2de1890d22b7970</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1016%2FS0378-5173%2897%2904907-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-5173%252897%252904907-7%26sid%3Dliteratum%253Aachs%26aulast%3DTak%25C3%25A1cs-Nov%25C3%25A1k%26aufirst%3DK.%26aulast%3DBox%26aufirst%3DK.%2BJ.%26aulast%3DAvdeef%26aufirst%3DA.%26atitle%3DPotentiometric%2520pKa%2520determination%2520of%2520water-insoluble%2520compounds%253A%2520validation%2520study%2520in%2520methanol%252Fwater%2520mixtures%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D1997%26volume%3D151%26spage%3D235%26epage%3D248%26doi%3D10.1016%2FS0378-5173%2897%2904907-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obando, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codd, R.</span></span> <span> </span><span class="NLM_article-title">The many faces of the adamantly group in drug design</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1949</span>– <span class="NLM_lpage">1963</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.01.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.ejmech.2011.01.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=1949-1963&author=J.+Liuauthor=D.+Obandoauthor=V.+Liaoauthor=T.+Lifaauthor=R.+Codd&title=The+many+faces+of+the+adamantly+group+in+drug+design&doi=10.1016%2Fj.ejmech.2011.01.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.01.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.01.047%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DObando%26aufirst%3DD.%26aulast%3DLiao%26aufirst%3DV.%26aulast%3DLifa%26aufirst%3DT.%26aulast%3DCodd%26aufirst%3DR.%26atitle%3DThe%2520many%2520faces%2520of%2520the%2520adamantly%2520group%2520in%2520drug%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D1949%26epage%3D1963%26doi%3D10.1016%2Fj.ejmech.2011.01.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barron, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien-Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werry, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chishty, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skarratt, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hibbs, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vugts, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windhorst, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span> <span> </span><span class="NLM_article-title">Pharmacological evaluation of novel bioisosteres of an admantanyl benzamide P2X<sub>7</sub> receptor antagonist</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2374</span>– <span class="NLM_lpage">2380</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00272</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00272" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlyhtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=2374-2380&author=S.+M.+Wilkinsonauthor=M.+L.+Barronauthor=J.+O%E2%80%99Brien-Brownauthor=B.+Janssenauthor=L.+Stokesauthor=E.+L.+Werryauthor=M.+Chishtyauthor=K.+K.+Skarrattauthor=J.+A.+Ongauthor=D.+E.+Hibbsauthor=D.+J.+Vugtsauthor=S.+Fullerauthor=A.+D.+Windhorstauthor=M.+Kassiou&title=Pharmacological+evaluation+of+novel+bioisosteres+of+an+admantanyl+benzamide+P2X7+receptor+antagonist&doi=10.1021%2Facschemneuro.7b00272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Evaluation of Novel Bioisosteres of an Adamantanyl Benzamide P2X7 Receptor Antagonist</span></div><div class="casAuthors">Wilkinson, Shane M.; Barron, Melissa L.; O'Brien-Brown, James; Janssen, Bieneke; Stokes, Leanne; Werry, Eryn L.; Chishty, Mansoor; Skarratt, Kristen K.; Ong, Jennifer A.; Hibbs, David E.; Vugts, Danielle J.; Fuller, Stephen; Windhorst, Albert D.; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2374-2380</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adamantanyl benzamide 1 was identified as a potent P2X7R antagonist but failed to progress further due to poor metabolic stability.  We describe the synthesis and SAR of a series of bioisosteres of benzamide 1 to explore improvements in the pharmacol. properties of this lead.  Initial efforts investigated a series of heteroarom. bioisosteres, which demonstrated improved physicochem. properties but reduced P2X7R antagonism.  Installation of bioisosteric fluorine on the adamantane bridgeheads was well tolerated and led to a series of bioisosteres with improved physicochem. properties and metabolic stability.  Trifluorinated benzamide 34 demonstrated optimal physicochem. parameters, superior metabolic stability (ten times longer than lead benzamide 1), and an improved physicokinetic profile and proved effective in the presence of several known P2X7R polymorphisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo77pXNGe3iy7Vg90H21EOLACvtfcHk0liglukKsZVMeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlyhtr7L&md5=6f1ee1daa1cccebc6859efde186eb39d</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00272%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DS.%2BM.%26aulast%3DBarron%26aufirst%3DM.%2BL.%26aulast%3DO%25E2%2580%2599Brien-Brown%26aufirst%3DJ.%26aulast%3DJanssen%26aufirst%3DB.%26aulast%3DStokes%26aufirst%3DL.%26aulast%3DWerry%26aufirst%3DE.%2BL.%26aulast%3DChishty%26aufirst%3DM.%26aulast%3DSkarratt%26aufirst%3DK.%2BK.%26aulast%3DOng%26aufirst%3DJ.%2BA.%26aulast%3DHibbs%26aufirst%3DD.%2BE.%26aulast%3DVugts%26aufirst%3DD.%2BJ.%26aulast%3DFuller%26aufirst%3DS.%26aulast%3DWindhorst%26aufirst%3DA.%2BD.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DPharmacological%2520evaluation%2520of%2520novel%2520bioisosteres%2520of%2520an%2520admantanyl%2520benzamide%2520P2X7%2520receptor%2520antagonist%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D2374%26epage%3D2380%26doi%3D10.1021%2Facschemneuro.7b00272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wanka, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiner, P. R.</span></span> <span> </span><span class="NLM_article-title">The lipophilic bullet hits the targets: medicinal chemistry of admantane derivatives</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">3516</span>– <span class="NLM_lpage">3604</span>, <span class="refDoi"> DOI: 10.1021/cr100264t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr100264t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=3516-3604&author=L.+Wankaauthor=K.+Iqbalauthor=P.+R.+Schreiner&title=The+lipophilic+bullet+hits+the+targets%3A+medicinal+chemistry+of+admantane+derivatives&doi=10.1021%2Fcr100264t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Fcr100264t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr100264t%26sid%3Dliteratum%253Aachs%26aulast%3DWanka%26aufirst%3DL.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DSchreiner%26aufirst%3DP.%2BR.%26atitle%3DThe%2520lipophilic%2520bullet%2520hits%2520the%2520targets%253A%2520medicinal%2520chemistry%2520of%2520admantane%2520derivatives%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3D3516%26epage%3D3604%26doi%3D10.1021%2Fcr100264t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knerr, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selmi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinàs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindqvist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ståhlberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorstensson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullah, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Mahony, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Högberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindhardt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Åstrand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duker, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Ca<sub>V</sub>3.2) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5557</span>– <span class="NLM_lpage">5561</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.06.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.bmcl.2011.06.092" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5557-5561&author=F.+Giordanettoauthor=L.+Knerrauthor=N.+Selmiauthor=A.+Llin%C3%A0sauthor=A.+Lindqvistauthor=Q.+D.+Wangauthor=P.+St%C3%A5hlbergauthor=F.+Thorstenssonauthor=V.+Ullahauthor=K.+Nilssonauthor=G.+O%E2%80%99Mahonyauthor=G.+H%C3%B6gbergauthor=E.+Lindhardtauthor=A.+%C3%85strandauthor=G.+Duker&title=Discovery+of+N-%281-adamantyl%29-2-%284-alkylpiperazin-1-yl%29acetamide+derivatives+as+T-type+calcium+channel+%28CaV3.2%29+inhibitors&doi=10.1016%2Fj.bmcl.2011.06.092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.06.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.06.092%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DKnerr%26aufirst%3DL.%26aulast%3DSelmi%26aufirst%3DN.%26aulast%3DLlin%25C3%25A0s%26aufirst%3DA.%26aulast%3DLindqvist%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%2BD.%26aulast%3DSt%25C3%25A5hlberg%26aufirst%3DP.%26aulast%3DThorstensson%26aufirst%3DF.%26aulast%3DUllah%26aufirst%3DV.%26aulast%3DNilsson%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DG.%26aulast%3DH%25C3%25B6gberg%26aufirst%3DG.%26aulast%3DLindhardt%26aufirst%3DE.%26aulast%3D%25C3%2585strand%26aufirst%3DA.%26aulast%3DDuker%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520N-%25281-adamantyl%2529-2-%25284-alkylpiperazin-1-yl%2529acetamide%2520derivatives%2520as%2520T-type%2520calcium%2520channel%2520%2528CaV3.2%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5557%26epage%3D5561%26doi%3D10.1016%2Fj.bmcl.2011.06.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brameld, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1021/ci7002494</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci7002494" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksV2isA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1-24&author=K.+A.+Brameldauthor=B.+Kuhnauthor=D.+C.+Reuterauthor=M.+Stahl&title=Small+molecule+conformational+preferences+derived+from+crystal+structure+data.+A+medicinal+chemistry+focused+analysis&doi=10.1021%2Fci7002494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule conformational preferences derived from crystal structure data. a medicinal chemistry focused analysis</span></div><div class="casAuthors">Brameld, Ken A.; Kuhn, Bernd; Reuter, Deborah C.; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-24</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Based on torsion angle distributions of frequently occurring substructures, conformation preferences of druglike mols. are presented, accompanied by a review of the relevant literature.  First, the relevance of the Cambridge Structural Database (CSD) for drug design is demonstrated by comparing substructures present in compds. entering clin. trials with those found in the CSD and protein-bound ligands in the Protein Data Bank (PDB).  Next, we briefly highlight preferred conformations of elementary acyclic systems, followed by a discussion of sulfonamide conformations.  Due to their central role in medicinal chem., we discuss properties of aryl ring substituents in depth, including biaryl systems and systems of two aryl rings connected by two acyclic bonds.  For a subset of torsion motifs, we also compare torsion angle histograms derived from CSD structures with those derived from ligands in the PDB.  Furthermore, selected properties of some six- and seven-membered ring systems are discussed.  The article closes with a section on attractive sulfur-oxygen contacts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBrdvMrRvKirVg90H21EOLACvtfcHk0lgremakMLEwSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksV2isA%253D%253D&md5=289969338dcb94a145ce736d19d05cf4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fci7002494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci7002494%26sid%3Dliteratum%253Aachs%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DReuter%26aufirst%3DD.%2BC.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DSmall%2520molecule%2520conformational%2520preferences%2520derived%2520from%2520crystal%2520structure%2520data.%2520A%2520medicinal%2520chemistry%2520focused%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D1%26epage%3D24%26doi%3D10.1021%2Fci7002494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P.
C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellingson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M. T.</span></span> <span> </span><span class="NLM_article-title">Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and the Cambridge Structural Database</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1021/ci100031x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100031x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=572-584&author=P.%0AC.+D.+Hawkinsauthor=A.+G.+Skillmanauthor=G.+L.+Warrenauthor=B.+A.+Ellingsonauthor=M.+T.+Stahl&title=Conformer+Generation+with+OMEGA%3A+Algorithm+and+Validation+Using+High+Quality+Structures+from+the+Protein+Databank+and+the+Cambridge+Structural+Database&doi=10.1021%2Fci100031x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Warren, Gregory L.; Ellingson, Benjamin A.; Stahl, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">572-584</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here, we present the algorithm and validation for OMEGA, a systematic, knowledge-based conformer generator.  The algorithm consists of three phases: assembly of an initial 3D structure from a library of fragments; exhaustive enumeration of all rotatable torsions using values drawn from a knowledge-based list of angles, thereby generating a large set of conformations; and sampling of this set by geometric and energy criteria.  Validation of conformer generators like OMEGA has often been undertaken by comparing computed conformer sets to exptl. mol. conformations from crystallog., usually from the Protein Databank (PDB).  Such an approach is fraught with difficulty due to the systematic problems with small mol. structures in the PDB.  Methods are presented to identify a diverse set of small mol. structures from cocomplexes in the PDB that has maximal reliability.  A challenging set of 197 high quality, carefully selected ligand structures from well-solved models was obtained using these methods.  This set will provide a sound basis for comparison and validation of conformer generators in the future.  Validation results from this set are compared to the results using structures of a set of druglike mols. extd. from the Cambridge Structural Database (CSD).  OMEGA is found to perform very well in reproducing the crystallog. conformations from both these data sets using two complementary metrics of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1SOwPH1NzrVg90H21EOLACvtfcHk0lgremakMLEwSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D&md5=fb87ecc9c51eddef63b41fffcd9babee</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fci100031x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100031x%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%2BD.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26aulast%3DEllingson%26aufirst%3DB.%2BA.%26aulast%3DStahl%26aufirst%3DM.%2BT.%26atitle%3DConformer%2520Generation%2520with%2520OMEGA%253A%2520Algorithm%2520and%2520Validation%2520Using%2520High%2520Quality%2520Structures%2520from%2520the%2520Protein%2520Databank%2520and%2520the%2520Cambridge%2520Structural%2520Database%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D572%26epage%3D584%26doi%3D10.1021%2Fci100031x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span> <i>OMEGA</i>, 2.5.1.4; <span class="NLM_publisher-name">OpenEye Scientific Software</span>: <span class="NLM_publisher-loc">Santa Fe, NM</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+OMEGA%2C+2.5.1.4%3B+OpenEye+Scientific+Software%3A+Santa+Fe%2C+NM%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DOMEGA%26pub%3DOpenEye%2520Scientific%2520Software%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span> <i>SZYBKI</i>, 1.9.0.3; <span class="NLM_publisher-name">OpenEye Scientific
Software</span>: <span class="NLM_publisher-loc">Santa Fe, NM</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+SZYBKI%2C+1.9.0.3%3B+OpenEye+Scientific%0ASoftware%3A+Santa+Fe%2C+NM%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSZYBKI%26pub%3DOpenEye%2520Scientific%250ASoftware%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span> <span> </span><span class="NLM_article-title">Volume of distribution in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5691</span>– <span class="NLM_lpage">5698</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00201</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00201" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFSlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5691-5698&author=D.+A.+Smithauthor=K.+Beaumontauthor=T.+S.+Maurerauthor=L.+Di&title=Volume+of+distribution+in+drug+design&doi=10.1021%2Facs.jmedchem.5b00201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Volume of Distribution in Drug Design</span></div><div class="casAuthors">Smith, Dennis A.; Beaumont, Kevin; Maurer, Tristan S.; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5691-5698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Vol. of distribution is one of the most important pharmacokinetic properties of a drug candidate.  It is a major determinant of half-life and dosing frequency of a drug.  For a similar log P, a basic mol. will tend to exhibit higher vol. of distribution than a neutral mol.  Acids often exhibit low vols. of distribution.  Although a design strategy against vol. of distribution can be advantageous in achieving desirable dosing regimen, it must be well-directed in order to avoid detrimental effects to other important properties.  Strategies to increase vol. of distribution include adding lipophilicity and introducing basic functional groups in a way that does not increase metabolic clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP7QwgPahf4bVg90H21EOLACvtfcHk0lgremakMLEwSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFSlsb0%253D&md5=2c7289b3602a8edef2d9ef0e6a82e483</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00201%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DVolume%2520of%2520distribution%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5691%26epage%3D5698%26doi%3D10.1021%2Facs.jmedchem.5b00201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Catterall, W.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cestèle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarov-Yarovoy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheuer, T.</span></span> <span> </span><span class="NLM_article-title">Voltage-gated ion channels and gating modifier toxins</span>. <i>Toxicon</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1016/j.toxicon.2006.09.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.toxicon.2006.09.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=17239913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD2sXps1emuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2007&pages=124-141&author=W.%0AA.+Catterallauthor=S.+Cest%C3%A8leauthor=V.+Yarov-Yarovoyauthor=F.+H.+Yuauthor=K.+Konokiauthor=T.+Scheuer&title=Voltage-gated+ion+channels+and+gating+modifier+toxins&doi=10.1016%2Fj.toxicon.2006.09.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated ion channels and gating modifier toxins</span></div><div class="casAuthors">Catterall, William A.; Cestele, Sandrine; Yarov-Yarovoy, Vladimir; Yu, Frank H.; Konoki, Keiichi; Scheuer, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Toxicon</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-141</span>CODEN:
                <span class="NLM_cas:coden">TOXIA6</span>;
        ISSN:<span class="NLM_cas:issn">0041-0101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium, calcium, and potassium channels generate elec. signals required for action potential generation and conduction and are the mol. targets for a broad range of potent neurotoxins.  These channels are built on a common structural motif contg. six transmembrane segments and a pore loop.  Their pores are formed by the S5/S6 segments and the pore loop between them, and they are gated by bending of the S6 segments at a hinge glycine or proline residue.  The voltage sensor domain consists of the S1-S4 segments, with pos. charged residues in the S4 segment serving as gating charges.  The diversity of toxin action on these channels is illustrated by sodium channels, which are the mol. targets for toxins that act at six or more distinct receptor sites on the channel protein.  Both hydrophilic low mol. wt. toxins and larger polypeptide toxins phys. block the pore and prevent sodium conductance.  Hydrophobic alkaloid toxins and related lipid-sol. toxins act at intramembrane sites and alter voltage-dependent gating of sodium channels via an allosteric mechanism.  In contrast, polypeptide toxins alter channel gating by voltage-sensor trapping through binding to extracellular receptor sites, and this toxin interaction has now been modeled at the at. level for a β-scorpion toxin.  The voltage-sensor trapping mechanism may be a common mode of action for polypeptide gating modifier toxins acting on all of the voltage-gated ion channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvR2ly__UVIbVg90H21EOLACvtfcHk0lgbaQ0FZ3sYbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXps1emuw%253D%253D&md5=23e334d91f54cb73375c1d3d6ab8b888</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2Fj.toxicon.2006.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxicon.2006.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26aulast%3DCest%25C3%25A8le%26aufirst%3DS.%26aulast%3DYarov-Yarovoy%26aufirst%3DV.%26aulast%3DYu%26aufirst%3DF.%2BH.%26aulast%3DKonoki%26aufirst%3DK.%26aulast%3DScheuer%26aufirst%3DT.%26atitle%3DVoltage-gated%2520ion%2520channels%2520and%2520gating%2520modifier%2520toxins%26jtitle%3DToxicon%26date%3D2007%26volume%3D49%26spage%3D124%26epage%3D141%26doi%3D10.1016%2Fj.toxicon.2006.09.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Deuis, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I.</span></span> <span> </span><span class="NLM_article-title">The pharmacology of voltage-gated sodium channel activators</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.neuropharm.2017.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=28416444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvF2jtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=87-108&author=J.+R.+Deuisauthor=A.+Muellerauthor=M.+R.+Israelauthor=I.+Vetter&title=The+pharmacology+of+voltage-gated+sodium+channel+activators&doi=10.1016%2Fj.neuropharm.2017.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology of voltage-gated sodium channel activators</span></div><div class="casAuthors">Deuis, Jennifer R.; Mueller, Alexander; Israel, Mathilde R.; Vetter, Irina</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-108</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Toxins and venom components that target voltage-gated sodium (NaV) channels have evolved numerous times due to the importance of this class of ion channels in the normal physiol. function of peripheral and central neurons as well as cardiac and skeletal muscle.  NaV channel activators in particular have been isolated from the venom of spiders, wasps, snakes, scorpions, cone snails and sea anemone and are also produced by plants, bacteria and algae.  These compds. have provided key insight into the mol. structure, function and pathophysiol. roles of NaV channels and are important tools due to their at times exquisite subtype-selectivity.  We review the pharmacol. of NaV channel activators with particular emphasis on mammalian isoforms and discuss putative applications for these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIVcjid2xGK7Vg90H21EOLACvtfcHk0lgbaQ0FZ3sYbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvF2jtb0%253D&md5=aabb844d2e8992b42ec6ddc53d43bf72</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DDeuis%26aufirst%3DJ.%2BR.%26aulast%3DMueller%26aufirst%3DA.%26aulast%3DIsrael%26aufirst%3DM.%2BR.%26aulast%3DVetter%26aufirst%3DI.%26atitle%3DThe%2520pharmacology%2520of%2520voltage-gated%2520sodium%2520channel%2520activators%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D127%26spage%3D87%26epage%3D108%26doi%3D10.1016%2Fj.neuropharm.2017.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baffoe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoe, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touré, B. B.</span></span> <span> </span><span class="NLM_article-title">Copper-mediated <i>N</i>-heteroarylation of primary sulfonamides: synthesis of mono-<i>N</i>-heteroaryl sulfonamides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1532</span>– <span class="NLM_lpage">1535</span>, <span class="refDoi"> DOI: 10.1021/ol100263r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol100263r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1Whu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1532-1535&author=J.+Baffoeauthor=M.+Y.+Hoeauthor=B.+B.+Tour%C3%A9&title=Copper-mediated+N-heteroarylation+of+primary+sulfonamides%3A+synthesis+of+mono-N-heteroaryl+sulfonamides&doi=10.1021%2Fol100263r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-Mediated N-Heteroarylation of Primary Sulfonamides: Synthesis of Mono-N-heteroaryl Sulfonamides</span></div><div class="casAuthors">Baffoe, Jonathan; Hoe, Madelene Y.; Toure, B. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1532-1535</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein is described the coupling of primary sulfonamides and various halogenated heterocyclic cores, with an emphasis on 2-heteroaryl halides, via copper catalysis.  These studies enabled the synthesis of many new mono-N-heteroaryl sulfonamides.  The electronic factors that influence the course of the reaction have also been investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxsqgu-eozA7Vg90H21EOLACvtfcHk0lgbaQ0FZ3sYbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1Whu7k%253D&md5=7f9c065b12a456c79e59a2020ff29d4a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fol100263r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol100263r%26sid%3Dliteratum%253Aachs%26aulast%3DBaffoe%26aufirst%3DJ.%26aulast%3DHoe%26aufirst%3DM.%2BY.%26aulast%3DTour%25C3%25A9%26aufirst%3DB.%2BB.%26atitle%3DCopper-mediated%2520N-heteroarylation%2520of%2520primary%2520sulfonamides%253A%2520synthesis%2520of%2520mono-N-heteroaryl%2520sulfonamides%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D1532%26epage%3D1535%26doi%3D10.1021%2Fol100263r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pease, J. H.</span></span> <span> </span><span class="NLM_article-title">A high throughput solubility assay for drug discovery using microscale shake-flask and rapid UHPLC–UV–CLND quantification</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2016.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1016%2Fj.jpba.2016.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=26855285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGhurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2016&pages=126-140&author=B.+Linauthor=J.+H.+Pease&title=A+high+throughput+solubility+assay+for+drug+discovery+using+microscale+shake-flask+and+rapid+UHPLC%E2%80%93UV%E2%80%93CLND+quantification&doi=10.1016%2Fj.jpba.2016.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A high throughput solubility assay for drug discovery using microscale shake-flask and rapid UHPLC-UV-CLND quantification</span></div><div class="casAuthors">Lin, Baiwei; Pease, Joseph H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">126-140</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The rapid detn. of key phys. properties of lead compds. is essential to the drug discovery process.  Soly. is one of the most important properties since good soly. is needed not only for obtaining reliable in vitro and in vivo assay results in early discovery but also to ensure sufficient concn. of the drug being in circulation to get the desired therapeutic exposure at the target of interest.  In order for medicinal chemists to tune soly. of lead compds., a rapid assay is needed to provide soly. data that is accurate and predictive so that it can be reliably used for designing the next generation of compds. with improved properties.  To ensure speed and data quality, we developed a high throughput soly. assay that utilizes a single calibration UHPLC-UV-CLND method and a 24 h shake-flask format for rapid quantification.  A set of 46 model compds. was used to demonstrate that the method is accurate, reproducible and predictive.  Here we present development of the assay, including evaluation of quantification method, filtration membranes, equil. times, DMSO concns., and buffer conditions.  A comparison of thermodn. soly. results to our high throughput 24 h shake-flask soly. assay results is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpojPpYm9G6NrVg90H21EOLACvtfcHk0lgbaQ0FZ3sYbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGhurg%253D&md5=98415728ed8254d173301d5f2c85e3f8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2016.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2016.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DB.%26aulast%3DPease%26aufirst%3DJ.%2BH.%26atitle%3DA%2520high%2520throughput%2520solubility%2520assay%2520for%2520drug%2520discovery%2520using%2520microscale%2520shake-flask%2520and%2520rapid%2520UHPLC%25E2%2580%2593UV%25E2%2580%2593CLND%2520quantification%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2016%26volume%3D122%26spage%3D126%26epage%3D140%26doi%3D10.1016%2Fj.jpba.2016.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pease, J. H.</span></span> <span> </span><span class="NLM_article-title">A novel method for high throughput lipophilicity determination by microscale shake flask and liquid chromatography tandem mass spectrometry</span>. <i>Comb. Chem. High Throughput Screening</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">825</span>, <span class="refDoi"> DOI: 10.2174/1386207311301010007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.2174%2F1386207311301010007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=24168238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWktLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=817-825&author=B.+Linauthor=J.+H.+Pease&title=A+novel+method+for+high+throughput+lipophilicity+determination+by+microscale+shake+flask+and+liquid+chromatography+tandem+mass+spectrometry&doi=10.2174%2F1386207311301010007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Method for High Throughput Lipophilicity Determination by Microscale Shake Flask and Liquid Chromatography Tandem Mass Spectrometry</span></div><div class="casAuthors">Lin, Baiwei; Pease, Joseph H.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">817-825</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Modern small mol. drug design requires the optimization of not only the binding characteristics of the mol. but also its physicochem. properties for ADMET performance.  A key phys. property is lipophilicity and medicinal chemists need rapid access to high quality data in order to drive their decision making.  Traditionally lipophilicity (log D) measurements are performed with a shake flask method and UV detn.  This method suffers from low sensitivity and is not easily converted to a high throughput format.  Over the past decade, several groups have taken different approaches to improve this assay, including replacing the shake flask method with one that utilizes reverse phase HPLC.  Here we describe a new microscale shake flask method that utilizes UPLC-MS/MS to achieve increased throughput, sensitivity and accuracy.  Approaches for assessing data quality are also described.  This platform technol. only requires micrograms of compd. and is routinely used by most small mol. drug discovery project teams at Genentech.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS0kv3IN4lnLVg90H21EOLACvtfcHk0lhAy9qEERss3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWktLbO&md5=1d863747144615780be712cc329ab344</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F1386207311301010007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207311301010007%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DB.%26aulast%3DPease%26aufirst%3DJ.%2BH.%26atitle%3DA%2520novel%2520method%2520for%2520high%2520throughput%2520lipophilicity%2520determination%2520by%2520microscale%2520shake%2520flask%2520and%2520liquid%2520chromatography%2520tandem%2520mass%2520spectrometry%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2013%26volume%3D16%26spage%3D817%26epage%3D825%26doi%3D10.2174%2F1386207311301010007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silber, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rance, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wastall, P.</span></span> <span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lhAy9qEERss3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, Y.</span></span> <span> </span><span class="NLM_article-title">Prediction of hepatic clearance in human from in vitro data for successful drug development</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1208/s12248-009-9103-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1208%2Fs12248-009-9103-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=19408130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=262-276&author=M.+Chibaauthor=Y.+Ishiiauthor=Y.+Sugiyama&title=Prediction+of+hepatic+clearance+in+human+from+in+vitro+data+for+successful+drug+development&doi=10.1208%2Fs12248-009-9103-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of hepatic clearance in human from in vitro data for successful drug development</span></div><div class="casAuthors">Chiba, Masato; Ishii, Yasuyuki; Sugiyama, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-276</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The in vivo metabolic clearance in human has been successfully predicted by using in vitro data of metabolic stability in cryopreserved prepns. of human hepatocytes.  In the predictions by human hepatocytes, the systematic underpredictions of in vivo clearance have been commonly obsd. among different datasets.  The regression-based scaling factor for the in vitro-to-in vivo extrapolation has mitigated discrepancy between in vitro prediction and in vivo observation.  In addn. to the elimination by metabolic degrdn., the important roles of transporter-mediated hepatic uptake and canalicular excretion have been increasingly recognized as a rate-detg. step in the hepatic clearance.  It has been, therefore, proposed that the in vitro assessment should allow the evaluation of clearances for both transporter(s)-mediated uptake/excretion and metabolic degrdn.  This review first outlines the limited ability of subcellular fractions such as liver microsomes to predict hepatic clearance in vivo.  It highlights the advantages of cryopreserved human hepatocytes as one of the versatile in vitro systems for the prediction of in vivo metabolic clearance in human at the early development state.  The following section discusses the mechanisms underlying the systematic underprediction of in vivo intrinsic clearance by hepatocytes.  It leads to the proposal for the assessment of hepatic uptake clearance as one of the kinetically important determinants for accurate predictions of hepatic clearance in human.  The judicious combination of advanced technologies and understandings for the drug disposition allows us to rationally optimize new chem. entities to the drug candidate with higher probability of success during the clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC52lEOUdlKLVg90H21EOLACvtfcHk0lhAy9qEERss3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqs7rI&md5=8c2b3366285c690ba1055d46f52f0b6b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1208%2Fs12248-009-9103-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-009-9103-6%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26atitle%3DPrediction%2520of%2520hepatic%2520clearance%2520in%2520human%2520from%2520in%2520vitro%2520data%2520for%2520successful%2520drug%2520development%26jtitle%3DAAPS%2520J.%26date%3D2009%26volume%3D11%26spage%3D262%26epage%3D276%26doi%3D10.1208%2Fs12248-009-9103-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGinnity, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbanowicz, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of fresh and cryopreseved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance</span>. <i>Drug. Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1253</span>, <span class="refDoi"> DOI: 10.1124/dmd.104.000026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;key=10.1124%2Fdmd.104.000026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=1247-1253&author=D.+F.+McGinnityauthor=M.+G.+Soarsauthor=R.+A.+Urbanowiczauthor=R.+J.+Riley&title=Evaluation+of+fresh+and+cryopreseved+hepatocytes+as+in+vitro+drug+metabolism+tools+for+the+prediction+of+metabolic+clearance&doi=10.1124%2Fdmd.104.000026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.000026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.000026%26sid%3Dliteratum%253Aachs%26aulast%3DMcGinnity%26aufirst%3DD.%2BF.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DUrbanowicz%26aufirst%3DR.%2BA.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DEvaluation%2520of%2520fresh%2520and%2520cryopreseved%2520hepatocytes%2520as%2520in%2520vitro%2520drug%2520metabolism%2520tools%2520for%2520the%2520prediction%2520of%2520metabolic%2520clearance%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D1247%26epage%3D1253%26doi%3D10.1124%2Fdmd.104.000026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=NM_006920" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=NM_006920','Genbank','NM_006920'); return false;">Genbank: NM_006920</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=NM_021007" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=NM_021007','Genbank','NM_021007'); return false;">Genbank: NM_021007</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=AC127597" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=AC127597','Genbank','AC127597'); return false;">Genbank: AC127597</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=NM_014191" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=NM_014191','Genbank','NM_014191'); return false;">Genbank: NM_014191</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=NM_002977" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=NM_002977','Genbank','NM_002977'); return false;">Genbank: NM_002977</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i103"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01826">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_65852"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01826">10.1021/acs.jmedchem.7b01826</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthetic schemes and procedures for the synthesis of compounds <b>5</b>, <b>8</b>, <b>16</b>–<b>20</b>, and <b>23</b>, including characterization data for intermediates, additional SAR, modeling and mutagenesis data, crystal structure data for <b>1</b>, determination of <i>k</i><sub>on</sub>, <i>k</i><sub>off</sub>, and residence times for <b>10</b>, <b>13</b>, and <b>25</b>, CEREP data for <b>13</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Crystallographic information for compound <b>1</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_002.cif">CIF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_001.pdf">jm7b01826_si_001.pdf (1.0 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_002.cif">jm7b01826_si_002.cif (22.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01826/suppl_file/jm7b01826_si_003.csv">jm7b01826_si_003.csv (2.23 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Full structural data for compound <b>1</b> were submitted to the CCDC as number 1590582. Authors will release the atomic coordinates and experimental data upon article publication. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via <a href="https://www.ccdc.cam.ac.uk/structures" class="extLink">https://www.ccdc.cam.ac.uk/structures</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-11%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01826%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01826" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679958b8ec101239","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
